{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import os\n",
    "import re\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "def funcion1(path = 'data/train-set-to-publish/cantemist-ner/'):\n",
    "    \n",
    "    \"\"\"Esta función sirve para leer los archivos de anotaciones y documentos contenidos en path/cantemist-ner/. \n",
    "    La entrada de esta función es un directorio con documentos .ann y .txt.\n",
    "    La salida son dos diccionarios, uno con anotaciones y otro con documentos de texto.\"\"\"\n",
    "    \n",
    "    \n",
    "    ANNOTdict = {}\n",
    "    CORPUSdict = {}\n",
    "    \n",
    "    filelist = os.listdir(path)\n",
    "\n",
    "    for x in filelist:\n",
    "        \n",
    "        try:\n",
    "\n",
    "            if x[-3:] == 'ann':\n",
    "                tempdf = pd.read_csv(path+x,sep=\"\\t\",encoding='UTF8',)\n",
    "                templabel = x[:-4]\n",
    "\n",
    "                firstrow = pd.Series(pd.read_csv(path+x,sep=\"\\t\",encoding='UTF8',).columns,\n",
    "                                     index=['T','MORFOLOGIA','CLAVE'])\n",
    "\n",
    "                d = {}\n",
    "\n",
    "                for y in enumerate(firstrow):\n",
    "\n",
    "                    d[y[1]] = firstrow.index[y[0]]\n",
    "\n",
    "                tempdf.rename(d,axis=1,inplace=True)\n",
    "\n",
    "                tempdf = tempdf.append(firstrow,ignore_index=True)\n",
    "\n",
    "                tempdf['T'].replace(\n",
    "                    {\"T1\":\"T01\",\"T2\":\"T02\",\"T3\":\"T03\",\"T4\":\"T04\",\"T5\":\"T05\",\n",
    "                     \"T6\":\"T06\",\"T7\":\"T07\",\"T8\":\"T08\",\"T9\":\"T09\",},\n",
    "                    inplace=True,)\n",
    "\n",
    "                tempdf = tempdf.sort_values(by='T').reset_index(drop=True)\n",
    "\n",
    "                ANNOTdict[templabel] = tempdf\n",
    "\n",
    "            elif x[-3:] == 'txt':\n",
    "                tempdf = pd.Series(data = open(path+x,encoding='UTF8').read())\n",
    "                templabel = x[:-4]\n",
    "                CORPUSdict[templabel] = tempdf\n",
    "        \n",
    "        except Exception as e: \n",
    "            print(f'{e} {path + x}')\n",
    "        \n",
    "    return (ANNOTdict,CORPUSdict)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "def funcion2(ANNOTdict,CORPUSdict):\n",
    "    \n",
    "    \n",
    "    \"\"\"Esta función sirve para indexar la posición de las palabras contenidas en los archivos .ann dentro de su respectivo .txt.\n",
    "    La entrada de esta función son dos diccionarios, uno de anotaciones y otro de documentos.\n",
    "    La salida son dos diccionarios, el primero contiene la posición de las palabras indexada, el segundo contiene las anotaciones junto con la posición.\"\"\"\n",
    "    \n",
    "    \n",
    "    pos = {}\n",
    "\n",
    "\n",
    "    for x in ANNOTdict.keys():\n",
    "        pos[x] = pd.DataFrame(columns=['startposition','endposition'])\n",
    "\n",
    "        templiststart = []\n",
    "\n",
    "        templistend = []\n",
    "\n",
    "        for y in enumerate(ANNOTdict[x]['CLAVE']):\n",
    "\n",
    "            start = CORPUSdict[x][0].find(ANNOTdict[x]['CLAVE'][y[0]])\n",
    "            end = CORPUSdict[x][0].find(ANNOTdict[x]['CLAVE'][y[0]]) + len(y[1])\n",
    "\n",
    "            templiststart.append(start)\n",
    "            templistend.append(end)\n",
    "\n",
    "        pos[x]['startposition'] = templiststart\n",
    "        pos[x]['endposition'] = templistend\n",
    "\n",
    "        ANNOTdict[x] = ANNOTdict[x].join(pos[x])\n",
    "    \n",
    "    return pos,ANNOTdict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "def funcion3(path = 'data/train-set-to-publish/cantemist-norm/'):\n",
    "\n",
    "    \"\"\"Esta función sirve para leer los archivos de anotaciones y documentos contenidos en path/cantemist-norm/. \n",
    "    La entrada de esta función es un directorio con documentos .ann y .txt.\n",
    "    La salida son dos diccionarios, uno con anotaciones y otro con documentos de texto.\"\"\"\n",
    "    \n",
    "    \n",
    "    ANNOTdict = {}\n",
    "    CORPUSdict = {}\n",
    "\n",
    "    filelist = os.listdir(path)\n",
    "\n",
    "    for x in filelist:\n",
    "\n",
    "        try:\n",
    "            if x[-3:] == 'ann':\n",
    "                tempdf = pd.read_csv(path+x,sep=\"\\t\",encoding='UTF8',)\n",
    "                templabel = x[:-4]\n",
    "\n",
    "                firstrow = pd.Series(pd.read_csv(path+x,sep=\"\\t\",encoding='UTF8',).columns,\n",
    "                                     index=['T','MORFOLOGIA','CLAVE'])\n",
    "\n",
    "                d = {}\n",
    "\n",
    "                for y in enumerate(firstrow):\n",
    "\n",
    "                    d[y[1]] = firstrow.index[y[0]]\n",
    "\n",
    "                tempdf.rename(d,axis=1,inplace=True)\n",
    "\n",
    "                tempdf = tempdf.append(firstrow,ignore_index=True)\n",
    "\n",
    "                tempdf['T'].replace(\n",
    "                    {\"#\":\"U\"},\n",
    "                    inplace=True,regex=True)\n",
    "\n",
    "                tempdf['T'].replace(\n",
    "                    {\"T1\":\"T01\",\"T2\":\"T02\",\"T3\":\"T03\",\"T4\":\"T04\",\"T5\":\"T05\",\n",
    "                     \"T6\":\"T06\",\"T7\":\"T07\",\"T8\":\"T08\",\"T9\":\"T09\",},\n",
    "                    inplace=True,)\n",
    "\n",
    "                tempdf['T'].replace(\n",
    "                    {\"U1\":\"U01\",\"U2\":\"U02\",\"U3\":\"U03\",\"U4\":\"U04\",\"U5\":\"U05\",\n",
    "                     \"U6\":\"U06\",\"U7\":\"U07\",\"U8\":\"U08\",\"U9\":\"U09\",},\n",
    "                    inplace=True,)\n",
    "\n",
    "                tempdf = tempdf.sort_values(by='T').reset_index(drop=True)\n",
    "\n",
    "                ICDcode = tempdf[tempdf['T'].apply(lambda x: x[0]=='U')].rename(\n",
    "                    {'CLAVE':'ICD-O-3'},axis=1).reset_index(drop=True)['ICD-O-3']\n",
    "\n",
    "                tempdf = tempdf[tempdf['T'].apply(lambda x: x[0]=='T')].join(ICDcode,)\n",
    "\n",
    "\n",
    "                ANNOTdict[templabel] = tempdf\n",
    "\n",
    "                \n",
    "        except Exception as e: \n",
    "                print(f'{e} {path + x}')\n",
    "                \n",
    "    return (ANNOTdict,CORPUSdict)\n",
    "    \n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "No columns to parse from file data/train-set-to-publish/cantemist-ner/cc_onco853.ann\n",
      "No columns to parse from file data/train-set-to-publish/cantemist-ner/cc_onco853.ann\n",
      "No columns to parse from file data/train-set-to-publish/cantemist-norm/cc_onco853.ann\n"
     ]
    }
   ],
   "source": [
    "def funcion4(dict1=funcion2(funcion1()[0],funcion1()[1])[1],\n",
    "             dict2=funcion3()[0]):\n",
    "    \n",
    "    \n",
    "    \"\"\"Esta función sirve para . \n",
    "    La primer entrada es un diccionario de archivos .ann que contiene la posición de palabras a indexar.\n",
    "    La segunda entrada es un diccionario de archivos .ann que contiene el código ICD-O-3.\n",
    "    La es un diccionario que contiene posición y código ICD-O-3.\"\"\"\n",
    "    \n",
    "    \n",
    "    tempdict = {}\n",
    "\n",
    "    for x in dict1.keys():\n",
    "                \n",
    "        tempdict[x] = dict1[x].join(dict2[x]['ICD-O-3'])\n",
    "    \n",
    "    return tempdict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "def funcion5(dict1=funcion4()):\n",
    "    \n",
    "    \"\"\"Regresa una tabla que contiene una morfología encontrada, posición de inicio y de fin, \n",
    "    ICD-O-3 y documento en donde se encontró\"\"\"\n",
    "    \n",
    "    final_df = pd.DataFrame()\n",
    "    tempdf = pd.DataFrame()\n",
    "\n",
    "    for key in dict1:\n",
    "        tempdf = dict1[key]\n",
    "        tempdf['document'] = key\n",
    "\n",
    "        final_df = final_df.append(tempdf)\n",
    "        \n",
    "    return final_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 156,
   "metadata": {},
   "outputs": [],
   "source": [
    "def funcion6(trainset = funcion5(), CORPUSdict = funcion1('data/test-background-set-to-publish/')[1],):\n",
    "    \n",
    "    \"\"\"Busca las morfologias contenidas en el set de entrenamiento, dentro de los documentos contenidos en el set de prueba. \n",
    "    El set de entrenamiento tiene  filas.\n",
    "    La salida es un diccionario con las morfologias encontradas, ICD-O-3, documento, índice dentro del documento.\"\"\"\n",
    "\n",
    "\n",
    "    tempdf = trainset[['CLAVE','ICD-O-3']][trainset['CLAVE'].apply(lambda x: x.lower()).duplicated() == False]\n",
    "\n",
    "    tempdf['len'] = tempdf['CLAVE'].apply(lambda x: len(x))\n",
    "    \n",
    "    finaldf = pd.DataFrame()\n",
    "\n",
    "    tempdict = {}\n",
    "    \n",
    "    for key in CORPUSdict.keys():\n",
    "\n",
    "        tempdict[key] = pd.DataFrame()\n",
    "        \n",
    "        text = CORPUSdict[key][0]\n",
    "\n",
    "        for word,code in zip(tempdf['CLAVE'],tempdf['ICD-O-3']):\n",
    "            \n",
    "            if len(word)>4:\n",
    "\n",
    "                startindex = text.lower().find(word.lower())\n",
    "\n",
    "                if startindex != -1:\n",
    "                    \n",
    "                    endindex = startindex+len(word)\n",
    "                    \n",
    "                    tempseries = pd.Series(data={'CLAVE':word,'startpos':startindex,'endpos':endindex,'ICD-O-3':code,'documento':key})\n",
    "\n",
    "                    finaldf = finaldf.append(tempseries,ignore_index=True,)\n",
    "                \n",
    "            elif len(word)<=4:\n",
    "                \n",
    "                startindex = text.find(word)\n",
    "                        \n",
    "                if startindex != -1:\n",
    "                    \n",
    "                    endindex = startindex+len(word)\n",
    "                    \n",
    "                    if(text[startindex-1] == ' ') or (text[startindex-1] == '\\n') or (text[startindex-1] == '.') or (text[startindex-1] == '-') or (text[startindex-1] == ':') or (text[startindex-1] == ';') or (text[startindex-1] == '(') or (text[startindex-1] == ')') or (text[startindex-1] == ',') : \n",
    "                    \n",
    "                        try:\n",
    "                    \n",
    "                            if (text[endindex+1] == ' ') or (text[endindex+1] == '\\n') or (text[endindex+1] == '.') or (text[endindex+1] == '-') or (text[endindex+1] == ':') or (text[endindex+1] == ';') or (text[startindex-1] == '(') or (text[startindex-1] == ')') or (text[startindex-1] == ',') :\n",
    "\n",
    "                                tempseries = pd.Series(data={'CLAVE':word,'startpos':startindex,'endpos':endindex,'ICD-O-3':code,'documento':key})\n",
    "\n",
    "                                finaldf = finaldf.append(tempseries,ignore_index=True,)\n",
    "                                \n",
    "                        except:\n",
    "                            \n",
    "                            if (len(text) == endindex):\n",
    "                                \n",
    "                                tempseries = pd.Series(data={'CLAVE':word,'startpos':startindex,'endpos':endindex,'ICD-O-3':code,'documento':key})\n",
    "\n",
    "                                finaldf = finaldf.append(tempseries,ignore_index=True,)\n",
    "\n",
    "\n",
    "    d1 = {}\n",
    "    for k in finaldf['documento'].unique():\n",
    "        d1[k] = finaldf[finaldf['documento']==k]\n",
    "        \n",
    "    for key in d1.keys():\n",
    "        \n",
    "        d1[key]['len'] = d1[key]['CLAVE'].apply(lambda x: len(x))\n",
    "        \n",
    "        d1[key] = d1[key].sort_values(by = ['len'],ascending=False)[d1[key].sort_values(by = ['len'],ascending=False)['startpos'].duplicated() == False].sort_values('startpos').reset_index(drop=True)\n",
    "        \n",
    "        d1[key] = d1[key].sort_values(by = ['len'],ascending=False)[d1[key].sort_values(by = ['len'],ascending=False)['endpos'].duplicated() == False].sort_values('startpos').reset_index(drop=True)\n",
    "        \n",
    "        d1[key].index = map(lambda x: \"T\"+str(x+1), d1[key].index)\n",
    "        \n",
    "        d1[key].drop('len',axis=1,inplace=True)\n",
    " \n",
    "        \n",
    "    return (d1,tempdf)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 157,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\L03040999\\Anaconda3\\lib\\site-packages\\ipykernel_launcher.py:69: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n"
     ]
    }
   ],
   "source": [
    "d2 = funcion6()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 158,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2809"
      ]
     },
     "execution_count": 158,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(d2[0].keys())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 149,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>CLAVE</th>\n",
       "      <th>ICD-O-3</th>\n",
       "      <th>len</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Carcinoma microcítico</td>\n",
       "      <td>8041/3</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>M0</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>metastásica</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>metástasis</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>neoplasia</td>\n",
       "      <td>8000/1</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>implante rectovesical</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>implantes en cara anterior de recto</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>implante en mesocolon</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>carcinoma urotelial de vejiga de alto grado</td>\n",
       "      <td>8120/3</td>\n",
       "      <td>43</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Paraganglioma</td>\n",
       "      <td>8680/1</td>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3397 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          CLAVE ICD-O-3  len\n",
       "0                         Carcinoma microcítico  8041/3   21\n",
       "2                                            M0  8000/6    2\n",
       "0                                   metastásica  8000/6   11\n",
       "1                                    metástasis  8000/6   10\n",
       "3                                     neoplasia  8000/1    9\n",
       "..                                          ...     ...  ...\n",
       "21                        implante rectovesical  8000/6   21\n",
       "22          implantes en cara anterior de recto  8000/6   35\n",
       "23                        implante en mesocolon  8000/6   21\n",
       "2   carcinoma urotelial de vejiga de alto grado  8120/3   43\n",
       "0                                 Paraganglioma  8680/1   13\n",
       "\n",
       "[3397 rows x 3 columns]"
      ]
     },
     "execution_count": 149,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "d2[1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 153,
   "metadata": {},
   "outputs": [],
   "source": [
    "# def funcion7(d1=funcion6()[0])):\n",
    "def funcion7(d1,traindf): \n",
    "    \n",
    "    \"\"\"Regresa las morfologias encontradas en formato NERbrat y NORMbrat.\"\"\"\n",
    "    \n",
    "    NERbratformat = {}\n",
    "\n",
    "    for key in d1.keys():\n",
    "\n",
    "        d1[key]['MORFOLOGIA NEOPLASIA'] = 'MORFOLOGIA_NEOPLASIA'\n",
    "\n",
    "        NERbratformat[key] = d1[key][['MORFOLOGIA NEOPLASIA','startpos','endpos','CLAVE']]\n",
    "        \n",
    "        NERbratformat[key][['startpos','endpos']] = NERbratformat[key][['startpos','endpos']].astype(int)\n",
    "        \n",
    "        NERbratformat[key].to_csv(f'data/team_bigbyte/cantemist-ner/{key}.ann', header=False, index=True, sep='\\t',)\n",
    "        \n",
    "    NORMbratformat = {}\n",
    "\n",
    "    \n",
    "    for key in NERbratformat.keys():\n",
    "\n",
    "        NORMbratformat[key] = pd.DataFrame()\n",
    "        \n",
    "        NERbratformat[key][['startpos','endpos']] = NERbratformat[key][['startpos','endpos']].astype(int)\n",
    "\n",
    "        for i,row in enumerate(NERbratformat[key].index):\n",
    "            tempseries = NERbratformat[key].loc[row].append(pd.Series(data={'index':row},name=row))\n",
    "\n",
    "            tempseries2 = pd.Series(data = {\n",
    "                'index':'#'+str(i+1), 'MORFOLOGIA NEOPLASIA':f'AnnotatorNotes {row}','startpos':d1[key].iloc[i]['ICD-O-3']}, \n",
    "                                    name=row\n",
    "                                   )\n",
    "            \n",
    "            tempdf = pd.concat([tempseries,tempseries2],axis=1).T.set_index('index').reset_index()\n",
    "\n",
    "            NORMbratformat[key] = NORMbratformat[key].append(tempdf)\n",
    "            \n",
    "        NORMbratformat[key].to_csv(f'data/team_bigbyte/cantemist-norm/{key}.ann', header=False, index=False, sep='\\t', )\n",
    "        \n",
    "    \n",
    "    tempdf = pd.DataFrame()\n",
    "\n",
    "    for x in d1.keys():\n",
    "    \n",
    "        tempdf = tempdf.append(d1[x].sort_values(by='startpos')[['documento','ICD-O-3']])\n",
    "        \n",
    "    \n",
    "    tempdf.to_csv(f'data/team_bigbyte/cantemist-coding/coding.tsv', header=False, index=False, sep='\\t', )\n",
    "    traindf.sort_values(by='CLAVE').to_csv(f'data/team_bigbyte/traindf.txt', header=True, index=False, sep='\\t', )\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 154,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\L03040999\\Anaconda3\\lib\\site-packages\\pandas\\core\\frame.py:2963: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  self[k1] = value[k2]\n"
     ]
    }
   ],
   "source": [
    "funcion7(d2[0],d2[1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 155,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>CLAVE</th>\n",
       "      <th>ICD-O-3</th>\n",
       "      <th>len</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>(LOE ) frontal</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>(LOE) de 15 mm hepática</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>23</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>(LOE) en el hígado</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>(LOE) hepática</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>(LOE) hepáticas</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>ypT3N0/M0</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>ypT3N0M0</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>ypT3N1M0</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>ypT3cN1M0</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>ypT4N0M0</td>\n",
       "      <td>8000/6</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3397 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                      CLAVE ICD-O-3  len\n",
       "10           (LOE ) frontal  8000/6   14\n",
       "18  (LOE) de 15 mm hepática  8000/6   23\n",
       "11       (LOE) en el hígado  8000/6   18\n",
       "9            (LOE) hepática  8000/6   14\n",
       "13          (LOE) hepáticas  8000/6   15\n",
       "..                      ...     ...  ...\n",
       "11                ypT3N0/M0  8000/6    9\n",
       "12                 ypT3N0M0  8000/6    8\n",
       "14                 ypT3N1M0  8000/6    8\n",
       "13                ypT3cN1M0  8000/6    9\n",
       "13                 ypT4N0M0  8000/6    8\n",
       "\n",
       "[3397 rows x 3 columns]"
      ]
     },
     "execution_count": 155,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "d2[1].sort_values(by='CLAVE')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 159,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'caso_clinico_radiologia1':         CLAVE ICD-O-3                 documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia1   564.0     555.0,\n",
       " 'caso_clinico_radiologia10':                        CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1       masas suprarrenales  8000/6  caso_clinico_radiologia10  1167.0   \n",
       " T2                 neoplasia  8000/1  caso_clinico_radiologia10  1253.0   \n",
       " T3                 Carcinoma  8010/3  caso_clinico_radiologia10  1283.0   \n",
       " T4                 poliposis  8210/0  caso_clinico_radiologia10  1331.0   \n",
       " T5  Carcinoma indiferenciado  8020/3  caso_clinico_radiologia10  1420.0   \n",
       " T6                metástasis  8000/6  caso_clinico_radiologia10  1459.0   \n",
       " \n",
       "     startpos  \n",
       " T1    1148.0  \n",
       " T2    1244.0  \n",
       " T3    1274.0  \n",
       " T4    1322.0  \n",
       " T5    1396.0  \n",
       " T6    1449.0  ,\n",
       " 'caso_clinico_radiologia1000':       CLAVE ICD-O-3                    documento  endpos  startpos\n",
       " T1  linfoma  9590/3  caso_clinico_radiologia1000   285.0     278.0,\n",
       " 'caso_clinico_radiologia1002':                 CLAVE ICD-O-3                    documento  endpos  startpos\n",
       " T1  neoplasia maligna  8000/3  caso_clinico_radiologia1002   367.0     350.0,\n",
       " 'caso_clinico_radiologia1004':     CLAVE ICD-O-3                    documento  endpos  startpos\n",
       " T1  tumor  8000/1  caso_clinico_radiologia1004   396.0     391.0,\n",
       " 'caso_clinico_radiologia1006':                   CLAVE ICD-O-3                    documento  endpos  startpos\n",
       " T1  enfermedad pulmonar  8000/6  caso_clinico_radiologia1006   464.0     445.0,\n",
       " 'caso_clinico_radiologia1007':         CLAVE ICD-O-3                    documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia1007   254.0     245.0,\n",
       " 'caso_clinico_radiologia1008':          CLAVE ICD-O-3                    documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia1008   599.0     589.0,\n",
       " 'caso_clinico_radiologia101':        CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  implante  8000/6  caso_clinico_radiologia101    51.0      43.0,\n",
       " 'caso_clinico_radiologia1011':    CLAVE ICD-O-3                    documento  endpos  startpos\n",
       " T1    SE  9260/3  caso_clinico_radiologia1011  2470.0    2468.0,\n",
       " 'caso_clinico_radiologia11':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  caso_clinico_radiologia11    82.0      68.0,\n",
       " 'caso_clinico_radiologia111':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  malignidad  8000/3  caso_clinico_radiologia111   527.0     517.0,\n",
       " 'caso_clinico_radiologia115':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neurofibroma  9540/0  caso_clinico_radiologia115    57.0      45.0,\n",
       " 'caso_clinico_radiologia116':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  caso_clinico_radiologia116    46.0      37.0,\n",
       " 'caso_clinico_radiologia119':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   neoplasia  8000/1  caso_clinico_radiologia119   424.0     415.0\n",
       " T2  metástasis  8000/6  caso_clinico_radiologia119   756.0     746.0\n",
       " T3    oat cell  8002/3  caso_clinico_radiologia119   810.0     802.0,\n",
       " 'caso_clinico_radiologia12':                            CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1  afectación de partes blandas  8000/6  caso_clinico_radiologia12   681.0   \n",
       " \n",
       "     startpos  \n",
       " T1     653.0  ,\n",
       " 'caso_clinico_radiologia120':                       CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  pseudomixoma peritoneal  8480/6  caso_clinico_radiologia120   665.0   \n",
       " T2                   mixoma  8840/0  caso_clinico_radiologia120   654.0   \n",
       " \n",
       "     startpos  \n",
       " T1     642.0  \n",
       " T2     648.0  ,\n",
       " 'caso_clinico_radiologia122':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia122   702.0     693.0,\n",
       " 'caso_clinico_radiologia126':                     CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  cistoadenoma mucinoso  8470/0  caso_clinico_radiologia126   535.0   \n",
       " T2                adenoma  8140/0  caso_clinico_radiologia126   526.0   \n",
       " T3             malignidad  8000/3  caso_clinico_radiologia126   572.0   \n",
       " \n",
       "     startpos  \n",
       " T1     514.0  \n",
       " T2     519.0  \n",
       " T3     562.0  ,\n",
       " 'caso_clinico_radiologia128':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1     tumoral  8000/1  caso_clinico_radiologia128   667.0     660.0\n",
       " T2  malignidad  8000/3  caso_clinico_radiologia128  1278.0    1268.0,\n",
       " 'caso_clinico_radiologia13':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  caso_clinico_radiologia13    46.0      37.0\n",
       " T2      tumor  8000/1  caso_clinico_radiologia13  1116.0    1111.0,\n",
       " 'caso_clinico_radiologia130':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  angiomiolipoma  8860/0  caso_clinico_radiologia130   425.0     411.0,\n",
       " 'caso_clinico_radiologia132':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Carcinomatosis  8010/9  caso_clinico_radiologia132  1000.0     986.0\n",
       " T2  adenocarcinoma  8140/3  caso_clinico_radiologia132  1219.0    1205.0\n",
       " T3           tumor  8000/1  caso_clinico_radiologia132  1252.0    1247.0\n",
       " T4      metástasis  8000/6  caso_clinico_radiologia132  1286.0    1276.0,\n",
       " 'caso_clinico_radiologia134':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia134   383.0     373.0\n",
       " T2   formación  8000/1  caso_clinico_radiologia134   892.0     883.0\n",
       " T3   cavernoma  9121/0  caso_clinico_radiologia134  1148.0    1139.0,\n",
       " 'caso_clinico_radiologia139':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia139   167.0     157.0,\n",
       " 'caso_clinico_radiologia142':             CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lesión lítica  8000/6  caso_clinico_radiologia142   158.0     145.0,\n",
       " 'caso_clinico_radiologia143':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  angiomiolipoma  8860/0  caso_clinico_radiologia143   707.0     693.0,\n",
       " 'caso_clinico_radiologia147':                CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1      masa pélvica  8000/6  caso_clinico_radiologia147   338.0     326.0\n",
       " T2             tumor  8000/1  caso_clinico_radiologia147   742.0     737.0\n",
       " T3  seminoma clásico  9061/3  caso_clinico_radiologia147   842.0     826.0\n",
       " T4        metástasis  8000/6  caso_clinico_radiologia147  1038.0    1028.0\n",
       " T5            cáncer  8000/3  caso_clinico_radiologia147  1416.0    1410.0,\n",
       " 'caso_clinico_radiologia149':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  caso_clinico_radiologia149    45.0      36.0\n",
       " T2    tumoral  8000/1  caso_clinico_radiologia149   194.0     187.0\n",
       " T3         Ca  8000/3  caso_clinico_radiologia149   313.0     311.0,\n",
       " 'caso_clinico_radiologia151':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lóbulo hepático  8000/6  caso_clinico_radiologia151   247.0     232.0,\n",
       " 'caso_clinico_radiologia153':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia153   337.0     328.0,\n",
       " 'caso_clinico_radiologia156':                 CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lesiones cutáneas  8000/6  caso_clinico_radiologia156   293.0     276.0\n",
       " T2            linfoma  9590/3  caso_clinico_radiologia156   919.0     912.0,\n",
       " 'caso_clinico_radiologia158':                       CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  adenocarcinoma mucinoso  8480/3  caso_clinico_radiologia158   808.0   \n",
       " T2                   mixoma  8840/0  caso_clinico_radiologia158   968.0   \n",
       " T3                    tumor  8000/1  caso_clinico_radiologia158   974.0   \n",
       " \n",
       "     startpos  \n",
       " T1     785.0  \n",
       " T2     962.0  \n",
       " T3     969.0  ,\n",
       " 'caso_clinico_radiologia159':                    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1             formación  8000/1  caso_clinico_radiologia159   655.0     646.0\n",
       " T2  hemangioma cavernoso  9121/0  caso_clinico_radiologia159   841.0     821.0\n",
       " T3               Angioma  9120/0  caso_clinico_radiologia159   831.0     824.0,\n",
       " 'caso_clinico_radiologia167':                  CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  nódulos pulmonares  8000/6  caso_clinico_radiologia167   392.0     374.0\n",
       " T2           formación  8000/1  caso_clinico_radiologia167   856.0     847.0,\n",
       " 'caso_clinico_radiologia170':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  caso_clinico_radiologia170    51.0      37.0,\n",
       " 'caso_clinico_radiologia180':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lesión en pene  8000/6  caso_clinico_radiologia180    58.0      44.0,\n",
       " 'caso_clinico_radiologia19':                                       CLAVE ICD-O-3  \\\n",
       " T1  lesiones ocupantes de espacio hepáticas  8000/6   \n",
       " T2                       lesiones hepáticas  8000/6   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  caso_clinico_radiologia19   333.0     294.0  \n",
       " T2  caso_clinico_radiologia19   548.0     530.0  ,\n",
       " 'caso_clinico_radiologia190':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  caso_clinico_radiologia190   108.0      94.0,\n",
       " 'caso_clinico_radiologia194':                CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  micosis fungoide  9700/3  caso_clinico_radiologia194    56.0      40.0\n",
       " T2    adenocarcinoma  8140/3  caso_clinico_radiologia194  1093.0    1079.0\n",
       " T3           linfoma  9590/3  caso_clinico_radiologia194  1325.0    1318.0\n",
       " T4        neoplasias  8000/1  caso_clinico_radiologia194  1417.0    1407.0,\n",
       " 'caso_clinico_radiologia200':      CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  cáncer  8000/3  caso_clinico_radiologia200    23.0      17.0,\n",
       " 'caso_clinico_radiologia202':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  angiomiolipoma  8860/0  caso_clinico_radiologia202   768.0     754.0\n",
       " T2             AML  8860/0  caso_clinico_radiologia202   773.0     770.0,\n",
       " 'caso_clinico_radiologia204':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  caso_clinico_radiologia204   131.0     117.0,\n",
       " 'caso_clinico_radiologia213':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  metástasis  8000/6  caso_clinico_radiologia213   418.0     408.0\n",
       " T2   neoplasia  8000/1  caso_clinico_radiologia213   812.0     803.0,\n",
       " 'caso_clinico_radiologia214':                      CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  masa de partes blandas  8000/6  caso_clinico_radiologia214   372.0   \n",
       " \n",
       "     startpos  \n",
       " T1     350.0  ,\n",
       " 'caso_clinico_radiologia216':        CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  teratoma  9080/1  caso_clinico_radiologia216   755.0     747.0,\n",
       " 'caso_clinico_radiologia23':        CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  implante  8000/6  caso_clinico_radiologia23   981.0     973.0,\n",
       " 'caso_clinico_radiologia232':     CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumor  8000/1  caso_clinico_radiologia232    38.0      33.0,\n",
       " 'caso_clinico_radiologia233':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  cistoadenoma  8440/0  caso_clinico_radiologia233   702.0     690.0,\n",
       " 'caso_clinico_radiologia237':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1      lipoma  8850/0  caso_clinico_radiologia237   454.0     448.0\n",
       " T2  metástasis  8000/6  caso_clinico_radiologia237   533.0     523.0,\n",
       " 'caso_clinico_radiologia243':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1      cáncer  8000/3  caso_clinico_radiologia243   115.0     109.0\n",
       " T2  metástasis  8000/6  caso_clinico_radiologia243   852.0     842.0,\n",
       " 'caso_clinico_radiologia244':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lesión traqueal  8000/6  caso_clinico_radiologia244   828.0     813.0,\n",
       " 'caso_clinico_radiologia25':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1    neoformación  8000/1  caso_clinico_radiologia25   823.0     811.0\n",
       " T2  adenocarcinoma  8140/3  caso_clinico_radiologia25   864.0     850.0,\n",
       " 'caso_clinico_radiologia252':                              CLAVE ICD-O-3                   documento  \\\n",
       " T1                    neoformativo  8000/1  caso_clinico_radiologia252   \n",
       " T2  neoplasia mucinosa apendicular  8480/1  caso_clinico_radiologia252   \n",
       " T3                         maligno  8000/3  caso_clinico_radiologia252   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   300.0     288.0  \n",
       " T2   369.0     339.0  \n",
       " T3   546.0     539.0  ,\n",
       " 'caso_clinico_radiologia254':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia254   588.0     579.0,\n",
       " 'caso_clinico_radiologia255':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  hipernefroma  8312/3  caso_clinico_radiologia255   115.0     103.0,\n",
       " 'caso_clinico_radiologia258':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  caso_clinico_radiologia258   227.0     213.0\n",
       " T2       neoplasia  8000/1  caso_clinico_radiologia258   353.0     344.0,\n",
       " 'caso_clinico_radiologia259':                CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumor carcinoide  8240/3  caso_clinico_radiologia259   927.0     911.0\n",
       " T2           linfoma  9590/3  caso_clinico_radiologia259   937.0     930.0\n",
       " T3        malignidad  8000/3  caso_clinico_radiologia259  1378.0    1368.0,\n",
       " 'caso_clinico_radiologia260':                      CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  adenocarcinoma papilar  8260/3  caso_clinico_radiologia260   471.0   \n",
       " \n",
       "     startpos  \n",
       " T1     449.0  ,\n",
       " 'caso_clinico_radiologia263':                                            CLAVE ICD-O-3  \\\n",
       " T1                                     tumorales  8000/1   \n",
       " T2  neoplasia mucinosa apendicular de bajo grado  8480/1   \n",
       " \n",
       "                      documento  endpos  startpos  \n",
       " T1  caso_clinico_radiologia263   118.0     109.0  \n",
       " T2  caso_clinico_radiologia263   744.0     700.0  ,\n",
       " 'caso_clinico_radiologia266':                        CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  síndrome mielodisplásico  9989/3  caso_clinico_radiologia266   300.0   \n",
       " \n",
       "     startpos  \n",
       " T1     276.0  ,\n",
       " 'caso_clinico_radiologia267':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  caso_clinico_radiologia267   116.0     107.0,\n",
       " 'caso_clinico_radiologia268':                    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumor neuroendocrino  8240/3  caso_clinico_radiologia268    57.0      37.0\n",
       " T2       lóbulo hepático  8000/6  caso_clinico_radiologia268   604.0     589.0,\n",
       " 'caso_clinico_radiologia272':                  CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lesiones hepáticas  8000/6  caso_clinico_radiologia272   653.0     635.0\n",
       " T2            malignas  8000/3  caso_clinico_radiologia272  1114.0    1106.0,\n",
       " 'caso_clinico_radiologia278':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoplásico  8000/1  caso_clinico_radiologia278   337.0     327.0,\n",
       " 'caso_clinico_radiologia281':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  angiomiolipomas  8860/0  caso_clinico_radiologia281   324.0     309.0,\n",
       " 'caso_clinico_radiologia282':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  masa anexial  8000/6  caso_clinico_radiologia282   519.0     507.0,\n",
       " 'caso_clinico_radiologia283':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia283   388.0     379.0,\n",
       " 'caso_clinico_radiologia284':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  caso_clinico_radiologia284    96.0      87.0\n",
       " T2    adenoma  8140/0  caso_clinico_radiologia284   150.0     143.0,\n",
       " 'caso_clinico_radiologia285':           CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1       cáncer  8000/3  caso_clinico_radiologia285    88.0      82.0\n",
       " T2  metastásico  8000/6  caso_clinico_radiologia285   109.0      98.0,\n",
       " 'caso_clinico_radiologia287':      CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  cáncer  8000/3  caso_clinico_radiologia287    68.0      62.0,\n",
       " 'caso_clinico_radiologia291':                        CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  síndrome mielodisplásico  9989/3  caso_clinico_radiologia291    84.0   \n",
       " \n",
       "     startpos  \n",
       " T1      60.0  ,\n",
       " 'caso_clinico_radiologia293':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  sarcoma  8800/3  caso_clinico_radiologia293   108.0     101.0,\n",
       " 'caso_clinico_radiologia296':        CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  leucemia  9800/3  caso_clinico_radiologia296   216.0     208.0\n",
       " T2       LMA  9861/3  caso_clinico_radiologia296   236.0     233.0,\n",
       " 'caso_clinico_radiologia299':                       CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1                 seminoma  9061/3  caso_clinico_radiologia299    46.0   \n",
       " T2  metástasis del seminoma  9061/6  caso_clinico_radiologia299   493.0   \n",
       " \n",
       "     startpos  \n",
       " T1      38.0  \n",
       " T2     470.0  ,\n",
       " 'caso_clinico_radiologia3':        CLAVE ICD-O-3                 documento  endpos  startpos\n",
       " T1  implante  8000/6  caso_clinico_radiologia3   575.0     567.0,\n",
       " 'caso_clinico_radiologia31':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia31   340.0     330.0,\n",
       " 'caso_clinico_radiologia311':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  maligna  8000/3  caso_clinico_radiologia311   646.0     639.0,\n",
       " 'caso_clinico_radiologia317':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia317   936.0     927.0,\n",
       " 'caso_clinico_radiologia318':                    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  masa retroperitoneal  8000/6  caso_clinico_radiologia318  1289.0    1269.0\n",
       " T2            tumoración  8000/1  caso_clinico_radiologia318  1374.0    1364.0\n",
       " T3            metástasis  8000/6  caso_clinico_radiologia318  1561.0    1551.0,\n",
       " 'caso_clinico_radiologia319':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lóbulo hepático  8000/6  caso_clinico_radiologia319   347.0     332.0,\n",
       " 'caso_clinico_radiologia322':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoformativo  8000/1  caso_clinico_radiologia322   521.0     509.0\n",
       " T2  neoformación  8000/1  caso_clinico_radiologia322   846.0     834.0,\n",
       " 'caso_clinico_radiologia330':                                   CLAVE ICD-O-3                   documento  \\\n",
       " T1  linfoma B difuso de células grandes  9680/3  caso_clinico_radiologia330   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   753.0     718.0  ,\n",
       " 'caso_clinico_radiologia331':                      CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1               neoplasia  8000/1  caso_clinico_radiologia331    47.0   \n",
       " T2  implantes peritoneales  8000/6  caso_clinico_radiologia331   127.0   \n",
       " \n",
       "     startpos  \n",
       " T1      38.0  \n",
       " T2     105.0  ,\n",
       " 'caso_clinico_radiologia334':                      CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  masa de partes blandas  8000/6  caso_clinico_radiologia334   363.0   \n",
       " \n",
       "     startpos  \n",
       " T1     341.0  ,\n",
       " 'caso_clinico_radiologia338':                      CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  masa de partes blandas  8000/6  caso_clinico_radiologia338   293.0   \n",
       " T2                 linfoma  9590/3  caso_clinico_radiologia338   868.0   \n",
       " T3                   LDCGB  9680/3  caso_clinico_radiologia338   902.0   \n",
       " \n",
       "     startpos  \n",
       " T1     271.0  \n",
       " T2     861.0  \n",
       " T3     897.0  ,\n",
       " 'caso_clinico_radiologia340':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia340   618.0     609.0,\n",
       " 'caso_clinico_radiologia345':                  CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1    lesión esplénica  8000/6  caso_clinico_radiologia345   295.0     279.0\n",
       " T2  lesiones hepáticas  8000/6  caso_clinico_radiologia345   514.0     496.0\n",
       " T3               tumor  8000/1  caso_clinico_radiologia345   723.0     718.0\n",
       " T4             maligno  8000/3  caso_clinico_radiologia345   740.0     733.0,\n",
       " 'caso_clinico_radiologia347':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  masa pélvica  8000/6  caso_clinico_radiologia347   178.0     166.0,\n",
       " 'caso_clinico_radiologia348':                              CLAVE ICD-O-3                   documento  \\\n",
       " T1    Melanoma cutáneo metastásico  8720/6  caso_clinico_radiologia348   \n",
       " T2                      metástasis  8000/6  caso_clinico_radiologia348   \n",
       " T3  nódulos pulmonares bilaterales  8000/6  caso_clinico_radiologia348   \n",
       " T4                   lesión lítica  8000/6  caso_clinico_radiologia348   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1    64.0      36.0  \n",
       " T2   169.0     159.0  \n",
       " T3   804.0     774.0  \n",
       " T4   862.0     849.0  ,\n",
       " 'caso_clinico_radiologia349':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia349  1201.0    1192.0,\n",
       " 'caso_clinico_radiologia36':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  caso_clinico_radiologia36    48.0      34.0,\n",
       " 'caso_clinico_radiologia360':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  teratoma maduro  9080/0  caso_clinico_radiologia360   499.0     484.0,\n",
       " 'caso_clinico_radiologia365':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  caso_clinico_radiologia365   145.0     136.0\n",
       " T2         Ca  8000/3  caso_clinico_radiologia365   215.0     213.0,\n",
       " 'caso_clinico_radiologia366':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  afectación ósea  8000/6  caso_clinico_radiologia366   690.0     675.0,\n",
       " 'caso_clinico_radiologia367':      CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  cáncer  8000/3  caso_clinico_radiologia367   492.0     486.0,\n",
       " 'caso_clinico_radiologia368':                      CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  masa de partes blandas  8000/6  caso_clinico_radiologia368   335.0   \n",
       " \n",
       "     startpos  \n",
       " T1     313.0  ,\n",
       " 'caso_clinico_radiologia372':                        CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1            adenocarcinoma  8140/3  caso_clinico_radiologia372    84.0   \n",
       " T2                metástasis  8000/6  caso_clinico_radiologia372   111.0   \n",
       " T3       afectación meníngea  8000/6  caso_clinico_radiologia372   615.0   \n",
       " T4  metástasis del carcinoma  8010/6  caso_clinico_radiologia372  1197.0   \n",
       " \n",
       "     startpos  \n",
       " T1      70.0  \n",
       " T2     101.0  \n",
       " T3     596.0  \n",
       " T4    1173.0  ,\n",
       " 'caso_clinico_radiologia373':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  angiomiolipoma  8860/0  caso_clinico_radiologia373    69.0      55.0\n",
       " T2     peritumoral  8000/1  caso_clinico_radiologia373   403.0     392.0,\n",
       " 'caso_clinico_radiologia375':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia375   480.0     470.0,\n",
       " 'caso_clinico_radiologia38':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1   formación  8000/1  caso_clinico_radiologia38   889.0     880.0\n",
       " T2     tumoral  8000/1  caso_clinico_radiologia38   937.0     930.0\n",
       " T3  neoplásico  8000/1  caso_clinico_radiologia38  1512.0    1502.0\n",
       " T4  meningioma  9530/0  caso_clinico_radiologia38  1566.0    1556.0,\n",
       " 'caso_clinico_radiologia381':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoral  8000/1  caso_clinico_radiologia381   412.0     405.0,\n",
       " 'caso_clinico_radiologia386':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  masa pélvica  8000/6  caso_clinico_radiologia386   308.0     296.0,\n",
       " 'caso_clinico_radiologia39':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  caso_clinico_radiologia39   476.0     467.0,\n",
       " 'caso_clinico_radiologia391':      CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  cáncer  8000/3  caso_clinico_radiologia391    43.0      37.0,\n",
       " 'caso_clinico_radiologia394':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  metástasis  8000/6  caso_clinico_radiologia394   625.0     615.0,\n",
       " 'caso_clinico_radiologia396':                     CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  lesión focal hepática  8000/6  caso_clinico_radiologia396   334.0   \n",
       " T2                tumoral  8000/1  caso_clinico_radiologia396   855.0   \n",
       " T3        hepatocarcinoma  8170/3  caso_clinico_radiologia396  1028.0   \n",
       " \n",
       "     startpos  \n",
       " T1     313.0  \n",
       " T2     848.0  \n",
       " T3    1013.0  ,\n",
       " 'caso_clinico_radiologia398':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neurinoma  9560/0  caso_clinico_radiologia398   585.0     576.0,\n",
       " 'caso_clinico_radiologia4':    CLAVE ICD-O-3                 documento  endpos  startpos\n",
       " T1    MO  8000/6  caso_clinico_radiologia4   401.0     399.0,\n",
       " 'caso_clinico_radiologia401':                         CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1                  Carcinoma  8010/3  caso_clinico_radiologia401   295.0   \n",
       " T2  linfangitis carcinomatosa  8000/3  caso_clinico_radiologia401   709.0   \n",
       " \n",
       "     startpos  \n",
       " T1     286.0  \n",
       " T2     684.0  ,\n",
       " 'caso_clinico_radiologia402':                         CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1                mesotelioma  9050/3  caso_clinico_radiologia402    87.0   \n",
       " T2  linfangitis carcinomatosa  8000/3  caso_clinico_radiologia402   687.0   \n",
       " \n",
       "     startpos  \n",
       " T1      76.0  \n",
       " T2     662.0  ,\n",
       " 'caso_clinico_radiologia406':                                            CLAVE ICD-O-3  \\\n",
       " T1  neoplasia mucinosa apendicular de bajo grado  8480/1   \n",
       " \n",
       "                      documento  endpos  startpos  \n",
       " T1  caso_clinico_radiologia406   531.0     487.0  ,\n",
       " 'caso_clinico_radiologia407':                          CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1                     linfoma  9590/3  caso_clinico_radiologia407   759.0   \n",
       " T2  proceso linfoproliferativo  9970/1  caso_clinico_radiologia407   849.0   \n",
       " \n",
       "     startpos  \n",
       " T1     752.0  \n",
       " T2     823.0  ,\n",
       " 'caso_clinico_radiologia410':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia410   577.0     568.0,\n",
       " 'caso_clinico_radiologia414':                          CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  consolidaciones pulmonares  8000/6  caso_clinico_radiologia414  1141.0   \n",
       " \n",
       "     startpos  \n",
       " T1    1115.0  ,\n",
       " 'caso_clinico_radiologia415':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  cavernoma  9121/0  caso_clinico_radiologia415   381.0     372.0\n",
       " T2  formación  8000/1  caso_clinico_radiologia415   437.0     428.0\n",
       " T3    Angioma  9120/0  caso_clinico_radiologia415   584.0     577.0,\n",
       " 'caso_clinico_radiologia416':             CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1     tumoración  8000/1  caso_clinico_radiologia416   373.0     363.0\n",
       " T2  neuroblastoma  9500/3  caso_clinico_radiologia416   893.0     880.0,\n",
       " 'caso_clinico_radiologia423':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia423   210.0     200.0,\n",
       " 'caso_clinico_radiologia424':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  maligna  8000/3  caso_clinico_radiologia424   549.0     542.0,\n",
       " 'caso_clinico_radiologia425':                              CLAVE ICD-O-3                   documento  \\\n",
       " T1  poliposis adenomatosa familiar  8220/0  caso_clinico_radiologia425   \n",
       " T2                     adenomatosa  8140/0  caso_clinico_radiologia425   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1    90.0      60.0  \n",
       " T2    81.0      70.0  ,\n",
       " 'caso_clinico_radiologia430':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1    tumoración  8000/1  caso_clinico_radiologia430   249.0     239.0\n",
       " T2  masa anexial  8000/6  caso_clinico_radiologia430   359.0     347.0,\n",
       " 'caso_clinico_radiologia435':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoraciones  8000/1  caso_clinico_radiologia435   323.0     311.0\n",
       " T2       tumoral  8000/1  caso_clinico_radiologia435   728.0     721.0,\n",
       " 'caso_clinico_radiologia440':                     CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1      Masa mediastínica  8000/6  caso_clinico_radiologia440   448.0   \n",
       " T2  afectación peritoneal  8000/6  caso_clinico_radiologia440   779.0   \n",
       " T3           omental cake  8000/6  caso_clinico_radiologia440   805.0   \n",
       " T4         Carcinomatosis  8010/9  caso_clinico_radiologia440   906.0   \n",
       " T5                  tumor  8000/1  caso_clinico_radiologia440   936.0   \n",
       " T6                linfoma  9590/3  caso_clinico_radiologia440   957.0   \n",
       " \n",
       "     startpos  \n",
       " T1     431.0  \n",
       " T2     758.0  \n",
       " T3     793.0  \n",
       " T4     892.0  \n",
       " T5     931.0  \n",
       " T6     950.0  ,\n",
       " 'caso_clinico_radiologia441':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  cistoadenoma  8440/0  caso_clinico_radiologia441   650.0     638.0,\n",
       " 'caso_clinico_radiologia443':                CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  masa suprarrenal  8000/6  caso_clinico_radiologia443   560.0     544.0\n",
       " T2    feocromocitoma  8700/3  caso_clinico_radiologia443   693.0     679.0,\n",
       " 'caso_clinico_radiologia445':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1    teratoma  9080/1  caso_clinico_radiologia445   410.0     402.0\n",
       " T2  tumoración  8000/1  caso_clinico_radiologia445   638.0     628.0\n",
       " T3  malignidad  8000/3  caso_clinico_radiologia445  1159.0    1149.0,\n",
       " 'caso_clinico_radiologia448':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  metástasis  8000/6  caso_clinico_radiologia448   802.0     792.0,\n",
       " 'caso_clinico_radiologia45':               CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  lóbulo hepático  8000/6  caso_clinico_radiologia45   795.0     780.0,\n",
       " 'caso_clinico_radiologia464':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1    Mioma  8895/0  caso_clinico_radiologia464   426.0     421.0\n",
       " T2  tumoral  8000/1  caso_clinico_radiologia464   525.0     518.0,\n",
       " 'caso_clinico_radiologia465':                CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  implante tumoral  8000/6  caso_clinico_radiologia465   313.0     297.0,\n",
       " 'caso_clinico_radiologia476':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lóbulo hepático  8000/6  caso_clinico_radiologia476   439.0     424.0,\n",
       " 'caso_clinico_radiologia478':        CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  implante  8000/6  caso_clinico_radiologia478   185.0     177.0,\n",
       " 'caso_clinico_radiologia48':                  CLAVE   ICD-O-3                  documento  endpos  startpos\n",
       " T1  carcinoma invasivo  8010/3/H  caso_clinico_radiologia48   228.0     210.0\n",
       " T2         metastásico    8000/6  caso_clinico_radiologia48   700.0     689.0,\n",
       " 'caso_clinico_radiologia481':                                           CLAVE ICD-O-3  \\\n",
       " T1                           Linfoma no Hodgkin  9591/3   \n",
       " T2  nódulos pulmonares milimétricos bilaterales  8000/6   \n",
       " T3                                           CM  8000/3   \n",
       " \n",
       "                      documento  endpos  startpos  \n",
       " T1  caso_clinico_radiologia481    57.0      39.0  \n",
       " T2  caso_clinico_radiologia481   385.0     342.0  \n",
       " T3  caso_clinico_radiologia481   484.0     482.0  ,\n",
       " 'caso_clinico_radiologia483':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia483   437.0     428.0,\n",
       " 'caso_clinico_radiologia484':                     CLAVE   ICD-O-3                   documento  endpos  \\\n",
       " T1     neoplasia mucinosa  8000/1/H  caso_clinico_radiologia484   985.0   \n",
       " T2  cistoadenoma mucinoso    8470/0  caso_clinico_radiologia484  1034.0   \n",
       " T3                adenoma    8140/0  caso_clinico_radiologia484  1025.0   \n",
       " T4         adenocarcinoma    8140/3  caso_clinico_radiologia484  1148.0   \n",
       " T5             metástasis    8000/6  caso_clinico_radiologia484  1256.0   \n",
       " \n",
       "     startpos  \n",
       " T1     967.0  \n",
       " T2    1013.0  \n",
       " T3    1018.0  \n",
       " T4    1134.0  \n",
       " T5    1246.0  ,\n",
       " 'caso_clinico_radiologia495':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1       tumor  8000/1  caso_clinico_radiologia495    85.0      80.0\n",
       " T2  meningioma  9530/0  caso_clinico_radiologia495   120.0     110.0,\n",
       " 'caso_clinico_radiologia499':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   formación  8000/1  caso_clinico_radiologia499   158.0     149.0\n",
       " T2  metástasis  8000/6  caso_clinico_radiologia499   525.0     515.0\n",
       " T3     linfoma  9590/3  caso_clinico_radiologia499   583.0     576.0\n",
       " T4   neoplasia  8000/1  caso_clinico_radiologia499  1103.0    1094.0,\n",
       " 'caso_clinico_radiologia5':                  CLAVE ICD-O-3                 documento  endpos  startpos\n",
       " T1             tumoral  8000/1  caso_clinico_radiologia5   471.0     464.0\n",
       " T2          metástasis  8000/6  caso_clinico_radiologia5   504.0     494.0\n",
       " T3  lesiones hepáticas  8000/6  caso_clinico_radiologia5   599.0     581.0,\n",
       " 'caso_clinico_radiologia500':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia500   612.0     603.0\n",
       " T2     lipoma  8850/0  caso_clinico_radiologia500   672.0     666.0,\n",
       " 'caso_clinico_radiologia501':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  caso_clinico_radiologia501   192.0     183.0,\n",
       " 'caso_clinico_radiologia510':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  masa pélvica  8000/6  caso_clinico_radiologia510   340.0     328.0\n",
       " T2  intratumoral  8000/1  caso_clinico_radiologia510   413.0     401.0\n",
       " T3    tumoración  8000/1  caso_clinico_radiologia510   595.0     585.0,\n",
       " 'caso_clinico_radiologia511':                   CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1            neoplasia  8000/1  caso_clinico_radiologia511    49.0      40.0\n",
       " T2  afectación hepática  8000/6  caso_clinico_radiologia511   319.0     300.0\n",
       " T3           metástasis  8000/6  caso_clinico_radiologia511   503.0     493.0,\n",
       " 'caso_clinico_radiologia512':                            CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  afectación de partes blandas  8000/6  caso_clinico_radiologia512   544.0   \n",
       " T2              tumor carcinoide  8240/3  caso_clinico_radiologia512   725.0   \n",
       " \n",
       "     startpos  \n",
       " T1     516.0  \n",
       " T2     709.0  ,\n",
       " 'caso_clinico_radiologia518':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1      cáncer  8000/3  caso_clinico_radiologia518    44.0      38.0\n",
       " T2  meningioma  9530/0  caso_clinico_radiologia518   473.0     463.0,\n",
       " 'caso_clinico_radiologia519':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoral  8000/1  caso_clinico_radiologia519   729.0     722.0,\n",
       " 'caso_clinico_radiologia521':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  LOE hepática  8000/6  caso_clinico_radiologia521   268.0     256.0,\n",
       " 'caso_clinico_radiologia523':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  caso_clinico_radiologia523   600.0     591.0,\n",
       " 'caso_clinico_radiologia525':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1           tumor  8000/1  caso_clinico_radiologia525   286.0     281.0\n",
       " T2       formación  8000/1  caso_clinico_radiologia525   602.0     593.0\n",
       " T3  adenocarcinoma  8140/3  caso_clinico_radiologia525   983.0     969.0,\n",
       " 'caso_clinico_radiologia528':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   implante  8000/6  caso_clinico_radiologia528   586.0     578.0\n",
       " T2  neoplasia  8000/1  caso_clinico_radiologia528   624.0     615.0,\n",
       " 'caso_clinico_radiologia53':                               CLAVE   ICD-O-3                  documento  \\\n",
       " T1  carcinoma urotelial infiltrante  8120/3/H  caso_clinico_radiologia53   \n",
       " T2                        formación    8000/1  caso_clinico_radiologia53   \n",
       " T3                      hemangiomas    9120/0  caso_clinico_radiologia53   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   106.0      75.0  \n",
       " T2   726.0     717.0  \n",
       " T3  1817.0    1806.0  ,\n",
       " 'caso_clinico_radiologia539':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  caso_clinico_radiologia539    30.0      21.0,\n",
       " 'caso_clinico_radiologia541':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1      cáncer  8000/3  caso_clinico_radiologia541    27.0      21.0\n",
       " T2  metástasis  8000/6  caso_clinico_radiologia541   142.0     132.0,\n",
       " 'caso_clinico_radiologia543':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoplásico  8000/1  caso_clinico_radiologia543   642.0     632.0,\n",
       " 'caso_clinico_radiologia547':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoformativo  8000/1  caso_clinico_radiologia547   629.0     617.0,\n",
       " 'caso_clinico_radiologia548':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoformación  8000/1  caso_clinico_radiologia548   530.0     518.0\n",
       " T2    metástasis  8000/6  caso_clinico_radiologia548   567.0     557.0,\n",
       " 'caso_clinico_radiologia552':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  glioblastoma  9440/3  caso_clinico_radiologia552   818.0     806.0,\n",
       " 'caso_clinico_radiologia559':                  CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1              cáncer  8000/3  caso_clinico_radiologia559    28.0      22.0\n",
       " T2  nódulos pulmonares  8000/6  caso_clinico_radiologia559   426.0     408.0\n",
       " T3          metástasis  8000/6  caso_clinico_radiologia559   453.0     443.0,\n",
       " 'caso_clinico_radiologia560':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  masa ovárica  8000/6  caso_clinico_radiologia560   595.0     583.0\n",
       " T2         Mioma  8895/0  caso_clinico_radiologia560   603.0     598.0,\n",
       " 'caso_clinico_radiologia562':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  caso_clinico_radiologia562   509.0     495.0,\n",
       " 'caso_clinico_radiologia567':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Angioma  9120/0  caso_clinico_radiologia567   872.0     865.0,\n",
       " 'caso_clinico_radiologia569':                       CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1           Carcinomatosis  8010/9  caso_clinico_radiologia569   789.0   \n",
       " T2   implantes mesentéricos  8000/6  caso_clinico_radiologia569   913.0   \n",
       " T3  pseudomixoma peritoneal  8480/6  caso_clinico_radiologia569  1038.0   \n",
       " T4                   mixoma  8840/0  caso_clinico_radiologia569  1027.0   \n",
       " \n",
       "     startpos  \n",
       " T1     775.0  \n",
       " T2     891.0  \n",
       " T3    1015.0  \n",
       " T4    1021.0  ,\n",
       " 'caso_clinico_radiologia575':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  metástasis  8000/6  caso_clinico_radiologia575   552.0     542.0\n",
       " T2   neoplasia  8000/1  caso_clinico_radiologia575   580.0     571.0\n",
       " T3     tumoral  8000/1  caso_clinico_radiologia575   676.0     669.0,\n",
       " 'caso_clinico_radiologia579':                   CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1       leucemia aguda  9801/3  caso_clinico_radiologia579   290.0     276.0\n",
       " T2                  LAM  9861/3  caso_clinico_radiologia579   310.0     307.0\n",
       " T3  afectación cerebral  8000/6  caso_clinico_radiologia579   842.0     823.0,\n",
       " 'caso_clinico_radiologia580':                                  CLAVE ICD-O-3                   documento  \\\n",
       " T1  tumor del estroma gastrointestinal  8936/3  caso_clinico_radiologia580   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1    84.0      50.0  ,\n",
       " 'caso_clinico_radiologia584':                CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lesión esplénica  8000/6  caso_clinico_radiologia584   924.0     908.0\n",
       " T2           linfoma  9590/3  caso_clinico_radiologia584   948.0     941.0,\n",
       " 'caso_clinico_radiologia585':                CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  células malignas  8001/3  caso_clinico_radiologia585   870.0     854.0,\n",
       " 'caso_clinico_radiologia587':                    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  nódulos peritoneales  8000/6  caso_clinico_radiologia587   409.0     389.0,\n",
       " 'caso_clinico_radiologia595':                     CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  Enfermedad de Hodgkin  9650/3  caso_clinico_radiologia595    42.0   \n",
       " \n",
       "     startpos  \n",
       " T1      21.0  ,\n",
       " 'caso_clinico_radiologia596':           CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1       cáncer  8000/3  caso_clinico_radiologia596    44.0      38.0\n",
       " T2  metastásica  8000/6  caso_clinico_radiologia596   405.0     394.0,\n",
       " 'caso_clinico_radiologia598':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lesión hepática  8000/6  caso_clinico_radiologia598   217.0     202.0,\n",
       " 'caso_clinico_radiologia6':              CLAVE ICD-O-3                 documento  endpos  startpos\n",
       " T1  Carcinomatosis  8010/9  caso_clinico_radiologia6   729.0     715.0\n",
       " T2         linfoma  9590/3  caso_clinico_radiologia6   749.0     742.0\n",
       " T3      neoplasias  8000/1  caso_clinico_radiologia6   768.0     758.0,\n",
       " 'caso_clinico_radiologia603':     CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Mioma  8895/0  caso_clinico_radiologia603    59.0      54.0,\n",
       " 'caso_clinico_radiologia604':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1       Mioma  8895/0  caso_clinico_radiologia604   106.0     101.0\n",
       " T2  tumoración  8000/1  caso_clinico_radiologia604   180.0     170.0,\n",
       " 'caso_clinico_radiologia605':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia605    95.0      85.0,\n",
       " 'caso_clinico_radiologia607':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  caso_clinico_radiologia607   485.0     476.0,\n",
       " 'caso_clinico_radiologia608':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia608   141.0     131.0,\n",
       " 'caso_clinico_radiologia61':                                    CLAVE ICD-O-3                  documento  \\\n",
       " T1                               linfoma  9590/3  caso_clinico_radiologia61   \n",
       " T2                        adenocarcinoma  8140/3  caso_clinico_radiologia61   \n",
       " T3                        Carcinomatosis  8010/9  caso_clinico_radiologia61   \n",
       " T4  tumores del estroma gastrointestinal  8936/3  caso_clinico_radiologia61   \n",
       " T5                                  GIST  8936/3  caso_clinico_radiologia61   \n",
       " T6                      tumor carcinoide  8240/3  caso_clinico_radiologia61   \n",
       " T7                  Melanoma metastásico  8720/6  caso_clinico_radiologia61   \n",
       " T8                   células neoplásicas  8001/1  caso_clinico_radiologia61   \n",
       " T9   linfoma B difuso de células grandes  9680/3  caso_clinico_radiologia61   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   384.0     377.0  \n",
       " T2   450.0     436.0  \n",
       " T3   499.0     485.0  \n",
       " T4   557.0     521.0  \n",
       " T5   563.0     559.0  \n",
       " T6   582.0     566.0  \n",
       " T7   604.0     584.0  \n",
       " T8   755.0     736.0  \n",
       " T9   874.0     839.0  ,\n",
       " 'caso_clinico_radiologia611':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  miomatosis  8895/0  caso_clinico_radiologia611   185.0     175.0,\n",
       " 'caso_clinico_radiologia612':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  linfoma  9590/3  caso_clinico_radiologia612    41.0      34.0,\n",
       " 'caso_clinico_radiologia615':           CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1      linfoma  9590/3  caso_clinico_radiologia615    52.0      45.0\n",
       " T2  metastásica  8000/6  caso_clinico_radiologia615   547.0     536.0,\n",
       " 'caso_clinico_radiologia616':             CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  masa pulmonar  8000/6  caso_clinico_radiologia616   495.0     482.0\n",
       " T2      neoplasia  8000/1  caso_clinico_radiologia616   553.0     544.0\n",
       " T3    metastásico  8000/6  caso_clinico_radiologia616   626.0     615.0,\n",
       " 'caso_clinico_radiologia621':      CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  cáncer  8000/3  caso_clinico_radiologia621    64.0      58.0,\n",
       " 'caso_clinico_radiologia626':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia626   454.0     445.0,\n",
       " 'caso_clinico_radiologia63':                     CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1        hepatocarcinoma  8170/3  caso_clinico_radiologia63   143.0     128.0\n",
       " T2  carcinoma metastásico  8010/6  caso_clinico_radiologia63   155.0     134.0,\n",
       " 'caso_clinico_radiologia645':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoplásico  8000/1  caso_clinico_radiologia645   493.0     483.0\n",
       " T2   formación  8000/1  caso_clinico_radiologia645   522.0     513.0,\n",
       " 'caso_clinico_radiologia646':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  caso_clinico_radiologia646    46.0      37.0,\n",
       " 'caso_clinico_radiologia654':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  realce meníngeo  8000/6  caso_clinico_radiologia654  1149.0    1134.0,\n",
       " 'caso_clinico_radiologia657':    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1    SE  9260/3  caso_clinico_radiologia657    50.0      48.0,\n",
       " 'caso_clinico_radiologia664':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  caso_clinico_radiologia664   164.0     155.0,\n",
       " 'caso_clinico_radiologia671':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia671   419.0     409.0,\n",
       " 'caso_clinico_radiologia672':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1     cáncer  8000/3  caso_clinico_radiologia672   355.0     349.0\n",
       " T2  neoplasia  8000/1  caso_clinico_radiologia672   606.0     597.0,\n",
       " 'caso_clinico_radiologia675':                              CLAVE ICD-O-3                   documento  \\\n",
       " T1              nódulos pulmonares  8000/6  caso_clinico_radiologia675   \n",
       " T2                       neoplasia  8000/1  caso_clinico_radiologia675   \n",
       " T3                      metástasis  8000/6  caso_clinico_radiologia675   \n",
       " T4                         tumoral  8000/1  caso_clinico_radiologia675   \n",
       " T5  nódulos pulmonares bilaterales  8000/6  caso_clinico_radiologia675   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   469.0     451.0  \n",
       " T2   526.0     517.0  \n",
       " T3   562.0     552.0  \n",
       " T4   724.0     717.0  \n",
       " T5   904.0     874.0  ,\n",
       " 'caso_clinico_radiologia682':                      CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  masa de partes blandas  8000/6  caso_clinico_radiologia682   299.0   \n",
       " T2              tumoración  8000/1  caso_clinico_radiologia682   442.0   \n",
       " \n",
       "     startpos  \n",
       " T1     277.0  \n",
       " T2     432.0  ,\n",
       " 'caso_clinico_radiologia685':                  CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  carcinoma escamoso  8070/3  caso_clinico_radiologia685    55.0      37.0\n",
       " T2           neoplasia  8000/1  caso_clinico_radiologia685   289.0     280.0,\n",
       " 'caso_clinico_radiologia687':                   CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lesiones cerebrales  8000/6  caso_clinico_radiologia687   502.0     483.0,\n",
       " 'caso_clinico_radiologia691':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  caso_clinico_radiologia691   784.0     775.0,\n",
       " 'caso_clinico_radiologia692':                     CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  lesión focal hepática  8000/6  caso_clinico_radiologia692   301.0   \n",
       " T2        lóbulo hepático  8000/6  caso_clinico_radiologia692   365.0   \n",
       " T3                  tumor  8000/1  caso_clinico_radiologia692   753.0   \n",
       " T4              Carcinoma  8010/3  caso_clinico_radiologia692   773.0   \n",
       " T5           cistoadenoma  8440/0  caso_clinico_radiologia692   801.0   \n",
       " T6    cistoadenocarcinoma  8440/3  caso_clinico_radiologia692   821.0   \n",
       " T7             metástasis  8000/6  caso_clinico_radiologia692   834.0   \n",
       " \n",
       "     startpos  \n",
       " T1     280.0  \n",
       " T2     350.0  \n",
       " T3     748.0  \n",
       " T4     764.0  \n",
       " T5     789.0  \n",
       " T6     802.0  \n",
       " T7     824.0  ,\n",
       " 'caso_clinico_radiologia697':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1     neoplasia  8000/1  caso_clinico_radiologia697    44.0      35.0\n",
       " T2  sarcomatoide  8033/3  caso_clinico_radiologia697    66.0      54.0,\n",
       " 'caso_clinico_radiologia698':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia698   631.0     621.0,\n",
       " 'caso_clinico_radiologia701':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  caso_clinico_radiologia701    99.0      90.0,\n",
       " 'caso_clinico_radiologia706':                         CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  Tumor de células gigantes  8003/3  caso_clinico_radiologia706   854.0   \n",
       " T2                 tumoración  8000/1  caso_clinico_radiologia706   886.0   \n",
       " \n",
       "     startpos  \n",
       " T1     829.0  \n",
       " T2     876.0  ,\n",
       " 'caso_clinico_radiologia707':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia707    85.0      75.0,\n",
       " 'caso_clinico_radiologia708':                  CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  carcinoma escamoso  8070/3  caso_clinico_radiologia708    61.0      43.0,\n",
       " 'caso_clinico_radiologia709':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  afectación ósea  8000/6  caso_clinico_radiologia709   340.0     325.0\n",
       " T2   Carcinomatosis  8010/9  caso_clinico_radiologia709   484.0     470.0,\n",
       " 'caso_clinico_radiologia712':                            CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  afectación de partes blandas  8000/6  caso_clinico_radiologia712   478.0   \n",
       " \n",
       "     startpos  \n",
       " T1     450.0  ,\n",
       " 'caso_clinico_radiologia716':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1         tumoral  8000/1  caso_clinico_radiologia716   526.0     519.0\n",
       " T2  Carcinomatosis  8010/9  caso_clinico_radiologia716   565.0     551.0,\n",
       " 'caso_clinico_radiologia717':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoplásico  8000/1  caso_clinico_radiologia717   380.0     370.0,\n",
       " 'caso_clinico_radiologia719':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  meningioma  9530/0  caso_clinico_radiologia719    51.0      41.0,\n",
       " 'caso_clinico_radiologia720':                     CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  afectación secundaria  8000/6  caso_clinico_radiologia720   736.0   \n",
       " \n",
       "     startpos  \n",
       " T1     715.0  ,\n",
       " 'caso_clinico_radiologia728':                          CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  afectación retroperitoneal  8000/6  caso_clinico_radiologia728   629.0   \n",
       " T2          afectación pélvica  8000/6  caso_clinico_radiologia728   942.0   \n",
       " T3                     tumoral  8000/1  caso_clinico_radiologia728  1008.0   \n",
       " T4                     sarcoma  8800/3  caso_clinico_radiologia728  1029.0   \n",
       " T5                diseminación  8000/6  caso_clinico_radiologia728  1054.0   \n",
       " T6                     linfoma  9590/3  caso_clinico_radiologia728  1079.0   \n",
       " \n",
       "     startpos  \n",
       " T1     603.0  \n",
       " T2     924.0  \n",
       " T3    1001.0  \n",
       " T4    1022.0  \n",
       " T5    1042.0  \n",
       " T6    1072.0  ,\n",
       " 'caso_clinico_radiologia734':                                 CLAVE  ICD-O-3                   documento  \\\n",
       " T1                       neoformación   8000/1  caso_clinico_radiologia734   \n",
       " T2                            tumoral   8000/1  caso_clinico_radiologia734   \n",
       " T3                 invasión vertebral   8000/6  caso_clinico_radiologia734   \n",
       " T4  carcinoma urotelial de alto grado  8120/34  caso_clinico_radiologia734   \n",
       " T5            diferenciación escamosa   8070/3  caso_clinico_radiologia734   \n",
       " T6                            tumores   8000/1  caso_clinico_radiologia734   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   533.0     521.0  \n",
       " T2   656.0     649.0  \n",
       " T3   874.0     856.0  \n",
       " T4   934.0     901.0  \n",
       " T5   962.0     939.0  \n",
       " T6  1095.0    1088.0  ,\n",
       " 'caso_clinico_radiologia736':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoformación  8000/1  caso_clinico_radiologia736   984.0     972.0\n",
       " T2     neoplasia  8000/1  caso_clinico_radiologia736  1068.0    1059.0,\n",
       " 'caso_clinico_radiologia737':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumorales  8000/1  caso_clinico_radiologia737  1412.0    1403.0,\n",
       " 'caso_clinico_radiologia738':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia738   391.0     382.0\n",
       " T2  neoplasia  8000/1  caso_clinico_radiologia738   439.0     430.0,\n",
       " 'caso_clinico_radiologia739':                    CLAVE  ICD-O-3                   documento  endpos  \\\n",
       " T1       lesión temporal   8000/6  caso_clinico_radiologia739   321.0   \n",
       " T2  glioma de alto grado  9380/34  caso_clinico_radiologia739   428.0   \n",
       " \n",
       "     startpos  \n",
       " T1     306.0  \n",
       " T2     408.0  ,\n",
       " 'caso_clinico_radiologia74':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia74   260.0     250.0,\n",
       " 'caso_clinico_radiologia743':                          CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1      masa de partes blandas  8000/6  caso_clinico_radiologia743   482.0   \n",
       " T2  proceso linfoproliferativo  9970/1  caso_clinico_radiologia743   893.0   \n",
       " T3                  malignidad  8000/3  caso_clinico_radiologia743  1020.0   \n",
       " \n",
       "     startpos  \n",
       " T1     460.0  \n",
       " T2     867.0  \n",
       " T3    1010.0  ,\n",
       " 'caso_clinico_radiologia744':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoral  8000/1  caso_clinico_radiologia744   635.0     628.0,\n",
       " 'caso_clinico_radiologia748':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  leucemia aguda  9801/3  caso_clinico_radiologia748    31.0      17.0,\n",
       " 'caso_clinico_radiologia750':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1     formación  8000/1  caso_clinico_radiologia750   190.0     181.0\n",
       " T2     neoplasia  8000/1  caso_clinico_radiologia750   373.0     364.0\n",
       " T3         tumor  8000/1  caso_clinico_radiologia750   822.0     817.0\n",
       " T4  neoformación  8000/1  caso_clinico_radiologia750   918.0     906.0,\n",
       " 'caso_clinico_radiologia751':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  metástasis  8000/6  caso_clinico_radiologia751  1148.0    1138.0\n",
       " T2       tumor  8000/1  caso_clinico_radiologia751  1219.0    1214.0,\n",
       " 'caso_clinico_radiologia752':     CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumor  8000/1  caso_clinico_radiologia752   711.0     706.0,\n",
       " 'caso_clinico_radiologia755':                                 CLAVE ICD-O-3                   documento  \\\n",
       " T1  carcinoma renal de células claras  8310/3  caso_clinico_radiologia755   \n",
       " T2                            tumoral  8000/1  caso_clinico_radiologia755   \n",
       " T3            metástasis de carcinoma  8010/6  caso_clinico_radiologia755   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   266.0     233.0  \n",
       " T2   574.0     567.0  \n",
       " T3   611.0     588.0  ,\n",
       " 'caso_clinico_radiologia758':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  afectación ósea  8000/6  caso_clinico_radiologia758   414.0     399.0\n",
       " T2   Carcinomatosis  8010/9  caso_clinico_radiologia758   558.0     544.0\n",
       " T3     metastásicas  8000/6  caso_clinico_radiologia758   700.0     688.0\n",
       " T4        neoplasia  8000/1  caso_clinico_radiologia758   774.0     765.0,\n",
       " 'caso_clinico_radiologia767':                            CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1                        cáncer  8000/3  caso_clinico_radiologia767    46.0   \n",
       " T2                    neoplásica  8000/1  caso_clinico_radiologia767   945.0   \n",
       " T3     linfangitis carcinomatosa  8000/3  caso_clinico_radiologia767  1009.0   \n",
       " T4  carcinoma ductal infiltrante  8500/3  caso_clinico_radiologia767  1042.0   \n",
       " \n",
       "     startpos  \n",
       " T1      40.0  \n",
       " T2     935.0  \n",
       " T3     984.0  \n",
       " T4    1014.0  ,\n",
       " 'caso_clinico_radiologia768':                  CLAVE   ICD-O-3                   documento  endpos  startpos\n",
       " T1          tumoración    8000/1  caso_clinico_radiologia768   538.0     528.0\n",
       " T2             maligna    8000/3  caso_clinico_radiologia768   546.0     539.0\n",
       " T3             linfoma    9590/3  caso_clinico_radiologia768   572.0     565.0\n",
       " T4  linfoma anaplásico  9590/3/H  caso_clinico_radiologia768   669.0     651.0,\n",
       " 'caso_clinico_radiologia770':                            CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1           afectación pulmonar  8000/6  caso_clinico_radiologia770   609.0   \n",
       " T2         Diseminación pulmonar  8000/6  caso_clinico_radiologia770   820.0   \n",
       " T3                 lesión lítica  8000/6  caso_clinico_radiologia770   856.0   \n",
       " T4  afectación de partes blandas  8000/6  caso_clinico_radiologia770  1251.0   \n",
       " T5                  neoformativo  8000/1  caso_clinico_radiologia770  1462.0   \n",
       " T6                    metástasis  8000/6  caso_clinico_radiologia770  1477.0   \n",
       " \n",
       "     startpos  \n",
       " T1     590.0  \n",
       " T2     799.0  \n",
       " T3     843.0  \n",
       " T4    1223.0  \n",
       " T5    1450.0  \n",
       " T6    1467.0  ,\n",
       " 'caso_clinico_radiologia774':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia774   297.0     288.0,\n",
       " 'caso_clinico_radiologia775':        CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  leucemia  9800/3  caso_clinico_radiologia775    26.0      18.0,\n",
       " 'caso_clinico_radiologia776':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  linfoma  9590/3  caso_clinico_radiologia776  1280.0    1273.0,\n",
       " 'caso_clinico_radiologia777':                          CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  proceso linfoproliferativo  9970/1  caso_clinico_radiologia777   744.0   \n",
       " \n",
       "     startpos  \n",
       " T1     718.0  ,\n",
       " 'caso_clinico_radiologia778':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1     formación  8000/1  caso_clinico_radiologia778   995.0     986.0\n",
       " T2  glioblastoma  9440/3  caso_clinico_radiologia778  1544.0    1532.0,\n",
       " 'caso_clinico_radiologia78':        CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  implante  8000/6  caso_clinico_radiologia78   383.0     375.0\n",
       " T2  teratoma  9080/1  caso_clinico_radiologia78   467.0     459.0,\n",
       " 'caso_clinico_radiologia780':     CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  MEN 2  8000/3  caso_clinico_radiologia780   917.0     912.0,\n",
       " 'caso_clinico_radiologia783':      CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lipoma  8850/0  caso_clinico_radiologia783   769.0     763.0,\n",
       " 'caso_clinico_radiologia786':     CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumor  8000/1  caso_clinico_radiologia786  1536.0    1531.0,\n",
       " 'caso_clinico_radiologia787':                  CLAVE   ICD-O-3                   documento  endpos  startpos\n",
       " T1   tumor neurogénico  8000/3/H  caso_clinico_radiologia787  1158.0    1141.0\n",
       " T2       neuroblastoma    9500/3  caso_clinico_radiologia787  1190.0    1177.0\n",
       " T3  masa paravertebral    8000/6  caso_clinico_radiologia787  1396.0    1378.0,\n",
       " 'caso_clinico_radiologia788':                           CLAVE  ICD-O-3                   documento  endpos  \\\n",
       " T1       masa de partes blandas   8000/6  caso_clinico_radiologia788   397.0   \n",
       " T2                   tumoración   8000/1  caso_clinico_radiologia788   606.0   \n",
       " T3  condrosarcoma de alto grado  9220/34  caso_clinico_radiologia788  1173.0   \n",
       " \n",
       "     startpos  \n",
       " T1     375.0  \n",
       " T2     596.0  \n",
       " T3    1146.0  ,\n",
       " 'caso_clinico_radiologia789':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   formación  8000/1  caso_clinico_radiologia789   156.0     147.0\n",
       " T2  metástasis  8000/6  caso_clinico_radiologia789   523.0     513.0\n",
       " T3     linfoma  9590/3  caso_clinico_radiologia789   581.0     574.0\n",
       " T4   neoplasia  8000/1  caso_clinico_radiologia789  1101.0    1092.0,\n",
       " 'caso_clinico_radiologia792':             CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  mielofibrosis  9961/3  caso_clinico_radiologia792    35.0      22.0\n",
       " T2             LB  9687/3  caso_clinico_radiologia792   582.0     580.0,\n",
       " 'caso_clinico_radiologia795':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  caso_clinico_radiologia795   424.0     415.0,\n",
       " 'caso_clinico_radiologia798':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  masa pélvica  8000/6  caso_clinico_radiologia798   338.0     326.0\n",
       " T2         tumor  8000/1  caso_clinico_radiologia798   742.0     737.0,\n",
       " 'caso_clinico_radiologia80':       CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoral  8000/1  caso_clinico_radiologia80   787.0     780.0,\n",
       " 'caso_clinico_radiologia807':                  CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  nódulos pulmonares  8000/6  caso_clinico_radiologia807   392.0     374.0\n",
       " T2           formación  8000/1  caso_clinico_radiologia807   856.0     847.0,\n",
       " 'caso_clinico_radiologia808':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  caso_clinico_radiologia808    51.0      37.0,\n",
       " 'caso_clinico_radiologia814':                CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  mieloma múltiple  9732/3  caso_clinico_radiologia814    40.0      24.0,\n",
       " 'caso_clinico_radiologia818':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  linfoma  9590/3  caso_clinico_radiologia818    31.0      24.0,\n",
       " 'caso_clinico_radiologia822':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  caso_clinico_radiologia822    73.0      64.0,\n",
       " 'caso_clinico_radiologia826':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia826  1201.0    1192.0,\n",
       " 'caso_clinico_radiologia830':                      CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  masa de partes blandas  8000/6  caso_clinico_radiologia830   335.0   \n",
       " \n",
       "     startpos  \n",
       " T1     313.0  ,\n",
       " 'caso_clinico_radiologia835':      CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  cáncer  8000/3  caso_clinico_radiologia835    43.0      37.0,\n",
       " 'caso_clinico_radiologia837':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  maligna  8000/3  caso_clinico_radiologia837   549.0     542.0,\n",
       " 'caso_clinico_radiologia838':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoraciones  8000/1  caso_clinico_radiologia838   323.0     311.0\n",
       " T2       tumoral  8000/1  caso_clinico_radiologia838   727.0     720.0,\n",
       " 'caso_clinico_radiologia841':                     CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1      Masa mediastínica  8000/6  caso_clinico_radiologia841   448.0   \n",
       " T2  afectación peritoneal  8000/6  caso_clinico_radiologia841   779.0   \n",
       " T3           omental cake  8000/6  caso_clinico_radiologia841   805.0   \n",
       " T4         Carcinomatosis  8010/9  caso_clinico_radiologia841   906.0   \n",
       " T5                  tumor  8000/1  caso_clinico_radiologia841   936.0   \n",
       " T6                linfoma  9590/3  caso_clinico_radiologia841   957.0   \n",
       " \n",
       "     startpos  \n",
       " T1     431.0  \n",
       " T2     758.0  \n",
       " T3     793.0  \n",
       " T4     892.0  \n",
       " T5     931.0  \n",
       " T6     950.0  ,\n",
       " 'caso_clinico_radiologia844':                           CLAVE  ICD-O-3                   documento  endpos  \\\n",
       " T1       masa de partes blandas   8000/6  caso_clinico_radiologia844   397.0   \n",
       " T2                   tumoración   8000/1  caso_clinico_radiologia844   606.0   \n",
       " T3  condrosarcoma de alto grado  9220/34  caso_clinico_radiologia844  1173.0   \n",
       " \n",
       "     startpos  \n",
       " T1     375.0  \n",
       " T2     596.0  \n",
       " T3    1146.0  ,\n",
       " 'caso_clinico_radiologia847':                          CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  consolidaciones pulmonares  8000/6  caso_clinico_radiologia847   272.0   \n",
       " \n",
       "     startpos  \n",
       " T1     246.0  ,\n",
       " 'caso_clinico_radiologia848':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  caso_clinico_radiologia848    45.0      36.0\n",
       " T2    tumoral  8000/1  caso_clinico_radiologia848   194.0     187.0\n",
       " T3         Ca  8000/3  caso_clinico_radiologia848   313.0     311.0,\n",
       " 'caso_clinico_radiologia861':                   CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  enfermedad pulmonar  8000/6  caso_clinico_radiologia861   956.0     937.0,\n",
       " 'caso_clinico_radiologia862':                   CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1      histiocitosis X  9751/3  caso_clinico_radiologia862  1796.0    1781.0\n",
       " T2  enfermedad pulmonar  8000/6  caso_clinico_radiologia862  1866.0    1847.0,\n",
       " 'caso_clinico_radiologia863':    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1    LB  9687/3  caso_clinico_radiologia863  1108.0    1106.0,\n",
       " 'caso_clinico_radiologia868':                   CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  células neoplásicas  8001/1  caso_clinico_radiologia868  2629.0    2610.0,\n",
       " 'caso_clinico_radiologia870':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoral  8000/1  caso_clinico_radiologia870   787.0     780.0,\n",
       " 'caso_clinico_radiologia871':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   formación  8000/1  caso_clinico_radiologia871   156.0     147.0\n",
       " T2  metástasis  8000/6  caso_clinico_radiologia871   523.0     513.0\n",
       " T3     linfoma  9590/3  caso_clinico_radiologia871   581.0     574.0\n",
       " T4   neoplasia  8000/1  caso_clinico_radiologia871  1101.0    1092.0,\n",
       " 'caso_clinico_radiologia875':                       CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1                    Mioma  8895/0  caso_clinico_radiologia875    54.0   \n",
       " T2                    tumor  8000/1  caso_clinico_radiologia875   512.0   \n",
       " T3                  tumoral  8000/1  caso_clinico_radiologia875  1014.0   \n",
       " T4      células neoplásicas  8001/1  caso_clinico_radiologia875  1615.0   \n",
       " T5  tumor fibroso solitario  8815/0  caso_clinico_radiologia875  2180.0   \n",
       " \n",
       "     startpos  \n",
       " T1      49.0  \n",
       " T2     507.0  \n",
       " T3    1007.0  \n",
       " T4    1596.0  \n",
       " T5    2157.0  ,\n",
       " 'caso_clinico_radiologia876':                  CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  carcinoma escamoso  8070/3  caso_clinico_radiologia876   554.0     536.0\n",
       " T2               tumor  8000/1  caso_clinico_radiologia876   893.0     888.0\n",
       " T3          metástasis  8000/6  caso_clinico_radiologia876  1219.0    1209.0\n",
       " T4                  M0  8000/6  caso_clinico_radiologia876  1229.0    1227.0,\n",
       " 'caso_clinico_radiologia877':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   implante  8000/6  caso_clinico_radiologia877   101.0      93.0\n",
       " T2  formación  8000/1  caso_clinico_radiologia877   581.0     572.0,\n",
       " 'caso_clinico_radiologia88':             CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  mielofibrosis  9961/3  caso_clinico_radiologia88    35.0      22.0\n",
       " T2             LB  9687/3  caso_clinico_radiologia88   582.0     580.0,\n",
       " 'caso_clinico_radiologia880':                   CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  células neoplásicas  8001/1  caso_clinico_radiologia880  1652.0    1633.0\n",
       " T2           tumoración  8000/1  caso_clinico_radiologia880  1708.0    1698.0,\n",
       " 'caso_clinico_radiologia881':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1      tumoración  8000/1  caso_clinico_radiologia881   541.0     531.0\n",
       " T2   masa pulmonar  8000/6  caso_clinico_radiologia881  1809.0    1796.0\n",
       " T3  lesiones óseas  8000/6  caso_clinico_radiologia881  2442.0    2428.0,\n",
       " 'caso_clinico_radiologia882':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1            Ca  8000/3  caso_clinico_radiologia882  2061.0    2059.0\n",
       " T2  metastásicas  8000/6  caso_clinico_radiologia882  2275.0    2263.0,\n",
       " 'caso_clinico_radiologia883':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neoplásica  8000/1  caso_clinico_radiologia883  1617.0    1607.0,\n",
       " 'caso_clinico_radiologia885':       CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoral  8000/1  caso_clinico_radiologia885  1758.0    1751.0,\n",
       " 'caso_clinico_radiologia888':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia888   573.0     564.0,\n",
       " 'caso_clinico_radiologia9':     CLAVE ICD-O-3                 documento  endpos  startpos\n",
       " T1  tumor  8000/1  caso_clinico_radiologia9   116.0     111.0,\n",
       " 'caso_clinico_radiologia909':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lesión pulmonar  8000/6  caso_clinico_radiologia909  2169.0    2154.0,\n",
       " 'caso_clinico_radiologia911':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia911  1025.0    1016.0,\n",
       " 'caso_clinico_radiologia914':                                      CLAVE ICD-O-3  \\\n",
       " T1  histiocitosis de células de Langerhans  9751/3   \n",
       " \n",
       "                      documento  endpos  startpos  \n",
       " T1  caso_clinico_radiologia914   729.0     691.0  ,\n",
       " 'caso_clinico_radiologia916':                   CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1            formación  8000/1  caso_clinico_radiologia916   505.0     496.0\n",
       " T2  enfermedad pulmonar  8000/6  caso_clinico_radiologia916   880.0     861.0,\n",
       " 'caso_clinico_radiologia917':                  CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  nódulos pulmonares  8000/6  caso_clinico_radiologia917   880.0     862.0,\n",
       " 'caso_clinico_radiologia918':                      CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1            fibroadenoma  9010/0  caso_clinico_radiologia918   295.0   \n",
       " T2          lesión pleural  8000/6  caso_clinico_radiologia918   936.0   \n",
       " T3  carcinoma sarcomatoide  8033/3  caso_clinico_radiologia918  1248.0   \n",
       " \n",
       "     startpos  \n",
       " T1     283.0  \n",
       " T2     922.0  \n",
       " T3    1226.0  ,\n",
       " 'caso_clinico_radiologia921':              CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neuroendocrina  8574/3  caso_clinico_radiologia921   753.0     739.0,\n",
       " 'caso_clinico_radiologia923':        CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  leucemia  9800/3  caso_clinico_radiologia923    44.0      36.0\n",
       " T2       LMA  9861/3  caso_clinico_radiologia923    64.0      61.0,\n",
       " 'caso_clinico_radiologia924':      CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  cáncer  8000/3  caso_clinico_radiologia924   407.0     401.0,\n",
       " 'caso_clinico_radiologia925':                             CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1                     metástasis  8000/6  caso_clinico_radiologia925  1018.0   \n",
       " T2  carcinoma papilar de tiroides  8260/3  caso_clinico_radiologia925  1200.0   \n",
       " \n",
       "     startpos  \n",
       " T1    1008.0  \n",
       " T2    1171.0  ,\n",
       " 'caso_clinico_radiologia926':                            CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1                        cáncer  8000/3  caso_clinico_radiologia926    61.0   \n",
       " T2                       maligno  8000/3  caso_clinico_radiologia926   235.0   \n",
       " T3                         tumor  8000/1  caso_clinico_radiologia926   388.0   \n",
       " T4                    malignidad  8000/3  caso_clinico_radiologia926   496.0   \n",
       " T5      Osteosarcoma metastásico  9180/6  caso_clinico_radiologia926   635.0   \n",
       " T6                       sarcoma  8800/3  caso_clinico_radiologia926   623.0   \n",
       " T7                    neoplasias  8000/1  caso_clinico_radiologia926   649.0   \n",
       " T8  carcinoma de células renales  8312/3  caso_clinico_radiologia926   712.0   \n",
       " T9                       linfoma  9590/3  caso_clinico_radiologia926   744.0   \n",
       " \n",
       "     startpos  \n",
       " T1      55.0  \n",
       " T2     228.0  \n",
       " T3     383.0  \n",
       " T4     486.0  \n",
       " T5     611.0  \n",
       " T6     616.0  \n",
       " T7     639.0  \n",
       " T8     684.0  \n",
       " T9     737.0  ,\n",
       " 'caso_clinico_radiologia927':                 CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1            linfoma  9590/3  caso_clinico_radiologia927   571.0     564.0\n",
       " T2  sarcoma de Kaposi  9140/3  caso_clinico_radiologia927   634.0     617.0\n",
       " T3  lesiones cutáneas  8000/6  caso_clinico_radiologia927   802.0     785.0,\n",
       " 'caso_clinico_radiologia928':                             CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1             masa paravertebral  8000/6  caso_clinico_radiologia928  1066.0   \n",
       " T2                        cordoma  9370/3  caso_clinico_radiologia928  1413.0   \n",
       " T3   Histiocitoma fibroso maligno  8830/3  caso_clinico_radiologia928  1445.0   \n",
       " T4                     metástasis  8000/6  caso_clinico_radiologia928  1459.0   \n",
       " T5                        tumores  8000/1  caso_clinico_radiologia928  1470.0   \n",
       " T6                  neurofibromas  9540/0  caso_clinico_radiologia928  1506.0   \n",
       " T7                    schwannomas  9560/0  caso_clinico_radiologia928  1519.0   \n",
       " T8                  Condrosarcoma  9220/3  caso_clinico_radiologia928  1537.0   \n",
       " T9                     neoplásico  8000/1  caso_clinico_radiologia928  1779.0   \n",
       " T10                       tumoral  8000/1  caso_clinico_radiologia928  1987.0   \n",
       " T11     condrosarcoma mesenquimal  9240/3  caso_clinico_radiologia928  2028.0   \n",
       " \n",
       "      startpos  \n",
       " T1     1048.0  \n",
       " T2     1406.0  \n",
       " T3     1417.0  \n",
       " T4     1449.0  \n",
       " T5     1463.0  \n",
       " T6     1493.0  \n",
       " T7     1508.0  \n",
       " T8     1524.0  \n",
       " T9     1769.0  \n",
       " T10    1980.0  \n",
       " T11    2003.0  ,\n",
       " 'caso_clinico_radiologia929':                   CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1        patrón difuso  8145/3  caso_clinico_radiologia929   389.0     376.0\n",
       " T2           Hemangioma  9120/0  caso_clinico_radiologia929   943.0     933.0\n",
       " T3  enfermedad pulmonar  8000/6  caso_clinico_radiologia929  1019.0    1000.0,\n",
       " 'caso_clinico_radiologia930':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  metastásicas  8000/6  caso_clinico_radiologia930   553.0     541.0,\n",
       " 'caso_clinico_radiologia931':                CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  masas pulmonares  8000/6  caso_clinico_radiologia931  1374.0    1358.0\n",
       " T2     masa pulmonar  8000/6  caso_clinico_radiologia931  1430.0    1417.0\n",
       " T3        neoplásico  8000/1  caso_clinico_radiologia931  1629.0    1619.0\n",
       " T4        metástasis  8000/6  caso_clinico_radiologia931  1641.0    1631.0\n",
       " T5             tumor  8000/1  caso_clinico_radiologia931  1647.0    1642.0,\n",
       " 'caso_clinico_radiologia933':                   CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  enfermedad pulmonar  8000/6  caso_clinico_radiologia933  2098.0    2079.0\n",
       " T2           Hemangioma  9120/0  caso_clinico_radiologia933  2123.0    2113.0,\n",
       " 'caso_clinico_radiologia934':                    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1                cáncer  8000/3  caso_clinico_radiologia934   183.0     177.0\n",
       " T2               sarcoma  8800/3  caso_clinico_radiologia934  1602.0    1595.0\n",
       " T3  metástasis de cáncer  8000/6  caso_clinico_radiologia934  1733.0    1713.0,\n",
       " 'caso_clinico_radiologia935':                              CLAVE ICD-O-3                   documento  \\\n",
       " T1  nódulos pulmonares bilaterales  8000/6  caso_clinico_radiologia935   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   497.0     467.0  ,\n",
       " 'caso_clinico_radiologia936':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1          CM  8000/3  caso_clinico_radiologia936  1099.0    1097.0\n",
       " T2  metastasis  8000/6  caso_clinico_radiologia936  1195.0    1185.0,\n",
       " 'caso_clinico_radiologia939':                      CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  masa de partes blandas  8000/6  caso_clinico_radiologia939   398.0   \n",
       " T2           Condrosarcoma  9220/3  caso_clinico_radiologia939   958.0   \n",
       " T3                blastoma  8000/3  caso_clinico_radiologia939   974.0   \n",
       " T4            osteosarcoma  9180/3  caso_clinico_radiologia939   988.0   \n",
       " T5              metástasis  8000/6  caso_clinico_radiologia939  1000.0   \n",
       " T6           neuroblastoma  9500/3  caso_clinico_radiologia939  1015.0   \n",
       " T7                   tumor  8000/1  caso_clinico_radiologia939  1438.0   \n",
       " \n",
       "     startpos  \n",
       " T1     376.0  \n",
       " T2     945.0  \n",
       " T3     966.0  \n",
       " T4     976.0  \n",
       " T5     990.0  \n",
       " T6    1002.0  \n",
       " T7    1433.0  ,\n",
       " 'caso_clinico_radiologia940':            CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1            Ca  8000/3  caso_clinico_radiologia940  1853.0    1851.0\n",
       " T2  metastásicas  8000/6  caso_clinico_radiologia940  2067.0    2055.0,\n",
       " 'caso_clinico_radiologia941':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  metástasis  8000/6  caso_clinico_radiologia941  1111.0    1101.0,\n",
       " 'caso_clinico_radiologia944':                 CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lesiones cutáneas  8000/6  caso_clinico_radiologia944   236.0     219.0\n",
       " T2   micosis fungoide  9700/3  caso_clinico_radiologia944  1088.0    1072.0\n",
       " T3            linfoma  9590/3  caso_clinico_radiologia944  1145.0    1138.0,\n",
       " 'caso_clinico_radiologia946':                  CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  nódulos pulmonares  8000/6  caso_clinico_radiologia946  1472.0    1454.0,\n",
       " 'caso_clinico_radiologia949':                  CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  masa paravertebral  8000/6  caso_clinico_radiologia949   548.0     530.0,\n",
       " 'caso_clinico_radiologia950':               CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  nódulo pulmonar  8000/6  caso_clinico_radiologia950   185.0     170.0,\n",
       " 'caso_clinico_radiologia951':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1     Timoma  8580/1  caso_clinico_radiologia951   745.0     739.0\n",
       " T2      tumor  8000/1  caso_clinico_radiologia951  1001.0     996.0\n",
       " T3  Carcinoma  8010/3  caso_clinico_radiologia951  1065.0    1056.0,\n",
       " 'caso_clinico_radiologia953':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  caso_clinico_radiologia953   755.0     746.0,\n",
       " 'caso_clinico_radiologia957':                            CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  tumoración de partes blandas  8800/1  caso_clinico_radiologia957   141.0   \n",
       " \n",
       "     startpos  \n",
       " T1     113.0  ,\n",
       " 'caso_clinico_radiologia958':        CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  implante  8000/6  caso_clinico_radiologia958  1627.0    1619.0,\n",
       " 'caso_clinico_radiologia961':           CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  lesión ósea  8000/6  caso_clinico_radiologia961    62.0      51.0,\n",
       " 'caso_clinico_radiologia963':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neurinoma  9560/0  caso_clinico_radiologia963    57.0      48.0,\n",
       " 'caso_clinico_radiologia964':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neurinoma  9560/0  caso_clinico_radiologia964   236.0     227.0,\n",
       " 'caso_clinico_radiologia965':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neurinoma  9560/0  caso_clinico_radiologia965   449.0     440.0,\n",
       " 'caso_clinico_radiologia966':                 CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1          poliposis  8210/0  caso_clinico_radiologia966    34.0      25.0\n",
       " T2         tumoración  8000/1  caso_clinico_radiologia966   123.0     113.0\n",
       " T3     adenocarcinoma  8140/3  caso_clinico_radiologia966   718.0     704.0\n",
       " T4  neoplasia maligna  8000/3  caso_clinico_radiologia966   738.0     721.0\n",
       " T5            linfoma  9590/3  caso_clinico_radiologia966   765.0     758.0,\n",
       " 'caso_clinico_radiologia967':    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   CBC  8090/3  caso_clinico_radiologia967   106.0     103.0,\n",
       " 'caso_clinico_radiologia968':    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   CBC  8090/3  caso_clinico_radiologia968   182.0     179.0,\n",
       " 'caso_clinico_radiologia969':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia969   451.0     441.0\n",
       " T2     lipomas  8850/0  caso_clinico_radiologia969   823.0     816.0\n",
       " T3     tumores  8000/1  caso_clinico_radiologia969   861.0     854.0\n",
       " T4    melanoma  8720/3  caso_clinico_radiologia969   878.0     870.0\n",
       " T5  schwannoma  9560/0  caso_clinico_radiologia969  1433.0    1423.0\n",
       " T6   neurinoma  9560/0  caso_clinico_radiologia969  1550.0    1541.0,\n",
       " 'caso_clinico_radiologia970':          CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  tumoración  8000/1  caso_clinico_radiologia970   604.0     594.0\n",
       " T2   neurinoma  9560/0  caso_clinico_radiologia970   635.0     626.0\n",
       " T3  Hemangioma  9120/0  caso_clinico_radiologia970   648.0     638.0,\n",
       " 'caso_clinico_radiologia972':        CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  implante  8000/6  caso_clinico_radiologia972    64.0      56.0,\n",
       " 'caso_clinico_radiologia973':    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   CBC  8090/3  caso_clinico_radiologia973   313.0     310.0,\n",
       " 'caso_clinico_radiologia975':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  poliposis  8210/0  caso_clinico_radiologia975   162.0     153.0,\n",
       " 'caso_clinico_radiologia976':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  formación  8000/1  caso_clinico_radiologia976   220.0     211.0\n",
       " T2    higroma  9173/0  caso_clinico_radiologia976   342.0     335.0,\n",
       " 'caso_clinico_radiologia977':             CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1     tumoración  8000/1  caso_clinico_radiologia977    61.0      51.0\n",
       " T2  Paraganglioma  8680/1  caso_clinico_radiologia977   775.0     762.0,\n",
       " 'caso_clinico_radiologia978':    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   CBC  8090/3  caso_clinico_radiologia978   151.0     148.0,\n",
       " 'caso_clinico_radiologia979':    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   CBC  8090/3  caso_clinico_radiologia979   266.0     263.0,\n",
       " 'caso_clinico_radiologia980':    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   CBC  8090/3  caso_clinico_radiologia980   210.0     207.0,\n",
       " 'caso_clinico_radiologia982':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  neurinoma  9560/0  caso_clinico_radiologia982   458.0     449.0,\n",
       " 'caso_clinico_radiologia985':    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1   CBC  8090/3  caso_clinico_radiologia985   318.0     315.0,\n",
       " 'caso_clinico_radiologia986':    CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1    LB  9687/3  caso_clinico_radiologia986  1257.0    1255.0,\n",
       " 'caso_clinico_radiologia993':         CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  caso_clinico_radiologia993   813.0     804.0\n",
       " T2    linfoma  9590/3  caso_clinico_radiologia993   838.0     831.0,\n",
       " 'caso_clinico_radiologia994':                   CLAVE ICD-O-3                   documento  endpos  startpos\n",
       " T1  enfermedad pulmonar  8000/6  caso_clinico_radiologia994   672.0     653.0,\n",
       " 'caso_clinico_radiologia998':                              CLAVE ICD-O-3                   documento  \\\n",
       " T1  carcinoma de células escamosas  8070/3  caso_clinico_radiologia998   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   333.0     303.0  ,\n",
       " 'caso_clinico_radiologia999':                          CLAVE ICD-O-3                   documento  endpos  \\\n",
       " T1  adenocarcinoma metastásico  8140/6  caso_clinico_radiologia999   283.0   \n",
       " \n",
       "     startpos  \n",
       " T1     257.0  ,\n",
       " 'cc_onco1002':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                          tumor  8000/1  cc_onco1002   321.0     316.0\n",
       " T2                  lesión lítica  8000/6  cc_onco1002  1887.0    1874.0\n",
       " T3        metástasis de carcinoma  8010/6  cc_onco1002  2557.0    2534.0\n",
       " T4  carcinoma papilar de tiroides  8260/3  cc_onco1002  2577.0    2548.0\n",
       " T5                 adenocarcinoma  8140/3  cc_onco1002  2815.0    2801.0\n",
       " T6                    metastásico  8000/6  cc_onco1002  3977.0    3966.0,\n",
       " 'cc_onco1003':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                 lesión lítica  8000/6  cc_onco1003  1017.0    1004.0\n",
       " T2                       tumores  8000/1  cc_onco1003  1451.0    1444.0\n",
       " T3  hepatocarcinoma fibrolamelar  8171/3  cc_onco1003  2114.0    2086.0\n",
       " T4                     Carcinoma  8010/3  cc_onco1003  2101.0    2092.0\n",
       " T5                    metástasis  8000/6  cc_onco1003  2490.0    2480.0\n",
       " T6             células tumorales  8001/1  cc_onco1003  2809.0    2792.0,\n",
       " 'cc_onco1004':                              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                       linfoma B  9591/3  cc_onco1004   284.0     275.0\n",
       " T2                          cáncer  8000/3  cc_onco1004   670.0     664.0\n",
       " T3  Carcinoma de células de Merkel  8247/3  cc_onco1004  2345.0    2315.0\n",
       " T4                         tumoral  8000/1  cc_onco1004  2862.0    2855.0\n",
       " T5                      tumoración  8000/1  cc_onco1004  3025.0    3015.0\n",
       " T6              carcinoma escamoso  8070/3  cc_onco1004  3180.0    3162.0\n",
       " T7                      metástasis  8000/6  cc_onco1004  3732.0    3722.0\n",
       " T8              lesiones hepáticas  8000/6  cc_onco1004  3908.0    3890.0,\n",
       " 'cc_onco1005':                                     CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                                 cáncer  8000/3  cc_onco1005    84.0   \n",
       " T2                         adenocarcinoma  8140/3  cc_onco1005   206.0   \n",
       " T3                                 T3N1M0  8000/6  cc_onco1005   234.0   \n",
       " T4                        nódulo pulmonar  8000/6  cc_onco1005   542.0   \n",
       " T5  metástasis pulmonar de adenocarcinoma  8140/6  cc_onco1005   703.0   \n",
       " T6                                tumoral  8000/1  cc_onco1005  1621.0   \n",
       " T7                    afectación pulmonar  8000/6  cc_onco1005  4611.0   \n",
       " T8            progresión a nivel pulmonar  8000/6  cc_onco1005  5361.0   \n",
       " \n",
       "     startpos  \n",
       " T1      78.0  \n",
       " T2     192.0  \n",
       " T3     228.0  \n",
       " T4     527.0  \n",
       " T5     666.0  \n",
       " T6    1614.0  \n",
       " T7    4592.0  \n",
       " T8    5334.0  ,\n",
       " 'cc_onco1006':                                CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                         tumorales   8000/1  cc_onco1006   664.0     655.0\n",
       " T2                      neoformación   8000/1  cc_onco1006   806.0     794.0\n",
       " T3                      metastásicas   8000/6  cc_onco1006   894.0     882.0\n",
       " T4  adenocarcinoma bien diferenciado  8140/31  cc_onco1006  1147.0    1115.0\n",
       " T5                         Carcinoma   8010/3  cc_onco1006  1129.0    1120.0\n",
       " T6               afectación hepática   8000/6  cc_onco1006  2191.0    2172.0\n",
       " T7                        metástasis   8000/6  cc_onco1006  2504.0    2494.0\n",
       " T8                lesiones hepáticas   8000/6  cc_onco1006  3549.0    3531.0\n",
       " T9        adenopatía supraclavicular   8000/6  cc_onco1006  4072.0    4046.0,\n",
       " 'cc_onco1013':                              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                          cáncer  8000/3  cc_onco1013    54.0      48.0\n",
       " T2                             CDI  8500/3  cc_onco1013    88.0      85.0\n",
       " T3                              HE  9133/1  cc_onco1013   138.0     136.0\n",
       " T4                Recaída pulmonar  8000/6  cc_onco1013  1163.0    1147.0\n",
       " T5  nódulos pulmonares bilaterales  8000/6  cc_onco1013  1389.0    1359.0\n",
       " T6                     metastásica  8000/6  cc_onco1013  1679.0    1668.0\n",
       " T7      proceso linfoproliferativo  9970/1  cc_onco1013  1975.0    1949.0\n",
       " T8              Linfoma no Hodgkin  9591/3  cc_onco1013  2009.0    1991.0\n",
       " T9                             LNH  9591/3  cc_onco1013  2014.0    2011.0,\n",
       " 'cc_onco1015':                       CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                   cáncer  8000/3  cc_onco1015   183.0     177.0\n",
       " T2          hepatocarcinoma  8170/3  cc_onco1015   265.0     250.0\n",
       " T3   enfermedad a distancia  8000/6  cc_onco1015   803.0     781.0\n",
       " T4           adenocarcinoma  8140/3  cc_onco1015   855.0     841.0\n",
       " T5                   T3N0M0  8000/6  cc_onco1015   871.0     865.0\n",
       " T6                   cancer  8000/3  cc_onco1015  1045.0    1039.0\n",
       " T7                tumorales  8000/1  cc_onco1015  1178.0    1169.0\n",
       " T8                  tumores  8000/1  cc_onco1015  1546.0    1539.0\n",
       " T9       lesiones hepáticas  8000/6  cc_onco1015  1737.0    1719.0\n",
       " T10              metástasis  8000/6  cc_onco1015  1854.0    1844.0\n",
       " T11       neoplasia maligna  8000/3  cc_onco1015  2878.0    2861.0\n",
       " T12             metastásica  8000/6  cc_onco1015  2899.0    2888.0,\n",
       " 'cc_onco1017':                           CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  adenocarcinoma mucosecretor  8481/3  cc_onco1017   284.0     257.0\n",
       " T2                    Carcinoma  8010/3  cc_onco1017   271.0     262.0\n",
       " T3         diseminación pleural  8000/6  cc_onco1017   335.0     315.0\n",
       " T4       masa de partes blandas  8000/6  cc_onco1017  1703.0    1681.0\n",
       " T5                    neoplasia  8000/1  cc_onco1017  2395.0    2386.0\n",
       " T6          implantes pleurales  8000/6  cc_onco1017  2702.0    2683.0\n",
       " T7             Lesiones líticas  8000/6  cc_onco1017  2901.0    2885.0\n",
       " T8                   metástasis  8000/6  cc_onco1017  2969.0    2959.0\n",
       " T9         diseminación tumoral  8000/6  cc_onco1017  3185.0    3165.0,\n",
       " 'cc_onco1023':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1            Carcinoma  8010/3  cc_onco1023    25.0      16.0\n",
       " T2   nódulos pulmonares  8000/6  cc_onco1023   703.0     685.0\n",
       " T3      nódulo pulmonar  8000/6  cc_onco1023   985.0     970.0\n",
       " T4        masa pulmonar  8000/6  cc_onco1023  1657.0    1644.0\n",
       " T5     masa suprarrenal  8000/6  cc_onco1023  2234.0    2218.0\n",
       " T6  lesiones pulmonares  8000/6  cc_onco1023  2974.0    2955.0\n",
       " T7           metástasis  8000/6  cc_onco1023  3571.0    3561.0,\n",
       " 'cc_onco1024':              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1          cáncer  8000/3  cc_onco1024   305.0     299.0\n",
       " T2       neoplasia  8000/1  cc_onco1024  1088.0    1079.0\n",
       " T3              CM  8000/3  cc_onco1024  1184.0    1182.0\n",
       " T4         tumores  8000/1  cc_onco1024  1642.0    1635.0\n",
       " T5  adenocarcinoma  8140/3  cc_onco1024  2978.0    2964.0\n",
       " T6         tumoral  8000/1  cc_onco1024  3732.0    3725.0,\n",
       " 'cc_onco1026':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                     neoplasia  8000/1  cc_onco1026   244.0     235.0\n",
       " T2  carcinoma ductal infiltrante  8500/3  cc_onco1026   339.0     311.0\n",
       " T3                            M0  8000/6  cc_onco1026   351.0     349.0\n",
       " T4                            HE  9133/1  cc_onco1026   395.0     393.0\n",
       " T5                     formación  8000/1  cc_onco1026  1394.0    1385.0\n",
       " T6                       maligna  8000/3  cc_onco1026  4685.0    4678.0,\n",
       " 'cc_onco1027':                                                CLAVE ICD-O-3    documento  \\\n",
       " T1  carcinoma de células renales tipo células claras  8310/3  cc_onco1027   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1  1302.0    1254.0  ,\n",
       " 'cc_onco1029':                                            CLAVE  ICD-O-3    documento  \\\n",
       " T1                                     tumorales   8000/1  cc_onco1029   \n",
       " T2                                    tumoración   8000/1  cc_onco1029   \n",
       " T3                                    neoplásica   8000/1  cc_onco1029   \n",
       " T4  carcinoma indiferenciado de células pequeñas  8041/34  cc_onco1029   \n",
       " T5                                  masa pélvica   8000/6  cc_onco1029   \n",
       " T6                    implantes intraabdominales   8000/6  cc_onco1029   \n",
       " T7                          nódulos peritoneales   8000/6  cc_onco1029   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   646.0     637.0  \n",
       " T2   779.0     769.0  \n",
       " T3  1187.0    1177.0  \n",
       " T4  2014.0    1970.0  \n",
       " T5  2723.0    2711.0  \n",
       " T6  2896.0    2870.0  \n",
       " T7  3769.0    3749.0  ,\n",
       " 'cc_onco1030':              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  cc_onco1030   916.0     902.0\n",
       " T2      neoplásica  8000/1  cc_onco1030  1384.0    1374.0\n",
       " T3      malignidad  8000/3  cc_onco1030  1495.0    1485.0\n",
       " T4     metastásica  8000/6  cc_onco1030  1589.0    1578.0\n",
       " T5      neoplásico  8000/1  cc_onco1030  4534.0    4524.0,\n",
       " 'cc_onco1037':                                  CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                          tumoración   8000/1  cc_onco1037  1016.0    1006.0\n",
       " T2          células tumorales malignas   8001/3  cc_onco1037  1161.0    1135.0\n",
       " T3                           tumorales   8000/1  cc_onco1037  1152.0    1143.0\n",
       " T4                 sarcoma pleomórfico   8802/3  cc_onco1037  1196.0    1177.0\n",
       " T5             tumor de partes blandas   8800/1  cc_onco1037  1254.0    1231.0\n",
       " T6                          metástasis   8000/6  cc_onco1037  1316.0    1306.0\n",
       " T7   sarcoma pleomórfico de alto grado  8802/34  cc_onco1037  1451.0    1418.0\n",
       " T8           sarcoma de partes blandas   8800/3  cc_onco1037  1704.0    1679.0\n",
       " T9                            pT2bN0M0   8000/6  cc_onco1037  1720.0    1712.0\n",
       " T10                progresión pulmonar   8000/6  cc_onco1037  1959.0    1940.0,\n",
       " 'cc_onco1038':                                               CLAVE ICD-O-3    documento  \\\n",
       " T1                carcinoma renal de células claras  8310/3  cc_onco1038   \n",
       " T2                                       metástasis  8000/6  cc_onco1038   \n",
       " T3                                  lesión cerebral  8000/6  cc_onco1038   \n",
       " T4                                          tumoral  8000/1  cc_onco1038   \n",
       " T5                                   neuroendocrino  8240/3  cc_onco1038   \n",
       " T6                                   Carcinomatosis  8010/9  cc_onco1038   \n",
       " T7                                         implante  8000/6  cc_onco1038   \n",
       " T8                                     metastásicos  8000/6  cc_onco1038   \n",
       " T9                                carcinoma papilar  8260/3  cc_onco1038   \n",
       " T10                         estadio IV por cerebral  8000/6  cc_onco1038   \n",
       " T11                                      neoplásico  8000/1  cc_onco1038   \n",
       " T12                           progresión peritoneal  8000/6  cc_onco1038   \n",
       " T13  enfermedad a nivel de sistema nervioso central  8000/6  cc_onco1038   \n",
       " T14                         metástasis de carcinoma  8010/6  cc_onco1038   \n",
       " T15                                      malignidad  8000/3  cc_onco1038   \n",
       " T16                             progresión cerebral  8000/6  cc_onco1038   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    505.0     472.0  \n",
       " T2    531.0     521.0  \n",
       " T3    875.0     860.0  \n",
       " T4   1046.0    1039.0  \n",
       " T5   3123.0    3109.0  \n",
       " T6   3955.0    3941.0  \n",
       " T7   4102.0    4094.0  \n",
       " T8   4116.0    4104.0  \n",
       " T9   4149.0    4132.0  \n",
       " T10  4179.0    4156.0  \n",
       " T11  4297.0    4287.0  \n",
       " T12  4373.0    4352.0  \n",
       " T13  4563.0    4517.0  \n",
       " T14  5904.0    5881.0  \n",
       " T15  6528.0    6518.0  \n",
       " T16  7388.0    7369.0  ,\n",
       " 'cc_onco1039':                                   CLAVE  ICD-O-3    documento  endpos  \\\n",
       " T1                               miomas   8895/0  cc_onco1039   124.0   \n",
       " T2                       masa abdominal   8000/6  cc_onco1039   192.0   \n",
       " T3                       Leiomiosarcoma   8890/3  cc_onco1039   544.0   \n",
       " T4               enfermedad a distancia   8000/6  cc_onco1039   712.0   \n",
       " T5                             implante   8000/6  cc_onco1039  1171.0   \n",
       " T6                  implante peritoneal   8000/6  cc_onco1039  1397.0   \n",
       " T7                              tumores   8000/1  cc_onco1039  1561.0   \n",
       " T8                           tumoración   8000/1  cc_onco1039  1746.0   \n",
       " T9   sarcoma pleomórfico indiferenciado  8802/34  cc_onco1039  2035.0   \n",
       " T10                             tumoral   8000/1  cc_onco1039  2088.0   \n",
       " T11                        intratumoral   8000/1  cc_onco1039  3877.0   \n",
       " T12               progresión peritoneal   8000/6  cc_onco1039  3935.0   \n",
       " T13                   recidiva pulmonar   8000/6  cc_onco1039  4174.0   \n",
       " \n",
       "      startpos  \n",
       " T1      118.0  \n",
       " T2      178.0  \n",
       " T3      530.0  \n",
       " T4      690.0  \n",
       " T5     1163.0  \n",
       " T6     1378.0  \n",
       " T7     1554.0  \n",
       " T8     1736.0  \n",
       " T9     2001.0  \n",
       " T10    2081.0  \n",
       " T11    3865.0  \n",
       " T12    3914.0  \n",
       " T13    4157.0  ,\n",
       " 'cc_onco104':                                          CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1                                   Carcinoma   8010/3  cc_onco104   693.0   \n",
       " T2                            células malignas   8001/3  cc_onco104  1072.0   \n",
       " T3                           teratoma quístico   9080/0  cc_onco104  1515.0   \n",
       " T4                                   neoplasia   8000/1  cc_onco104  1841.0   \n",
       " T5                                  malignidad   8000/3  cc_onco104  2683.0   \n",
       " T6                          nódulos pulmonares   8000/6  cc_onco104  2721.0   \n",
       " T7                     diseminación peritoneal   8000/6  cc_onco104  3264.0   \n",
       " T8                         afectación visceral   8000/6  cc_onco104  3334.0   \n",
       " T9  carcinoma escamoso pobremente diferenciado  8070/33  cc_onco104  3927.0   \n",
       " \n",
       "     startpos  \n",
       " T1     684.0  \n",
       " T2    1056.0  \n",
       " T3    1498.0  \n",
       " T4    1832.0  \n",
       " T5    2673.0  \n",
       " T6    2703.0  \n",
       " T7    3241.0  \n",
       " T8    3315.0  \n",
       " T9    3885.0  ,\n",
       " 'cc_onco1040':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                         tumor  8000/1  cc_onco1040    80.0      75.0\n",
       " T2                   metastásica  8000/6  cc_onco1040   149.0     138.0\n",
       " T3                lesiones óseas  8000/6  cc_onco1040  2015.0    2001.0\n",
       " T4  carcinoma ductal infiltrante  8500/3  cc_onco1040  2187.0    2159.0\n",
       " T5                            HE  9133/1  cc_onco1040  2555.0    2553.0\n",
       " T6              oligometastásica  8000/6  cc_onco1040  2620.0    2604.0\n",
       " T7               progresión ósea  8000/6  cc_onco1040  3597.0    3582.0\n",
       " T8   infiltración de médula ósea  8000/6  cc_onco1040  4192.0    4165.0\n",
       " T9       progresión a nivel óseo  8000/6  cc_onco1040  4723.0    4700.0,\n",
       " 'cc_onco1044':            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1    tumoración  8000/1  cc_onco1044   439.0     429.0\n",
       " T2  neoformación  8000/1  cc_onco1044   490.0     478.0\n",
       " T3  glioblastoma  9440/3  cc_onco1044   623.0     611.0\n",
       " T4    metástasis  8000/6  cc_onco1044  2481.0    2471.0,\n",
       " 'cc_onco1046':                          CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1           Masa mediastínica  8000/6  cc_onco1046  1285.0    1268.0\n",
       " T2      lesión retroperitoneal  8000/6  cc_onco1046  1810.0    1788.0\n",
       " T3                   tumorales  8000/1  cc_onco1046  2055.0    2046.0\n",
       " T4                      Timoma  8580/1  cc_onco1046  2157.0    2151.0\n",
       " T5    Carcinoma indiferenciado  8020/3  cc_onco1046  2585.0    2561.0\n",
       " T6              neuroendocrino  8240/3  cc_onco1046  2693.0    2679.0\n",
       " T7            carcinoma tímico  8586/3  cc_onco1046  2895.0    2879.0\n",
       " T8  afectación retroperitoneal  8000/6  cc_onco1046  3041.0    3015.0\n",
       " T9                     tumores  8000/1  cc_onco1046  3847.0    3840.0,\n",
       " 'cc_onco1050':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                       maligno  8000/3  cc_onco1050   416.0     409.0\n",
       " T2                     neoplasia  8000/1  cc_onco1050   953.0     944.0\n",
       " T3                    neoplásica  8000/1  cc_onco1050  1352.0    1342.0\n",
       " T4                    malignidad  8000/3  cc_onco1050  1523.0    1513.0\n",
       " T5                    metástasis  8000/6  cc_onco1050  1723.0    1713.0\n",
       " T6              melanoma maligno  8720/3  cc_onco1050  1790.0    1774.0\n",
       " T7       adenomas tubulovellosos  8263/0  cc_onco1050  1851.0    1828.0\n",
       " T8                  diseminación  8000/6  cc_onco1050  1918.0    1906.0\n",
       " T9         enfermedad diseminada  8000/6  cc_onco1050  2278.0    2257.0\n",
       " T10  progresión a nivel pulmonar  8000/6  cc_onco1050  2789.0    2762.0\n",
       " T11          afectación hepática  8000/6  cc_onco1050  3725.0    3706.0\n",
       " T12       metástasis de melanoma  8720/6  cc_onco1050  3945.0    3923.0\n",
       " T13         pólipos adenomatosos  8210/0  cc_onco1050  4412.0    4392.0\n",
       " T14                      tumoral  8000/1  cc_onco1050  4663.0    4656.0,\n",
       " 'cc_onco1051':                                                 CLAVE    ICD-O-3    documento  \\\n",
       " T1         adenocarcinoma de endometrio endometrioide     8380/3  cc_onco1051   \n",
       " T2                                          Carcinoma     8010/3  cc_onco1051   \n",
       " T3                                    nódulo pulmonar     8000/6  cc_onco1051   \n",
       " T4                                    lesión pulmonar     8000/6  cc_onco1051   \n",
       " T5  adenocarcinoma de LSD, de patrón sólido predom...  8140/32/H  cc_onco1051   \n",
       " T6                                            T1aN2M0     8000/6  cc_onco1051   \n",
       " T7                                 nódulos pulmonares     8000/6  cc_onco1051   \n",
       " T8                                            tumoral     8000/1  cc_onco1051   \n",
       " T9                                         metástasis     8000/6  cc_onco1051   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   224.0     182.0  \n",
       " T2   196.0     187.0  \n",
       " T3   383.0     368.0  \n",
       " T4  1243.0    1228.0  \n",
       " T5  1611.0    1508.0  \n",
       " T6  1657.0    1650.0  \n",
       " T7  2070.0    2052.0  \n",
       " T8  2312.0    2305.0  \n",
       " T9  2338.0    2328.0  ,\n",
       " 'cc_onco1053':                                 CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                  lesiones cutáneas  8000/6  cc_onco1053   519.0     502.0\n",
       " T2                            tumores  8000/1  cc_onco1053  1093.0    1086.0\n",
       " T3                         tumoración  8000/1  cc_onco1053  1274.0    1264.0\n",
       " T4                          neoplasia  8000/1  cc_onco1053  1682.0    1673.0\n",
       " T5  carcinoma renal de células claras  8310/3  cc_onco1053  1899.0    1866.0\n",
       " T6                           pT1aN0M0  8000/6  cc_onco1053  2419.0    2411.0,\n",
       " 'cc_onco1056':                                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                            tumorales  8000/1  cc_onco1056  1469.0    1460.0\n",
       " T2                          sarcomatosa  8800/9  cc_onco1056  1771.0    1760.0\n",
       " T3                           tumoración  8000/1  cc_onco1056  1819.0    1809.0\n",
       " T4                       Leiomiosarcoma  8890/3  cc_onco1056  1968.0    1954.0\n",
       " T5                        tumor maligno  8000/3  cc_onco1056  2076.0    2063.0\n",
       " T6                     melanoma maligno  8720/3  cc_onco1056  2574.0    2558.0\n",
       " T7                      rabdomiosarcoma  8900/3  cc_onco1056  2635.0    2620.0\n",
       " T8                              linfoma  9590/3  cc_onco1056  2674.0    2667.0\n",
       " T9                  mesotelioma maligno  9050/3  cc_onco1056  2716.0    2697.0\n",
       " T10                    sarcoma de Ewing  9260/3  cc_onco1056  2804.0    2788.0\n",
       " T11  tumor del estroma gastrointestinal  8936/3  cc_onco1056  2863.0    2829.0\n",
       " T12                                GIST  8936/3  cc_onco1056  2869.0    2865.0\n",
       " T13                            sarcomas  8800/3  cc_onco1056  5374.0    5366.0\n",
       " T14                              cancer  8000/3  cc_onco1056  5606.0    5600.0\n",
       " T15                             tumores  8000/1  cc_onco1056  6822.0    6815.0\n",
       " T16                 recidiva de sarcoma  8800/6  cc_onco1056  7627.0    7608.0,\n",
       " 'cc_onco1057':                                                  CLAVE    ICD-O-3  \\\n",
       " T1                                        tumoraciones     8000/1   \n",
       " T2   tumor indiferenciado formado por células redondas  8000/34/H   \n",
       " T3                                                  Ca     8000/3   \n",
       " T4                                       tumor maligno     8000/3   \n",
       " T5                     Rabdomiosarcoma sólido alveolar   8920/3/H   \n",
       " T6                                             sarcoma     8800/3   \n",
       " T7                                          metástasis     8000/6   \n",
       " T8                         infiltración de médula ósea     8000/6   \n",
       " T9            sarcoma desmoplásico de células redondas     8806/3   \n",
       " T10                  afectación ganglionar a distancia     8000/6   \n",
       " T11                 tumor de células pequeñas redondas   8000/1/H   \n",
       " T12  rabdomiosarcoma alveolar de muy alto riesgo (p...   8920/3/H   \n",
       " T13                                   rabdomiosarcomas     8900/3   \n",
       " T14                                            maligna     8000/3   \n",
       " \n",
       "        documento  endpos  startpos  \n",
       " T1   cc_onco1057  1406.0    1394.0  \n",
       " T2   cc_onco1057  1929.0    1880.0  \n",
       " T3   cc_onco1057  2105.0    2103.0  \n",
       " T4   cc_onco1057  2308.0    2295.0  \n",
       " T5   cc_onco1057  2553.0    2522.0  \n",
       " T6   cc_onco1057  2537.0    2530.0  \n",
       " T7   cc_onco1057  2611.0    2601.0  \n",
       " T8   cc_onco1057  2695.0    2668.0  \n",
       " T9   cc_onco1057  2831.0    2791.0  \n",
       " T10  cc_onco1057  3385.0    3352.0  \n",
       " T11  cc_onco1057  3654.0    3620.0  \n",
       " T12  cc_onco1057  3897.0    3839.0  \n",
       " T13  cc_onco1057  5497.0    5481.0  \n",
       " T14  cc_onco1057  6022.0    6015.0  ,\n",
       " 'cc_onco1059':                                  CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                     Nódulo tiroideo   8000/6  cc_onco1059  1523.0    1508.0\n",
       " T2                   masa paratraqueal   8000/6  cc_onco1059  1600.0    1583.0\n",
       " T3                          metástasis   8000/6  cc_onco1059  1885.0    1875.0\n",
       " T4                               tumor   8000/1  cc_onco1059  1930.0    1925.0\n",
       " T5                lesión endobronquial   8000/6  cc_onco1059  2129.0    2109.0\n",
       " T6                          neoplásico   8000/1  cc_onco1059  2151.0    2141.0\n",
       " T7            carcinoma neuroendocrino   8246/3  cc_onco1059  2412.0    2388.0\n",
       " T8                tumor neuroendocrino   8240/3  cc_onco1059  2570.0    2550.0\n",
       " T9          adenopatía supraclavicular   8000/6  cc_onco1059  2659.0    2633.0\n",
       " T10                         malignidad   8000/3  cc_onco1059  2712.0    2702.0\n",
       " T11     nódulos pulmonares bilaterales   8000/6  cc_onco1059  2952.0    2922.0\n",
       " T12         células tumorales malignas   8001/3  cc_onco1059  3393.0    3367.0\n",
       " T13                          tumorales   8000/1  cc_onco1059  3384.0    3375.0\n",
       " T14                          neoplasia   8000/1  cc_onco1059  3600.0    3591.0\n",
       " T15      carcinoma medular de tiroides   8510/3  cc_onco1059  3656.0    3627.0\n",
       " T16  carcinoma pobremente diferenciado  8010/33  cc_onco1059  3874.0    3841.0\n",
       " T17      afectación pulmonar bilateral   8000/6  cc_onco1059  4271.0    4242.0\n",
       " T18                         tumoración   8000/1  cc_onco1059  4876.0    4866.0\n",
       " T19           Carcinoma indiferenciado   8020/3  cc_onco1059  5624.0    5600.0\n",
       " T20                células neoplásicas   8001/1  cc_onco1059  5682.0    5663.0\n",
       " T21                         carcinomas   8010/3  cc_onco1059  6410.0    6400.0\n",
       " T22                lesiones pulmonares   8000/6  cc_onco1059  6780.0    6761.0\n",
       " T23      lesiones nodulares pulmonares   8000/6  cc_onco1059  7074.0    7045.0,\n",
       " 'cc_onco1060':                                 CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                          Carcinoma   8010/3  cc_onco1060   423.0     414.0\n",
       " T2  carcinoma urotelial de alto grado  8120/34  cc_onco1060   626.0     593.0\n",
       " T3                         metástasis   8000/6  cc_onco1060   758.0     748.0\n",
       " T4                  lesiones cutáneas   8000/6  cc_onco1060  2178.0    2161.0\n",
       " T5                        lesión ósea   8000/6  cc_onco1060  2730.0    2719.0\n",
       " T6             masa de partes blandas   8000/6  cc_onco1060  2763.0    2741.0\n",
       " T7                         neoplásica   8000/1  cc_onco1060  3490.0    3480.0,\n",
       " 'cc_onco1064':                           CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  tumor de células germinales  9064/3  cc_onco1064   455.0     428.0\n",
       " T2                     seminoma  9061/3  cc_onco1064   464.0     456.0\n",
       " T3                          TCG  9064/3  cc_onco1064   473.0     470.0\n",
       " T4                   metástasis  8000/6  cc_onco1064  2668.0    2658.0\n",
       " T5          células neoplásicas  8001/1  cc_onco1064  2756.0    2737.0\n",
       " T6                  metastásica  8000/6  cc_onco1064  3544.0    3533.0\n",
       " T7            lesión cerebelosa  8000/6  cc_onco1064  4096.0    4079.0\n",
       " T8                lesión dorsal  8000/6  cc_onco1064  4248.0    4235.0,\n",
       " 'cc_onco1065':            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1    tumoración  8000/1  cc_onco1065  1243.0    1233.0\n",
       " T2    malignidad  8000/3  cc_onco1065  1432.0    1422.0\n",
       " T3  angiosarcoma  9120/3  cc_onco1065  2959.0    2947.0\n",
       " T4    metástasis  8000/6  cc_onco1065  3354.0    3344.0,\n",
       " 'cc_onco1066':                                      CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1              adenopatía supraclavicular  8000/6  cc_onco1066   899.0   \n",
       " T2  metástasis de carcinoma indiferenciado  8020/6  cc_onco1066  1278.0   \n",
       " T3                              malignidad  8000/3  cc_onco1066  1666.0   \n",
       " T4                                      M1  8000/6  cc_onco1066  1901.0   \n",
       " T5                             metastásico  8000/6  cc_onco1066  1952.0   \n",
       " T6                                   tumor  8000/1  cc_onco1066  2455.0   \n",
       " T7                  carcinoma inflamatorio  8530/3  cc_onco1066  3741.0   \n",
       " \n",
       "     startpos  \n",
       " T1     873.0  \n",
       " T2    1240.0  \n",
       " T3    1656.0  \n",
       " T4    1899.0  \n",
       " T5    1941.0  \n",
       " T6    2450.0  \n",
       " T7    3719.0  ,\n",
       " 'cc_onco1075':                      CLAVE   ICD-O-3    documento  endpos  startpos\n",
       " T1               neoplasia    8000/1  cc_onco1075  1310.0    1301.0\n",
       " T2                 maligna    8000/3  cc_onco1075  1328.0    1321.0\n",
       " T3                malignas    8000/3  cc_onco1075  1822.0    1814.0\n",
       " T4  carcinoma inflamatorio    8530/3  cc_onco1075  1933.0    1911.0\n",
       " T5   carcinoma infiltrante  8010/3/H  cc_onco1075  2938.0    2917.0,\n",
       " 'cc_onco1078':                 CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma papilar  8260/3  cc_onco1078   142.0     125.0\n",
       " T2    nódulo pulmonar  8000/6  cc_onco1078   265.0     250.0\n",
       " T3     adenocarcinoma  8140/3  cc_onco1078   442.0     428.0\n",
       " T4    afectación ósea  8000/6  cc_onco1078   483.0     468.0\n",
       " T5   células malignas  8001/3  cc_onco1078  1823.0    1807.0\n",
       " T6       diseminación  8000/6  cc_onco1078  2204.0    2192.0\n",
       " T7     Carcinomatosis  8010/9  cc_onco1078  2231.0    2217.0\n",
       " T8          formación  8000/1  cc_onco1078  2441.0    2432.0,\n",
       " 'cc_onco1080':                                                CLAVE  ICD-O-3    documento  \\\n",
       " T1                              lesión endobronquial   8000/6  cc_onco1080   \n",
       " T2                             carcinoma epidermoide   8070/3  cc_onco1080   \n",
       " T3                                       metastásica   8000/6  cc_onco1080   \n",
       " T4                        adenopatía supraclavicular   8000/6  cc_onco1080   \n",
       " T5                                        malignidad   8000/3  cc_onco1080   \n",
       " T6  carcinoma epidermoide moderadamente diferenciado  8070/32  cc_onco1080   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1  1296.0    1276.0  \n",
       " T2  1352.0    1331.0  \n",
       " T3  1764.0    1753.0  \n",
       " T4  1847.0    1821.0  \n",
       " T5  1901.0    1891.0  \n",
       " T6  2230.0    2182.0  ,\n",
       " 'cc_onco1081':                                                  CLAVE  ICD-O-3    documento  \\\n",
       " T1                           adenocarcinoma intestinal   8144/3  cc_onco1081   \n",
       " T2                                           Carcinoma   8010/3  cc_onco1081   \n",
       " T3                                          metastásis   8000/6  cc_onco1081   \n",
       " T4           adenocarcinoma moderadamente diferenciado  8140/32  cc_onco1081   \n",
       " T5                                             cT4N0M0   8000/6  cc_onco1081   \n",
       " T6   adenocarcinoma de recto moderadamente diferenc...   8140/6  cc_onco1081   \n",
       " T7                                    recaída hepática   8000/6  cc_onco1081   \n",
       " T8                                    Recaída pulmonar   8000/6  cc_onco1081   \n",
       " T9                          adenocarcinoma metastásico   8140/6  cc_onco1081   \n",
       " T10                                  recidiva pulmonar   8000/6  cc_onco1081   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    783.0     758.0  \n",
       " T2    772.0     763.0  \n",
       " T3    952.0     942.0  \n",
       " T4   1038.0     997.0  \n",
       " T5   1130.0    1123.0  \n",
       " T6   1319.0    1269.0  \n",
       " T7   1749.0    1733.0  \n",
       " T8   2546.0    2530.0  \n",
       " T9   2897.0    2871.0  \n",
       " T10  3785.0    3768.0  ,\n",
       " 'cc_onco1082':                     CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                     CM  8000/3  cc_onco1082  3667.0    3665.0\n",
       " T2              tumorales  8000/1  cc_onco1082  4431.0    4422.0\n",
       " T3  Carcinoma microcítico  8041/3  cc_onco1082  4855.0    4834.0\n",
       " T4             neoplásico  8000/1  cc_onco1082  5161.0    5151.0,\n",
       " 'cc_onco1083':                              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1    carcinoma ductal infiltrante  8500/3  cc_onco1083   185.0     157.0\n",
       " T2                              CM  8000/3  cc_onco1083   379.0     377.0\n",
       " T3       Leucemia mieloide crónica  9863/3  cc_onco1083   585.0     560.0\n",
       " T4                          cáncer  8000/3  cc_onco1083   747.0     741.0\n",
       " T5                    recaída ósea  8000/6  cc_onco1083   862.0     850.0\n",
       " T6  progresión exclusivamente ósea  8000/6  cc_onco1083  1114.0    1084.0\n",
       " T7                  lesiones óseas  8000/6  cc_onco1083  1343.0    1329.0\n",
       " T8                     metastásica  8000/6  cc_onco1083  5590.0    5579.0,\n",
       " 'cc_onco1084':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma ductal infiltrante  8500/3  cc_onco1084   173.0     145.0\n",
       " T2                         tumor  8000/1  cc_onco1084  1620.0    1615.0\n",
       " T3        masa de partes blandas  8000/6  cc_onco1084  2523.0    2501.0\n",
       " T4                   metastásica  8000/6  cc_onco1084  2654.0    2643.0\n",
       " T5                        cáncer  8000/3  cc_onco1084  2729.0    2723.0\n",
       " T6                   metastásico  8000/6  cc_onco1084  3090.0    3079.0,\n",
       " 'cc_onco1085':                           CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1             células malignas  8001/3  cc_onco1085  1119.0    1103.0\n",
       " T2                   neoplásica  8000/1  cc_onco1085  1438.0    1428.0\n",
       " T3                     angiomas  9120/0  cc_onco1085  4012.0    4004.0\n",
       " T4                   metástasis  8000/6  cc_onco1085  4287.0    4277.0\n",
       " T5                   tumoración  8000/1  cc_onco1085  4299.0    4289.0\n",
       " T6                      sarcoma  8800/3  cc_onco1085  4502.0    4495.0\n",
       " T7                 angiosarcoma  9120/3  cc_onco1085  5070.0    5058.0\n",
       " T8                           M1  8000/6  cc_onco1085  5207.0    5205.0\n",
       " T9              lesión hepática  8000/6  cc_onco1085  5778.0    5763.0\n",
       " T10   tumor fusocelular maligno  8004/3  cc_onco1085  6078.0    6053.0\n",
       " T11  metástasis de angiosarcoma  9120/6  cc_onco1085  6374.0    6348.0\n",
       " T12                 metastásica  8000/6  cc_onco1085  6644.0    6633.0,\n",
       " 'cc_onco1086':                         CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1        enfermedad pulmonar  8000/6  cc_onco1086   251.0     232.0\n",
       " T2                  Carcinoma  8010/3  cc_onco1086   288.0     279.0\n",
       " T3              masa pulmonar  8000/6  cc_onco1086  3868.0    3855.0\n",
       " T4               neoformación  8000/1  cc_onco1086  4126.0    4114.0\n",
       " T5               metastásicas  8000/6  cc_onco1086  4517.0    4505.0\n",
       " T6           células malignas  8001/3  cc_onco1086  4682.0    4666.0\n",
       " T7   carcinoma no microcítico  8046/3  cc_onco1086  4887.0    4863.0\n",
       " T8             adenocarcinoma  8140/3  cc_onco1086  4903.0    4889.0\n",
       " T9                 metástasis  8000/6  cc_onco1086  5045.0    5035.0\n",
       " T10           lesión cerebral  8000/6  cc_onco1086  5719.0    5704.0\n",
       " T11            lesión frontal  8000/6  cc_onco1086  5796.0    5782.0,\n",
       " 'cc_onco1087':                                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                            melanoma  8720/3  cc_onco1087    96.0      88.0\n",
       " T2   melanoma de extensión superficial  8743/3  cc_onco1087   182.0     149.0\n",
       " T3                      lesión cutánea  8000/6  cc_onco1087   338.0     324.0\n",
       " T4                          malignidad  8000/3  cc_onco1087   485.0     475.0\n",
       " T5                   nódulo subcutáneo  8000/6  cc_onco1087   536.0     519.0\n",
       " T6                    melanoma maligno  8720/3  cc_onco1087   756.0     740.0\n",
       " T7                          metástasis  8000/6  cc_onco1087   838.0     828.0\n",
       " T8                      Carcinomatosis  8010/9  cc_onco1087  1244.0    1230.0\n",
       " T9              implantes peritoneales  8000/6  cc_onco1087  2211.0    2189.0\n",
       " T10                    nódulo pulmonar  8000/6  cc_onco1087  3116.0    3101.0\n",
       " T11               Melanoma metastásico  8720/6  cc_onco1087  4903.0    4883.0,\n",
       " 'cc_onco1092':                       CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1               tumoración  8000/1  cc_onco1092   145.0     135.0\n",
       " T2  metástasis por melanoma  8720/6  cc_onco1092   333.0     310.0\n",
       " T3                    nevus  8720/0  cc_onco1092   645.0     640.0\n",
       " T4               malignidad  8000/3  cc_onco1092   708.0     698.0\n",
       " T5                  tumoral  8000/1  cc_onco1092  1285.0    1278.0,\n",
       " 'cc_onco1095':                CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1   hepatocarcinoma  8170/3  cc_onco1095   439.0     424.0\n",
       " T2            cáncer  8000/3  cc_onco1095   470.0     464.0\n",
       " T3        tumoración  8000/1  cc_onco1095  1930.0    1920.0\n",
       " T4        malignidad  8000/3  cc_onco1095  2003.0    1993.0\n",
       " T5    adenocarcinoma  8140/3  cc_onco1095  2058.0    2044.0\n",
       " T6          implante  8000/6  cc_onco1095  2468.0    2460.0\n",
       " T7           cT4N1M1  8000/6  cc_onco1095  2572.0    2565.0\n",
       " T8           tumores  8000/1  cc_onco1095  2639.0    2632.0\n",
       " T9        metástasis  8000/6  cc_onco1095  3127.0    3117.0\n",
       " T10        tumorales  8000/1  cc_onco1095  4390.0    4381.0\n",
       " T11  lóbulo hepático  8000/6  cc_onco1095  5618.0    5603.0\n",
       " T12          adenoma  8140/0  cc_onco1095  8246.0    8239.0,\n",
       " 'cc_onco1096':                        CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                     tumor  8000/1  cc_onco1096    94.0      89.0\n",
       " T2                  seminoma  9061/3  cc_onco1096   167.0     159.0\n",
       " T3        nódulos pulmonares  8000/6  cc_onco1096   328.0     310.0\n",
       " T4                tumoración  8000/1  cc_onco1096   361.0     351.0\n",
       " T5          suelta de globos  8000/6  cc_onco1096  1124.0    1108.0\n",
       " T6              metastásicas  8000/6  cc_onco1096  1294.0    1282.0\n",
       " T7                malignidad  8000/3  cc_onco1096  2204.0    2194.0\n",
       " T8           lesión pulmonar  8000/6  cc_onco1096  2279.0    2264.0\n",
       " T9                   tumoral  8000/1  cc_onco1096  2395.0    2388.0\n",
       " T10  metástasis de carcinoma  8010/6  cc_onco1096  2651.0    2628.0\n",
       " T11      lesiones pulmonares  8000/6  cc_onco1096  2791.0    2772.0\n",
       " T12         masa suprarrenal  8000/6  cc_onco1096  2823.0    2807.0,\n",
       " 'cc_onco1099':                      CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                 tumoral  8000/1  cc_onco1099  1240.0    1233.0\n",
       " T2               neoplasia  8000/1  cc_onco1099  1528.0    1519.0\n",
       " T3  afectación a distancia  8000/6  cc_onco1099  1867.0    1845.0\n",
       " T4   carcinoma epidermoide  8070/3  cc_onco1099  1999.0    1978.0,\n",
       " 'cc_onco1100':                                      CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                              neoplásico  8000/1  cc_onco1100   780.0   \n",
       " T2                          adenocarcinoma  8140/3  cc_onco1100   960.0   \n",
       " T3                             metastásica  8000/6  cc_onco1100  1286.0   \n",
       " T4  adenocarcinoma gástrico de tipo difuso  8145/3  cc_onco1100  1652.0   \n",
       " T5                      nódulo suprarrenal  8000/6  cc_onco1100  2116.0   \n",
       " \n",
       "     startpos  \n",
       " T1     770.0  \n",
       " T2     946.0  \n",
       " T3    1275.0  \n",
       " T4    1614.0  \n",
       " T5    2098.0  ,\n",
       " 'cc_onco1103':                          CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1              adenocarcinoma  8140/3  cc_onco1103   126.0     112.0\n",
       " T2           nódulos hepáticos  8000/6  cc_onco1103   344.0     327.0\n",
       " T3              lesiones óseas  8000/6  cc_onco1103   381.0     367.0\n",
       " T4       enfermedad diseminada  8000/6  cc_onco1103   471.0     450.0\n",
       " T5                  neoplásico  8000/1  cc_onco1103  1161.0    1151.0\n",
       " T6              Carcinomatosis  8010/9  cc_onco1103  1382.0    1368.0\n",
       " T7  diseminación leptomeníngea  8000/6  cc_onco1103  1524.0    1498.0,\n",
       " 'cc_onco1105':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1            neoplasia  8000/1  cc_onco1105   217.0     208.0\n",
       " T2           metástasis  8000/6  cc_onco1105   239.0     229.0\n",
       " T3       adenocarcinoma  8140/3  cc_onco1105   350.0     336.0\n",
       " T4  enfermedad hepática  8000/6  cc_onco1105   821.0     802.0\n",
       " T5         metastásicas  8000/6  cc_onco1105   927.0     915.0\n",
       " T6   lesiones hepáticas  8000/6  cc_onco1105  1430.0    1412.0,\n",
       " 'cc_onco1106':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1              colangiocarcinoma  8160/3  cc_onco1106   269.0     252.0\n",
       " T2                        tumoral  8000/1  cc_onco1106   796.0     789.0\n",
       " T3                      neoplasia  8000/1  cc_onco1106  1379.0    1370.0\n",
       " T4  afectación pulmonar bilateral  8000/6  cc_onco1106  2714.0    2685.0\n",
       " T5                             LB  9687/3  cc_onco1106  3709.0    3707.0\n",
       " T6            afectación hepática  8000/6  cc_onco1106  3990.0    3971.0,\n",
       " 'cc_onco1107':                                                  CLAVE ICD-O-3    documento  \\\n",
       " T1                                      lesión cutánea  8000/6  cc_onco1107   \n",
       " T2                                       patrón difuso  8145/3  cc_onco1107   \n",
       " T3                           sarcoma de células claras  9044/3  cc_onco1107   \n",
       " T4                                                 SCC  9044/3  cc_onco1107   \n",
       " T5                                               tumor  8000/1  cc_onco1107   \n",
       " T6       adenopatías a nivel cervical, supraclavicular  8000/6  cc_onco1107   \n",
       " T7                                   lesiones cutáneas  8000/6  cc_onco1107   \n",
       " T8                                          malignidad  8000/3  cc_onco1107   \n",
       " T9                                   nódulos pleurales  8000/6  cc_onco1107   \n",
       " T10                                         metástasis  8000/6  cc_onco1107   \n",
       " T11                                   células malignas  8001/3  cc_onco1107   \n",
       " T12                                   melanoma maligno  8720/3  cc_onco1107   \n",
       " T13                                         tumoración  8000/1  cc_onco1107   \n",
       " T14  recidiva de sarcoma de células claras a nivel ...  9044/6  cc_onco1107   \n",
       " T15                         sarcomas de partes blandas  9044/3  cc_onco1107   \n",
       " T16                      Adenopatías supraclaviculares  8000/6  cc_onco1107   \n",
       " T17                                 lesiones pleurales  8000/6  cc_onco1107   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    182.0     168.0  \n",
       " T2    422.0     409.0  \n",
       " T3    710.0     685.0  \n",
       " T4    715.0     712.0  \n",
       " T5    968.0     963.0  \n",
       " T6   1792.0    1747.0  \n",
       " T7   1863.0    1846.0  \n",
       " T8   1889.0    1879.0  \n",
       " T9   2091.0    2074.0  \n",
       " T10  2127.0    2117.0  \n",
       " T11  2340.0    2324.0  \n",
       " T12  2477.0    2461.0  \n",
       " T13  3035.0    3025.0  \n",
       " T14  3449.0    3396.0  \n",
       " T15  3676.0    3650.0  \n",
       " T16  4001.0    3972.0  \n",
       " T17  4070.0    4052.0  ,\n",
       " 'cc_onco1108':                                         CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                                     cáncer  8000/3  cc_onco1108   283.0   \n",
       " T2  adenopatías cervicales, supraclaviculares  8000/6  cc_onco1108   694.0   \n",
       " T3                                    cordoma  9370/3  cc_onco1108  1151.0   \n",
       " T4                                 tumoración  8000/1  cc_onco1108  1703.0   \n",
       " T5                          células tumorales  8001/1  cc_onco1108  2125.0   \n",
       " T6                                 neoplásica  8000/1  cc_onco1108  3046.0   \n",
       " \n",
       "     startpos  \n",
       " T1     277.0  \n",
       " T2     653.0  \n",
       " T3    1144.0  \n",
       " T4    1693.0  \n",
       " T5    2108.0  \n",
       " T6    3036.0  ,\n",
       " 'cc_onco1109':                                          CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                                   Carcinoma  8010/3  cc_onco1109   265.0   \n",
       " T2                                     adenoma  8140/0  cc_onco1109   331.0   \n",
       " T3                                   tumorales  8000/1  cc_onco1109  1155.0   \n",
       " T4                        tumor neuroendocrino  8240/3  cc_onco1109  1998.0   \n",
       " T5                        metástasis de cáncer  8000/6  cc_onco1109  2058.0   \n",
       " T6   metástasis de carcinoma de células claras  8310/6  cc_onco1109  2421.0   \n",
       " T7         carcinoma de células claras renales  8312/3  cc_onco1109  2429.0   \n",
       " T8                                     tumores  8000/1  cc_onco1109  2756.0   \n",
       " T9                                diseminación  8000/6  cc_onco1109  3594.0   \n",
       " T10                                  neoplasia  8000/1  cc_onco1109  3865.0   \n",
       " T11                    tumores neuroendocrinos  8240/3  cc_onco1109  4177.0   \n",
       " T12                                        TNE  8240/3  cc_onco1109  4182.0   \n",
       " \n",
       "      startpos  \n",
       " T1      256.0  \n",
       " T2      324.0  \n",
       " T3     1146.0  \n",
       " T4     1978.0  \n",
       " T5     2038.0  \n",
       " T6     2380.0  \n",
       " T7     2394.0  \n",
       " T8     2749.0  \n",
       " T9     3582.0  \n",
       " T10    3856.0  \n",
       " T11    4154.0  \n",
       " T12    4179.0  ,\n",
       " 'cc_onco1110':                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma escamoso  8070/3  cc_onco1110   328.0     310.0\n",
       " T2     realce meníngeo  8000/6  cc_onco1110  2649.0    2634.0\n",
       " T3             tumores  8000/1  cc_onco1110  3613.0    3606.0,\n",
       " 'cc_onco1112':                                 CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1             masa de partes blandas  8000/6  cc_onco1112  1277.0    1255.0\n",
       " T2                   masa pericárdica  8000/6  cc_onco1112  1394.0    1378.0\n",
       " T3                      LOE hepáticas  8000/6  cc_onco1112  1477.0    1464.0\n",
       " T4                         metástasis  8000/6  cc_onco1112  1503.0    1493.0\n",
       " T5               masa retroperitoneal  8000/6  cc_onco1112  1525.0    1505.0\n",
       " T6  linfoma B difuso de célula grande  9680/3  cc_onco1112  2351.0    2318.0\n",
       " T7                   células malignas  8001/3  cc_onco1112  2496.0    2480.0\n",
       " T8                 lesiones hepáticas  8000/6  cc_onco1112  3111.0    3093.0\n",
       " T9                         neoplásica  8000/1  cc_onco1112  3510.0    3500.0,\n",
       " 'cc_onco1113':                     CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma epidermoide  8070/3  cc_onco1113   126.0     105.0\n",
       " T2     nódulos pulmonares  8000/6  cc_onco1113  1900.0    1882.0\n",
       " T3          masa pulmonar  8000/6  cc_onco1113  1976.0    1963.0\n",
       " T4            metastásica  8000/6  cc_onco1113  3843.0    3832.0\n",
       " T5    afectación cerebral  8000/6  cc_onco1113  4155.0    4136.0,\n",
       " 'cc_onco1114':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                      neoplasia  8000/1  cc_onco1114   122.0     113.0\n",
       " T2                 adenocarcinoma  8140/3  cc_onco1114   965.0     951.0\n",
       " T3     células en anillo de sello  8490/3  cc_onco1114  1014.0     988.0\n",
       " T4                     neoplásico  8000/1  cc_onco1114  1396.0    1386.0\n",
       " T5                         T3N1M0  8000/6  cc_onco1114  1786.0    1780.0\n",
       " T6                        tumores  8000/1  cc_onco1114  1846.0    1839.0\n",
       " T7          enfermedad peritoneal  8000/6  cc_onco1114  2017.0    1996.0\n",
       " T8         implantes peritoneales  8000/6  cc_onco1114  2133.0    2111.0\n",
       " T9                     metástasis  8000/6  cc_onco1114  2247.0    2237.0\n",
       " T10                    malignidad  8000/3  cc_onco1114  2295.0    2285.0\n",
       " T11                           CCR  8312/3  cc_onco1114  2645.0    2642.0\n",
       " T12                        cáncer  8000/3  cc_onco1114  3083.0    3077.0\n",
       " T13                   metastásico  8000/6  cc_onco1114  3111.0    3100.0\n",
       " T14                     tumorales  8000/1  cc_onco1114  4119.0    4110.0\n",
       " T15                Carcinomatosis  8010/9  cc_onco1114  4595.0    4581.0\n",
       " T16  metástasis de adenocarcinoma  8140/6  cc_onco1114  5138.0    5110.0\n",
       " T17          nódulos peritoneales  8000/6  cc_onco1114  5191.0    5171.0\n",
       " T18        enfermedad a distancia  8000/6  cc_onco1114  5734.0    5712.0,\n",
       " 'cc_onco1116':                          CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                      cáncer   8000/3  cc_onco1116    81.0      75.0\n",
       " T2                  tumoración   8000/1  cc_onco1116   383.0     373.0\n",
       " T3            nódulos cutáneos   8000/6  cc_onco1116   944.0     928.0\n",
       " T4  angiosarcoma de alto grado  9120/34  cc_onco1116  1524.0    1498.0,\n",
       " 'cc_onco1119':                              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                       poliposis  8210/0  cc_onco1119    56.0      47.0\n",
       " T2  poliposis adenomatosa familiar  8220/0  cc_onco1119   534.0     504.0\n",
       " T3                     adenomatosa  8140/0  cc_onco1119   525.0     514.0\n",
       " T4                  tumor desmoide  8821/1  cc_onco1119  2551.0    2537.0\n",
       " T5                    tumoraciones  8000/1  cc_onco1119  2591.0    2579.0\n",
       " T6                      tumoración  8000/1  cc_onco1119  3171.0    3161.0\n",
       " T7             síndrome de Gardner  8220/0  cc_onco1119  3454.0    3435.0\n",
       " T8                         tumores  8000/1  cc_onco1119  3625.0    3618.0\n",
       " T9               tumores desmoides  8821/1  cc_onco1119  4113.0    4096.0,\n",
       " 'cc_onco112':                                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                  hemangioblastomas  9161/1  cc_onco112   143.0     126.0\n",
       " T2                           blastoma  8000/3  cc_onco112   142.0     134.0\n",
       " T3                          neoplasia  8000/1  cc_onco112   287.0     278.0\n",
       " T4  carcinoma renal de células claras  8310/3  cc_onco112   363.0     330.0\n",
       " T5                               CCRc  8310/3  cc_onco112   684.0     680.0\n",
       " T6                         tumoración  8000/1  cc_onco112  1005.0     995.0\n",
       " T7           metástasis por carcinoma  8010/6  cc_onco112  2255.0    2231.0\n",
       " T8                        hemangiomas  9120/0  cc_onco112  3161.0    3150.0\n",
       " T9                   células malignas  8001/3  cc_onco112  3369.0    3353.0,\n",
       " 'cc_onco1120':                                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                           tumoración  8000/1  cc_onco1120  1933.0    1923.0\n",
       " T2                       masa abdominal  8000/6  cc_onco1120  2484.0    2470.0\n",
       " T3                             sarcomas  8800/3  cc_onco1120  2560.0    2552.0\n",
       " T4  tumor miofibroblástico inflamatorio  8825/1  cc_onco1120  3264.0    3229.0\n",
       " T5                              tumores  8000/1  cc_onco1120  3754.0    3747.0,\n",
       " 'cc_onco1122':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                      tumorales  8000/1  cc_onco1122   801.0     792.0\n",
       " T2                       cT1bN0Mx  8000/6  cc_onco1122  1034.0    1026.0\n",
       " T3                     malignidad  8000/3  cc_onco1122  1068.0    1058.0\n",
       " T4                     metástasis  8000/6  cc_onco1122  1118.0    1108.0\n",
       " T5   carcinoma ductal infiltrante  8500/3  cc_onco1122  1236.0    1208.0\n",
       " T6                             M0  8000/6  cc_onco1122  1443.0    1441.0\n",
       " T7                 lesiones óseas  8000/6  cc_onco1122  1900.0    1886.0\n",
       " T8             lesiones hepáticas  8000/6  cc_onco1122  1962.0    1944.0\n",
       " T9                    metastásica  8000/6  cc_onco1122  2113.0    2102.0\n",
       " T10               progresión ósea  8000/6  cc_onco1122  2436.0    2421.0\n",
       " T11   progresión a nivel hepático  8000/6  cc_onco1122  3241.0    3214.0\n",
       " T12           progresión hepática  8000/6  cc_onco1122  3542.0    3523.0\n",
       " T13                   metastásico  8000/6  cc_onco1122  4710.0    4699.0,\n",
       " 'cc_onco1125':                CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1             tumor  8000/1  cc_onco1125   320.0     315.0\n",
       " T2           tumoral  8000/1  cc_onco1125   808.0     801.0\n",
       " T3  carcinoma ductal  8500/3  cc_onco1125  1693.0    1677.0\n",
       " T4            cancer  8000/3  cc_onco1125  1975.0    1969.0,\n",
       " 'cc_onco1126':                        CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  síndrome mielodisplásico  9989/3  cc_onco1126  1485.0    1461.0\n",
       " T2             mielofibrosis  9961/3  cc_onco1126  1707.0    1694.0,\n",
       " 'cc_onco1128':                         CLAVE ICD-O-3    documento   endpos  startpos\n",
       " T1          lesiones cutáneas  8000/6  cc_onco1128   3254.0    3237.0\n",
       " T2      carcinoma basocelular  8090/3  cc_onco1128   5104.0    5083.0\n",
       " T3                         CM  8000/3  cc_onco1128   5492.0    5490.0\n",
       " T4                  tumorales  8000/1  cc_onco1128   5611.0    5602.0\n",
       " T5       lesiones cerebelosas  8000/6  cc_onco1128   6506.0    6486.0\n",
       " T6                metastásica  8000/6  cc_onco1128   8015.0    8004.0\n",
       " T7           neoproliferativo  8000/1  cc_onco1128   8305.0    8289.0\n",
       " T8         nódulos pulmonares  8000/6  cc_onco1128   8356.0    8338.0\n",
       " T9                 metástasis  8000/6  cc_onco1128   8430.0    8420.0\n",
       " T10            LOEs hepáticas  8000/6  cc_onco1128   8821.0    8807.0\n",
       " T11                 neoplasia  8000/1  cc_onco1128   8934.0    8925.0\n",
       " T12                        M1  8000/6  cc_onco1128   8961.0    8959.0\n",
       " T13         lesión cerebelosa  8000/6  cc_onco1128   9357.0    9340.0\n",
       " T14                  melanoma  8720/3  cc_onco1128  10778.0   10770.0\n",
       " T15            adenocarcinoma  8140/3  cc_onco1128  10794.0   10780.0\n",
       " T16   glioblastoma multiforme  9440/3  cc_onco1128  11192.0   11169.0\n",
       " T17                  blastoma  8000/3  cc_onco1128  11181.0   11173.0\n",
       " T18  carcinoma no microcítico  8046/3  cc_onco1128  12338.0   12314.0,\n",
       " 'cc_onco1129':                                          CLAVE  ICD-O-3    documento   endpos  \\\n",
       " T1   adenopatías cervicales, supraclaviculares   8000/6  cc_onco1129   2270.0   \n",
       " T2                           lesiones cutáneas   8000/6  cc_onco1129   2852.0   \n",
       " T3                                   tumorales   8000/1  cc_onco1129   3965.0   \n",
       " T4                                          CM   8000/3  cc_onco1129   4914.0   \n",
       " T5                                   neoplasia   8000/1  cc_onco1129   5949.0   \n",
       " T6                  adenopatía supraclavicular   8000/6  cc_onco1129   5986.0   \n",
       " T7                                 metastásica   8000/6  cc_onco1129   6016.0   \n",
       " T8                                  neoplásico   8000/1  cc_onco1129   6398.0   \n",
       " T9                                  metástasis   8000/6  cc_onco1129   6613.0   \n",
       " T10                                 neoplasias   8000/1  cc_onco1129   9662.0   \n",
       " T11                      Carcinoma microcítico   8041/3  cc_onco1129   9731.0   \n",
       " T12                         nódulos pulmonares   8000/6  cc_onco1129   9793.0   \n",
       " T13                                metastatiza   8000/6  cc_onco1129   9919.0   \n",
       " T14                         Linfoma no Hodgkin   9591/3  cc_onco1129  10005.0   \n",
       " T15                            hepatocarcinoma   8170/3  cc_onco1129  10248.0   \n",
       " T16                          colangiocarcinoma   8160/3  cc_onco1129  10267.0   \n",
       " T17                             adenocarcinoma   8140/3  cc_onco1129  10283.0   \n",
       " T18                                     cáncer   8000/3  cc_onco1129  10303.0   \n",
       " T19                  sarcoma de partes blandas   8800/3  cc_onco1129  10701.0   \n",
       " T20                    tumores neuroendocrinos   8240/3  cc_onco1129  10732.0   \n",
       " T21                             neuroendocrino   8240/3  cc_onco1129  10731.0   \n",
       " T22                                   melanoma   8720/3  cc_onco1129  10742.0   \n",
       " T23                                   malignas   8000/3  cc_onco1129  10880.0   \n",
       " T24                        afectación hepática   8000/6  cc_onco1129  10998.0   \n",
       " T25                      infiltración hepática   8000/6  cc_onco1129  11046.0   \n",
       " T26                                 neoplásica   8000/1  cc_onco1129  11301.0   \n",
       " T27                                neoplásicos   8000/1  cc_onco1129  11593.0   \n",
       " T28              síndromes linfoproliferativos   9970/1  cc_onco1129  11687.0   \n",
       " T29     carcinoma neuroendocrino de alto grado  8246/34  cc_onco1129  13801.0   \n",
       " T30                     neoplásica metastásica   8000/6  cc_onco1129  14179.0   \n",
       " T31                  metastásica por carcinoma   8010/6  cc_onco1129  14193.0   \n",
       " \n",
       "      startpos  \n",
       " T1     2229.0  \n",
       " T2     2835.0  \n",
       " T3     3956.0  \n",
       " T4     4912.0  \n",
       " T5     5940.0  \n",
       " T6     5960.0  \n",
       " T7     6005.0  \n",
       " T8     6388.0  \n",
       " T9     6603.0  \n",
       " T10    9652.0  \n",
       " T11    9710.0  \n",
       " T12    9775.0  \n",
       " T13    9908.0  \n",
       " T14    9987.0  \n",
       " T15   10233.0  \n",
       " T16   10250.0  \n",
       " T17   10269.0  \n",
       " T18   10297.0  \n",
       " T19   10676.0  \n",
       " T20   10709.0  \n",
       " T21   10717.0  \n",
       " T22   10734.0  \n",
       " T23   10872.0  \n",
       " T24   10979.0  \n",
       " T25   11025.0  \n",
       " T26   11291.0  \n",
       " T27   11582.0  \n",
       " T28   11658.0  \n",
       " T29   13763.0  \n",
       " T30   14157.0  \n",
       " T31   14168.0  ,\n",
       " 'cc_onco113':                                            CLAVE ICD-O-3   documento  endpos  \\\n",
       " T1                                        cáncer  8000/3  cc_onco113   317.0   \n",
       " T2                               nódulo pulmonar  8000/6  cc_onco113   619.0   \n",
       " T3                       tumor de células claras  8005/1  cc_onco113  1175.0   \n",
       " T4                                     neoplasia  8000/1  cc_onco113  1736.0   \n",
       " T5                                   metastásico  8000/6  cc_onco113  1912.0   \n",
       " T6                                       tumores  8000/1  cc_onco113  1969.0   \n",
       " T7   nódulos pulmonares milimétricos bilaterales  8000/6  cc_onco113  2346.0   \n",
       " T8                                    metástasis  8000/6  cc_onco113  2371.0   \n",
       " T9                                   metastásica  8000/6  cc_onco113  2606.0   \n",
       " T10    metástasis de carcinoma de células claras  8310/6  cc_onco113  4526.0   \n",
       " T11                  enfermedad a nivel pulmonar  8000/6  cc_onco113  4789.0   \n",
       " \n",
       "      startpos  \n",
       " T1      311.0  \n",
       " T2      604.0  \n",
       " T3     1152.0  \n",
       " T4     1727.0  \n",
       " T5     1901.0  \n",
       " T6     1962.0  \n",
       " T7     2303.0  \n",
       " T8     2361.0  \n",
       " T9     2595.0  \n",
       " T10    4485.0  \n",
       " T11    4762.0  ,\n",
       " 'cc_onco1134':                                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                      adenocarcinoma  8140/3  cc_onco1134    62.0      48.0\n",
       " T2                              cáncer  8000/3  cc_onco1134   104.0      98.0\n",
       " T3    tumor neuroendocrino pancreático  8150/1  cc_onco1134   534.0     502.0\n",
       " T4                      neuroendocrino  8240/3  cc_onco1134   522.0     508.0\n",
       " T5                          metástasis  8000/6  cc_onco1134   692.0     682.0\n",
       " T6  metástasis de tumor neuroendocrino  8240/6  cc_onco1134   889.0     855.0,\n",
       " 'cc_onco1135':                    CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1   afectación pulmonar  8000/6  cc_onco1135   434.0     415.0\n",
       " T2             tumorales  8000/1  cc_onco1135  1381.0    1372.0\n",
       " T3  masa retroperitoneal  8000/6  cc_onco1135  1647.0    1627.0\n",
       " T4               tumores  8000/1  cc_onco1135  1968.0    1961.0\n",
       " T5      sarcoma de Ewing  9260/3  cc_onco1135  2626.0    2610.0\n",
       " T6           sarcomatosa  8800/9  cc_onco1135  3202.0    3191.0,\n",
       " 'cc_onco1136':                           CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                lesión lítica  8000/6  cc_onco1136   227.0     214.0\n",
       " T2                     leucemia  9800/3  cc_onco1136   826.0     818.0\n",
       " T3                    tumorales  8000/1  cc_onco1136  1733.0    1724.0\n",
       " T4             Lesiones líticas  8000/6  cc_onco1136  2418.0    2402.0\n",
       " T5                    neoplasia  8000/1  cc_onco1136  2715.0    2706.0\n",
       " T6              tumoral maligna  8000/3  cc_onco1136  3995.0    3980.0\n",
       " T7             mieloma múltiple  9732/3  cc_onco1136  4068.0    4052.0\n",
       " T8  infiltración de médula ósea  8000/6  cc_onco1136  4257.0    4230.0,\n",
       " 'cc_onco1139':                                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                           neoplasia  8000/1  cc_onco1139   532.0     523.0\n",
       " T2                       masa pulmonar  8000/6  cc_onco1139  1365.0    1352.0\n",
       " T3                  nódulos pulmonares  8000/6  cc_onco1139  1411.0    1393.0\n",
       " T4                        metastásicos  8000/6  cc_onco1139  1816.0    1804.0\n",
       " T5   tumor de células germinales mixto  9085/3  cc_onco1139  2139.0    2106.0\n",
       " T6          tumor del seno endodérmico  9071/3  cc_onco1139  2187.0    2161.0\n",
       " T7                     teratoma maduro  9080/0  cc_onco1139  2216.0    2201.0\n",
       " T8                             tumores  8000/1  cc_onco1139  2688.0    2681.0\n",
       " T9                   Masa mediastínica  8000/6  cc_onco1139  2780.0    2763.0\n",
       " T10                         metástasis  8000/6  cc_onco1139  3095.0    3085.0\n",
       " T11                         tumoración  8000/1  cc_onco1139  3639.0    3629.0\n",
       " T12                 lesiones hepáticas  8000/6  cc_onco1139  4524.0    4506.0\n",
       " T13                progresión cerebral  8000/6  cc_onco1139  5112.0    5093.0\n",
       " T14                       metastáticos  8000/6  cc_onco1139  5596.0    5584.0\n",
       " T15                       LOE hepática  8000/6  cc_onco1139  5695.0    5683.0\n",
       " T16                      lesión lítica  8000/6  cc_onco1139  5728.0    5715.0\n",
       " T17                        metastásica  8000/6  cc_onco1139  5740.0    5729.0,\n",
       " 'cc_onco1140':                                       CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1             carcinoma ductal infiltrante  8500/3  cc_onco1140   146.0   \n",
       " T2                                    tumor  8000/1  cc_onco1140   242.0   \n",
       " T3                    carcinoma intraductal  8500/2  cc_onco1140   598.0   \n",
       " T4                  metástasis de carcinoma  8010/6  cc_onco1140   721.0   \n",
       " T5                               neoplásica  8000/1  cc_onco1140   808.0   \n",
       " T6                             tumoraciones  8000/1  cc_onco1140  2409.0   \n",
       " T7  adenopatías axilares, supraclaviculares  8000/6  cc_onco1140  2476.0   \n",
       " T8                      implantes tumorales  8000/6  cc_onco1140  7247.0   \n",
       " T9                              metastásico  8000/6  cc_onco1140  8327.0   \n",
       " \n",
       "     startpos  \n",
       " T1     118.0  \n",
       " T2     237.0  \n",
       " T3     577.0  \n",
       " T4     698.0  \n",
       " T5     798.0  \n",
       " T6    2397.0  \n",
       " T7    2437.0  \n",
       " T8    7228.0  \n",
       " T9    8316.0  ,\n",
       " 'cc_onco1144':                                CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                lesiones hepáticas  8000/6  cc_onco1144   216.0     198.0\n",
       " T2  tumor neuroendocrino pancreático  8150/1  cc_onco1144   287.0     255.0\n",
       " T3                    neuroendocrino  8240/3  cc_onco1144   275.0     261.0\n",
       " T4                        metástasis  8000/6  cc_onco1144   337.0     327.0\n",
       " T5                           maligno  8000/3  cc_onco1144   389.0     382.0\n",
       " T6                        carcinoide  8240/3  cc_onco1144   560.0     550.0\n",
       " T7                     masa hepática  8000/6  cc_onco1144   707.0     694.0\n",
       " T8                   lóbulo hepático  8000/6  cc_onco1144  3648.0    3633.0,\n",
       " 'cc_onco1146':                                CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma lobulillar infiltrante  8520/3  cc_onco1146   157.0     125.0\n",
       " T2                          pT1bN0M0  8000/6  cc_onco1146   185.0     177.0\n",
       " T3                        metástasis  8000/6  cc_onco1146   318.0     308.0\n",
       " T4                    Carcinomatosis  8010/9  cc_onco1146  2179.0    2165.0\n",
       " T5                          implante  8000/6  cc_onco1146  2213.0    2205.0\n",
       " T6      carcinoma de tipo lobulillar  8500/3  cc_onco1146  3134.0    3106.0,\n",
       " 'cc_onco1148':                        CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                  melanoma  8720/3  cc_onco1148   366.0     358.0\n",
       " T2                  pT2aN0M0  8000/6  cc_onco1148   511.0     503.0\n",
       " T3        nevus melanocítico  8720/0  cc_onco1148   695.0     677.0\n",
       " T4    metástasis de melanoma  8720/6  cc_onco1148  1305.0    1283.0\n",
       " T5              intratumoral  8000/1  cc_onco1148  1333.0    1321.0\n",
       " T6       lesiones pulmonares  8000/6  cc_onco1148  1616.0    1597.0\n",
       " T7           lesión cerebral  8000/6  cc_onco1148  1850.0    1835.0\n",
       " T8         nódulo subcutáneo  8000/6  cc_onco1148  2322.0    2305.0\n",
       " T9   metastásico de melanoma  8720/6  cc_onco1148  2495.0    2472.0\n",
       " T10                  maligna  8000/3  cc_onco1148  4456.0    4449.0\n",
       " T11              metastásica  8000/6  cc_onco1148  6066.0    6055.0\n",
       " T12     lesiones subcutáneas  8000/6  cc_onco1148  6649.0    6629.0,\n",
       " 'cc_onco1149':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1         carcinoma intraductal  8500/2  cc_onco1149   821.0     800.0\n",
       " T2  carcinoma ductal infiltrante  8500/3  cc_onco1149  1187.0    1159.0\n",
       " T3                     tumorales  8000/1  cc_onco1149  1972.0    1963.0\n",
       " T4                      pT1aN0M0  8000/6  cc_onco1149  2102.0    2094.0\n",
       " T5        enfermedad a distancia  8000/6  cc_onco1149  2253.0    2231.0\n",
       " T6                     neoplasia  8000/1  cc_onco1149  5063.0    5054.0\n",
       " T7               nódulo pulmonar  8000/6  cc_onco1149  5145.0    5130.0,\n",
       " 'cc_onco1153':                          CLAVE   ICD-O-3    documento  endpos  startpos\n",
       " T1              masa abdominal    8000/6  cc_onco1153   970.0     956.0\n",
       " T2                  tumoración    8000/1  cc_onco1153  1493.0    1483.0\n",
       " T3                    implante    8000/6  cc_onco1153  1657.0    1649.0\n",
       " T4               tumor maligno    8000/3  cc_onco1153  1700.0    1687.0\n",
       " T5   sarcoma de células claras    9044/3  cc_onco1153  2514.0    2489.0\n",
       " T6        Melanoma metastásico    8720/6  cc_onco1153  2706.0    2686.0\n",
       " T7     metástasis de carcinoma    8010/6  cc_onco1153  2808.0    2785.0\n",
       " T8                      PEComa  8011/1/H  cc_onco1153  2826.0    2820.0\n",
       " T9                   neoplasia    8000/1  cc_onco1153  2837.0    2828.0\n",
       " T10     metástasis de melanoma    8720/6  cc_onco1153  3189.0    3167.0\n",
       " T11                        AML    8860/0  cc_onco1153  3194.0    3191.0,\n",
       " 'cc_onco1155':                    CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1   enfermedad pulmonar  8000/6  cc_onco1155   130.0     111.0\n",
       " T2                cáncer  8000/3  cc_onco1155   449.0     443.0\n",
       " T3     lesiones cutáneas  8000/6  cc_onco1155  1282.0    1265.0\n",
       " T4      células malignas  8001/3  cc_onco1155  4151.0    4135.0\n",
       " T5          neoformación  8000/1  cc_onco1155  4299.0    4287.0\n",
       " T6             Carcinoma  8010/3  cc_onco1155  4715.0    4706.0\n",
       " T7            malignidad  8000/3  cc_onco1155  5173.0    5163.0\n",
       " T8       afectación ósea  8000/6  cc_onco1155  5426.0    5411.0\n",
       " T9               tumoral  8000/1  cc_onco1155  5551.0    5544.0\n",
       " T10           neoplásico  8000/1  cc_onco1155  5813.0    5803.0\n",
       " T11  afectación pulmonar  8000/6  cc_onco1155  6319.0    6300.0,\n",
       " 'cc_onco1156':                                         CLAVE  ICD-O-3    documento  endpos  \\\n",
       " T1                                  neoplasia   8000/1  cc_onco1156   221.0   \n",
       " T2                                  Carcinoma   8010/3  cc_onco1156   444.0   \n",
       " T3                            lesión parietal   8000/6  cc_onco1156  1505.0   \n",
       " T4                               LOE cerebral   8000/6  cc_onco1156  1783.0   \n",
       " T5              metástasis por adenocarcinoma   8140/6  cc_onco1156  1889.0   \n",
       " T6  adenocarcinoma moderadamente diferenciado  8140/32  cc_onco1156  1916.0   \n",
       " T7                           recaída cerebral   8000/6  cc_onco1156  1976.0   \n",
       " T8                            lesión cerebral   8000/6  cc_onco1156  2192.0   \n",
       " \n",
       "     startpos  \n",
       " T1     212.0  \n",
       " T2     435.0  \n",
       " T3    1490.0  \n",
       " T4    1771.0  \n",
       " T5    1860.0  \n",
       " T6    1875.0  \n",
       " T7    1960.0  \n",
       " T8    2177.0  ,\n",
       " 'cc_onco1157':                                         CLAVE  ICD-O-3    documento  endpos  \\\n",
       " T1           adenocarcinoma bien diferenciado  8140/31  cc_onco1157   529.0   \n",
       " T2                                  Carcinoma   8010/3  cc_onco1157   511.0   \n",
       " T3  adenocarcinoma moderadamente diferenciado  8140/32  cc_onco1157   774.0   \n",
       " T4                                      tumor   8000/1  cc_onco1157  1144.0   \n",
       " T5                                    tumoral   8000/1  cc_onco1157  1439.0   \n",
       " T6                               metastásicas   8000/6  cc_onco1157  3513.0   \n",
       " T7                                  tumorales   8000/1  cc_onco1157  3537.0   \n",
       " T8                                 neoplásico   8000/1  cc_onco1157  3831.0   \n",
       " T9                            adenocarcinomas   8140/3  cc_onco1157  4597.0   \n",
       " \n",
       "     startpos  \n",
       " T1     497.0  \n",
       " T2     502.0  \n",
       " T3     733.0  \n",
       " T4    1139.0  \n",
       " T5    1432.0  \n",
       " T6    3501.0  \n",
       " T7    3528.0  \n",
       " T8    3821.0  \n",
       " T9    4582.0  ,\n",
       " 'cc_onco1158':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma ductal infiltrante  8500/3  cc_onco1158   767.0     739.0\n",
       " T2                           CDI  8500/3  cc_onco1158   772.0     769.0\n",
       " T3                         tumor  8000/1  cc_onco1158  1280.0    1275.0\n",
       " T4                      melanoma  8720/3  cc_onco1158  1621.0    1613.0\n",
       " T5        enfermedad a distancia  8000/6  cc_onco1158  2042.0    2020.0\n",
       " T6              melanoma maligno  8720/3  cc_onco1158  2161.0    2145.0\n",
       " T7                    metástasis  8000/6  cc_onco1158  2754.0    2744.0,\n",
       " 'cc_onco1160':                       CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1          tumor Phyllodes  9020/1  cc_onco1160   461.0     446.0\n",
       " T2                  maligno  8000/3  cc_onco1160   653.0     646.0\n",
       " T3                  sarcoma  8800/3  cc_onco1160   891.0     884.0\n",
       " T4  recidiva pleuropulmonar  8000/6  cc_onco1160  1120.0    1097.0\n",
       " T5       progresión pleural  8000/6  cc_onco1160  1547.0    1529.0\n",
       " T6               metástasis  8000/6  cc_onco1160  2898.0    2888.0\n",
       " T7                 malignas  8000/3  cc_onco1160  3043.0    3035.0\n",
       " T8                  tumoral  8000/1  cc_onco1160  3409.0    3402.0\n",
       " T9      progresión cerebral  8000/6  cc_onco1160  3598.0    3579.0,\n",
       " 'cc_onco1161':                                    CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                     neurofibromatosis  9540/1  cc_onco1161   116.0   \n",
       " T2                         neurofibromas  9540/0  cc_onco1161   153.0   \n",
       " T3                            tumoración  8000/1  cc_onco1161  1081.0   \n",
       " T4    tumor del estroma gastrointestinal  8936/3  cc_onco1161  3174.0   \n",
       " T5                                  GIST  8936/3  cc_onco1161  3180.0   \n",
       " T6                          tumoraciones  8000/1  cc_onco1161  3704.0   \n",
       " T7                             formación  8000/1  cc_onco1161  3820.0   \n",
       " T8  tumores del estroma gastrointestinal  8936/3  cc_onco1161  5299.0   \n",
       " \n",
       "     startpos  \n",
       " T1      99.0  \n",
       " T2     140.0  \n",
       " T3    1071.0  \n",
       " T4    3140.0  \n",
       " T5    3176.0  \n",
       " T6    3692.0  \n",
       " T7    3811.0  \n",
       " T8    5263.0  ,\n",
       " 'cc_onco1162':                              CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1              tumoración benigna   8000/0  cc_onco1162   116.0      98.0\n",
       " T2                  masa abdominal   8000/6  cc_onco1162   231.0     217.0\n",
       " T3                carcinoma seroso   8441/3  cc_onco1162   283.0     267.0\n",
       " T4  carcinoma seroso de alto grado  8441/34  cc_onco1162  1984.0    1954.0\n",
       " T5           progresión peritoneal   8000/6  cc_onco1162  2427.0    2406.0\n",
       " T6       implantes en el peritoneo   8000/6  cc_onco1162  2506.0    2481.0\n",
       " T7                     metastásica   8000/6  cc_onco1162  2887.0    2876.0\n",
       " T8                  Carcinomatosis   8010/9  cc_onco1162  2919.0    2905.0,\n",
       " 'cc_onco1165':                                       CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                                 melanoma  8720/3  cc_onco1165    80.0   \n",
       " T2                                neoplasia  8000/1  cc_onco1165   182.0   \n",
       " T3              lesiones en la cavidad oral  8000/6  cc_onco1165   639.0   \n",
       " T4                               tumoración  8000/1  cc_onco1165   741.0   \n",
       " T5  afectación del sistema nervioso central  8000/6  cc_onco1165  1263.0   \n",
       " T6                               metástasis  8000/6  cc_onco1165  1706.0   \n",
       " T7                 Carcinoma indiferenciado  8020/3  cc_onco1165  1907.0   \n",
       " T8                     afectación orbitaria  8000/6  cc_onco1165  3242.0   \n",
       " T9                           Carcinomatosis  8010/9  cc_onco1165  4224.0   \n",
       " \n",
       "     startpos  \n",
       " T1      72.0  \n",
       " T2     173.0  \n",
       " T3     612.0  \n",
       " T4     731.0  \n",
       " T5    1224.0  \n",
       " T6    1696.0  \n",
       " T7    1883.0  \n",
       " T8    3222.0  \n",
       " T9    4210.0  ,\n",
       " 'cc_onco1167':                          CLAVE   ICD-O-3    documento  endpos  startpos\n",
       " T1                   neoplasia    8000/1  cc_onco1167   424.0     415.0\n",
       " T2                   Carcinoma    8010/3  cc_onco1167   455.0     446.0\n",
       " T3              adenocarcinoma    8140/3  cc_onco1167  1894.0    1880.0\n",
       " T4  adenocarcinoma infiltrante  8140/3/H  cc_onco1167  2193.0    2167.0\n",
       " T5  células en anillo de sello    8490/3  cc_onco1167  2276.0    2250.0\n",
       " T6                diseminación    8000/6  cc_onco1167  2970.0    2958.0\n",
       " T7                  malignidad    8000/3  cc_onco1167  3429.0    3419.0,\n",
       " 'cc_onco1169':                                             CLAVE   ICD-O-3    documento  \\\n",
       " T1                                 Carcinomatosis    8010/9  cc_onco1169   \n",
       " T2                                   tumoraciones    8000/1  cc_onco1169   \n",
       " T3                            neoplasia primitiva  8000/1/H  cc_onco1169   \n",
       " T4  adenocarcinoma con células en anillo de sello    8490/3  cc_onco1169   \n",
       " T5                                     neoplásico    8000/1  cc_onco1169   \n",
       " T6                                        maligna    8000/3  cc_onco1169   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   387.0     373.0  \n",
       " T2   413.0     401.0  \n",
       " T3   468.0     449.0  \n",
       " T4   739.0     694.0  \n",
       " T5  5418.0    5408.0  \n",
       " T6  5520.0    5513.0  ,\n",
       " 'cc_onco1174':                                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                               Mioma  8895/0  cc_onco1174   129.0     124.0\n",
       " T2                      Leiomiosarcoma  8890/3  cc_onco1174   725.0     711.0\n",
       " T3                          tumoración  8000/1  cc_onco1174  1244.0    1234.0\n",
       " T4                        masa pélvica  8000/6  cc_onco1174  1368.0    1356.0\n",
       " T5   enfermedad residual y a distancia  8000/6  cc_onco1174  1614.0    1581.0\n",
       " T6                      nódulo pélvico  8000/6  cc_onco1174  2134.0    2120.0\n",
       " T7                       LOE hepáticas  8000/6  cc_onco1174  3099.0    3086.0\n",
       " T8                             tumores  8000/1  cc_onco1174  3209.0    3202.0\n",
       " T9                          metástasis  8000/6  cc_onco1174  3411.0    3401.0\n",
       " T10                progresión hepática  8000/6  cc_onco1174  3625.0    3606.0\n",
       " T11            progresión mediastínica  8000/6  cc_onco1174  4244.0    4221.0\n",
       " T12                   Lesiones líticas  8000/6  cc_onco1174  4273.0    4257.0,\n",
       " 'cc_onco1176':                 CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  sarcoma de Kaposi  9140/3  cc_onco1176  2469.0    2452.0,\n",
       " 'cc_onco1178':                                    CLAVE  ICD-O-3    documento  endpos  \\\n",
       " T1                             neoplasia   8000/1  cc_onco1178   211.0   \n",
       " T2  carcinoma ductal infiltrante grado 3  8500/33  cc_onco1178   383.0   \n",
       " T3                               tumoral   8000/1  cc_onco1178  4189.0   \n",
       " \n",
       "     startpos  \n",
       " T1     202.0  \n",
       " T2     347.0  \n",
       " T3    4182.0  ,\n",
       " 'cc_onco1180':                           CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                   malignidad  8000/3  cc_onco1180   396.0     386.0\n",
       " T2                   metástasis  8000/6  cc_onco1180  1028.0    1018.0\n",
       " T3       enfermedad a distancia  8000/6  cc_onco1180  1578.0    1556.0\n",
       " T4  enfermedad a nivel pulmonar  8000/6  cc_onco1180  2676.0    2649.0\n",
       " T5     Carcinoma indiferenciado  8020/3  cc_onco1180  2723.0    2699.0\n",
       " T6                 sarcomatoide  8033/3  cc_onco1180  2770.0    2758.0\n",
       " T7  progresión a nivel pulmonar  8000/6  cc_onco1180  3730.0    3703.0,\n",
       " 'cc_onco1182':                         CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1            lesión gástrica  8000/6  cc_onco1182   657.0     642.0\n",
       " T2             adenocarcinoma  8140/3  cc_onco1182   967.0     953.0\n",
       " T3  adenocarcinoma intestinal  8144/3  cc_onco1182  1171.0    1146.0\n",
       " T4                      tumor  8000/1  cc_onco1182  1358.0    1353.0\n",
       " T5     enfermedad a distancia  8000/6  cc_onco1182  1438.0    1416.0\n",
       " T6                    pT2N1M0  8000/6  cc_onco1182  1535.0    1528.0\n",
       " T7                  tumorales  8000/1  cc_onco1182  1849.0    1840.0\n",
       " T8   afectación extrahepática  8000/6  cc_onco1182  2135.0    2111.0\n",
       " T9           implante tumoral  8000/6  cc_onco1182  4564.0    4548.0,\n",
       " 'cc_onco1185':                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma escamoso  8070/3  cc_onco1185   312.0     294.0\n",
       " T2             tumoral  8000/1  cc_onco1185  4013.0    4006.0\n",
       " T3          neoplásica  8000/1  cc_onco1185  4293.0    4283.0\n",
       " T4        diseminación  8000/6  cc_onco1185  5178.0    5166.0,\n",
       " 'cc_onco1190':                               CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                       tumoración  8000/1  cc_onco1190   426.0     416.0\n",
       " T2                          cordoma  9370/3  cc_onco1190   647.0     640.0\n",
       " T3                       malignidad  8000/3  cc_onco1190  1032.0    1022.0\n",
       " T4                   adenocarcinoma  8140/3  cc_onco1190  1172.0    1158.0\n",
       " T5               nódulos pulmonares  8000/6  cc_onco1190  1334.0    1316.0\n",
       " T6   nódulos pulmonares bilaterales  8000/6  cc_onco1190  1594.0    1564.0\n",
       " T7                       metástasis  8000/6  cc_onco1190  1667.0    1657.0\n",
       " T8              lesiones pulmonares  8000/6  cc_onco1190  1857.0    1838.0\n",
       " T9                  afectación ósea  8000/6  cc_onco1190  2634.0    2619.0\n",
       " T10                         tumoral  8000/1  cc_onco1190  2952.0    2945.0\n",
       " T11                          cáncer  8000/3  cc_onco1190  3421.0    3415.0,\n",
       " 'cc_onco1191':                        CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1            adenocarcinoma  8140/3  cc_onco1191  1025.0    1011.0\n",
       " T2                metástasis  8000/6  cc_onco1191  1213.0    1203.0\n",
       " T3                       cM0  8000/6  cc_onco1191  1278.0    1275.0\n",
       " T4  carcinoma no microcítico  8046/3  cc_onco1191  1317.0    1293.0\n",
       " T5                   tumoral  8000/1  cc_onco1191  1568.0    1561.0\n",
       " T6       progresión pulmonar  8000/6  cc_onco1191  1893.0    1874.0,\n",
       " 'cc_onco1192':                    CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1      células malignas  8001/3  cc_onco1192  1162.0    1146.0\n",
       " T2        adenocarcinoma  8140/3  cc_onco1192  1178.0    1164.0\n",
       " T3          metastásicos  8000/6  cc_onco1192  1436.0    1424.0\n",
       " T4  nódulos subpleurales  8000/6  cc_onco1192  2018.0    1998.0\n",
       " T5         masa pulmonar  8000/6  cc_onco1192  2633.0    2620.0\n",
       " T6               tumoral  8000/1  cc_onco1192  3551.0    3544.0,\n",
       " 'cc_onco1193':                                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1               afectación secundaria  8000/6  cc_onco1193   451.0     430.0\n",
       " T2                    suelta de globos  8000/6  cc_onco1193   527.0     511.0\n",
       " T3                          metástasis  8000/6  cc_onco1193  1594.0    1584.0\n",
       " T4                             tumoral  8000/1  cc_onco1193  1885.0    1878.0\n",
       " T5                           tumorales  8000/1  cc_onco1193  1937.0    1928.0\n",
       " T6   tumor de células germinales mixto  9085/3  cc_onco1193  2129.0    2096.0\n",
       " T7           tumor de seno endodérmico  9071/3  cc_onco1193  2160.0    2135.0\n",
       " T8                     teratoma maduro  9080/0  cc_onco1193  2210.0    2195.0\n",
       " T9                 afectación pulmonar  8000/6  cc_onco1193  2864.0    2845.0\n",
       " T10      lesiones focales intraaxiales  8000/6  cc_onco1193  3239.0    3210.0,\n",
       " 'cc_onco1195':                               CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                  masa parahiliar   8000/6  cc_onco1195   909.0     894.0\n",
       " T2                        tumorales   8000/1  cc_onco1195  1277.0    1268.0\n",
       " T3                       tumoración   8000/1  cc_onco1195  1376.0    1366.0\n",
       " T4               nódulos pulmonares   8000/6  cc_onco1195  1610.0    1592.0\n",
       " T5                     metastásicos   8000/6  cc_onco1195  1623.0    1611.0\n",
       " T6        linfangitis carcinomatosa   8000/3  cc_onco1195  1663.0    1638.0\n",
       " T7                       metástasis   8000/6  cc_onco1195  1786.0    1776.0\n",
       " T8                      metastatiza   8000/6  cc_onco1195  2068.0    2057.0\n",
       " T9                          maligno   8000/3  cc_onco1195  2099.0    2092.0\n",
       " T10                  adenocarcinoma   8140/3  cc_onco1195  2155.0    2141.0\n",
       " T11               neoplasia maligna   8000/3  cc_onco1195  2269.0    2252.0\n",
       " T12                  coriocarcinoma   9100/3  cc_onco1195  2395.0    2381.0\n",
       " T13  neoplasia pulmonar metastásica   8000/6  cc_onco1195  2474.0    2444.0\n",
       " T14  nódulos pulmonares bilaterales   8000/6  cc_onco1195  2506.0    2476.0\n",
       " T15                  Tumor germinal   9064/3  cc_onco1195  2975.0    2961.0\n",
       " T16           maligna de alto grado  8000/34  cc_onco1195  3801.0    3780.0\n",
       " T17              carcinoma escamoso   8070/3  cc_onco1195  3993.0    3975.0,\n",
       " 'cc_onco1196':                     CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1              Carcinoma  8010/3  cc_onco1196   167.0     158.0\n",
       " T2  carcinoma epidermoide  8070/3  cc_onco1196   537.0     516.0\n",
       " T3                tumoral  8000/1  cc_onco1196   784.0     777.0,\n",
       " 'cc_onco1197':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                     tumoración  8000/1  cc_onco1197   139.0     129.0\n",
       " T2               carcinoma ductal  8500/3  cc_onco1197   370.0     354.0\n",
       " T3                    metastásica  8000/6  cc_onco1197   450.0     439.0\n",
       " T4                    satelitosis  8001/1  cc_onco1197  1327.0    1316.0\n",
       " T5                      tumorales  8000/1  cc_onco1197  1440.0    1431.0\n",
       " T6                       implante  8000/6  cc_onco1197  1585.0    1577.0\n",
       " T7                   metastásicos  8000/6  cc_onco1197  1599.0    1587.0\n",
       " T8   carcinoma ductal infiltrante  8500/3  cc_onco1197  2244.0    2216.0\n",
       " T9                             M0  8000/6  cc_onco1197  2269.0    2267.0\n",
       " T10                            HE  9133/1  cc_onco1197  2328.0    2326.0\n",
       " T11             lesiones cutáneas  8000/6  cc_onco1197  4165.0    4148.0,\n",
       " 'cc_onco12':                  CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1    melanoma nodular  8721/3  cc_onco12   211.0     195.0\n",
       " T2             maligno  8000/3  cc_onco12   219.0     212.0\n",
       " T3  nódulos pulmonares  8000/6  cc_onco12   577.0     559.0\n",
       " T4          metástasis  8000/6  cc_onco12   672.0     662.0\n",
       " T5         metastásica  8000/6  cc_onco12  4023.0    4012.0,\n",
       " 'cc_onco1200':                      CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1          Tumor germinal  9064/3  cc_onco1200    75.0      61.0\n",
       " T2              metástasis  8000/6  cc_onco1200   115.0     105.0\n",
       " T3               formación  8000/1  cc_onco1200   810.0     801.0\n",
       " T4               Carcinoma  8010/3  cc_onco1200  1300.0    1291.0\n",
       " T5                 tumoral  8000/1  cc_onco1200  1667.0    1660.0\n",
       " T6    porocarcinoma ecrino  8409/3  cc_onco1200  1702.0    1682.0\n",
       " T7             metastásica  8000/6  cc_onco1200  1807.0    1796.0\n",
       " T8              Oncocitoma  8290/0  cc_onco1200  2379.0    2369.0\n",
       " T9  enfermedad a distancia  8000/6  cc_onco1200  2637.0    2615.0,\n",
       " 'cc_onco1202':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1          invasión mediastínica  8000/6  cc_onco1202   776.0     755.0\n",
       " T2      linfangitis carcinomatosa  8000/3  cc_onco1202   997.0     972.0\n",
       " T3             lesiones hepáticas  8000/6  cc_onco1202  1027.0    1009.0\n",
       " T4                     metástasis  8000/6  cc_onco1202  1054.0    1044.0\n",
       " T5  Adenopatías supraclaviculares  8000/6  cc_onco1202  1086.0    1057.0\n",
       " T6    adenopático supraclavicular  8000/6  cc_onco1202  1150.0    1123.0\n",
       " T7          Carcinoma microcítico  8041/3  cc_onco1202  1208.0    1187.0\n",
       " T8                    metastásica  8000/6  cc_onco1202  2024.0    2013.0,\n",
       " 'cc_onco1204':                                        CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1  lesiones expansivas intraparenquimatosas  8000/6  cc_onco1204  1114.0   \n",
       " T2                                metástasis  8000/6  cc_onco1204  1235.0   \n",
       " T3                           nódulo pulmonar  8000/6  cc_onco1204  1301.0   \n",
       " T4                              neoformación  8000/1  cc_onco1204  1346.0   \n",
       " T5                           lesión pulmonar  8000/6  cc_onco1204  1685.0   \n",
       " T6                            adenocarcinoma  8140/3  cc_onco1204  1733.0   \n",
       " T7                               metastásica  8000/6  cc_onco1204  2142.0   \n",
       " T8                       progresión pulmonar  8000/6  cc_onco1204  3094.0   \n",
       " \n",
       "     startpos  \n",
       " T1    1074.0  \n",
       " T2    1225.0  \n",
       " T3    1286.0  \n",
       " T4    1334.0  \n",
       " T5    1670.0  \n",
       " T6    1719.0  \n",
       " T7    2131.0  \n",
       " T8    3075.0  ,\n",
       " 'cc_onco1205':                                          CLAVE   ICD-O-3    documento  endpos  \\\n",
       " T1                                   neoplasia    8000/1  cc_onco1205   343.0   \n",
       " T2                          carcinoma escamoso    8070/3  cc_onco1205   370.0   \n",
       " T3                                       tumor    8000/1  cc_onco1205   648.0   \n",
       " T4   carcinoma urotelial papilar de bajo grado   8120/31  cc_onco1205   837.0   \n",
       " T5                                  tumoración    8000/1  cc_onco1205  1545.0   \n",
       " T6                  adenocarcinoma infiltrante  8140/3/H  cc_onco1205  2002.0   \n",
       " T7                       lesión focal hepática    8000/6  cc_onco1205  2527.0   \n",
       " T8                                  metástasis    8000/6  cc_onco1205  2583.0   \n",
       " T9                          nódulos pulmonares    8000/6  cc_onco1205  2810.0   \n",
       " T10                         enfermedad pleural    8000/6  cc_onco1205  2999.0   \n",
       " T11                                    adenoma    8140/0  cc_onco1205  5038.0   \n",
       " T12               adenocarcinoma de bajo grado   8140/31  cc_onco1205  5285.0   \n",
       " T13                            lesión hepática    8000/6  cc_onco1205  5643.0   \n",
       " T14                            hepatocarcinoma    8170/3  cc_onco1205  5732.0   \n",
       " T15                                mestástasis    8000/6  cc_onco1205  6292.0   \n",
       " T16                          colangiocarcinoma    8160/3  cc_onco1205  6340.0   \n",
       " T17                                    tumoral    8000/1  cc_onco1205  6386.0   \n",
       " \n",
       "      startpos  \n",
       " T1      334.0  \n",
       " T2      352.0  \n",
       " T3      643.0  \n",
       " T4      796.0  \n",
       " T5     1535.0  \n",
       " T6     1976.0  \n",
       " T7     2506.0  \n",
       " T8     2573.0  \n",
       " T9     2792.0  \n",
       " T10    2981.0  \n",
       " T11    5031.0  \n",
       " T12    5257.0  \n",
       " T13    5628.0  \n",
       " T14    5717.0  \n",
       " T15    6281.0  \n",
       " T16    6323.0  \n",
       " T17    6379.0  ,\n",
       " 'cc_onco1206':                           CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                   metástasis  8000/6  cc_onco1206  1118.0    1108.0\n",
       " T2          lesión endotraqueal  8000/6  cc_onco1206  2437.0    2418.0\n",
       " T3                   tumoración  8000/1  cc_onco1206  2555.0    2545.0\n",
       " T4  carcinoma adenoide quístico  8200/3  cc_onco1206  2652.0    2625.0\n",
       " T5       infiltración esofágica  8000/6  cc_onco1206  2779.0    2757.0\n",
       " T6           nódulos pulmonares  8000/6  cc_onco1206  2809.0    2791.0\n",
       " T7          lesiones pulmonares  8000/6  cc_onco1206  3682.0    3663.0\n",
       " T8                   neoplásica  8000/1  cc_onco1206  3916.0    3906.0,\n",
       " 'cc_onco1207':                         CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1   melanoma maligno nodular  8721/3  cc_onco1207   348.0     324.0\n",
       " T2                    maligno  8000/3  cc_onco1207   340.0     333.0\n",
       " T3    micronódulos pulmonares  8000/6  cc_onco1207   687.0     664.0\n",
       " T4            lesión hepática  8000/6  cc_onco1207   712.0     697.0\n",
       " T5                metastásica  8000/6  cc_onco1207   757.0     746.0\n",
       " T6                 metástasis  8000/6  cc_onco1207   851.0     841.0\n",
       " T7           melanoma nodular  8721/3  cc_onco1207  1150.0    1134.0\n",
       " T8                metastásico  8000/6  cc_onco1207  1162.0    1151.0\n",
       " T9             lesiones óseas  8000/6  cc_onco1207  1746.0    1732.0\n",
       " T10    masa de partes blandas  8000/6  cc_onco1207  1799.0    1777.0\n",
       " T11       tumoral metastásica  8000/6  cc_onco1207  2492.0    2473.0\n",
       " T12    metástasis de melanoma  8720/6  cc_onco1207  3083.0    3061.0,\n",
       " 'cc_onco1209':                            CLAVE   ICD-O-3    documento  endpos  startpos\n",
       " T1    adenocarcinoma infiltrante  8140/3/H  cc_onco1209   384.0     358.0\n",
       " T2         adenoma tubulovelloso    8263/3  cc_onco1209   421.0     400.0\n",
       " T3                       cT4N2M0    8000/6  cc_onco1209   429.0     422.0\n",
       " T4   progresión a nivel hepático    8000/6  cc_onco1209  1442.0    1415.0\n",
       " T5               progresión ósea    8000/6  cc_onco1209  1929.0    1914.0\n",
       " T6                    metástasis    8000/6  cc_onco1209  1944.0    1934.0\n",
       " T7           progresión hepática    8000/6  cc_onco1209  2127.0    2108.0\n",
       " T8                   lesión ósea    8000/6  cc_onco1209  3440.0    3429.0\n",
       " T9        masa de partes blandas    8000/6  cc_onco1209  3539.0    3517.0\n",
       " T10                  metastásica    8000/6  cc_onco1209  3919.0    3908.0\n",
       " T11        infiltración meníngea    8000/6  cc_onco1209  4430.0    4409.0,\n",
       " 'cc_onco1210':                                    CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                                 tumor  8000/1  cc_onco1210   261.0   \n",
       " T2                           metastásica  8000/6  cc_onco1210   868.0   \n",
       " T3  Lesión lítica en el cuerpo vertebral  8000/6  cc_onco1210  1200.0   \n",
       " T4                      células malignas  8001/3  cc_onco1210  1431.0   \n",
       " \n",
       "     startpos  \n",
       " T1     256.0  \n",
       " T2     857.0  \n",
       " T3    1164.0  \n",
       " T4    1415.0  ,\n",
       " 'cc_onco1212':                                        CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                                    cáncer  8000/3  cc_onco1212   160.0   \n",
       " T2                                tumoración  8000/1  cc_onco1212   705.0   \n",
       " T3                              masa pélvica  8000/6  cc_onco1212   898.0   \n",
       " T4                                 tumorales  8000/1  cc_onco1212  1054.0   \n",
       " T5                células en anillo de sello  8490/3  cc_onco1212  1311.0   \n",
       " T6                                malignidad  8000/3  cc_onco1212  1658.0   \n",
       " T7                                   maligno  8000/3  cc_onco1212  2325.0   \n",
       " T8   carcinoma de células en anillo de sello  8490/3  cc_onco1212  2440.0   \n",
       " T9                                   tumores  8000/1  cc_onco1212  2612.0   \n",
       " T10                          nódulo hepático  8000/6  cc_onco1212  2819.0   \n",
       " \n",
       "      startpos  \n",
       " T1      154.0  \n",
       " T2      695.0  \n",
       " T3      886.0  \n",
       " T4     1045.0  \n",
       " T5     1285.0  \n",
       " T6     1648.0  \n",
       " T7     2318.0  \n",
       " T8     2401.0  \n",
       " T9     2605.0  \n",
       " T10    2804.0  ,\n",
       " 'cc_onco1213':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                     malignidad  8000/3  cc_onco1213   817.0     807.0\n",
       " T2                 adenocarcinoma  8140/3  cc_onco1213   966.0     952.0\n",
       " T3  lesiones intraparenquimatosas  8000/6  cc_onco1213  2526.0    2497.0\n",
       " T4                     neoplásica  8000/1  cc_onco1213  2658.0    2648.0\n",
       " T5                     metástasis  8000/6  cc_onco1213  2813.0    2803.0,\n",
       " 'cc_onco1214':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma ductal infiltrante  8500/3  cc_onco1214   243.0     215.0\n",
       " T2                    metástasis  8000/6  cc_onco1214  1096.0    1086.0\n",
       " T3        masa de partes blandas  8000/6  cc_onco1214  1265.0    1243.0\n",
       " T4         lesión única hepática  8000/6  cc_onco1214  1380.0    1359.0\n",
       " T5               lesión hepática  8000/6  cc_onco1214  1460.0    1445.0\n",
       " T6                   lesión ósea  8000/6  cc_onco1214  1548.0    1537.0,\n",
       " 'cc_onco1216':                                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                            tumorales  8000/1  cc_onco1216  1469.0    1460.0\n",
       " T2                          sarcomatosa  8800/9  cc_onco1216  1771.0    1760.0\n",
       " T3                           tumoración  8000/1  cc_onco1216  1819.0    1809.0\n",
       " T4                       Leiomiosarcoma  8890/3  cc_onco1216  1968.0    1954.0\n",
       " T5                        tumor maligno  8000/3  cc_onco1216  2076.0    2063.0\n",
       " T6                     melanoma maligno  8720/3  cc_onco1216  2574.0    2558.0\n",
       " T7                      rabdomiosarcoma  8900/3  cc_onco1216  2635.0    2620.0\n",
       " T8                              linfoma  9590/3  cc_onco1216  2674.0    2667.0\n",
       " T9                  mesotelioma maligno  9050/3  cc_onco1216  2716.0    2697.0\n",
       " T10                    sarcoma de Ewing  9260/3  cc_onco1216  2804.0    2788.0\n",
       " T11  tumor del estroma gastrointestinal  8936/3  cc_onco1216  2863.0    2829.0\n",
       " T12                                GIST  8936/3  cc_onco1216  2869.0    2865.0\n",
       " T13                            sarcomas  8800/3  cc_onco1216  5374.0    5366.0\n",
       " T14                              cancer  8000/3  cc_onco1216  5606.0    5600.0\n",
       " T15                             tumores  8000/1  cc_onco1216  6822.0    6815.0\n",
       " T16                 recidiva de sarcoma  8800/6  cc_onco1216  7627.0    7608.0,\n",
       " 'cc_onco1219':                                CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                         neoplasia   8000/1  cc_onco1219  1159.0    1150.0\n",
       " T2                    adenocarcinoma   8140/3  cc_onco1219  1252.0    1238.0\n",
       " T3                      masa anexial   8000/6  cc_onco1219  1546.0    1534.0\n",
       " T4                            miomas   8895/0  cc_onco1219  1646.0    1640.0\n",
       " T5            enfermedad a distancia   8000/6  cc_onco1219  1708.0    1686.0\n",
       " T6                        miomatosis   8895/0  cc_onco1219  2026.0    2016.0\n",
       " T7                           tumores   8000/1  cc_onco1219  2107.0    2100.0\n",
       " T8                           tumoral   8000/1  cc_onco1219  2651.0    2644.0\n",
       " T9           metástasis de carcinoma   8010/6  cc_onco1219  3268.0    3245.0\n",
       " T10  adenocarcinoma mal diferenciado  8140/33  cc_onco1219  3317.0    3286.0\n",
       " T11                       leiomiomas   8890/0  cc_onco1219  3364.0    3354.0\n",
       " T12               nódulos pulmonares   8000/6  cc_onco1219  3536.0    3518.0,\n",
       " 'cc_onco122':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                  masa pulmonar  8000/6  cc_onco122  1160.0    1147.0\n",
       " T2                 angiomiolipoma  8860/0  cc_onco122  1259.0    1245.0\n",
       " T3                     Oncocitoma  8290/0  cc_onco122  1296.0    1286.0\n",
       " T4   carcinoma de células renales  8312/3  cc_onco122  1334.0    1306.0\n",
       " T5                nódulo pulmonar  8000/6  cc_onco122  2172.0    2157.0\n",
       " T6                 coriocarcinoma  9100/3  cc_onco122  3322.0    3308.0\n",
       " T7                     metástasis  8000/6  cc_onco122  3349.0    3339.0\n",
       " T8                lesión pulmonar  8000/6  cc_onco122  3837.0    3822.0\n",
       " T9                        tumoral  8000/1  cc_onco122  4422.0    4415.0\n",
       " T10                     tumorales  8000/1  cc_onco122  5185.0    5176.0\n",
       " T11                   metastásica  8000/6  cc_onco122  5234.0    5223.0\n",
       " T12                  diseminación  8000/6  cc_onco122  5818.0    5806.0\n",
       " T13           afectación pulmonar  8000/6  cc_onco122  6134.0    6115.0\n",
       " T14                       tumores  8000/1  cc_onco122  8675.0    8668.0,\n",
       " 'cc_onco1220':                            CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma de células renales   8312/3  cc_onco1220   150.0     122.0\n",
       " T2    angiosarcoma de alto grado  9120/34  cc_onco1220  2051.0    2025.0\n",
       " T3                   metastásica   8000/6  cc_onco1220  3254.0    3243.0\n",
       " T4               afectación ósea   8000/6  cc_onco1220  3674.0    3659.0\n",
       " T5   progresión tumoral pulmonar   8000/6  cc_onco1220  3971.0    3944.0\n",
       " T6                       tumoral   8000/1  cc_onco1220  3962.0    3955.0,\n",
       " 'cc_onco1223':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1            neoplasia  8000/1  cc_onco1223   305.0     296.0\n",
       " T2  carcinoma urotelial  8120/3  cc_onco1223   326.0     307.0\n",
       " T3              tumoral  8000/1  cc_onco1223  1722.0    1715.0,\n",
       " 'cc_onco1224':                                          CLAVE  ICD-O-3    documento  endpos  \\\n",
       " T1   adenocarcinoma moderadamente diferenciado  8140/32  cc_onco1224  1058.0   \n",
       " T2                                   Carcinoma   8010/3  cc_onco1224  1031.0   \n",
       " T3                               LOE hepáticas   8000/6  cc_onco1224  1289.0   \n",
       " T4                                  metástasis   8000/6  cc_onco1224  1314.0   \n",
       " T5                                       tumor   8000/1  cc_onco1224  1663.0   \n",
       " T6                                      cáncer   8000/3  cc_onco1224  1972.0   \n",
       " T7                                     tumoral   8000/1  cc_onco1224  2410.0   \n",
       " T8                             nódulo pulmonar   8000/6  cc_onco1224  2491.0   \n",
       " T9                metástasis de adenocarcinoma   8140/6  cc_onco1224  2602.0   \n",
       " T10                        progresión pulmonar   8000/6  cc_onco1224  2660.0   \n",
       " T11                         nódulos pulmonares   8000/6  cc_onco1224  2835.0   \n",
       " T12                progresión tumoral pulmonar   8000/6  cc_onco1224  3526.0   \n",
       " T13                       enfermedad abdominal   8000/6  cc_onco1224  3562.0   \n",
       " T14                          recidiva pulmonar   8000/6  cc_onco1224  4545.0   \n",
       " T15                                metastásica   8000/6  cc_onco1224  4718.0   \n",
       " \n",
       "      startpos  \n",
       " T1     1017.0  \n",
       " T2     1022.0  \n",
       " T3     1276.0  \n",
       " T4     1304.0  \n",
       " T5     1658.0  \n",
       " T6     1966.0  \n",
       " T7     2403.0  \n",
       " T8     2476.0  \n",
       " T9     2574.0  \n",
       " T10    2641.0  \n",
       " T11    2817.0  \n",
       " T12    3499.0  \n",
       " T13    3542.0  \n",
       " T14    4528.0  \n",
       " T15    4707.0  ,\n",
       " 'cc_onco1231':                 CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1           melanoma  8720/3  cc_onco1231   519.0     511.0\n",
       " T2         malignidad  8000/3  cc_onco1231   852.0     842.0\n",
       " T3  linfoma folicular  9690/3  cc_onco1231  1863.0    1846.0,\n",
       " 'cc_onco1233':                            CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                adenocarcinoma   8140/3  cc_onco1233   509.0     495.0\n",
       " T2                    neoplásico   8000/1  cc_onco1233   653.0     643.0\n",
       " T3                       tumoral   8000/1  cc_onco1233  1504.0    1497.0\n",
       " T4                    meningioma   9530/0  cc_onco1233  2323.0    2313.0\n",
       " T5                       maligno   8000/3  cc_onco1233  2331.0    2324.0\n",
       " T6                  osteosarcoma   9180/3  cc_onco1233  2481.0    2469.0\n",
       " T7                  neoformativo   8000/1  cc_onco1233  2927.0    2915.0\n",
       " T8  adenocarcinoma de bajo grado  8140/31  cc_onco1233  3688.0    3660.0\n",
       " T9                lesión frontal   8000/6  cc_onco1233  3820.0    3806.0,\n",
       " 'cc_onco1238':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                adenocarcinoma  8140/3  cc_onco1238   169.0     155.0\n",
       " T2                        TxN3M0  8000/6  cc_onco1238   298.0     292.0\n",
       " T3                     letálides  8000/6  cc_onco1238   877.0     868.0\n",
       " T4  metástasis de adenocarcinoma  8140/6  cc_onco1238  1027.0     999.0\n",
       " T5                    neoplásica  8000/1  cc_onco1238  2080.0    2070.0\n",
       " T6    adenopatía supraclavicular  8000/6  cc_onco1238  6208.0    6182.0\n",
       " T7                         tumor  8000/1  cc_onco1238  6284.0    6279.0,\n",
       " 'cc_onco1240':                               CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                  nódulo hepático  8000/6  cc_onco1240   550.0     535.0\n",
       " T2                        neoplasia  8000/1  cc_onco1240   626.0     617.0\n",
       " T3                   adenocarcinoma  8140/3  cc_onco1240   742.0     728.0\n",
       " T4                              ADC  8140/3  cc_onco1240   843.0     840.0\n",
       " T5                  lóbulo hepático  8000/6  cc_onco1240   907.0     892.0\n",
       " T6                       metástasis  8000/6  cc_onco1240  1043.0    1033.0\n",
       " T7                          tumores  8000/1  cc_onco1240  1235.0    1228.0\n",
       " T8    metástasis por adenocarcinoma  8140/6  cc_onco1240  1344.0    1315.0\n",
       " T9   adenocarcinoma tipo intestinal  8144/3  cc_onco1240  1360.0    1330.0\n",
       " T10              lesiones hepáticas  8000/6  cc_onco1240  1698.0    1680.0\n",
       " T11                     metastásico  8000/6  cc_onco1240  1803.0    1792.0\n",
       " T12                     metastásica  8000/6  cc_onco1240  2357.0    2346.0\n",
       " T13               nódulo subpleural  8000/6  cc_onco1240  2625.0    2608.0\n",
       " T14    metástasis de adenocarcinoma  8140/6  cc_onco1240  2942.0    2914.0,\n",
       " 'cc_onco1242':                                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                    melanoma maligno  8720/3  cc_onco1242   327.0     311.0\n",
       " T2                          tumoración  8000/1  cc_onco1242   748.0     738.0\n",
       " T3                           tumorales  8000/1  cc_onco1242   861.0     852.0\n",
       " T4   masa en la región supraclavicular  8000/6  cc_onco1242  1125.0    1092.0\n",
       " T5                Masa supraclavicular  8000/6  cc_onco1242  1304.0    1284.0\n",
       " T6          células tumorales malignas  8001/3  cc_onco1242  1359.0    1333.0\n",
       " T7                           neoplasia  8000/1  cc_onco1242  1370.0    1361.0\n",
       " T8              lesión supraclavicular  8000/6  cc_onco1242  1581.0    1559.0\n",
       " T9      metástasis de melanoma maligno  8720/6  cc_onco1242  1657.0    1627.0\n",
       " T10                progresión pulmonar  8000/6  cc_onco1242  2134.0    2115.0\n",
       " T11                  lesiones cutáneas  8000/6  cc_onco1242  4848.0    4831.0\n",
       " T12                lesiones cerebrales  8000/6  cc_onco1242  5063.0    5044.0\n",
       " T13                progresión cerebral  8000/6  cc_onco1242  6036.0    6017.0\n",
       " T14                            tumores  8000/1  cc_onco1242  6130.0    6123.0,\n",
       " 'cc_onco1243':                              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                  adenocarcinoma  8140/3  cc_onco1243   131.0     117.0\n",
       " T2  nódulos pulmonares bilaterales  8000/6  cc_onco1243   185.0     155.0\n",
       " T3             progresión pulmonar  8000/6  cc_onco1243   618.0     599.0\n",
       " T4                      metástasis  8000/6  cc_onco1243  1395.0    1385.0\n",
       " T5             progresión cerebral  8000/6  cc_onco1243  1471.0    1452.0,\n",
       " 'cc_onco1244':                                    CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                  Masa supraclavicular  8000/6  cc_onco1244   392.0   \n",
       " T2                             tumorales  8000/1  cc_onco1244   912.0   \n",
       " T3                            metástasis  8000/6  cc_onco1244  1187.0   \n",
       " T4   metástasis de carcinoma embrionario  9070/6  cc_onco1244  1626.0   \n",
       " T5                              seminoma  9061/3  cc_onco1244  1902.0   \n",
       " T6                              teratoma  9080/1  cc_onco1244  1919.0   \n",
       " T7        tumor germinal no seminomatoso  9065/3  cc_onco1244  2047.0   \n",
       " T8                                  TGNS  9065/3  cc_onco1244  2053.0   \n",
       " T9                            neoplásico  8000/1  cc_onco1244  3680.0   \n",
       " T10                      teratoma maduro  9080/0  cc_onco1244  4342.0   \n",
       " T11                            formación  8000/1  cc_onco1244  4392.0   \n",
       " \n",
       "      startpos  \n",
       " T1      372.0  \n",
       " T2      903.0  \n",
       " T3     1177.0  \n",
       " T4     1591.0  \n",
       " T5     1894.0  \n",
       " T6     1911.0  \n",
       " T7     2017.0  \n",
       " T8     2049.0  \n",
       " T9     3670.0  \n",
       " T10    4327.0  \n",
       " T11    4383.0  ,\n",
       " 'cc_onco1246':                                CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                         neoplasia  8000/1  cc_onco1246   160.0     151.0\n",
       " T2                             tumor  8000/1  cc_onco1246   206.0     201.0\n",
       " T3  carcinoma lobulillar infiltrante  8520/3  cc_onco1246   331.0     299.0\n",
       " T4                                CM  8000/3  cc_onco1246   542.0     540.0\n",
       " T5             carcinoma intraductal  8500/2  cc_onco1246   865.0     844.0\n",
       " T6                        neoplásico  8000/1  cc_onco1246  2916.0    2906.0\n",
       " T7           metástasis de carcinoma  8010/6  cc_onco1246  3480.0    3457.0\n",
       " T8                         tumorales  8000/1  cc_onco1246  3951.0    3942.0,\n",
       " 'cc_onco1247':              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1      malignidad  8000/3  cc_onco1247  1917.0    1907.0\n",
       " T2           tumor  8000/1  cc_onco1247  1937.0    1932.0\n",
       " T3      neoplásica  8000/1  cc_onco1247  2010.0    2000.0\n",
       " T4  adenocarcinoma  8140/3  cc_onco1247  2040.0    2026.0,\n",
       " 'cc_onco1248':                                CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                             tumor  8000/1  cc_onco1248  1299.0    1294.0\n",
       " T2  tumor neuroectodérmico primitivo  9473/3  cc_onco1248  2011.0    1979.0\n",
       " T3                          blastoma  8000/3  cc_onco1248  2119.0    2111.0\n",
       " T4                           tumoral  8000/1  cc_onco1248  3770.0    3763.0\n",
       " T5       progresión a nivel cerebral  8000/6  cc_onco1248  4234.0    4207.0\n",
       " T6                    Carcinomatosis  8010/9  cc_onco1248  4251.0    4237.0,\n",
       " 'cc_onco1249':                                 CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                             cáncer  8000/3  cc_onco1249   253.0     247.0\n",
       " T2                              tumor  8000/1  cc_onco1249   518.0     513.0\n",
       " T3  carcinoma renal de células claras  8310/3  cc_onco1249   640.0     607.0\n",
       " T4                            pT2N0M0  8000/6  cc_onco1249   649.0     642.0\n",
       " T5                         metástasis  8000/6  cc_onco1249   818.0     808.0\n",
       " T6               metástasis del tumor  8000/6  cc_onco1249  1005.0     985.0\n",
       " T7                            tumoral  8000/1  cc_onco1249  2716.0    2709.0,\n",
       " 'cc_onco1250':              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1      tumoración  8000/1  cc_onco1250  2534.0    2524.0\n",
       " T2  adenocarcinoma  8140/3  cc_onco1250  3033.0    3019.0\n",
       " T3         tumoral  8000/1  cc_onco1250  3637.0    3630.0,\n",
       " 'cc_onco1251':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                          tumor  8000/1  cc_onco1251   107.0     102.0\n",
       " T2   carcinoma ductal infiltrante  8500/3  cc_onco1251   148.0     120.0\n",
       " T3                        tumoral  8000/1  cc_onco1251   517.0     510.0\n",
       " T4                     metástasis  8000/6  cc_onco1251  1874.0    1864.0\n",
       " T5                nódulo pulmonar  8000/6  cc_onco1251  1956.0    1941.0\n",
       " T6                    metastásico  8000/6  cc_onco1251  1997.0    1986.0\n",
       " T7                        linfoma  9590/3  cc_onco1251  2239.0    2232.0\n",
       " T8                           MALT  9699/3  cc_onco1251  2286.0    2282.0\n",
       " T9                     neoplásico  8000/1  cc_onco1251  2499.0    2489.0\n",
       " T10                        cáncer  8000/3  cc_onco1251  2781.0    2775.0,\n",
       " 'cc_onco1252':                          CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  adenopatía supraclavicular  8000/6  cc_onco1252  1680.0    1654.0\n",
       " T2           lesiones cutáneas  8000/6  cc_onco1252  2947.0    2930.0\n",
       " T3           sarcoma de Kaposi  9140/3  cc_onco1252  3098.0    3081.0,\n",
       " 'cc_onco1259':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1       adenocarcinoma  8140/3  cc_onco1259   234.0     220.0\n",
       " T2           neoplásico  8000/1  cc_onco1259   437.0     427.0\n",
       " T3  lesiones cerebrales  8000/6  cc_onco1259  1555.0    1536.0\n",
       " T4           metástasis  8000/6  cc_onco1259  1621.0    1611.0\n",
       " T5         diseminación  8000/6  cc_onco1259  1771.0    1759.0\n",
       " T6       Carcinomatosis  8010/9  cc_onco1259  1935.0    1921.0,\n",
       " 'cc_onco1261':                                CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  enfermedad de Paget extramamaria  8542/3  cc_onco1261   393.0     361.0\n",
       " T2      metástasis de adenocarcinoma  8140/6  cc_onco1261   634.0     606.0\n",
       " T3                        neoplasias  8000/1  cc_onco1261  1417.0    1407.0\n",
       " T4                           tumores  8000/1  cc_onco1261  1445.0    1438.0\n",
       " T5                        malignidad  8000/3  cc_onco1261  1878.0    1868.0,\n",
       " 'cc_onco1263':                 CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1            adenoma   8140/0  cc_onco1263   117.0     110.0\n",
       " T2          neoplasia   8000/1  cc_onco1263   297.0     288.0\n",
       " T3     adenocarcinoma   8140/3  cc_onco1263   448.0     434.0\n",
       " T4            cT3N0M0   8000/6  cc_onco1263   502.0     495.0\n",
       " T5  adenocarcinoma G3  8140/33  cc_onco1263   864.0     847.0\n",
       " T6                 MO   8000/6  cc_onco1263  1709.0    1707.0,\n",
       " 'cc_onco1265':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1       adenocarcinoma  8140/3  cc_onco1265   169.0     155.0\n",
       " T2           malignidad  8000/3  cc_onco1265   774.0     764.0\n",
       " T3             implante  8000/6  cc_onco1265   912.0     904.0\n",
       " T4          mesotelioma  9050/3  cc_onco1265  1021.0    1010.0\n",
       " T5  mesotelioma maligno  9050/3  cc_onco1265  1055.0    1036.0,\n",
       " 'cc_onco1266':                      CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  implantes peritoneales  8000/6  cc_onco1266   206.0     184.0\n",
       " T2      lesiones hepáticas  8000/6  cc_onco1266   300.0     282.0\n",
       " T3                 sarcoma  8800/3  cc_onco1266   427.0     420.0\n",
       " T4       nódulos hepáticos  8000/6  cc_onco1266  1773.0    1756.0,\n",
       " 'cc_onco1268':                                                 CLAVE ICD-O-3    documento  \\\n",
       " T1                                         malignidad  8000/3  cc_onco1268   \n",
       " T2                                         neoplásica  8000/1  cc_onco1268   \n",
       " T3                                      neuroblastoma  9500/3  cc_onco1268   \n",
       " T4                              Carcinoma microcítico  8041/3  cc_onco1268   \n",
       " T5       carcinoma neuroendocrino de células pequeñas  8041/3  cc_onco1268   \n",
       " T6                                     neuroendocrino  8240/3  cc_onco1268   \n",
       " T7  Carcinoma microcítico de pulmón, enfermedad ex...  8041/6  cc_onco1268   \n",
       " T8                                         neoplásico  8000/1  cc_onco1268   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   493.0     483.0  \n",
       " T2  2038.0    2028.0  \n",
       " T3  2063.0    2050.0  \n",
       " T4  2098.0    2077.0  \n",
       " T5  2362.0    2318.0  \n",
       " T6  2342.0    2328.0  \n",
       " T7  2438.0    2385.0  \n",
       " T8  2481.0    2471.0  ,\n",
       " 'cc_onco1269':                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1     lesión hepática  8000/6  cc_onco1269   185.0     170.0\n",
       " T2          Hemangioma  9120/0  cc_onco1269   209.0     199.0\n",
       " T3          malignidad  8000/3  cc_onco1269   306.0     296.0\n",
       " T4           tumorales  8000/1  cc_onco1269   633.0     624.0\n",
       " T5     hepatocarcinoma  8170/3  cc_onco1269  1035.0    1020.0\n",
       " T6             pT3NxMx  8000/6  cc_onco1269  1333.0    1326.0\n",
       " T7  lesiones hepáticas  8000/6  cc_onco1269  1564.0    1546.0\n",
       " T8         metastásica  8000/6  cc_onco1269  2179.0    2168.0,\n",
       " 'cc_onco1270':              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  cc_onco1270    60.0      46.0\n",
       " T2          T4N3M1  8000/6  cc_onco1270    77.0      71.0\n",
       " T3         tumoral  8000/1  cc_onco1270  2254.0    2247.0,\n",
       " 'cc_onco1274':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma ductal infiltrante  8500/3  cc_onco1274   133.0     105.0\n",
       " T2                            M0  8000/6  cc_onco1274   321.0     319.0\n",
       " T3                       tumoral  8000/1  cc_onco1274   506.0     499.0\n",
       " T4                    tumoración  8000/1  cc_onco1274   706.0     696.0\n",
       " T5                     formación  8000/1  cc_onco1274  1216.0    1207.0,\n",
       " 'cc_onco1278':                              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                        melanoma  8720/3  cc_onco1278    61.0      53.0\n",
       " T2                         tumoral  8000/1  cc_onco1278   182.0     175.0\n",
       " T3                melanoma maligno  8720/3  cc_onco1278   283.0     267.0\n",
       " T4                      metástasis  8000/6  cc_onco1278   464.0     454.0\n",
       " T5  nódulos pulmonares bilaterales  8000/6  cc_onco1278  1118.0    1088.0\n",
       " T6                     metastásico  8000/6  cc_onco1278  2740.0    2729.0\n",
       " T7    Melanoma cutáneo metastásico  8720/6  cc_onco1278  3236.0    3208.0,\n",
       " 'cc_onco1279':                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  nódulos pulmonares  8000/6  cc_onco1279  1049.0    1031.0\n",
       " T2  lesiones hepáticas  8000/6  cc_onco1279  1071.0    1053.0\n",
       " T3      adenocarcinoma  8140/3  cc_onco1279  1171.0    1157.0\n",
       " T4          tumoración  8000/1  cc_onco1279  1386.0    1376.0,\n",
       " 'cc_onco1281':                     CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1     lesiones hepáticas  8000/6  cc_onco1281  1446.0    1428.0\n",
       " T2             metástasis  8000/6  cc_onco1281  1493.0    1483.0\n",
       " T3   Carcinoma anaplásico  8021/3  cc_onco1281  1721.0    1701.0\n",
       " T4  Carcinoma microcítico  8041/3  cc_onco1281  1803.0    1782.0\n",
       " T5                 T4N3M1  8000/6  cc_onco1281  1828.0    1822.0\n",
       " T6             neoplásico  8000/1  cc_onco1281  1874.0    1864.0,\n",
       " 'cc_onco1282':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                         miomas  8895/0  cc_onco1282   113.0     107.0\n",
       " T2             lesiones hepáticas  8000/6  cc_onco1282   399.0     381.0\n",
       " T3  carcinoma medular de tiroides  8510/3  cc_onco1282   506.0     477.0\n",
       " T4                      tumorales  8000/1  cc_onco1282   851.0     842.0\n",
       " T5                    metastásico  8000/6  cc_onco1282   993.0     982.0\n",
       " T6                     metástasis  8000/6  cc_onco1282  1295.0    1285.0\n",
       " T7                     neoplasias  8000/1  cc_onco1282  1432.0    1422.0,\n",
       " 'cc_onco1284':                                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                        lesión renal  8000/6  cc_onco1284   293.0     281.0\n",
       " T2                           neoplasia  8000/1  cc_onco1284   316.0     307.0\n",
       " T3                          tumoración  8000/1  cc_onco1284   436.0     426.0\n",
       " T4                        masa anexial  8000/6  cc_onco1284   533.0     521.0\n",
       " T5              implantes peritoneales  8000/6  cc_onco1284   609.0     587.0\n",
       " T6                        omental cake  8000/6  cc_onco1284   642.0     630.0\n",
       " T7                           Carcinoma  8010/3  cc_onco1284   665.0     656.0\n",
       " T8                             tumoral  8000/1  cc_onco1284   758.0     751.0\n",
       " T9   carcinoma renal de células claras  8310/3  cc_onco1284   947.0     914.0\n",
       " T10                               CRCC  8310/3  cc_onco1284   953.0     949.0\n",
       " T11                  células tumorales  8001/1  cc_onco1284  1330.0    1313.0\n",
       " T12                   carcinoma seroso  8441/3  cc_onco1284  1386.0    1370.0\n",
       " T13                            tumores  8000/1  cc_onco1284  2268.0    2261.0,\n",
       " 'cc_onco1285':                    CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                 tumor  8000/1  cc_onco1285    47.0      42.0\n",
       " T2                cáncer  8000/3  cc_onco1285   112.0     106.0\n",
       " T3             neoplasia  8000/1  cc_onco1285   146.0     137.0\n",
       " T4       afectación ósea  8000/6  cc_onco1285   241.0     226.0\n",
       " T5                   CDI  8500/3  cc_onco1285   247.0     244.0\n",
       " T6          diseminación  8000/6  cc_onco1285  2142.0    2130.0\n",
       " T7  Estesioneuroblastoma  9522/3  cc_onco1285  2402.0    2382.0,\n",
       " 'cc_onco1287':                       CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  glioblastoma multiforme  9440/3  cc_onco1287   133.0     110.0\n",
       " T2                 blastoma  8000/3  cc_onco1287   122.0     114.0\n",
       " T3                  tumoral  8000/1  cc_onco1287  1294.0    1287.0,\n",
       " 'cc_onco1288':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1            tumorales  8000/1  cc_onco1288   978.0     969.0\n",
       " T2       adenocarcinoma  8140/3  cc_onco1288  1566.0    1552.0\n",
       " T3               T3N2M0  8000/6  cc_onco1288  1918.0    1912.0\n",
       " T4           neoplásico  8000/1  cc_onco1288  2000.0    1990.0\n",
       " T5  progresión hepática  8000/6  cc_onco1288  2751.0    2732.0,\n",
       " 'cc_onco1289':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1              carcinoma medular  8510/3  cc_onco1289   105.0      88.0\n",
       " T2                     tumoración  8000/1  cc_onco1289   314.0     304.0\n",
       " T3                       implante  8000/6  cc_onco1289   494.0     486.0\n",
       " T4                      tumorales  8000/1  cc_onco1289   604.0     595.0\n",
       " T5                     metástasis  8000/6  cc_onco1289   927.0     917.0\n",
       " T6   carcinoma ductal infiltrante  8500/3  cc_onco1289  1180.0    1152.0\n",
       " T7                            CDI  8500/3  cc_onco1289  1185.0    1182.0\n",
       " T8            implante peritoneal  8000/6  cc_onco1289  1223.0    1204.0\n",
       " T9         adenocarcinoma papilar  8260/3  cc_onco1289  1247.0    1225.0\n",
       " T10                     neoplasia  8000/1  cc_onco1289  1385.0    1376.0\n",
       " T11                        T2N0M0  8000/6  cc_onco1289  1413.0    1407.0\n",
       " T12                  omental cake  8000/6  cc_onco1289  1532.0    1520.0\n",
       " T13                       tumores  8000/1  cc_onco1289  1767.0    1760.0\n",
       " T14        implantes peritoneales  8000/6  cc_onco1289  2117.0    2095.0,\n",
       " 'cc_onco1290':                                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1   carcinoma renal de células claras  8310/3  cc_onco1290   261.0     228.0\n",
       " T2                   nódulo subpleural  8000/6  cc_onco1290   384.0     367.0\n",
       " T3                          metástasis  8000/6  cc_onco1290   496.0     486.0\n",
       " T4                            implante  8000/6  cc_onco1290   638.0     630.0\n",
       " T5                         metastásico  8000/6  cc_onco1290   650.0     639.0\n",
       " T6         carcinoma de células claras  8310/3  cc_onco1290   735.0     708.0\n",
       " T7                     nódulo pulmonar  8000/6  cc_onco1290   906.0     891.0\n",
       " T8                     masa subpleural  8000/6  cc_onco1290  1088.0    1073.0\n",
       " T9                   lesión subpleural  8000/6  cc_onco1290  1727.0    1710.0\n",
       " T10                 nódulos pulmonares  8000/6  cc_onco1290  2649.0    2631.0,\n",
       " 'cc_onco1291':                                      CLAVE   ICD-O-3    documento  endpos  \\\n",
       " T1                                  cáncer    8000/3  cc_onco1291   156.0   \n",
       " T2                   carcinoma infiltrante  8010/3/H  cc_onco1291   667.0   \n",
       " T3            carcinoma ductal infiltrante    8500/3  cc_onco1291   892.0   \n",
       " T4          nódulos pulmonares bilaterales    8000/6  cc_onco1291  1457.0   \n",
       " T5              adenopatía supraclavicular    8000/6  cc_onco1291  1897.0   \n",
       " T6                              malignidad    8000/3  cc_onco1291  1945.0   \n",
       " T7  histiocitosis de células de Langerhans    9751/3  cc_onco1291  2328.0   \n",
       " \n",
       "     startpos  \n",
       " T1     150.0  \n",
       " T2     646.0  \n",
       " T3     864.0  \n",
       " T4    1427.0  \n",
       " T5    1871.0  \n",
       " T6    1935.0  \n",
       " T7    2290.0  ,\n",
       " 'cc_onco1292':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                     tumorales  8000/1  cc_onco1292  1171.0    1162.0\n",
       " T2                 masa hepática  8000/6  cc_onco1292  1282.0    1269.0\n",
       " T3               lesión hepática  8000/6  cc_onco1292  1430.0    1415.0\n",
       " T4  hepatocarcinoma fibrolamelar  8171/3  cc_onco1292  1494.0    1466.0\n",
       " T5                     Carcinoma  8010/3  cc_onco1292  1481.0    1472.0\n",
       " T6          nódulos peritoneales  8000/6  cc_onco1292  2103.0    2083.0\n",
       " T7                Carcinomatosis  8010/9  cc_onco1292  2222.0    2208.0\n",
       " T8                    metástasis  8000/6  cc_onco1292  2510.0    2500.0,\n",
       " 'cc_onco1294':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1          carcinoma lobulillar  8520/3  cc_onco1294   134.0     114.0\n",
       " T2  adenocarcinoma endometrioide  8380/3  cc_onco1294   435.0     407.0\n",
       " T3                    metástasis  8000/6  cc_onco1294  1212.0    1202.0\n",
       " T4                     tumorales  8000/1  cc_onco1294  1303.0    1294.0,\n",
       " 'cc_onco1297':                       CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1            lesión lítica  8000/6  cc_onco1297   506.0     493.0\n",
       " T2              lesión ósea  8000/6  cc_onco1297   813.0     802.0\n",
       " T3   masa de partes blandas  8000/6  cc_onco1297   926.0     904.0\n",
       " T4                  tumoral  8000/1  cc_onco1297   975.0     968.0\n",
       " T5     infiltración medular  8000/6  cc_onco1297  1049.0    1029.0\n",
       " T6             osteosarcoma  9180/3  cc_onco1297  1155.0    1143.0\n",
       " T7         sarcoma de Ewing  9260/3  cc_onco1297  1176.0    1160.0\n",
       " T8                neoplasia  8000/1  cc_onco1297  1383.0    1374.0\n",
       " T9        sarcoma pleomorfo  8802/3  cc_onco1297  1587.0    1570.0\n",
       " T10              metástasis  8000/6  cc_onco1297  1607.0    1597.0\n",
       " T11             peritumoral  8000/1  cc_onco1297  2275.0    2264.0\n",
       " T12              neoplásica  8000/1  cc_onco1297  2949.0    2939.0,\n",
       " 'cc_onco1298':                      CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1               Carcinoma  8010/3  cc_onco1298   225.0     216.0\n",
       " T2                pT1bN0M0  8000/6  cc_onco1298   250.0     242.0\n",
       " T3        células malignas  8001/3  cc_onco1298   835.0     819.0\n",
       " T4        masa pancreática  8000/6  cc_onco1298   945.0     929.0\n",
       " T5                 maligno  8000/3  cc_onco1298   985.0     978.0\n",
       " T6          adenocarcinoma  8140/3  cc_onco1298  1004.0     990.0\n",
       " T7                  T4N0M0  8000/6  cc_onco1298  1506.0    1500.0\n",
       " T8  carcinoma endometroide  8380/3  cc_onco1298  1584.0    1562.0,\n",
       " 'cc_onco1299':                                                 CLAVE ICD-O-3    documento  \\\n",
       " T1                                          neoplasia  8000/1  cc_onco1299   \n",
       " T2  adenocarcinoma gástrico difuso con células en ...  8490/3  cc_onco1299   \n",
       " T3                                          Carcinoma  8010/3  cc_onco1299   \n",
       " T4                                            cT3N0M0  8000/6  cc_onco1299   \n",
       " T5                                        metastásica  8000/6  cc_onco1299   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   355.0     346.0  \n",
       " T2   440.0     379.0  \n",
       " T3   393.0     384.0  \n",
       " T4   527.0     520.0  \n",
       " T5  1670.0    1659.0  ,\n",
       " 'cc_onco130':                       CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  lesiones osteoblásticas  8000/6  cc_onco130  1504.0    1481.0\n",
       " T2     carcinoma lobulillar  8520/3  cc_onco130  2214.0    2194.0\n",
       " T3         células malignas  8001/3  cc_onco130  2302.0    2286.0\n",
       " T4               metástasis  8000/6  cc_onco130  2919.0    2909.0\n",
       " T5                neoplasia  8000/1  cc_onco130  3143.0    3134.0\n",
       " T6              metastásica  8000/6  cc_onco130  3173.0    3162.0,\n",
       " 'cc_onco1300':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                     malignidad  8000/3  cc_onco1300   134.0     124.0\n",
       " T2                      neoplasia  8000/1  cc_onco1300   575.0     566.0\n",
       " T3  Adenopatías supraclaviculares  8000/6  cc_onco1300  1092.0    1063.0\n",
       " T4                     tumoración  8000/1  cc_onco1300  1141.0    1131.0\n",
       " T5   carcinoma ductal infiltrante  8500/3  cc_onco1300  1356.0    1328.0\n",
       " T6                     metástasis  8000/6  cc_onco1300  1586.0    1576.0\n",
       " T7                         T3N1M0  8000/6  cc_onco1300  1828.0    1822.0,\n",
       " 'cc_onco1301':                           CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  tumor de células germinales  9064/3  cc_onco1301    71.0      44.0\n",
       " T2                          TCG  9064/3  cc_onco1301    76.0      73.0\n",
       " T3                     seminoma  9061/3  cc_onco1301    89.0      81.0\n",
       " T4                    tumorales  8000/1  cc_onco1301   381.0     372.0\n",
       " T5         masa retroperitoneal  8000/6  cc_onco1301   429.0     409.0\n",
       " T6               masa abdominal  8000/6  cc_onco1301   988.0     974.0\n",
       " T7                   malignidad  8000/3  cc_onco1301  1392.0    1382.0\n",
       " T8                   metástasis  8000/6  cc_onco1301  2618.0    2608.0\n",
       " T9   tumor del seno endodérmico  9071/3  cc_onco1301  2694.0    2668.0,\n",
       " 'cc_onco1302':               CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1       tumoración  8000/1  cc_onco1302   133.0     123.0\n",
       " T2              TCG  9064/3  cc_onco1302   305.0     302.0\n",
       " T3       metástasis  8000/6  cc_onco1302   621.0     611.0\n",
       " T4       malignidad  8000/3  cc_onco1302   890.0     880.0\n",
       " T5            Mioma  8895/0  cc_onco1302  1308.0    1303.0\n",
       " T6   Leiomiosarcoma  8890/3  cc_onco1302  1324.0    1310.0\n",
       " T7          tumoral  8000/1  cc_onco1302  1759.0    1752.0\n",
       " T8  nódulo pulmonar  8000/6  cc_onco1302  2091.0    2076.0,\n",
       " 'cc_onco1303':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma papilar de tiroides  8260/3  cc_onco1303   160.0     131.0\n",
       " T2          carcinoma epidermoide  8070/3  cc_onco1303   326.0     305.0\n",
       " T3                       pT2aN0M0  8000/6  cc_onco1303   407.0     399.0\n",
       " T4                 adenocarcinoma  8140/3  cc_onco1303   449.0     435.0\n",
       " T5             carcinoma escamoso  8070/3  cc_onco1303   884.0     866.0\n",
       " T6                     tumoración  8000/1  cc_onco1303  1448.0    1438.0\n",
       " T7                     metástasis  8000/6  cc_onco1303  1724.0    1714.0,\n",
       " 'cc_onco1305':                          CLAVE   ICD-O-3    documento  endpos  startpos\n",
       " T1               lesión lítica    8000/6  cc_onco1305   616.0     603.0\n",
       " T2                 metastásica    8000/6  cc_onco1305   839.0     828.0\n",
       " T3                  metastásis    8000/6  cc_onco1305   949.0     939.0\n",
       " T4  adenocarcinoma infiltrante  8140/3/H  cc_onco1305  1164.0    1138.0\n",
       " T5                   neoplasia    8000/1  cc_onco1305  1186.0    1177.0\n",
       " T6         lesión lítica L4-L5    8000/6  cc_onco1305  2109.0    2090.0\n",
       " T7                  metástasis    8000/6  cc_onco1305  2570.0    2560.0,\n",
       " 'cc_onco1306':                                 CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  cáncer de mama ductal infiltrante  8500/3  cc_onco1306   140.0     107.0\n",
       " T2                             T2N1M0  8000/6  cc_onco1306   179.0     173.0\n",
       " T3                          tumorales  8000/1  cc_onco1306  1087.0    1078.0\n",
       " T4                     Carcinomatosis  8010/9  cc_onco1306  1327.0    1313.0\n",
       " T5                                 CM  8000/3  cc_onco1306  1340.0    1338.0\n",
       " T6                         malignidad  8000/3  cc_onco1306  1876.0    1866.0,\n",
       " 'cc_onco1309':                                      CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                     enfermedad pulmonar  8000/6  cc_onco1309    63.0   \n",
       " T2                                 tumoral  8000/1  cc_onco1309   639.0   \n",
       " T3                       lesiones cutáneas  8000/6  cc_onco1309   720.0   \n",
       " T4                              metástasis  8000/6  cc_onco1309   932.0   \n",
       " T5  tumor neuroendocrino bien diferenciado  8240/3  cc_onco1309  1158.0   \n",
       " T6                          neuroendocrino  8240/3  cc_onco1309  1140.0   \n",
       " T7                        tumor carcinoide  8240/3  cc_onco1309  1206.0   \n",
       " \n",
       "     startpos  \n",
       " T1      44.0  \n",
       " T2     632.0  \n",
       " T3     703.0  \n",
       " T4     922.0  \n",
       " T5    1120.0  \n",
       " T6    1126.0  \n",
       " T7    1190.0  ,\n",
       " 'cc_onco1310':                                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                          tumoración  8000/1  cc_onco1310   310.0     300.0\n",
       " T2                      tumor estromal  8935/1  cc_onco1310  1048.0    1034.0\n",
       " T3  tumor del estroma gastrointestinal  8936/3  cc_onco1310  1276.0    1242.0\n",
       " T4                             maligno  8000/3  cc_onco1310  1294.0    1287.0\n",
       " T5                   recidiva hepática  8000/6  cc_onco1310  1758.0    1741.0\n",
       " T6                 progresión hepática  8000/6  cc_onco1310  1855.0    1836.0\n",
       " T7                  lesiones hepáticas  8000/6  cc_onco1310  2147.0    2129.0,\n",
       " 'cc_onco1313':                                          CLAVE   ICD-O-3    documento  endpos  \\\n",
       " T1                              adenocarcinoma    8140/3  cc_onco1313   280.0   \n",
       " T2                  adenocarcinoma infiltrante  8140/3/H  cc_onco1313   456.0   \n",
       " T3                                     tumoral    8000/1  cc_onco1313   572.0   \n",
       " T4                                   neoplasia    8000/1  cc_onco1313  1488.0   \n",
       " T5                         implantes omentales    8000/6  cc_onco1313  1829.0   \n",
       " T6                                metastásicos    8000/6  cc_onco1313  1842.0   \n",
       " T7   adenocarcinoma moderadamente diferenciado   8140/32  cc_onco1313  2021.0   \n",
       " T8                                  metástasis    8000/6  cc_onco1313  2047.0   \n",
       " T9                              Carcinomatosis    8010/9  cc_onco1313  2226.0   \n",
       " T10       Adenocarcinoma de pulmón metastásico    8140/6  cc_onco1313  2332.0   \n",
       " \n",
       "      startpos  \n",
       " T1      266.0  \n",
       " T2      430.0  \n",
       " T3      565.0  \n",
       " T4     1479.0  \n",
       " T5     1810.0  \n",
       " T6     1830.0  \n",
       " T7     1980.0  \n",
       " T8     2037.0  \n",
       " T9     2212.0  \n",
       " T10    2296.0  ,\n",
       " 'cc_onco1316':                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1      adenocarcinoma  8140/3  cc_onco1316    89.0      75.0\n",
       " T2              T3N0M0  8000/6  cc_onco1316   124.0     118.0\n",
       " T3          metástasis  8000/6  cc_onco1316  1020.0    1010.0\n",
       " T4             maligna  8000/3  cc_onco1316  1177.0    1170.0\n",
       " T5  nódulos pulmonares  8000/6  cc_onco1316  1608.0    1590.0\n",
       " T6             tumores  8000/1  cc_onco1316  1661.0    1654.0,\n",
       " 'cc_onco132':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  carcinoma ductal infiltrante  8500/3  cc_onco132    84.0      56.0\n",
       " T2                        T2N2M0  8000/6  cc_onco132   132.0     126.0\n",
       " T3             lesiones cutáneas  8000/6  cc_onco132   523.0     506.0\n",
       " T4                  diseminación  8000/6  cc_onco132   891.0     879.0\n",
       " T5                    tumoración  8000/1  cc_onco132  1148.0    1138.0\n",
       " T6                            CM  8000/3  cc_onco132  1939.0    1937.0\n",
       " T7                     tumorales  8000/1  cc_onco132  2034.0    2025.0\n",
       " T8                    malignidad  8000/3  cc_onco132  2243.0    2233.0\n",
       " T9                    neoplásica  8000/1  cc_onco132  3143.0    3133.0,\n",
       " 'cc_onco1321':                               CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1   poliposis adenomatosa familiar   8220/0  cc_onco1321    75.0      45.0\n",
       " T2                      adenomatosa   8140/0  cc_onco1321    66.0      55.0\n",
       " T3                   masa abdominal   8000/6  cc_onco1321   183.0     169.0\n",
       " T4                            tumor   8000/1  cc_onco1321   962.0     957.0\n",
       " T5                     fibrosarcoma   8810/3  cc_onco1321  1210.0    1198.0\n",
       " T6            Sarcoma de bajo grado  8800/31  cc_onco1321  1224.0    1203.0\n",
       " T7                         sarcomas   8800/3  cc_onco1321  1291.0    1283.0\n",
       " T8                 masa mesentérica   8000/6  cc_onco1321  1676.0    1660.0\n",
       " T9                          tumoral   8000/1  cc_onco1321  1809.0    1802.0\n",
       " T10                         tumores   8000/1  cc_onco1321  1868.0    1861.0\n",
       " T11               tumor mesenquimal   8800/1  cc_onco1321  2091.0    2074.0,\n",
       " 'cc_onco1322':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1           tumoración  8000/1  cc_onco1322   110.0     100.0\n",
       " T2  sarcoma fusocelular  8801/3  cc_onco1322   297.0     278.0\n",
       " T3       Leiomiosarcoma  8890/3  cc_onco1322   327.0     313.0\n",
       " T4      nódulo pulmonar  8000/6  cc_onco1322   524.0     509.0\n",
       " T5           metástasis  8000/6  cc_onco1322   938.0     928.0\n",
       " T6           malignidad  8000/3  cc_onco1322  1405.0    1395.0\n",
       " T7          metastásico  8000/6  cc_onco1322  2010.0    1999.0,\n",
       " 'cc_onco1327':                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1          tumoración  8000/1  cc_onco1327   324.0     314.0\n",
       " T2         metastásica  8000/6  cc_onco1327   965.0     954.0\n",
       " T3    seminoma clásico  9061/3  cc_onco1327  1073.0    1057.0\n",
       " T4                 M1a  8000/6  cc_onco1327  1355.0    1352.0\n",
       " T5           tumorales  8000/1  cc_onco1327  1716.0    1707.0\n",
       " T6  tumores germinales  9064/3  cc_onco1327  1935.0    1917.0\n",
       " T7           neoplasia  8000/1  cc_onco1327  2069.0    2060.0\n",
       " T8          malignidad  8000/3  cc_onco1327  2142.0    2132.0,\n",
       " 'cc_onco1332':                                                 CLAVE  ICD-O-3    documento  \\\n",
       " T1                              carcinoma epidermoide   8070/3  cc_onco1332   \n",
       " T2                  neoplasia urotelial de bajo grado  8000/11  cc_onco1332   \n",
       " T3                            metástasis de carcinoma   8010/6  cc_onco1332   \n",
       " T4                     carcinoma de células escamosas   8070/3  cc_onco1332   \n",
       " T5                                                SCC   9044/3  cc_onco1332   \n",
       " T6                      Adenopatías supraclaviculares   8000/6  cc_onco1332   \n",
       " T7                                   células malignas   8001/3  cc_onco1332   \n",
       " T8  metástasis de carcinoma, sugerente de epidermoide   8070/6  cc_onco1332   \n",
       " T9                      tumor urotelial de bajo grado  8000/11  cc_onco1332   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   109.0      88.0  \n",
       " T2   238.0     205.0  \n",
       " T3   883.0     860.0  \n",
       " T4   972.0     942.0  \n",
       " T5   977.0     974.0  \n",
       " T6  1080.0    1051.0  \n",
       " T7  1519.0    1503.0  \n",
       " T8  1740.0    1691.0  \n",
       " T9  1953.0    1924.0  ,\n",
       " 'cc_onco1334':     CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  LDCGB  9680/3  cc_onco1334   449.0     444.0,\n",
       " 'cc_onco1335':              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  LOEs hepáticas  8000/6  cc_onco1335   986.0     972.0\n",
       " T2  adenocarcinoma  8140/3  cc_onco1335  1033.0    1019.0\n",
       " T3          cáncer  8000/3  cc_onco1335  1226.0    1220.0\n",
       " T4     metastásico  8000/6  cc_onco1335  1408.0    1397.0,\n",
       " 'cc_onco1341':                                      CLAVE   ICD-O-3    documento  endpos  \\\n",
       " T1                               tumorales    8000/1  cc_onco1341   812.0   \n",
       " T2                              metástasis    8000/6  cc_onco1341   945.0   \n",
       " T3                      lesiones blásticas    8000/6  cc_onco1341  1019.0   \n",
       " T4                          LOEs hepáticas    8000/6  cc_onco1341  1455.0   \n",
       " T5                 lesiones osteoblásticas    8000/6  cc_onco1341  1480.0   \n",
       " T6                          adenocarcinoma    8140/3  cc_onco1341  1753.0   \n",
       " T7  adenocarcinoma pobremente diferenciado   8140/33  cc_onco1341  1905.0   \n",
       " T8              adenocarcinoma infiltrante  8140/3/H  cc_onco1341  2121.0   \n",
       " \n",
       "     startpos  \n",
       " T1     803.0  \n",
       " T2     935.0  \n",
       " T3    1001.0  \n",
       " T4    1441.0  \n",
       " T5    1457.0  \n",
       " T6    1739.0  \n",
       " T7    1867.0  \n",
       " T8    2095.0  ,\n",
       " 'cc_onco1342':                              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  adenocarcinoma gástrico difuso  8145/3  cc_onco1342   672.0     642.0\n",
       " T2                       Carcinoma  8010/3  cc_onco1342   656.0     647.0\n",
       " T3     infiltración de médula ósea  8000/6  cc_onco1342   704.0     677.0\n",
       " T4                              HE  9133/1  cc_onco1342   719.0     717.0\n",
       " T5           afectación secundaria  8000/6  cc_onco1342  2252.0    2231.0\n",
       " T6                          lipoma  8850/0  cc_onco1342  2390.0    2384.0,\n",
       " 'cc_onco1343':                       CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                  tumoral  8000/1  cc_onco1343  1335.0    1328.0\n",
       " T2                  linfoma  9590/3  cc_onco1343  1474.0    1467.0\n",
       " T3               neoplásico  8000/1  cc_onco1343  1898.0    1888.0\n",
       " T4              astrocitoma  9400/3  cc_onco1343  2165.0    2154.0\n",
       " T5  glioblastoma multiforme  9440/3  cc_onco1343  2930.0    2907.0\n",
       " T6                 blastoma  8000/3  cc_onco1343  2919.0    2911.0,\n",
       " 'cc_onco1344':                              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                        melanoma  8720/3  cc_onco1344   253.0     245.0\n",
       " T2                  masa abdominal  8000/6  cc_onco1344   371.0     357.0\n",
       " T3                melanoma maligno  8720/3  cc_onco1344   438.0     422.0\n",
       " T4  nódulos pulmonares bilaterales  8000/6  cc_onco1344   635.0     605.0\n",
       " T5                  LOEs hepáticas  8000/6  cc_onco1344   660.0     646.0\n",
       " T6                    metastásicas  8000/6  cc_onco1344   673.0     661.0\n",
       " T7             implantes tumorales  8000/6  cc_onco1344   717.0     698.0\n",
       " T8              masas peritoneales  8000/6  cc_onco1344  1742.0    1724.0,\n",
       " 'cc_onco1345':                                  CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                          tumoración   8000/1  cc_onco1345   155.0     145.0\n",
       " T2  sarcoma pleomórfico indiferenciado  8802/34  cc_onco1345   237.0     203.0\n",
       " T3                             tumoral   8000/1  cc_onco1345   413.0     406.0\n",
       " T4                         metástasica   8000/6  cc_onco1345   641.0     630.0\n",
       " T5                           tumorales   8000/1  cc_onco1345  1723.0    1714.0\n",
       " T6                     enfermedad ósea   8000/6  cc_onco1345  2844.0    2829.0,\n",
       " 'cc_onco1346':                           CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                 hipernefroma  8312/3  cc_onco1346    74.0      62.0\n",
       " T2       afectación a distancia  8000/6  cc_onco1346   101.0      79.0\n",
       " T3  carcinoma de células claras  8310/3  cc_onco1346   188.0     161.0\n",
       " T4                   metástasis  8000/6  cc_onco1346   508.0     498.0\n",
       " T5          implantes pleurales  8000/6  cc_onco1346   577.0     558.0\n",
       " T6           nódulo suprarrenal  8000/6  cc_onco1346   598.0     580.0,\n",
       " 'cc_onco1347':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma ductal infiltrante  8500/3  cc_onco1347   132.0     104.0\n",
       " T2                lesión cutánea  8000/6  cc_onco1347   634.0     620.0\n",
       " T3        enfermedad a distancia  8000/6  cc_onco1347  1181.0    1159.0\n",
       " T4       angiosarcoma epiteloide  8804/3  cc_onco1347  1247.0    1224.0\n",
       " T5                       sarcoma  8800/3  cc_onco1347  1236.0    1229.0,\n",
       " 'cc_onco1348':                    CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1            tumoración  8000/1  cc_onco1348   388.0     378.0\n",
       " T2             tumorales  8000/1  cc_onco1348  1223.0    1214.0\n",
       " T3            metástasis  8000/6  cc_onco1348  1469.0    1459.0\n",
       " T4   lesiones pulmonares  8000/6  cc_onco1348  1522.0    1503.0\n",
       " T5          mestastásica  8000/6  cc_onco1348  1547.0    1535.0\n",
       " T6    lesiones hepáticas  8000/6  cc_onco1348  1662.0    1644.0\n",
       " T7    masa paravertebral  8000/6  cc_onco1348  1769.0    1751.0\n",
       " T8          metastásicas  8000/6  cc_onco1348  1832.0    1820.0\n",
       " T9             neoplasia  8000/1  cc_onco1348  1983.0    1974.0\n",
       " T10        Paraganglioma  8680/1  cc_onco1348  2263.0    2250.0\n",
       " T11              maligno  8000/3  cc_onco1348  2271.0    2264.0,\n",
       " 'cc_onco1349':             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1     neoplásica  8000/1  cc_onco1349  1357.0    1347.0\n",
       " T2  lesión lítica  8000/6  cc_onco1349  1629.0    1616.0\n",
       " T3        maligna  8000/3  cc_onco1349  1711.0    1704.0,\n",
       " 'cc_onco1352':                          CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  lesiones focales hepáticas  8000/6  cc_onco1352   331.0     305.0\n",
       " T2             hepatocarcinoma  8170/3  cc_onco1352   383.0     368.0\n",
       " T3            células malignas  8001/3  cc_onco1352   476.0     460.0\n",
       " T4               LOE hepáticas  8000/6  cc_onco1352  1426.0    1413.0\n",
       " T5      implantes peritoneales  8000/6  cc_onco1352  1569.0    1547.0\n",
       " T6                  malignidad  8000/3  cc_onco1352  1662.0    1652.0\n",
       " T7        nódulos peritoneales  8000/6  cc_onco1352  2073.0    2053.0\n",
       " T8                      cancer  8000/3  cc_onco1352  2324.0    2318.0,\n",
       " 'cc_onco1357':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma ductal infiltrante  8500/3  cc_onco1357    72.0      44.0\n",
       " T2               afectación ósea  8000/6  cc_onco1357   129.0     114.0\n",
       " T3                    metástasis  8000/6  cc_onco1357  1039.0    1029.0,\n",
       " 'cc_onco136':                                             CLAVE    ICD-O-3   documento  \\\n",
       " T1                                      tumorales     8000/1  cc_onco136   \n",
       " T2                                     malignidad     8000/3  cc_onco136   \n",
       " T3                                nódulo pulmonar     8000/6  cc_onco136   \n",
       " T4                                  masa pulmonar     8000/6  cc_onco136   \n",
       " T5                                 adenocarcinoma     8140/3  cc_onco136   \n",
       " T6   adenocarcinoma infiltrante bien diferenciado  8140/31/H  cc_onco136   \n",
       " T7                          carcinoma infiltrante   8010/3/H  cc_onco136   \n",
       " T8                              carcinoma in situ     8010/2  cc_onco136   \n",
       " T9                                      neoplasia     8000/1  cc_onco136   \n",
       " T10                                            M0     8000/6  cc_onco136   \n",
       " T11                                       tumores     8000/1  cc_onco136   \n",
       " T12                                      malignos     8000/3  cc_onco136   \n",
       " T13                                        cancer     8000/3  cc_onco136   \n",
       " T14                           lesiones pulmonares     8000/6  cc_onco136   \n",
       " T15                           progresión pulmonar     8000/6  cc_onco136   \n",
       " T16                            nódulos pulmonares     8000/6  cc_onco136   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1   1493.0    1484.0  \n",
       " T2   1688.0    1678.0  \n",
       " T3   1857.0    1842.0  \n",
       " T4   2082.0    2069.0  \n",
       " T5   2171.0    2157.0  \n",
       " T6   2400.0    2356.0  \n",
       " T7   2382.0    2361.0  \n",
       " T8   2508.0    2491.0  \n",
       " T9   2567.0    2558.0  \n",
       " T10  2620.0    2618.0  \n",
       " T11  2689.0    2682.0  \n",
       " T12  2698.0    2690.0  \n",
       " T13  2764.0    2758.0  \n",
       " T14  3151.0    3132.0  \n",
       " T15  3858.0    3839.0  \n",
       " T16  3928.0    3910.0  ,\n",
       " 'cc_onco1360':                          CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1           lesiones cutáneas  8000/6  cc_onco1360   322.0     305.0\n",
       " T2                  malignidad  8000/3  cc_onco1360   347.0     337.0\n",
       " T3  adenopatía supraclavicular  8000/6  cc_onco1360   400.0     374.0\n",
       " T4             nódulo pulmonar  8000/6  cc_onco1360  1249.0    1234.0\n",
       " T5                  metástasis  8000/6  cc_onco1360  1673.0    1663.0\n",
       " T6           nódulo subcutáneo  8000/6  cc_onco1360  1929.0    1912.0\n",
       " T7    metástasis por carcinoma  8010/6  cc_onco1360  1975.0    1951.0\n",
       " T8       carcinoma epidermoide  8070/3  cc_onco1360  1987.0    1966.0\n",
       " T9        infiltración medular  8000/6  cc_onco1360  2449.0    2429.0,\n",
       " 'cc_onco1362':                                         CLAVE  ICD-O-3    documento  endpos  \\\n",
       " T1                                 tumoración   8000/1  cc_onco1362   577.0   \n",
       " T2                                    tumoral   8000/1  cc_onco1362   708.0   \n",
       " T3                     afectación a distancia   8000/6  cc_onco1362   801.0   \n",
       " T4  adenocarcinoma moderadamente diferenciado  8140/32  cc_onco1362   977.0   \n",
       " T5                                  Carcinoma   8010/3  cc_onco1362   950.0   \n",
       " T6                                    cT3NxM0   8000/6  cc_onco1362  2035.0   \n",
       " \n",
       "     startpos  \n",
       " T1     567.0  \n",
       " T2     701.0  \n",
       " T3     779.0  \n",
       " T4     936.0  \n",
       " T5     941.0  \n",
       " T6    2028.0  ,\n",
       " 'cc_onco1364':                                       CLAVE  ICD-O-3    documento  endpos  \\\n",
       " T1                           adenocarcinoma   8140/3  cc_onco1364    93.0   \n",
       " T2                                  cT3N2M0   8000/6  cc_onco1364   124.0   \n",
       " T3                                  tumoral   8000/1  cc_onco1364   269.0   \n",
       " T4                      progresión pulmonar   8000/6  cc_onco1364   985.0   \n",
       " T5                      progresión hepática   8000/6  cc_onco1364  1388.0   \n",
       " T6                  metástasis de carcinoma   8010/6  cc_onco1364  1998.0   \n",
       " T7   carcinoma neuroendocrino de alto grado  8246/34  cc_onco1364  2057.0   \n",
       " T8                           neuroendocrino   8240/3  cc_onco1364  2043.0   \n",
       " T9                                formación   8000/1  cc_onco1364  2305.0   \n",
       " T10             carcinoma de célula pequeña   8041/3  cc_onco1364  2335.0   \n",
       " T11                                oat cell   8002/3  cc_onco1364  2487.0   \n",
       " \n",
       "      startpos  \n",
       " T1       79.0  \n",
       " T2      117.0  \n",
       " T3      262.0  \n",
       " T4      966.0  \n",
       " T5     1369.0  \n",
       " T6     1975.0  \n",
       " T7     2019.0  \n",
       " T8     2029.0  \n",
       " T9     2296.0  \n",
       " T10    2308.0  \n",
       " T11    2479.0  ,\n",
       " 'cc_onco1365':                             CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1   lesiones nodulares hepáticas   8000/6  cc_onco1365   760.0     732.0\n",
       " T2                        tumoral   8000/1  cc_onco1365   921.0     914.0\n",
       " T3               células malignas   8001/3  cc_onco1365  1087.0    1071.0\n",
       " T4                 adenocarcinoma   8140/3  cc_onco1365  1118.0    1104.0\n",
       " T5            implantes tumorales   8000/6  cc_onco1365  1273.0    1254.0\n",
       " T6                     metástasis   8000/6  cc_onco1365  1411.0    1401.0\n",
       " T7    carcinoma poco diferenciado  8010/33  cc_onco1365  1541.0    1514.0\n",
       " T8                 Carcinomatosis   8010/9  cc_onco1365  1726.0    1712.0\n",
       " T9                 lesión cutánea   8000/6  cc_onco1365  2296.0    2282.0\n",
       " T10             lesiones cutáneas   8000/6  cc_onco1365  2745.0    2728.0,\n",
       " 'cc_onco1366':                        CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1   masas a nivel abdominal  8000/6  cc_onco1366   390.0     367.0\n",
       " T2                tumoración  8000/1  cc_onco1366   662.0     652.0\n",
       " T3  Carcinoma adrenocortical  8370/3  cc_onco1366   741.0     717.0\n",
       " T4        nódulo suprarrenal  8000/6  cc_onco1366  1078.0    1060.0\n",
       " T5            adenocarcinoma  8140/3  cc_onco1366  1275.0    1261.0\n",
       " T6                  implante  8000/6  cc_onco1366  1604.0    1596.0\n",
       " T7          células malignas  8001/3  cc_onco1366  2697.0    2681.0,\n",
       " 'cc_onco1367':                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1   síndrome de Lynch  8000/3  cc_onco1367    48.0      31.0\n",
       " T2           neoplasia  8000/1  cc_onco1367   985.0     976.0\n",
       " T3  nódulos pulmonares  8000/6  cc_onco1367  1114.0    1096.0\n",
       " T4          metástasis  8000/6  cc_onco1367  1141.0    1131.0\n",
       " T5          neoplásica  8000/1  cc_onco1367  1264.0    1254.0\n",
       " T6      adenocarcinoma  8140/3  cc_onco1367  1323.0    1309.0,\n",
       " 'cc_onco1369':                                 CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                     adenocarcinoma  8140/3  cc_onco1369   362.0     348.0\n",
       " T2                        metastásica  8000/6  cc_onco1369   403.0     392.0\n",
       " T3  adenocarcinoma de tipo intestinal  8144/3  cc_onco1369   577.0     544.0\n",
       " T4                            pT2N0M0  8000/6  cc_onco1369   619.0     612.0\n",
       " T5                         metástasis  8000/6  cc_onco1369   873.0     863.0\n",
       " T6                progresión hepática  8000/6  cc_onco1369  1156.0    1137.0\n",
       " T7        progresión a nivel pulmonar  8000/6  cc_onco1369  2713.0    2686.0,\n",
       " 'cc_onco1370':                                             CLAVE   ICD-O-3    documento  \\\n",
       " T1                                 retinoblastoma    9510/3  cc_onco1370   \n",
       " T2   neoplasia maligna de células redondas azules  8000/3/H  cc_onco1370   \n",
       " T3                                        maligna    8000/3  cc_onco1370   \n",
       " T4                    rabdomiosarcoma embrionario    8910/3  cc_onco1370   \n",
       " T5                                        sarcoma    8800/3  cc_onco1370   \n",
       " T6               Rabdomiosarcoma tipo embrionario    8910/3  cc_onco1370   \n",
       " T7                          lesión única hepática    8000/6  cc_onco1370   \n",
       " T8                                     metástasis    8000/6  cc_onco1370   \n",
       " T9                 metástasis por rabdomiosarcoma    8900/6  cc_onco1370   \n",
       " T10                                   metastásica    8000/6  cc_onco1370   \n",
       " T11                            nódulos cervicales    8000/6  cc_onco1370   \n",
       " T12                           lesiones cervicales    8000/6  cc_onco1370   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1     70.0      56.0  \n",
       " T2    798.0     754.0  \n",
       " T3    771.0     764.0  \n",
       " T4   1014.0     987.0  \n",
       " T5   1002.0     995.0  \n",
       " T6   1104.0    1072.0  \n",
       " T7   1714.0    1693.0  \n",
       " T8   1790.0    1780.0  \n",
       " T9   1957.0    1927.0  \n",
       " T10  2016.0    2005.0  \n",
       " T11  2102.0    2084.0  \n",
       " T12  2252.0    2233.0  ,\n",
       " 'cc_onco1372':                CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  seminoma clásico  9061/3  cc_onco1372   383.0     367.0\n",
       " T2          pT1bN1M0  8000/6  cc_onco1372   392.0     384.0,\n",
       " 'cc_onco1374':                              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                       miomatoso  8895/0  cc_onco1374   270.0     261.0\n",
       " T2  nódulos pulmonares bilaterales  8000/6  cc_onco1374  1088.0    1058.0\n",
       " T3                suelta de globos  8000/6  cc_onco1374  1137.0    1121.0\n",
       " T4                      tumoración  8000/1  cc_onco1374  1390.0    1380.0\n",
       " T5                      metástasis  8000/6  cc_onco1374  1445.0    1435.0\n",
       " T6                   masa pulmonar  8000/6  cc_onco1374  1612.0    1599.0\n",
       " T7                  metastatizante  8000/6  cc_onco1374  1732.0    1718.0\n",
       " T8                      miomatosis  8895/0  cc_onco1374  1955.0    1945.0,\n",
       " 'cc_onco1375':                                            CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                Carcinoma de células de Merkel  8247/3  cc_onco1375   552.0   \n",
       " T2  metástasis de carcinoma de células de Merkel  8247/6  cc_onco1375   819.0   \n",
       " T3                                        T1N1M0  8000/6  cc_onco1375   828.0   \n",
       " T4                             células tumorales  8001/1  cc_onco1375  1228.0   \n",
       " \n",
       "     startpos  \n",
       " T1     522.0  \n",
       " T2     775.0  \n",
       " T3     822.0  \n",
       " T4    1211.0  ,\n",
       " 'cc_onco1378':                            CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                adenocarcinoma   8140/3  cc_onco1378  1053.0    1039.0\n",
       " T2                    metástasis   8000/6  cc_onco1378  1707.0    1697.0\n",
       " T3            lesiones hepáticas   8000/6  cc_onco1378  2196.0    2178.0\n",
       " T4  adenocarcinoma de bajo grado  8140/31  cc_onco1378  2408.0    2380.0\n",
       " T5                   metastásico   8000/6  cc_onco1378  2420.0    2409.0\n",
       " T6                       tumoral   8000/1  cc_onco1378  2452.0    2445.0,\n",
       " 'cc_onco1379':                                            CLAVE  ICD-O-3    documento  \\\n",
       " T1                                     neoplasia   8000/1  cc_onco1379   \n",
       " T2                                    metástasis   8000/6  cc_onco1379   \n",
       " T3                                    tumoración   8000/1  cc_onco1379   \n",
       " T4                                adenocarcinoma   8140/3  cc_onco1379   \n",
       " T5  adenocarcinoma colorrectal bien diferenciado  8140/31  cc_onco1379   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   308.0     299.0  \n",
       " T2   545.0     535.0  \n",
       " T3  1491.0    1481.0  \n",
       " T4  1654.0    1640.0  \n",
       " T5  1799.0    1755.0  ,\n",
       " 'cc_onco1380':                 CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1          Carcinoma  8010/3  cc_onco1380   259.0     250.0\n",
       " T2  nódulos hepáticos  8000/6  cc_onco1380   872.0     855.0\n",
       " T3     adenocarcinoma  8140/3  cc_onco1380   984.0     970.0\n",
       " T4      LOE hepáticas  8000/6  cc_onco1380  1073.0    1060.0\n",
       " T5         malignidad  8000/3  cc_onco1380  1126.0    1116.0\n",
       " T6        metastásica  8000/6  cc_onco1380  1989.0    1978.0,\n",
       " 'cc_onco1381':                            CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                     neoplasia   8000/1  cc_onco1381    81.0      72.0\n",
       " T2                        cáncer   8000/3  cc_onco1381   116.0     110.0\n",
       " T3                    tumoración   8000/1  cc_onco1381   564.0     554.0\n",
       " T4                    neoplasias   8000/1  cc_onco1381   648.0     638.0\n",
       " T5                      implante   8000/6  cc_onco1381   902.0     894.0\n",
       " T6   carcinoma poco diferenciado  8010/33  cc_onco1381  1089.0    1062.0\n",
       " T7       metástasis de carcinoma   8010/6  cc_onco1381  1222.0    1199.0\n",
       " T8             quístico y sólido   8452/1  cc_onco1381  1923.0    1906.0\n",
       " T9             neoplasia maligna   8000/3  cc_onco1381  1955.0    1938.0\n",
       " T10           enfermedad pélvica   8000/6  cc_onco1381  2322.0    2304.0\n",
       " T11                  metastásica   8000/6  cc_onco1381  2782.0    2771.0\n",
       " T12                    tumorales   8000/1  cc_onco1381  2809.0    2800.0,\n",
       " 'cc_onco1385':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                    tumoración  8000/1  cc_onco1385   194.0     184.0\n",
       " T2              células malignas  8001/3  cc_onco1385   803.0     787.0\n",
       " T3  carcinoma ductal infiltrante  8500/3  cc_onco1385   882.0     854.0\n",
       " T4           Nódulos subcutáneos  8000/6  cc_onco1385  1792.0    1773.0\n",
       " T5              lesión orbitaria  8000/6  cc_onco1385  1978.0    1962.0\n",
       " T6                lesiones óseas  8000/6  cc_onco1385  2080.0    2066.0\n",
       " T7               progresión ósea  8000/6  cc_onco1385  2459.0    2444.0\n",
       " T8            lesiones blásticas  8000/6  cc_onco1385  2496.0    2478.0,\n",
       " 'cc_onco1386':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  Nódulos subcutáneos  8000/6  cc_onco1386   284.0     265.0\n",
       " T2    nódulo subcutáneo  8000/6  cc_onco1386  1389.0    1372.0\n",
       " T3           metástasis  8000/6  cc_onco1386  1401.0    1391.0\n",
       " T4       adenocarcinoma  8140/3  cc_onco1386  1428.0    1414.0\n",
       " T5         metastásicas  8000/6  cc_onco1386  1614.0    1602.0\n",
       " T6          lesión ósea  8000/6  cc_onco1386  2149.0    2138.0,\n",
       " 'cc_onco1389':                        CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                 neoplasia   8000/1  cc_onco1389   833.0     824.0\n",
       " T2                metástasis   8000/6  cc_onco1389   949.0     939.0\n",
       " T3             tumor maligno   8000/3  cc_onco1389   966.0     953.0\n",
       " T4            neuroendocrina   8574/3  cc_onco1389   992.0     978.0\n",
       " T5  neuroblastoma anaplásico  9500/34  cc_onco1389  1268.0    1244.0\n",
       " T6                  blastoma   8000/3  cc_onco1389  1257.0    1249.0\n",
       " T7              masa pélvica   8000/6  cc_onco1389  2372.0    2360.0,\n",
       " 'cc_onco139':                                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                          neoplasia  8000/1  cc_onco139   160.0     151.0\n",
       " T2                          tumorales  8000/1  cc_onco139  1319.0    1310.0\n",
       " T3                                SCC  9044/3  cc_onco139  1401.0    1398.0\n",
       " T4                         neoplásico  8000/1  cc_onco139  1510.0    1500.0\n",
       " T5  adenocarcinoma de tipo intestinal  8144/3  cc_onco139  1565.0    1532.0\n",
       " T6                          Carcinoma  8010/3  cc_onco139  1546.0    1537.0\n",
       " T7                            cT3N1M0  8000/6  cc_onco139  1995.0    1988.0\n",
       " T8                         metástasis  8000/6  cc_onco139  3638.0    3628.0,\n",
       " 'cc_onco1394':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                        cáncer  8000/3  cc_onco1394   168.0     162.0\n",
       " T2  carcinoma ductal infiltrante  8500/3  cc_onco1394   856.0     828.0\n",
       " T3                        T4N2M0  8000/6  cc_onco1394  1077.0    1071.0\n",
       " T4                       tumoral  8000/1  cc_onco1394  1589.0    1582.0,\n",
       " 'cc_onco1395':                                CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                        malignidad  8000/3  cc_onco1395   850.0     840.0\n",
       " T2                         tumorales  8000/1  cc_onco1395   872.0     863.0\n",
       " T3  adenocarcinoma de células claras  8310/3  cc_onco1395  1121.0    1089.0\n",
       " T4                        tumoración  8000/1  cc_onco1395  1320.0    1310.0\n",
       " T5                  masa pancreática  8000/6  cc_onco1395  1479.0    1463.0\n",
       " T6              infiltración pleural  8000/6  cc_onco1395  1741.0    1721.0\n",
       " T7                       metastásica  8000/6  cc_onco1395  1753.0    1742.0,\n",
       " 'cc_onco1396':                    CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  tumor neuroendocrino  8240/3  cc_onco1396   121.0     101.0\n",
       " T2            carcinoide  8240/3  cc_onco1396   193.0     183.0\n",
       " T3            malignidad  8000/3  cc_onco1396   474.0     464.0\n",
       " T4               tumoral  8000/1  cc_onco1396   583.0     576.0\n",
       " T5      tumor carcinoide  8240/3  cc_onco1396  1445.0    1429.0\n",
       " T6   progresión hepática  8000/6  cc_onco1396  1655.0    1636.0,\n",
       " 'cc_onco1398':                 CLAVE   ICD-O-3    documento  endpos  startpos\n",
       " T1            linfoma    9590/3  cc_onco1398    39.0      32.0\n",
       " T2         tumoración    8000/1  cc_onco1398   211.0     201.0\n",
       " T3      Paraganglioma    8680/1  cc_onco1398   737.0     724.0\n",
       " T4      patrón difuso    8145/3  cc_onco1398   962.0     949.0\n",
       " T5      tumor maligno    8000/3  cc_onco1398  1133.0    1120.0\n",
       " T6             PEComa  8011/1/H  cc_onco1398  1194.0    1188.0\n",
       " T7            tumores    8000/1  cc_onco1398  1420.0    1413.0\n",
       " T8            tumoral    8000/1  cc_onco1398  1678.0    1671.0\n",
       " T9  infiltración ósea    8000/6  cc_onco1398  1961.0    1944.0,\n",
       " 'cc_onco1399':                                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                         masa anexial  8000/6  cc_onco1399   253.0     241.0\n",
       " T2                           neoplásico  8000/1  cc_onco1399   719.0     709.0\n",
       " T3                       Carcinomatosis  8010/9  cc_onco1399  1683.0    1669.0\n",
       " T4                           metástasis  8000/6  cc_onco1399  1706.0    1696.0\n",
       " T5                              tumoral  8000/1  cc_onco1399  1929.0    1922.0\n",
       " T6  linfoma B difuso de células grandes  9680/3  cc_onco1399  2185.0    2150.0\n",
       " T7                                LBDCG  9680/3  cc_onco1399  2192.0    2187.0,\n",
       " 'cc_onco1400':                              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                       formación  8000/1  cc_onco1400   627.0     618.0\n",
       " T2                     metastásico  8000/6  cc_onco1400   850.0     839.0\n",
       " T3                      metástasis  8000/6  cc_onco1400   959.0     949.0\n",
       " T4                melanoma maligno  8720/3  cc_onco1400  1035.0    1019.0\n",
       " T5  metástasis de melanoma maligno  8720/6  cc_onco1400  1428.0    1398.0\n",
       " T6             progresión pulmonar  8000/6  cc_onco1400  1768.0    1749.0\n",
       " T7            Melanoma metastásico  8720/6  cc_onco1400  1915.0    1895.0\n",
       " T8                 progresión ósea  8000/6  cc_onco1400  2066.0    2051.0,\n",
       " 'cc_onco1401':                          CLAVE   ICD-O-3    documento  endpos  startpos\n",
       " T1                     linfoma    9590/3  cc_onco1401   107.0     100.0\n",
       " T2               masa pulmonar    8000/6  cc_onco1401   445.0     432.0\n",
       " T3                  malignidad    8000/3  cc_onco1401   897.0     887.0\n",
       " T4                     tumores    8000/1  cc_onco1401  1373.0    1366.0\n",
       " T5  adenocarcinoma infiltrante  8140/3/H  cc_onco1401  1486.0    1460.0\n",
       " T6                      T3N0M0    8000/6  cc_onco1401  1567.0    1561.0,\n",
       " 'cc_onco1403':                                              CLAVE ICD-O-3    documento  \\\n",
       " T1                                       formación  8000/1  cc_onco1403   \n",
       " T2                                       neoplasia  8000/1  cc_onco1403   \n",
       " T3                                      tumoración  8000/1  cc_onco1403   \n",
       " T4                    metástasis de adenocarcinoma  8140/6  cc_onco1403   \n",
       " T5   adenocarcinoma con células en anillo de sello  8490/3  cc_onco1403   \n",
       " T6                             implante peritoneal  8000/6  cc_onco1403   \n",
       " T7                                              HE  9133/1  cc_onco1403   \n",
       " T8                                 afectación ósea  8000/6  cc_onco1403   \n",
       " T9                                 progresión ósea  8000/6  cc_onco1403   \n",
       " T10                             lesión osteolítica  8000/6  cc_onco1403   \n",
       " T11                            progresión pulmonar  8000/6  cc_onco1403   \n",
       " T12                      linfangitis carcinomatosa  8000/3  cc_onco1403   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    555.0     546.0  \n",
       " T2    593.0     584.0  \n",
       " T3    789.0     779.0  \n",
       " T4    947.0     919.0  \n",
       " T5    978.0     933.0  \n",
       " T6   1302.0    1283.0  \n",
       " T7   1404.0    1402.0  \n",
       " T8   1571.0    1556.0  \n",
       " T9   2089.0    2074.0  \n",
       " T10  2150.0    2132.0  \n",
       " T11  2250.0    2231.0  \n",
       " T12  2620.0    2595.0  ,\n",
       " 'cc_onco1406':                        CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma no microcítico  8046/3  cc_onco1406  1101.0    1077.0\n",
       " T2        afectación pleural  8000/6  cc_onco1406  1194.0    1176.0\n",
       " T3             masa pulmonar  8000/6  cc_onco1406  1929.0    1916.0,\n",
       " 'cc_onco1407':                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1            melanoma  8720/3  cc_onco1407   158.0     150.0\n",
       " T2    melanoma maligno  8720/3  cc_onco1407   277.0     261.0\n",
       " T3  lesiones pleurales  8000/6  cc_onco1407   546.0     528.0\n",
       " T4         metastásico  8000/6  cc_onco1407   884.0     873.0,\n",
       " 'cc_onco1408':                      CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1              tumoración   8000/1  cc_onco1408    78.0      68.0\n",
       " T2                   Mioma   8895/0  cc_onco1408   188.0     183.0\n",
       " T3           masa pulmonar   8000/6  cc_onco1408   296.0     283.0\n",
       " T4       tumor mesenquimal   8800/1  cc_onco1408   361.0     344.0\n",
       " T5          Leiomiosarcoma   8890/3  cc_onco1408   420.0     406.0\n",
       " T6   Sarcoma de bajo grado  8800/31  cc_onco1408   434.0     413.0\n",
       " T7       nódulos pleurales   8000/6  cc_onco1408   492.0     475.0\n",
       " T8         masa pararrenal   8000/6  cc_onco1408   753.0     738.0\n",
       " T9                 tumoral   8000/1  cc_onco1408  1050.0    1043.0\n",
       " T10             miomatosis   8895/0  cc_onco1408  1311.0    1301.0\n",
       " T11         metastatizante   8000/6  cc_onco1408  1326.0    1312.0\n",
       " T12   masa retroperitoneal   8000/6  cc_onco1408  1521.0    1501.0,\n",
       " 'cc_onco1409':                      CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1              tumoración   8000/1  cc_onco1409    78.0      68.0\n",
       " T2                   Mioma   8895/0  cc_onco1409   188.0     183.0\n",
       " T3           masa pulmonar   8000/6  cc_onco1409   296.0     283.0\n",
       " T4       tumor mesenquimal   8800/1  cc_onco1409   361.0     344.0\n",
       " T5          Leiomiosarcoma   8890/3  cc_onco1409   420.0     406.0\n",
       " T6   Sarcoma de bajo grado  8800/31  cc_onco1409   434.0     413.0\n",
       " T7       nódulos pleurales   8000/6  cc_onco1409   492.0     475.0\n",
       " T8         masa pararrenal   8000/6  cc_onco1409   753.0     738.0\n",
       " T9                 tumoral   8000/1  cc_onco1409  1050.0    1043.0\n",
       " T10             miomatosis   8895/0  cc_onco1409  1311.0    1301.0\n",
       " T11         metastatizante   8000/6  cc_onco1409  1326.0    1312.0\n",
       " T12   masa retroperitoneal   8000/6  cc_onco1409  1521.0    1501.0,\n",
       " 'cc_onco1410':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                     tumorales  8000/1  cc_onco1410   477.0     468.0\n",
       " T2               lóbulo hepático  8000/6  cc_onco1410   564.0     549.0\n",
       " T3                    metástasis  8000/6  cc_onco1410   856.0     846.0\n",
       " T4  hepatocarcinoma fibrolamelar  8171/3  cc_onco1410  1002.0     974.0\n",
       " T5                     Carcinoma  8010/3  cc_onco1410   989.0     980.0\n",
       " T6            lesiones hepáticas  8000/6  cc_onco1410  1666.0    1648.0\n",
       " T7            nódulos pulmonares  8000/6  cc_onco1410  2152.0    2134.0\n",
       " T8           lesiones pulmonares  8000/6  cc_onco1410  2395.0    2376.0\n",
       " T9               lesión hepática  8000/6  cc_onco1410  2532.0    2517.0,\n",
       " 'cc_onco1411':                           CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1             Lesiones líticas  8000/6  cc_onco1411   929.0     913.0\n",
       " T2                 metastásicas  8000/6  cc_onco1411   942.0     930.0\n",
       " T3              lóbulo hepático  8000/6  cc_onco1411  1017.0    1002.0\n",
       " T4                   metástasis  8000/6  cc_onco1411  1136.0    1126.0\n",
       " T5                      tumoral  8000/1  cc_onco1411  1412.0    1405.0\n",
       " T6          progresión hepática  8000/6  cc_onco1411  2209.0    2190.0\n",
       " T7  progresión a nivel hepático  8000/6  cc_onco1411  2360.0    2333.0,\n",
       " 'cc_onco1413':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                          tumor  8000/1  cc_onco1413   107.0     102.0\n",
       " T2   carcinoma ductal infiltrante  8500/3  cc_onco1413   148.0     120.0\n",
       " T3                        tumoral  8000/1  cc_onco1413   517.0     510.0\n",
       " T4                     metástasis  8000/6  cc_onco1413  1874.0    1864.0\n",
       " T5                nódulo pulmonar  8000/6  cc_onco1413  1956.0    1941.0\n",
       " T6                    metastásico  8000/6  cc_onco1413  1997.0    1986.0\n",
       " T7                        linfoma  9590/3  cc_onco1413  2239.0    2232.0\n",
       " T8                           MALT  9699/3  cc_onco1413  2286.0    2282.0\n",
       " T9                     neoplásico  8000/1  cc_onco1413  2499.0    2489.0\n",
       " T10                        cáncer  8000/3  cc_onco1413  2782.0    2776.0,\n",
       " 'cc_onco1414':                     CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma epidermoide  8070/3  cc_onco1414    72.0      51.0,\n",
       " 'cc_onco1416':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1              tumores  8000/1  cc_onco1416    21.0      14.0\n",
       " T2             malignos  8000/3  cc_onco1416   157.0     149.0\n",
       " T3        angiosarcomas  9120/3  cc_onco1416   186.0     173.0\n",
       " T4         metastásicos  8000/6  cc_onco1416   209.0     197.0\n",
       " T5     Lesiones líticas  8000/6  cc_onco1416  1028.0    1012.0\n",
       " T6           metástasis  8000/6  cc_onco1416  1190.0    1180.0\n",
       " T7  progresión hepática  8000/6  cc_onco1416  2390.0    2371.0,\n",
       " 'cc_onco1417':                                         CLAVE  ICD-O-3    documento  endpos  \\\n",
       " T1                     masa de partes blandas   8000/6  cc_onco1417   453.0   \n",
       " T2                            nódulo pulmonar   8000/6  cc_onco1417   690.0   \n",
       " T3                               masa pélvica   8000/6  cc_onco1417   772.0   \n",
       " T4                               fibrosarcoma   8810/3  cc_onco1417   902.0   \n",
       " T5                      Sarcoma de bajo grado  8800/31  cc_onco1417  1309.0   \n",
       " T6  carcinoma neuroendocrino de célula grande   8013/3  cc_onco1417  2531.0   \n",
       " T7                             neuroendocrino   8240/3  cc_onco1417  2514.0   \n",
       " \n",
       "     startpos  \n",
       " T1     431.0  \n",
       " T2     675.0  \n",
       " T3     760.0  \n",
       " T4     890.0  \n",
       " T5    1288.0  \n",
       " T6    2490.0  \n",
       " T7    2500.0  ,\n",
       " 'cc_onco142':                                 CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1  carcinoma renal de células claras    8310/3  cc_onco142   551.0     518.0\n",
       " T2                    lesión cerebral    8000/6  cc_onco142  1458.0    1443.0\n",
       " T3                            tumoral    8000/1  cc_onco142  2280.0    2273.0\n",
       " T4                afectación pulmonar    8000/6  cc_onco142  2911.0    2892.0\n",
       " T5                                 CM    8000/3  cc_onco142  3641.0    3639.0\n",
       " T6       células epiteliales malignas  8001/3/H  cc_onco142  3834.0    3806.0\n",
       " T7          linfangitis carcinomatosa    8000/3  cc_onco142  4125.0    4100.0,\n",
       " 'cc_onco1421':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1        masa pulmonar  8000/6  cc_onco1421   266.0     253.0\n",
       " T2       adenocarcinoma  8140/3  cc_onco1421   373.0     359.0\n",
       " T3               T4N2M0  8000/6  cc_onco1421   390.0     384.0\n",
       " T4           metástasis  8000/6  cc_onco1421   908.0     898.0\n",
       " T5  progresión cerebral  8000/6  cc_onco1421  1256.0    1237.0\n",
       " T6    células tumorales  8001/1  cc_onco1421  1618.0    1601.0,\n",
       " 'cc_onco1422':                                                 CLAVE  ICD-O-3    documento  \\\n",
       " T1  adenocarcinoma de sigma moderadamente diferenc...  8140/32  cc_onco1422   \n",
       " T2                                          Carcinoma   8010/3  cc_onco1422   \n",
       " T3                                         metástasis   8000/6  cc_onco1422   \n",
       " T4                                progresión pulmonar   8000/6  cc_onco1422   \n",
       " T5                                         neoplásica   8000/1  cc_onco1422   \n",
       " T6                                         neoplásico   8000/1  cc_onco1422   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   135.0      85.0  \n",
       " T2    99.0      90.0  \n",
       " T3   355.0     345.0  \n",
       " T4   627.0     608.0  \n",
       " T5  2085.0    2075.0  \n",
       " T6  2551.0    2541.0  ,\n",
       " 'cc_onco1423':                               CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                       tumoración  8000/1  cc_onco1423   204.0     194.0\n",
       " T2                          sarcoma  8800/3  cc_onco1423   598.0     591.0\n",
       " T3                       metástasis  8000/6  cc_onco1423  1192.0    1182.0\n",
       " T4              progresión pulmonar  8000/6  cc_onco1423  1391.0    1372.0\n",
       " T5  liposarcoma de células redondas  8853/3  cc_onco1423  1544.0    1513.0\n",
       " T6              enfermedad pulmonar  8000/6  cc_onco1423  1830.0    1811.0\n",
       " T7      infiltración de médula ósea  8000/6  cc_onco1423  2045.0    2018.0,\n",
       " 'cc_onco1425':                                                  CLAVE  ICD-O-3    documento  \\\n",
       " T1                                           neoplasia   8000/1  cc_onco1425   \n",
       " T2                                    nódulos cutáneos   8000/6  cc_onco1425   \n",
       " T3                       metástasis por adenocarcinoma   8140/6  cc_onco1425   \n",
       " T4                                       masa pulmonar   8000/6  cc_onco1425   \n",
       " T5                                  nódulos pulmonares   8000/6  cc_onco1425   \n",
       " T6                                         metastásica   8000/6  cc_onco1425   \n",
       " T7                               nódulos suprarrenales   8000/6  cc_onco1425   \n",
       " T8                                      Carcinomatosis   8010/9  cc_onco1425   \n",
       " T9                                   nódulo subcutáneo   8000/6  cc_onco1425   \n",
       " T10  metástasis de adenocarcinoma moderadamente dif...  8140/62  cc_onco1425   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    412.0     403.0  \n",
       " T2    733.0     717.0  \n",
       " T3    923.0     894.0  \n",
       " T4   1503.0    1490.0  \n",
       " T5   1567.0    1549.0  \n",
       " T6   1656.0    1645.0  \n",
       " T7   1679.0    1658.0  \n",
       " T8   1719.0    1705.0  \n",
       " T9   1904.0    1887.0  \n",
       " T10  1982.0    1927.0  ,\n",
       " 'cc_onco1426':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1        masa pulmonar  8000/6  cc_onco1426   728.0     715.0\n",
       " T2              tumoral  8000/1  cc_onco1426  1305.0    1298.0\n",
       " T3       adenocarcinoma  8140/3  cc_onco1426  1508.0    1494.0\n",
       " T4               T2N2M1  8000/6  cc_onco1426  1639.0    1633.0\n",
       " T5          lesión ósea  8000/6  cc_onco1426  1654.0    1643.0\n",
       " T6      lesión pulmonar  8000/6  cc_onco1426  1855.0    1840.0\n",
       " T7  lesiones cerebrales  8000/6  cc_onco1426  2450.0    2431.0,\n",
       " 'cc_onco1430':                                           CLAVE  ICD-O-3    documento  endpos  \\\n",
       " T1                                 masa ovárica   8000/6  cc_onco1430   376.0   \n",
       " T2                     Carcinoma indiferenciado   8020/3  cc_onco1430   735.0   \n",
       " T3  adenocarcinoma seroso papilar de alto grado  8460/34  cc_onco1430  1241.0   \n",
       " T4                                  metastatiza   8000/6  cc_onco1430  1314.0   \n",
       " T5                                       cáncer   8000/3  cc_onco1430  1810.0   \n",
       " T6                                   neoplásica   8000/1  cc_onco1430  1940.0   \n",
       " \n",
       "     startpos  \n",
       " T1     364.0  \n",
       " T2     711.0  \n",
       " T3    1198.0  \n",
       " T4    1303.0  \n",
       " T5    1804.0  \n",
       " T6    1930.0  ,\n",
       " 'cc_onco1431':                               CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                 sarcoma de Ewing  9260/3  cc_onco1431    97.0      81.0\n",
       " T2                       metástasis  8000/6  cc_onco1431   184.0     174.0\n",
       " T3                          tumoral  8000/1  cc_onco1431   454.0     447.0\n",
       " T4                 células malignas  8001/3  cc_onco1431  1116.0    1100.0\n",
       " T5                    lesión lítica  8000/6  cc_onco1431  1395.0    1382.0\n",
       " T6                       tumoración  8000/1  cc_onco1431  1558.0    1548.0\n",
       " T7                     osteosarcoma  9180/3  cc_onco1431  1681.0    1669.0\n",
       " T8               nódulos pulmonares  8000/6  cc_onco1431  2137.0    2119.0\n",
       " T9         Osteosarcoma metastásico  9180/6  cc_onco1431  2361.0    2337.0\n",
       " T10  nódulos pulmonares bilaterales  8000/6  cc_onco1431  2691.0    2661.0,\n",
       " 'cc_onco1433':                                      CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                         Nódulo tiroideo  8000/6  cc_onco1433   178.0   \n",
       " T2                         adenoma tubular  8211/0  cc_onco1433  1277.0   \n",
       " T3                              neoplásica  8000/1  cc_onco1433  1667.0   \n",
       " T4           Carcinoma de células pequeñas  8041/3  cc_onco1433  1804.0   \n",
       " T5                               tumorales  8000/1  cc_onco1433  1826.0   \n",
       " T6  carcinoma pulmonar de células pequeñas  8041/3  cc_onco1433  2206.0   \n",
       " T7                                  TxN2M0  8000/6  cc_onco1433  2215.0   \n",
       " T8                              neoplásico  8000/1  cc_onco1433  2325.0   \n",
       " \n",
       "     startpos  \n",
       " T1     163.0  \n",
       " T2    1262.0  \n",
       " T3    1657.0  \n",
       " T4    1775.0  \n",
       " T5    1817.0  \n",
       " T6    2168.0  \n",
       " T7    2209.0  \n",
       " T8    2315.0  ,\n",
       " 'cc_onco1434':                        CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1         Masa mediastínica  8000/6  cc_onco1434  1391.0    1374.0\n",
       " T2  angiosarcoma epitelioide  8804/3  cc_onco1434  1647.0    1623.0\n",
       " T3                tumoración  8000/1  cc_onco1434  1941.0    1931.0\n",
       " T4                metástasis  8000/6  cc_onco1434  2197.0    2187.0,\n",
       " 'cc_onco1436':                        CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                 neoplasia  8000/1  cc_onco1436   422.0     413.0\n",
       " T2   diseminación peritoneal  8000/6  cc_onco1436   507.0     484.0\n",
       " T3  carcinoma seroso papilar  8460/3  cc_onco1436   651.0     627.0\n",
       " T4                neoplásica  8000/1  cc_onco1436  2020.0    2010.0\n",
       " T5       afectación pulmonar  8000/6  cc_onco1436  2343.0    2324.0\n",
       " T6         lesiones cutáneas  8000/6  cc_onco1436  2446.0    2429.0,\n",
       " 'cc_onco1439':                                             CLAVE    ICD-O-3    documento  \\\n",
       " T1                                     tumoración     8000/1  cc_onco1439   \n",
       " T2  carcinoma infiltrante pobremente diferenciado  8010/33/H  cc_onco1439   \n",
       " T3                                   neoformación     8000/1  cc_onco1439   \n",
       " T4                                 adenocarcinoma     8140/3  cc_onco1439   \n",
       " T5                                        tumoral     8000/1  cc_onco1439   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   276.0     266.0  \n",
       " T2   966.0     921.0  \n",
       " T3  1076.0    1064.0  \n",
       " T4  1438.0    1424.0  \n",
       " T5  1807.0    1800.0  ,\n",
       " 'cc_onco1440':                      CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma sarcomatoide  8033/3  cc_onco1440    81.0      59.0\n",
       " T2              metástasis  8000/6  cc_onco1440   119.0     109.0\n",
       " T3             metastásica  8000/6  cc_onco1440  1553.0    1542.0\n",
       " T4          Carcinomatosis  8010/9  cc_onco1440  1609.0    1595.0\n",
       " T5  masa de partes blandas  8000/6  cc_onco1440  1689.0    1667.0\n",
       " T6     progresión pulmonar  8000/6  cc_onco1440  1752.0    1733.0\n",
       " T7                 tumoral  8000/1  cc_onco1440  2641.0    2634.0,\n",
       " 'cc_onco1441':          CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1          MO  8000/6  cc_onco1441  1042.0    1040.0\n",
       " T2   tumorales  8000/1  cc_onco1441  1268.0    1259.0\n",
       " T3     linfoma  9590/3  cc_onco1441  1822.0    1815.0\n",
       " T4  neoplásica  8000/1  cc_onco1441  1883.0    1873.0,\n",
       " 'cc_onco1442':                          CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  Cáncer de mama metastásico  8000/6  cc_onco1442   145.0     119.0,\n",
       " 'cc_onco1443':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                     tumoración  8000/1  cc_onco1443   111.0     101.0\n",
       " T2   carcinoma ductal infiltrante  8500/3  cc_onco1443   210.0     182.0\n",
       " T3                       pT1pN0M0  8000/6  cc_onco1443   323.0     315.0\n",
       " T4                 adenocarcinoma  8140/3  cc_onco1443   792.0     778.0\n",
       " T5              lesiones cutáneas  8000/6  cc_onco1443   966.0     949.0\n",
       " T6                   tumoraciones  8000/1  cc_onco1443  1020.0    1008.0\n",
       " T7                      tumorales  8000/1  cc_onco1443  1156.0    1147.0\n",
       " T8          carcinoma intraductal  8500/2  cc_onco1443  1756.0    1735.0\n",
       " T9                     benignidad  8000/0  cc_onco1443  1932.0    1922.0\n",
       " T10                      pT2pN0M0  8000/6  cc_onco1443  2129.0    2121.0,\n",
       " 'cc_onco1445':                                    CLAVE  ICD-O-3    documento  endpos  \\\n",
       " T1                           metastásica   8000/6  cc_onco1445   321.0   \n",
       " T2  adenocarcinoma de próstata Gleason 8  8140/33  cc_onco1445   435.0   \n",
       " T3                             Carcinoma   8010/3  cc_onco1445   413.0   \n",
       " T4                            neoplásico   8000/1  cc_onco1445  1893.0   \n",
       " T5                            metástasis   8000/6  cc_onco1445  2087.0   \n",
       " T6     carcinoma de próstata metastásico   8010/6  cc_onco1445  2141.0   \n",
       " T7                      lesión en clivus   8000/6  cc_onco1445  2272.0   \n",
       " \n",
       "     startpos  \n",
       " T1     310.0  \n",
       " T2     399.0  \n",
       " T3     404.0  \n",
       " T4    1883.0  \n",
       " T5    2077.0  \n",
       " T6    2108.0  \n",
       " T7    2256.0  ,\n",
       " 'cc_onco1446':                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1      Leiomiosarcoma  8890/3  cc_onco1446   545.0     531.0\n",
       " T2             tumoral  8000/1  cc_onco1446   761.0     754.0\n",
       " T3        neurofibroma  9540/0  cc_onco1446   972.0     960.0\n",
       " T4           neurinoma  9560/0  cc_onco1446   984.0     975.0\n",
       " T5  nódulos pulmonares  8000/6  cc_onco1446  1052.0    1034.0\n",
       " T6          metástasis  8000/6  cc_onco1446  1296.0    1286.0,\n",
       " 'cc_onco1447':                               CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                       leiomiomas  8890/0  cc_onco1447   270.0     260.0\n",
       " T2                          linfoma  9590/3  cc_onco1447   653.0     646.0\n",
       " T3                       malignidad  8000/3  cc_onco1447  1482.0    1472.0\n",
       " T4     carcinoma ductal infiltrante  8500/3  cc_onco1447  1636.0    1608.0\n",
       " T5                               M0  8000/6  cc_onco1447  1797.0    1795.0\n",
       " T6                           cancer  8000/3  cc_onco1447  1840.0    1834.0\n",
       " T7                            tumor  8000/1  cc_onco1447  2072.0    2067.0\n",
       " T8                        tumorales  8000/1  cc_onco1447  3954.0    3945.0\n",
       " T9   nódulos pulmonares bilaterales  8000/6  cc_onco1447  4778.0    4748.0\n",
       " T10                     metastásica  8000/6  cc_onco1447  5021.0    5010.0,\n",
       " 'cc_onco1450':                                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                          tumoración  8000/1  cc_onco1450   165.0     155.0\n",
       " T2                 implante peritoneal  8000/6  cc_onco1450   320.0     301.0\n",
       " T3                        masa pélvica  8000/6  cc_onco1450   658.0     646.0\n",
       " T4  tumor del estroma gastrointestinal  8936/3  cc_onco1450   859.0     825.0\n",
       " T5                             tumoral  8000/1  cc_onco1450  2166.0    2159.0\n",
       " T6                     lesión hepática  8000/6  cc_onco1450  3658.0    3643.0\n",
       " T7                            sarcomas  8800/3  cc_onco1450  4272.0    4264.0,\n",
       " 'cc_onco1452':                                      CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1  adenocarcinoma renal de células claras  8310/3  cc_onco1452   385.0   \n",
       " T2                      lesiones hepáticas  8000/6  cc_onco1452   738.0   \n",
       " T3                              metástasis  8000/6  cc_onco1452   784.0   \n",
       " T4                                 maligna  8000/3  cc_onco1452   896.0   \n",
       " T5                cáncer renal metastásico  8000/6  cc_onco1452   993.0   \n",
       " \n",
       "     startpos  \n",
       " T1     347.0  \n",
       " T2     720.0  \n",
       " T3     774.0  \n",
       " T4     889.0  \n",
       " T5     969.0  ,\n",
       " 'cc_onco1453':                     CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1    enfermedad pulmonar  8000/6  cc_onco1453   116.0      97.0\n",
       " T2         adenocarcinoma  8140/3  cc_onco1453   297.0     283.0\n",
       " T3     lesiones hepáticas  8000/6  cc_onco1453   810.0     792.0\n",
       " T4             metástasis  8000/6  cc_onco1453   858.0     848.0\n",
       " T5     nódulos pulmonares  8000/6  cc_onco1453  1360.0    1342.0\n",
       " T6  afectación secundaria  8000/6  cc_onco1453  1814.0    1793.0\n",
       " T7    progresión pulmonar  8000/6  cc_onco1453  2402.0    2383.0\n",
       " T8             malignidad  8000/3  cc_onco1453  4492.0    4482.0\n",
       " T9                tumoral  8000/1  cc_onco1453  5019.0    5012.0,\n",
       " 'cc_onco1454':                 CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1     adenocarcinoma  8140/3  cc_onco1454   298.0     284.0\n",
       " T2  diseminación ósea  8000/6  cc_onco1454   397.0     380.0,\n",
       " 'cc_onco1455':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma ductal infiltrante  8500/3  cc_onco1455   239.0     211.0\n",
       " T2                            M0  8000/6  cc_onco1455   325.0     323.0\n",
       " T3                           CHC  8170/3  cc_onco1455  1743.0    1740.0\n",
       " T4                        cáncer  8000/3  cc_onco1455  2345.0    2339.0,\n",
       " 'cc_onco1456':                    CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                cáncer  8000/3  cc_onco1456   129.0     123.0\n",
       " T2           metastático  8000/6  cc_onco1456   149.0     138.0\n",
       " T3               tumoral  8000/1  cc_onco1456   690.0     683.0\n",
       " T4           metastásica  8000/6  cc_onco1456   820.0     809.0\n",
       " T5             Carcinoma  8010/3  cc_onco1456   917.0     908.0\n",
       " T6            metástasis  8000/6  cc_onco1456  2130.0    2120.0\n",
       " T7  afectación sistémica  8000/6  cc_onco1456  4348.0    4328.0,\n",
       " 'cc_onco1457':                                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                               cáncer  8000/3  cc_onco1457   189.0     183.0\n",
       " T2                                tumor  8000/1  cc_onco1457   215.0     210.0\n",
       " T3                       adenocarcinoma  8140/3  cc_onco1457   294.0     280.0\n",
       " T4                               T3N0M0  8000/6  cc_onco1457   310.0     304.0\n",
       " T5   tumor del estroma gastrointestinal  8936/3  cc_onco1457   661.0     627.0\n",
       " T6                                 GIST  8936/3  cc_onco1457   667.0     663.0\n",
       " T7                           malignidad  8000/3  cc_onco1457   834.0     824.0\n",
       " T8                   nódulos pulmonares  8000/6  cc_onco1457   856.0     838.0\n",
       " T9               lesión retroperitoneal  8000/6  cc_onco1457  1153.0    1131.0\n",
       " T10                          metástasis  8000/6  cc_onco1457  1228.0    1218.0\n",
       " T11                             tumoral  8000/1  cc_onco1457  2397.0    2390.0,\n",
       " 'cc_onco1458':                                           CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1  tumor de células germinales no seminomatoso  9065/3  cc_onco1458   146.0   \n",
       " T2                                     seminoma  9061/3  cc_onco1458   142.0   \n",
       " T3                                       cancer  8000/3  cc_onco1458   246.0   \n",
       " T4                                      tumoral  8000/1  cc_onco1458   498.0   \n",
       " T5                                    tumorales  8000/1  cc_onco1458   932.0   \n",
       " T6                                   metástasis  8000/6  cc_onco1458  2690.0   \n",
       " T7                            Masa mediastínica  8000/6  cc_onco1458  3519.0   \n",
       " T8               tumor germinal no seminomatoso  9065/3  cc_onco1458  3580.0   \n",
       " T9                               lesiones óseas  8000/6  cc_onco1458  3596.0   \n",
       " \n",
       "     startpos  \n",
       " T1     103.0  \n",
       " T2     134.0  \n",
       " T3     240.0  \n",
       " T4     491.0  \n",
       " T5     923.0  \n",
       " T6    2680.0  \n",
       " T7    3502.0  \n",
       " T8    3550.0  \n",
       " T9    3582.0  ,\n",
       " 'cc_onco1460':                              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                          cáncer  8000/3  cc_onco1460    67.0      61.0\n",
       " T2                   lesión lítica  8000/6  cc_onco1460   469.0     456.0\n",
       " T3                           tumor  8000/1  cc_onco1460   520.0     515.0\n",
       " T4                  lesión cutánea  8000/6  cc_onco1460  1097.0    1083.0\n",
       " T5    carcinoma ductal infiltrante  8500/3  cc_onco1460  1155.0    1127.0\n",
       " T6                             CDI  8500/3  cc_onco1460  1160.0    1157.0\n",
       " T7        metástasis por carcinoma  8010/6  cc_onco1460  1254.0    1230.0\n",
       " T8   Adenopatías supraclaviculares  8000/6  cc_onco1460  1392.0    1363.0\n",
       " T9                        implante  8000/6  cc_onco1460  1620.0    1612.0\n",
       " T10               Lesiones líticas  8000/6  cc_onco1460  1662.0    1646.0,\n",
       " 'cc_onco1464':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  lesiones pulmonares  8000/6  cc_onco1464  1945.0    1926.0\n",
       " T2  Nódulos subcutáneos  8000/6  cc_onco1464  2602.0    2583.0\n",
       " T3              linfoma  9590/3  cc_onco1464  2741.0    2734.0\n",
       " T4  afectación pulmonar  8000/6  cc_onco1464  2870.0    2851.0\n",
       " T5    lesiones cutáneas  8000/6  cc_onco1464  3620.0    3603.0,\n",
       " 'cc_onco1465':                 CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1              tumor  8000/1  cc_onco1465   773.0     768.0\n",
       " T2       neoformación  8000/1  cc_onco1465   858.0     846.0\n",
       " T3  células tumorales  8001/1  cc_onco1465   960.0     943.0\n",
       " T4            sarcoma  8800/3  cc_onco1465  1433.0    1426.0,\n",
       " 'cc_onco1466':                     CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1     lesiones hepáticas  8000/6  cc_onco1466   986.0     968.0\n",
       " T2             metástasis  8000/6  cc_onco1466  1013.0    1003.0\n",
       " T3        nódulo pulmonar  8000/6  cc_onco1466  1225.0    1210.0\n",
       " T4      masa prevertebral  8000/6  cc_onco1466  1290.0    1273.0\n",
       " T5       tumor carcinoide  8240/3  cc_onco1466  1505.0    1489.0\n",
       " T6   tumor neuroendocrino  8240/3  cc_onco1466  1707.0    1687.0\n",
       " T7                tumoral  8000/1  cc_onco1466  1933.0    1926.0\n",
       " T8         neuroendocrina  8574/3  cc_onco1466  1948.0    1934.0\n",
       " T9                maligno  8000/3  cc_onco1466  1991.0    1984.0\n",
       " T10   progresión hepática  8000/6  cc_onco1466  3985.0    3966.0\n",
       " T11            neoplásica  8000/1  cc_onco1466  5034.0    5024.0,\n",
       " 'cc_onco1468':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                     tumorales  8000/1  cc_onco1468  2932.0    2923.0\n",
       " T2                    malignidad  8000/3  cc_onco1468  3559.0    3549.0\n",
       " T3    proceso linfoproliferativo  9970/1  cc_onco1468  3731.0    3705.0\n",
       " T4                       linfoma  9590/3  cc_onco1468  3825.0    3818.0\n",
       " T5            Linfoma no Hodgkin  9591/3  cc_onco1468  3882.0    3864.0\n",
       " T6      afectación leptomeníngea  8000/6  cc_onco1468  4585.0    4561.0\n",
       " T7  carcinoma de células renales  8312/3  cc_onco1468  6264.0    6236.0\n",
       " T8           afectación hepática  8000/6  cc_onco1468  6624.0    6605.0,\n",
       " 'cc_onco1469':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                           CHC  8170/3  cc_onco1469  1144.0    1141.0\n",
       " T2                    tumoración  8000/1  cc_onco1469  1599.0    1589.0\n",
       " T3                    metástasis  8000/6  cc_onco1469  1861.0    1851.0\n",
       " T4                     Carcinoma  8010/3  cc_onco1469  2327.0    2318.0\n",
       " T5                 metastatizado  8000/6  cc_onco1469  2602.0    2589.0\n",
       " T6                   metastásica  8000/6  cc_onco1469  2717.0    2706.0\n",
       " T7                        cáncer  8000/3  cc_onco1469  2990.0    2984.0\n",
       " T8               enfermedad ósea  8000/6  cc_onco1469  3327.0    3312.0\n",
       " T9                   lesión ósea  8000/6  cc_onco1469  3587.0    3576.0\n",
       " T10                      tumoral  8000/1  cc_onco1469  4116.0    4109.0\n",
       " T11  enfermedad a nivel pulmonar  8000/6  cc_onco1469  4178.0    4151.0,\n",
       " 'cc_onco1470':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1        pseudomixoma peritoneal  8480/6  cc_onco1470  2102.0    2079.0\n",
       " T2                         mixoma  8840/0  cc_onco1470  2091.0    2085.0\n",
       " T3         pseudomixoma peritonei  8480/6  cc_onco1470  2464.0    2442.0\n",
       " T4        diseminación peritoneal  8000/6  cc_onco1470  2605.0    2582.0\n",
       " T5                        tumoral  8000/1  cc_onco1470  2714.0    2707.0\n",
       " T6                        adenoma  8140/0  cc_onco1470  2848.0    2841.0\n",
       " T7                       implante  8000/6  cc_onco1470  2884.0    2876.0\n",
       " T8  enfermedad a nivel peritoneal  8000/6  cc_onco1470  3521.0    3492.0\n",
       " T9        adenocarcinoma mucinoso  8480/3  cc_onco1470  3754.0    3731.0,\n",
       " 'cc_onco1471':                            CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  carcinoma ductal infiltrante  8500/3  cc_onco1471   247.0     219.0\n",
       " T2                     tumorales  8000/1  cc_onco1471   822.0     813.0\n",
       " T3                     neoplasia  8000/1  cc_onco1471  1027.0    1018.0\n",
       " T4                    tumoración  8000/1  cc_onco1471  1131.0    1121.0\n",
       " T5                    schwannoma  9560/0  cc_onco1471  1755.0    1745.0\n",
       " T6                   neurilemoma  9560/0  cc_onco1471  1776.0    1765.0\n",
       " T7                    malignidad  8000/3  cc_onco1471  2028.0    2018.0,\n",
       " 'cc_onco1472':                CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  MOLA HIDATIFORME  9100/0  cc_onco1472  2502.0    2486.0\n",
       " T2             tumor  8000/1  cc_onco1472  2541.0    2536.0\n",
       " T3           tumoral  8000/1  cc_onco1472  3357.0    3350.0,\n",
       " 'cc_onco1473':                         CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                    sarcoma   8800/3  cc_onco1473    97.0      90.0\n",
       " T2                      tumor   8000/1  cc_onco1473   718.0     713.0\n",
       " T3                    adenoma   8140/0  cc_onco1473  1331.0    1324.0\n",
       " T4   macroadenoma hipofisario   8272/0  cc_onco1473  1959.0    1935.0\n",
       " T5               tumoraciones   8000/1  cc_onco1473  2113.0    2101.0\n",
       " T6                    lipomas   8850/0  cc_onco1473  2310.0    2303.0\n",
       " T7           células malignas   8001/3  cc_onco1473  2447.0    2431.0\n",
       " T8                 tumoración   8000/1  cc_onco1473  4631.0    4621.0\n",
       " T9                    tumoral   8000/1  cc_onco1473  5007.0    5000.0\n",
       " T10     Sarcoma de bajo grado  8800/31  cc_onco1473  5185.0    5164.0\n",
       " T11   tumores neuroendocrinos   8240/3  cc_onco1473  5331.0    5308.0\n",
       " T12            neuroendocrino   8240/3  cc_onco1473  5330.0    5316.0,\n",
       " 'cc_onco1476':                                             CLAVE  ICD-O-3    documento  \\\n",
       " T1                                     tumoración   8000/1  cc_onco1476   \n",
       " T2                               células malignas   8001/3  cc_onco1476   \n",
       " T3                       carcinoma no microcítico   8046/3  cc_onco1476   \n",
       " T4                          carcinoma epidermoide   8070/3  cc_onco1476   \n",
       " T5  carcinoma epidermoide pobremente diferenciado  8070/33  cc_onco1476   \n",
       " T6              carcinoma pobremente diferenciado  8010/33  cc_onco1476   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   694.0     684.0  \n",
       " T2  1301.0    1285.0  \n",
       " T3  1327.0    1303.0  \n",
       " T4  1362.0    1341.0  \n",
       " T5  1446.0    1401.0  \n",
       " T6  2139.0    2106.0  ,\n",
       " 'cc_onco1477':                               CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                        tumorales  8000/1  cc_onco1477  1906.0    1897.0\n",
       " T2                          maligna  8000/3  cc_onco1477  2311.0    2304.0\n",
       " T3                       metástasis  8000/6  cc_onco1477  2336.0    2326.0\n",
       " T4                     metastásicos  8000/6  cc_onco1477  2766.0    2754.0\n",
       " T5                    lesión lítica  8000/6  cc_onco1477  2834.0    2821.0\n",
       " T6           masa de partes blandas  8000/6  cc_onco1477  3034.0    3012.0\n",
       " T7          metástasis de carcinoma  8010/6  cc_onco1477  4102.0    4079.0\n",
       " T8  hemangioendotelioma epitelioide  9133/1  cc_onco1477  4148.0    4117.0\n",
       " T9                  progresión ósea  8000/6  cc_onco1477  4873.0    4858.0,\n",
       " 'cc_onco1479':                                   CLAVE  ICD-O-3    documento  endpos  \\\n",
       " T1                                tumor   8000/1  cc_onco1479   590.0   \n",
       " T2                sarcoma granulocítico   9930/3  cc_onco1479  1222.0   \n",
       " T3                             leucemia   9800/3  cc_onco1479  1315.0   \n",
       " T4                     células malignas   8001/3  cc_onco1479  1997.0   \n",
       " T5         tumor maligno indiferenciado  8000/34  cc_onco1479  2042.0   \n",
       " T6                              maligno   8000/3  cc_onco1479  2027.0   \n",
       " T7                    células tumorales   8001/1  cc_onco1479  2152.0   \n",
       " T8                       TUMOR RABDOIDE   8963/3  cc_onco1479  2579.0   \n",
       " T9                      adenocarcinomas   8140/3  cc_onco1479  2638.0   \n",
       " T10  tumor del estroma gastrointestinal   8936/3  cc_onco1479  2696.0   \n",
       " T11                            sarcomas   8800/3  cc_onco1479  2728.0   \n",
       " T12                    masa mesentérica   8000/6  cc_onco1479  2862.0   \n",
       " T13             infiltración peritoneal   8000/6  cc_onco1479  3092.0   \n",
       " T14       hígado con múltiples lesiones   8000/6  cc_onco1479  3162.0   \n",
       " T15              Sarcoma indiferenciado   8805/3  cc_onco1479  3317.0   \n",
       " T16          sarcomas de partes blandas   9044/3  cc_onco1479  3521.0   \n",
       " T17               progresión peritoneal   8000/6  cc_onco1479  4051.0   \n",
       " T18                  lesiones hepáticas   8000/6  cc_onco1479  4568.0   \n",
       " T19                  lesión mesentérica   8000/6  cc_onco1479  4592.0   \n",
       " \n",
       "      startpos  \n",
       " T1      585.0  \n",
       " T2     1201.0  \n",
       " T3     1307.0  \n",
       " T4     1981.0  \n",
       " T5     2014.0  \n",
       " T6     2020.0  \n",
       " T7     2135.0  \n",
       " T8     2565.0  \n",
       " T9     2623.0  \n",
       " T10    2662.0  \n",
       " T11    2720.0  \n",
       " T12    2846.0  \n",
       " T13    3069.0  \n",
       " T14    3133.0  \n",
       " T15    3295.0  \n",
       " T16    3495.0  \n",
       " T17    4030.0  \n",
       " T18    4550.0  \n",
       " T19    4574.0  ,\n",
       " 'cc_onco1480':                  CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1  lesión osteolítica  8000/6  cc_onco1480  1361.0    1343.0\n",
       " T2       lesión lítica  8000/6  cc_onco1480  1549.0    1536.0\n",
       " T3               tumor  8000/1  cc_onco1480  1949.0    1944.0\n",
       " T4  tumoración benigna  8000/0  cc_onco1480  2034.0    2016.0\n",
       " T5            malignos  8000/3  cc_onco1480  2365.0    2357.0\n",
       " T6            blastoma  8000/3  cc_onco1480  2500.0    2492.0\n",
       " T7        osteosarcoma  9180/3  cc_onco1480  2570.0    2558.0\n",
       " T8             tumoral  8000/1  cc_onco1480  3355.0    3348.0,\n",
       " 'cc_onco1481':              CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1    cistoadenoma  8440/0  cc_onco1481   327.0     315.0\n",
       " T2        adenomas  8140/0  cc_onco1481   328.0     320.0\n",
       " T3           tumor  8000/1  cc_onco1481   627.0     622.0\n",
       " T4      malignidad  8000/3  cc_onco1481   696.0     686.0\n",
       " T5         sarcoma  8800/3  cc_onco1481   725.0     718.0\n",
       " T6  Carcinomatosis  8010/9  cc_onco1481  3930.0    3916.0,\n",
       " 'cc_onco1483':                                             CLAVE  ICD-O-3    documento  \\\n",
       " T1                            carcinoma urotelial   8120/3  cc_onco1483   \n",
       " T2                                      neoplasia   8000/1  cc_onco1483   \n",
       " T3                               Lesiones líticas   8000/6  cc_onco1483   \n",
       " T4                                   metastásicas   8000/6  cc_onco1483   \n",
       " T5   carcinoma indiferenciado de células pequeñas  8041/34  cc_onco1483   \n",
       " T6                              carcinoma papilar   8260/3  cc_onco1483   \n",
       " T7                          Carcinoma microcítico   8041/3  cc_onco1483   \n",
       " T8                                             M1   8000/6  cc_onco1483   \n",
       " T9                                     metástasis   8000/6  cc_onco1483   \n",
       " T10                                    neoplásico   8000/1  cc_onco1483   \n",
       " T11                                        cáncer   8000/3  cc_onco1483   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    601.0     582.0  \n",
       " T2    790.0     781.0  \n",
       " T3   3445.0    3429.0  \n",
       " T4   3475.0    3463.0  \n",
       " T5   3745.0    3701.0  \n",
       " T6   3777.0    3760.0  \n",
       " T7   3980.0    3959.0  \n",
       " T8   4039.0    4037.0  \n",
       " T9   4119.0    4109.0  \n",
       " T10  4663.0    4653.0  \n",
       " T11  6220.0    6214.0  ,\n",
       " 'cc_onco1485':                             CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                     metástasis  8000/6  cc_onco1485  1668.0    1658.0\n",
       " T2             lesiones hepáticas  8000/6  cc_onco1485  1774.0    1756.0\n",
       " T3                 feocromocitoma  8700/3  cc_onco1485  1958.0    1944.0\n",
       " T4        metástasis de carcinoma  8010/6  cc_onco1485  2037.0    2014.0\n",
       " T5                      neoplasia  8000/1  cc_onco1485  2423.0    2414.0\n",
       " T6  carcinoma medular de tiroides  8510/3  cc_onco1485  2491.0    2462.0\n",
       " T7                             M1  8000/6  cc_onco1485  3196.0    3194.0\n",
       " T8        progresión a nivel óseo  8000/6  cc_onco1485  3267.0    3244.0\n",
       " T9                      tumorales  8000/1  cc_onco1485  3785.0    3776.0,\n",
       " 'cc_onco1486':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1               cáncer  8000/3  cc_onco1486   141.0     135.0\n",
       " T2           tumoración  8000/1  cc_onco1486   801.0     791.0\n",
       " T3           meningioma  9530/0  cc_onco1486   920.0     910.0\n",
       " T4              tumoral  8000/1  cc_onco1486  1594.0    1587.0\n",
       " T5       lesiones óseas  8000/6  cc_onco1486  3417.0    3403.0\n",
       " T6           metástasis  8000/6  cc_onco1486  3600.0    3590.0\n",
       " T7  lesiones pulmonares  8000/6  cc_onco1486  4556.0    4537.0,\n",
       " 'cc_onco1489':                         CLAVE  ICD-O-3    documento  endpos  startpos\n",
       " T1                    linfoma   9590/3  cc_onco1489   919.0     912.0\n",
       " T2          tumor mesenquimal   8800/1  cc_onco1489   939.0     922.0\n",
       " T3                  tumorales   8000/1  cc_onco1489   978.0     969.0\n",
       " T4                 neoplásico   8000/1  cc_onco1489  1622.0    1612.0\n",
       " T5                 metástasis   8000/6  cc_onco1489  1673.0    1663.0\n",
       " T6         Linfoma no Hodgkin   9591/3  cc_onco1489  1747.0    1729.0\n",
       " T7                    tumores   8000/1  cc_onco1489  1757.0    1750.0\n",
       " T8       tumor indiferenciado  8000/34  cc_onco1489  1882.0    1862.0\n",
       " T9                  neoplasia   8000/1  cc_onco1489  1913.0    1904.0\n",
       " T10            neuroendocrino   8240/3  cc_onco1489  2403.0    2389.0\n",
       " T11  Carcinoma indiferenciado   8020/3  cc_onco1489  4590.0    4566.0,\n",
       " 'cc_onco1491':                   CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1               Timoma  8580/1  cc_onco1491   321.0     315.0\n",
       " T2           tumoración  8000/1  cc_onco1491   406.0     396.0\n",
       " T3           neoplásica  8000/1  cc_onco1491  1292.0    1282.0\n",
       " T4  implantes tumorales  8000/6  cc_onco1491  2061.0    2042.0\n",
       " T5   lesiones pleurales  8000/6  cc_onco1491  4729.0    4711.0,\n",
       " 'cc_onco1493':                          CLAVE   ICD-O-3    documento  endpos  startpos\n",
       " T1                  neoplásica    8000/1  cc_onco1493  1479.0    1469.0\n",
       " T2                 tumor mixto  8000/1/H  cc_onco1493  1526.0    1515.0\n",
       " T3                  carcinoide    8240/3  cc_onco1493  1617.0    1607.0\n",
       " T4  células en anillo de sello    8490/3  cc_onco1493  1738.0    1712.0\n",
       " T5                   neoplasia    8000/1  cc_onco1493  2056.0    2047.0\n",
       " T6            tumor carcinoide    8240/3  cc_onco1493  2328.0    2312.0\n",
       " T7                     pT3NxM0    8000/6  cc_onco1493  2345.0    2338.0\n",
       " T8             adenoma tubular    8211/0  cc_onco1493  2515.0    2500.0\n",
       " T9                     tumores    8000/1  cc_onco1493  2559.0    2552.0,\n",
       " 'cc_onco1496':                                 CLAVE ICD-O-3    documento  endpos  startpos\n",
       " T1                         tumoración  8000/1  cc_onco1496   945.0     935.0\n",
       " T2                          Carcinoma  8010/3  cc_onco1496  1575.0    1566.0\n",
       " T3                        metastásica  8000/6  cc_onco1496  1608.0    1597.0\n",
       " T4                            tumoral  8000/1  cc_onco1496  1806.0    1799.0\n",
       " T5                        metastásico  8000/6  cc_onco1496  1818.0    1807.0\n",
       " T6                         metástasis  8000/6  cc_onco1496  1830.0    1820.0\n",
       " T7                          neoplasia  8000/1  cc_onco1496  2068.0    2059.0\n",
       " T8                      tumor maligno  8000/3  cc_onco1496  2497.0    2484.0\n",
       " T9   tumor neuroectodérmico primitivo  9473/3  cc_onco1496  2566.0    2534.0\n",
       " T10                 células tumorales  8001/1  cc_onco1496  2630.0    2613.0\n",
       " T11                           tumores  8000/1  cc_onco1496  2867.0    2860.0,\n",
       " 'cc_onco1498':                                    CLAVE ICD-O-3    documento  endpos  \\\n",
       " T1                    nódulos pulmonares  8000/6  cc_onco1498   141.0   \n",
       " T2                      suelta de globos  8000/6  cc_onco1498   183.0   \n",
       " T3                            metástasis  8000/6  cc_onco1498  1276.0   \n",
       " T4                            tumoración  8000/1  cc_onco1498  2279.0   \n",
       " T5                          neoformativo  8000/1  cc_onco1498  2362.0   \n",
       " T6                            malignidad  8000/3  cc_onco1498  2663.0   \n",
       " T7                             Carcinoma  8010/3  cc_onco1498  2898.0   \n",
       " T8   carcinoma de células transicionales  8120/3  cc_onco1498  2972.0   \n",
       " T9                        coriocarcinoma  9100/3  cc_onco1498  3075.0   \n",
       " T10                            neoplasia  8000/1  cc_onco1498  3179.0   \n",
       " T11                              tumores  8000/1  cc_onco1498  4496.0   \n",
       " \n",
       "      startpos  \n",
       " T1      123.0  \n",
       " T2      167.0  \n",
       " T3     1266.0  \n",
       " T4     2269.0  \n",
       " T5     2350.0  \n",
       " T6     2653.0  \n",
       " T7     2889.0  \n",
       " T8     2937.0  \n",
       " T9     3061.0  \n",
       " T10    3170.0  \n",
       " T11    4489.0  ,\n",
       " 'cc_onco1499':                                                 CLAVE ICD-O-3    documento  \\\n",
       " T1                                         tumoración  8000/1  cc_onco1499   \n",
       " T2                                  neoplasia maligna  8000/3  cc_onco1499   \n",
       " T3  tumor desmoplásico de células pequeñas y redondas  8806/3  cc_onco1499   \n",
       " T4                                            cT4N1M0  8000/6  cc_onco1499   \n",
       " T5                                progresión pulmonar  8000/6  cc_onco1499   \n",
       " T6                             masa de partes blandas  8000/6  cc_onco1499   \n",
       " T7                                            tumoral  8000/1  cc_onco1499   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   696.0     686.0  \n",
       " T2  1243.0    1226.0  \n",
       " T3  1821.0    1772.0  \n",
       " T4  1854.0    1847.0  \n",
       " T5  3516.0    3497.0  \n",
       " T6  4683.0    4661.0  \n",
       " T7  4691.0    4684.0  ,\n",
       " 'cc_onco151':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1   carcinoma ductal infiltrante  8500/3  cc_onco151   224.0     196.0\n",
       " T2                            CDI  8500/3  cc_onco151   229.0     226.0\n",
       " T3                          tumor  8000/1  cc_onco151   723.0     718.0\n",
       " T4                   tumoraciones  8000/1  cc_onco151  1480.0    1468.0\n",
       " T5            lesiones cerebrales  8000/6  cc_onco151  1931.0    1912.0\n",
       " T6                     metástasis  8000/6  cc_onco151  1958.0    1948.0\n",
       " T7                        tumoral  8000/1  cc_onco151  2165.0    2158.0\n",
       " T8                         cancer  8000/3  cc_onco151  2518.0    2512.0\n",
       " T9                     metastasis  8000/6  cc_onco151  2555.0    2545.0\n",
       " T10               lesión parietal  8000/6  cc_onco151  4006.0    3991.0\n",
       " T11           progresión cerebral  8000/6  cc_onco151  4394.0    4375.0,\n",
       " 'cc_onco165':                               CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                        tumorales  8000/1  cc_onco165  1097.0    1088.0\n",
       " T2                 células malignas  8001/3  cc_onco165  1465.0    1449.0\n",
       " T3                  lesión pulmonar  8000/6  cc_onco165  1509.0    1494.0\n",
       " T4                tumor mesenquimal  8800/1  cc_onco165  1559.0    1542.0\n",
       " T5           enfermedad a distancia  8000/6  cc_onco165  1752.0    1730.0\n",
       " T6                       tumoración  8000/1  cc_onco165  2024.0    2014.0\n",
       " T7        sarcoma sinovial bifásico  9043/3  cc_onco165  2607.0    2582.0\n",
       " T8                           T1N0M0  8000/6  cc_onco165  2658.0    2652.0\n",
       " T9                   lesiones óseas  8000/6  cc_onco165  3469.0    3455.0\n",
       " T10  metástasis de sarcoma sinovial  9040/6  cc_onco165  3657.0    3627.0\n",
       " T11             progresión pulmonar  8000/6  cc_onco165  4084.0    4065.0\n",
       " T12              nódulos pulmonares  8000/6  cc_onco165  4144.0    4126.0\n",
       " T13             lesiones pulmonares  8000/6  cc_onco165  4893.0    4874.0\n",
       " T14                     metastásica  8000/6  cc_onco165  5610.0    5599.0\n",
       " T15     progresión tumoral pulmonar  8000/6  cc_onco165  5680.0    5653.0\n",
       " T16                      neoplásica  8000/1  cc_onco165  5910.0    5900.0,\n",
       " 'cc_onco172':                                          CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1                              adenocarcinoma   8140/3  cc_onco172   237.0   \n",
       " T2                                     cT4N0M0   8000/6  cc_onco172   278.0   \n",
       " T3                                       tumor   8000/1  cc_onco172   700.0   \n",
       " T4   adenocarcinoma moderadamente diferenciado  8140/32  cc_onco172  1116.0   \n",
       " T5                             nódulo pulmonar   8000/6  cc_onco172  1409.0   \n",
       " T6                                  metástasis   8000/6  cc_onco172  1751.0   \n",
       " T7                                  tumoración   8000/1  cc_onco172  2592.0   \n",
       " T8                            recaída cerebral   8000/6  cc_onco172  2911.0   \n",
       " T9                metástasis de adenocarcinoma   8140/6  cc_onco172  3294.0   \n",
       " T10                               diseminación   8000/6  cc_onco172  3322.0   \n",
       " T11                                    tumoral   8000/1  cc_onco172  3519.0   \n",
       " \n",
       "      startpos  \n",
       " T1      223.0  \n",
       " T2      271.0  \n",
       " T3      695.0  \n",
       " T4     1075.0  \n",
       " T5     1394.0  \n",
       " T6     1741.0  \n",
       " T7     2582.0  \n",
       " T8     2895.0  \n",
       " T9     3266.0  \n",
       " T10    3310.0  \n",
       " T11    3512.0  ,\n",
       " 'cc_onco178':                              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                        leucemia  9800/3  cc_onco178   162.0     154.0\n",
       " T2                          cáncer  8000/3  cc_onco178   188.0     182.0\n",
       " T3                           tumor  8000/1  cc_onco178   313.0     308.0\n",
       " T4             implantes pleurales  8000/6  cc_onco178   985.0     966.0\n",
       " T5                   masa pulmonar  8000/6  cc_onco178  1191.0    1178.0\n",
       " T6                  adenocarcinoma  8140/3  cc_onco178  1221.0    1207.0\n",
       " T7                células malignas  8001/3  cc_onco178  1383.0    1367.0\n",
       " T8   enfermedad a nivel peritoneal  8000/6  cc_onco178  1863.0    1834.0\n",
       " T9      progresión a nivel pleural  8000/6  cc_onco178  2201.0    2175.0\n",
       " T10    carcinoma de células claras  8310/3  cc_onco178  3383.0    3356.0,\n",
       " 'cc_onco179':                                                CLAVE  ICD-O-3   documento  \\\n",
       " T1                                            cáncer   8000/3  cc_onco179   \n",
       " T2                          Carcinoma indiferenciado   8020/3  cc_onco179   \n",
       " T3                                        metástasis   8000/6  cc_onco179   \n",
       " T4                 carcinoma pobremente diferenciado  8010/33  cc_onco179   \n",
       " T5                  carcinoma lobulillar infiltrante   8520/3  cc_onco179   \n",
       " T6                                               CLI   8520/3  cc_onco179   \n",
       " T7                                        malignidad   8000/3  cc_onco179   \n",
       " T8                                 carcinoma in situ   8010/2  cc_onco179   \n",
       " T9                                        Hemangioma   9120/0  cc_onco179   \n",
       " T10                                            tumor   8000/1  cc_onco179   \n",
       " T11                                  Macrometástasis   8000/6  cc_onco179   \n",
       " T12                                  recaída cutánea   8000/6  cc_onco179   \n",
       " T13                                    lesión dorsal   8000/6  cc_onco179   \n",
       " T14                          metástasis de carcinoma   8010/6  cc_onco179   \n",
       " T15                                       neoplásico   8000/1  cc_onco179   \n",
       " T16                                        tumorales   8000/1  cc_onco179   \n",
       " T17                                 Lesiones líticas   8000/6  cc_onco179   \n",
       " T18  metástasis de carcinoma pobremente diferenciado  8010/63  cc_onco179   \n",
       " T19                                        letálides   8000/6  cc_onco179   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    607.0     601.0  \n",
       " T2    677.0     653.0  \n",
       " T3    744.0     734.0  \n",
       " T4    926.0     893.0  \n",
       " T5   1486.0    1454.0  \n",
       " T6   1491.0    1488.0  \n",
       " T7   1775.0    1765.0  \n",
       " T8   1998.0    1981.0  \n",
       " T9   2301.0    2291.0  \n",
       " T10  2639.0    2634.0  \n",
       " T11  2789.0    2774.0  \n",
       " T12  3552.0    3537.0  \n",
       " T13  4286.0    4273.0  \n",
       " T14  4468.0    4445.0  \n",
       " T15  5163.0    5153.0  \n",
       " T16  5305.0    5296.0  \n",
       " T17  5739.0    5723.0  \n",
       " T18  5895.0    5848.0  \n",
       " T19  6458.0    6449.0  ,\n",
       " 'cc_onco190':                               CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1              enfermedad pulmonar    8000/6  cc_onco190   412.0     393.0\n",
       " T2               carcinoma escamoso    8070/3  cc_onco190  1148.0    1130.0\n",
       " T3                        neoplasia    8000/1  cc_onco190  1391.0    1382.0\n",
       " T4               nódulos pulmonares    8000/6  cc_onco190  1563.0    1545.0\n",
       " T5                       malignidad    8000/3  cc_onco190  2774.0    2764.0\n",
       " T6                          tumores    8000/1  cc_onco190  2810.0    2803.0\n",
       " T7   carcinoma escamoso infiltrante  8070/3/H  cc_onco190  3128.0    3098.0\n",
       " T8                          tumoral    8000/1  cc_onco190  3751.0    3744.0\n",
       " T9                               M1    8000/6  cc_onco190  4675.0    4673.0\n",
       " T10                      metástasis    8000/6  cc_onco190  5150.0    5140.0,\n",
       " 'cc_onco191':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  carcinoma ductal infiltrante  8500/3  cc_onco191   356.0     328.0\n",
       " T2                       pT2N0M0  8000/6  cc_onco191   443.0     436.0\n",
       " T3                    neoplásico  8000/1  cc_onco191  1221.0    1211.0\n",
       " T4                    neoplásica  8000/1  cc_onco191  1330.0    1320.0\n",
       " T5                    meningioma  9530/0  cc_onco191  2661.0    2651.0\n",
       " T6                     neoplasia  8000/1  cc_onco191  3690.0    3681.0\n",
       " T7                     tumorales  8000/1  cc_onco191  3869.0    3860.0\n",
       " T8   progresión a nivel pulmonar  8000/6  cc_onco191  3975.0    3948.0,\n",
       " 'cc_onco209':                              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                       tumorales  8000/1  cc_onco209   814.0     805.0\n",
       " T2                      tumoración  8000/1  cc_onco209   852.0     842.0\n",
       " T3          masa de partes blandas  8000/6  cc_onco209  1020.0     998.0\n",
       " T4                   lesión lítica  8000/6  cc_onco209  1953.0    1940.0\n",
       " T5  Tumor de células gigantes óseo  9250/1  cc_onco209  2734.0    2704.0\n",
       " T6                       formación  8000/1  cc_onco209  3401.0    3392.0,\n",
       " 'cc_onco21':                                  CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1   carcinoma renal de células claras  8310/3  cc_onco21   124.0      91.0\n",
       " T2                            pT2bN0M0  8000/6  cc_onco21   135.0     127.0\n",
       " T3                           formación  8000/1  cc_onco21   930.0     921.0\n",
       " T4                        neoformación  8000/1  cc_onco21  1152.0    1140.0\n",
       " T5                          tumoración  8000/1  cc_onco21  1546.0    1536.0\n",
       " T6             metástasis de carcinoma  8010/6  cc_onco21  1667.0    1644.0\n",
       " T7                         metastásica  8000/6  cc_onco21  1744.0    1733.0\n",
       " T8                             tumoral  8000/1  cc_onco21  1924.0    1917.0\n",
       " T9                          malignidad  8000/3  cc_onco21  2202.0    2192.0\n",
       " T10             masa de partes blandas  8000/6  cc_onco21  2690.0    2668.0\n",
       " T11                       diseminación  8000/6  cc_onco21  2923.0    2911.0,\n",
       " 'cc_onco221':                                                 CLAVE  ICD-O-3   documento  \\\n",
       " T1  adenocarcinoma de colon moderadamente diferenc...  8140/32  cc_onco221   \n",
       " T2                                          Carcinoma   8010/3  cc_onco221   \n",
       " T3                                        metastásica   8000/6  cc_onco221   \n",
       " T4                             afectación pancreática   8000/6  cc_onco221   \n",
       " T5                                         neoplásica   8000/1  cc_onco221   \n",
       " T6                                                 CM   8000/3  cc_onco221   \n",
       " T7                               adenoma de hipófisis   8272/0  cc_onco221   \n",
       " T8                                                 M0   8000/6  cc_onco221   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   938.0     888.0  \n",
       " T2   902.0     893.0  \n",
       " T3  1172.0    1161.0  \n",
       " T4  2584.0    2562.0  \n",
       " T5  2595.0    2585.0  \n",
       " T6  3097.0    3095.0  \n",
       " T7  5307.0    5287.0  \n",
       " T8  5372.0    5370.0  ,\n",
       " 'cc_onco228':              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  cc_onco228   351.0     337.0\n",
       " T2          TxN3M0  8000/6  cc_onco228   368.0     362.0\n",
       " T3   masa pulmonar  8000/6  cc_onco228  2269.0    2256.0\n",
       " T4         tumoral  8000/1  cc_onco228  4941.0    4934.0,\n",
       " 'cc_onco238':                       CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                tumorales  8000/1  cc_onco238  1841.0    1832.0\n",
       " T2           carcinosarcoma  8980/3  cc_onco238  1940.0    1926.0\n",
       " T3                  pT4N0M0  8000/6  cc_onco238  1975.0    1968.0\n",
       " T4               tumoración  8000/1  cc_onco238  2077.0    2067.0\n",
       " T5        neoplasia maligna  8000/3  cc_onco238  2553.0    2536.0\n",
       " T6               malignidad  8000/3  cc_onco238  3295.0    3285.0\n",
       " T7   implantes peritoneales  8000/6  cc_onco238  4076.0    4054.0\n",
       " T8             metastásicos  8000/6  cc_onco238  4089.0    4077.0\n",
       " T9               metástasis  8000/6  cc_onco238  4155.0    4145.0\n",
       " T10      lesiones hepáticas  8000/6  cc_onco238  4972.0    4954.0,\n",
       " 'cc_onco24':                              CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1                carcinoma sólido  8230/3  cc_onco24   397.0     381.0\n",
       " T2                  adenocarcinoma  8140/3  cc_onco24   835.0     821.0\n",
       " T3      proceso linfoproliferativo  9970/1  cc_onco24   934.0     908.0\n",
       " T4                      metástasis  8000/6  cc_onco24  3518.0    3508.0\n",
       " T5                         tumoral  8000/1  cc_onco24  4842.0    4835.0\n",
       " T6                     lesión ósea  8000/6  cc_onco24  5544.0    5533.0\n",
       " T7   diferenciación neuroendocrina  8574/3  cc_onco24  5749.0    5720.0\n",
       " T8               células tumorales  8001/1  cc_onco24  6085.0    6068.0\n",
       " T9                      tumoración  8000/1  cc_onco24  6161.0    6151.0\n",
       " T10              carcinoma papilar  8260/3  cc_onco24  7053.0    7036.0\n",
       " T11                        maligna  8000/3  cc_onco24  7266.0    7259.0\n",
       " T12                   masa pélvica  8000/6  cc_onco24  7626.0    7614.0\n",
       " T13                        tumores  8000/1  cc_onco24  7942.0    7935.0,\n",
       " 'cc_onco240':                                      CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1                              tumoración   8000/1  cc_onco240   474.0   \n",
       " T2                Carcinoma indiferenciado   8020/3  cc_onco240  1321.0   \n",
       " T3                                 tumoral   8000/1  cc_onco240  1440.0   \n",
       " T4                                      Ca   8000/3  cc_onco240  1845.0   \n",
       " T5                    Estesioneuroblastoma   9522/3  cc_onco240  2088.0   \n",
       " T6                                 tumores   8000/1  cc_onco240  2253.0   \n",
       " T7                              metástasis   8000/6  cc_onco240  3529.0   \n",
       " T8                          neuroendocrino   8240/3  cc_onco240  4088.0   \n",
       " T9  carcinoma neuroendocrino de alto grado  8246/34  cc_onco240  4282.0   \n",
       " \n",
       "     startpos  \n",
       " T1     464.0  \n",
       " T2    1297.0  \n",
       " T3    1433.0  \n",
       " T4    1843.0  \n",
       " T5    2068.0  \n",
       " T6    2246.0  \n",
       " T7    3519.0  \n",
       " T8    4074.0  \n",
       " T9    4244.0  ,\n",
       " 'cc_onco241':                                    CLAVE   ICD-O-3   documento  endpos  \\\n",
       " T1            adenocarcinoma infiltrante  8140/3/H  cc_onco241   979.0   \n",
       " T2                               tumoral    8000/1  cc_onco241  1031.0   \n",
       " T3                         lesión lítica    8000/6  cc_onco241  1238.0   \n",
       " T4                            metástasis    8000/6  cc_onco241  1366.0   \n",
       " T5                               tumores    8000/1  cc_onco241  1676.0   \n",
       " T6                             tumorales    8000/1  cc_onco241  4890.0   \n",
       " T7                            tumoración    8000/1  cc_onco241  5133.0   \n",
       " T8                          plasmocitoma    9731/3  cc_onco241  5679.0   \n",
       " T9             Tumor de células gigantes    8003/3  cc_onco241  5707.0   \n",
       " T10                          lesión ósea    8000/6  cc_onco241  5883.0   \n",
       " T11  tumor de células gigantes del hueso    9250/3  cc_onco241  6092.0   \n",
       " T12                            formación    8000/1  cc_onco241  6273.0   \n",
       " T13                              maligna    8000/3  cc_onco241  6281.0   \n",
       " \n",
       "      startpos  \n",
       " T1      953.0  \n",
       " T2     1024.0  \n",
       " T3     1225.0  \n",
       " T4     1356.0  \n",
       " T5     1669.0  \n",
       " T6     4881.0  \n",
       " T7     5123.0  \n",
       " T8     5667.0  \n",
       " T9     5682.0  \n",
       " T10    5872.0  \n",
       " T11    6057.0  \n",
       " T12    6264.0  \n",
       " T13    6274.0  ,\n",
       " 'cc_onco242':                                  CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                      masa abdominal  8000/6  cc_onco242   356.0     342.0\n",
       " T2                           neoplasia  8000/1  cc_onco242   503.0     494.0\n",
       " T3                            implante  8000/6  cc_onco242   640.0     632.0\n",
       " T4                          neoplásico  8000/1  cc_onco242   671.0     661.0\n",
       " T5                          malignidad  8000/3  cc_onco242   939.0     929.0\n",
       " T6               carcinoma epidermoide  8070/3  cc_onco242  1366.0    1345.0\n",
       " T7                            malignas  8000/3  cc_onco242  3749.0    3741.0\n",
       " T8                masa retroperitoneal  8000/6  cc_onco242  4219.0    4199.0\n",
       " T9   linfoma B difuso de célula grande  9680/3  cc_onco242  4285.0    4252.0\n",
       " T10                          formación  8000/1  cc_onco242  4720.0    4711.0\n",
       " T11                 Linfoma no Hodgkin  9591/3  cc_onco242  6259.0    6241.0\n",
       " T12                   masa mesentérica  8000/6  cc_onco242  7535.0    7519.0,\n",
       " 'cc_onco245':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  carcinoma ductal infiltrante  8500/3  cc_onco245   750.0     722.0\n",
       " T2               LOES cerebrales  8000/6  cc_onco245  1642.0    1627.0\n",
       " T3                     neoplasia  8000/1  cc_onco245  3115.0    3106.0\n",
       " T4               lesión pulmonar  8000/6  cc_onco245  3150.0    3135.0\n",
       " T5                    neoplásico  8000/1  cc_onco245  3236.0    3226.0\n",
       " T6         Carcinoma microcítico  8041/3  cc_onco245  4147.0    4126.0,\n",
       " 'cc_onco248':                                 CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1                         tumoración   8000/1  cc_onco248   669.0     659.0\n",
       " T2                        metastásica   8000/6  cc_onco248  1819.0    1808.0\n",
       " T3                   células malignas   8001/3  cc_onco248  2094.0    2078.0\n",
       " T4        carcinoma poco diferenciado  8010/33  cc_onco248  2288.0    2261.0\n",
       " T5           Carcinoma indiferenciado   8020/3  cc_onco248  2559.0    2535.0\n",
       " T6                        metastásico   8000/6  cc_onco248  2571.0    2560.0\n",
       " T7  carcinoma pobremente diferenciado  8010/33  cc_onco248  2847.0    2814.0,\n",
       " 'cc_onco260':                          CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                  neoplásica  8000/1  cc_onco260   154.0     144.0\n",
       " T2  adenopatía supraclavicular  8000/6  cc_onco260   983.0     957.0\n",
       " T3           masa paratraqueal  8000/6  cc_onco260  1471.0    1454.0\n",
       " T4               masa pulmonar  8000/6  cc_onco260  1520.0    1507.0\n",
       " T5                  metástasis  8000/6  cc_onco260  1829.0    1819.0\n",
       " T6          cáncer microcítico  8041/3  cc_onco260  2055.0    2037.0\n",
       " T7          lesiones hepáticas  8000/6  cc_onco260  2304.0    2286.0\n",
       " T8        enfermedad extendida  8000/6  cc_onco260  2460.0    2440.0\n",
       " T9                 metastásica  8000/6  cc_onco260  4609.0    4598.0,\n",
       " 'cc_onco268':                                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                          neoplasia  8000/1  cc_onco268   230.0     221.0\n",
       " T2  adenocarcinoma de tipo intestinal  8144/3  cc_onco268   332.0     299.0\n",
       " T3                          Carcinoma  8010/3  cc_onco268   313.0     304.0\n",
       " T4                 nódulos pulmonares  8000/6  cc_onco268   434.0     416.0\n",
       " T5                         metástasis  8000/6  cc_onco268   493.0     483.0\n",
       " T6                  lesiones cutáneas  8000/6  cc_onco268   824.0     807.0,\n",
       " 'cc_onco270':                                 CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1                            adenoma   8140/0  cc_onco270   173.0     166.0\n",
       " T2                     adenocarcinoma   8140/3  cc_onco270   703.0     689.0\n",
       " T3   adenocarcinoma bien diferenciado  8140/31  cc_onco270  1705.0    1673.0\n",
       " T4                            tumoral   8000/1  cc_onco270  2019.0    2012.0\n",
       " T5                       neoformativo   8000/1  cc_onco270  2123.0    2111.0\n",
       " T6                        metastático   8000/6  cc_onco270  2225.0    2214.0\n",
       " T7                     LOEs hepáticas   8000/6  cc_onco270  2325.0    2311.0\n",
       " T8           lesión de partes blandas   8000/6  cc_onco270  2947.0    2923.0\n",
       " T9                         metástasis   8000/6  cc_onco270  3263.0    3253.0\n",
       " T10                         tumorales   8000/1  cc_onco270  3719.0    3710.0\n",
       " T11                               M1b   8000/6  cc_onco270  3838.0    3835.0\n",
       " T12        consolidaciones pulmonares   8000/6  cc_onco270  7517.0    7491.0,\n",
       " 'cc_onco281':                                                CLAVE  ICD-O-3   documento  \\\n",
       " T1                      adenocarcinoma endometrioide   8380/3  cc_onco281   \n",
       " T2                                         Carcinoma   8010/3  cc_onco281   \n",
       " T3                   endometrioide bien diferenciado  8380/31  cc_onco281   \n",
       " T4                            enfermedad a distancia   8000/6  cc_onco281   \n",
       " T5   Adenocarcinoma de endometrio tipo endometrioide   8380/3  cc_onco281   \n",
       " T6                                        metástasis   8000/6  cc_onco281   \n",
       " T7                                         neoplasia   8000/1  cc_onco281   \n",
       " T8        Carcinoma neuroendocrino de célula pequeña   8041/3  cc_onco281   \n",
       " T9                                    neuroendocrino   8240/3  cc_onco281   \n",
       " T10                                       tumoración   8000/1  cc_onco281   \n",
       " T11                    diferenciación neuroendocrina   8574/3  cc_onco281   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    782.0     754.0  \n",
       " T2    768.0     759.0  \n",
       " T3    800.0     769.0  \n",
       " T4    931.0     909.0  \n",
       " T5   1043.0     996.0  \n",
       " T6   1471.0    1461.0  \n",
       " T7   2372.0    2363.0  \n",
       " T8   2492.0    2450.0  \n",
       " T9   2474.0    2460.0  \n",
       " T10  2668.0    2658.0  \n",
       " T11  2967.0    2938.0  ,\n",
       " 'cc_onco283':                                CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1            masa de partes blandas    8000/6  cc_onco283   801.0     779.0\n",
       " T2                             tumor    8000/1  cc_onco283  1004.0     999.0\n",
       " T3                        metástasis    8000/6  cc_onco283  1084.0    1074.0\n",
       " T4                          seminoma    9061/3  cc_onco283  1096.0    1088.0\n",
       " T5                        tumoración    8000/1  cc_onco283  1350.0    1340.0\n",
       " T6              tumor germinal mixto  9064/3/H  cc_onco283  1576.0    1556.0\n",
       " T7                          teratoma    9080/1  cc_onco283  1634.0    1626.0\n",
       " T8   neoplasia germinal intratubular    9064/2  cc_onco283  1692.0    1661.0\n",
       " T9              masa retroperitoneal    8000/6  cc_onco283  2017.0    1997.0\n",
       " T10                      metastásica    8000/6  cc_onco283  2088.0    2077.0\n",
       " T11                        tumorales    8000/1  cc_onco283  2111.0    2102.0\n",
       " T12                               M1    8000/6  cc_onco283  2300.0    2298.0\n",
       " T13            enfermedad diseminada    8000/6  cc_onco283  2414.0    2393.0,\n",
       " 'cc_onco285':                   CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1      tumor primitivo  8000/1/H  cc_onco285  1154.0    1139.0\n",
       " T2         angiosarcoma    9120/3  cc_onco285  1168.0    1156.0\n",
       " T3           malignidad    8000/3  cc_onco285  1552.0    1542.0\n",
       " T4          PE pulmonar    8000/6  cc_onco285  2948.0    2937.0\n",
       " T5           metástasis    8000/6  cc_onco285  5158.0    5148.0\n",
       " T6     suelta de globos    8000/6  cc_onco285  5189.0    5173.0\n",
       " T7              tumoral    8000/1  cc_onco285  5760.0    5753.0\n",
       " T8  lesiones pulmonares    8000/6  cc_onco285  6003.0    5984.0\n",
       " T9            neoplasia    8000/1  cc_onco285  6622.0    6613.0,\n",
       " 'cc_onco287':                  CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1      adenocarcinoma  8140/3  cc_onco287   499.0     485.0\n",
       " T2         metastásica  8000/6  cc_onco287   821.0     810.0\n",
       " T3          metástasis  8000/6  cc_onco287   903.0     893.0\n",
       " T4              cáncer  8000/3  cc_onco287  1530.0    1524.0\n",
       " T5     afectación ósea  8000/6  cc_onco287  1573.0    1558.0\n",
       " T6  lesiones blásticas  8000/6  cc_onco287  3005.0    2987.0\n",
       " T7           neoplasia  8000/1  cc_onco287  3483.0    3474.0\n",
       " T8          malignidad  8000/3  cc_onco287  3700.0    3690.0\n",
       " T9      Carcinomatosis  8010/9  cc_onco287  4050.0    4036.0,\n",
       " 'cc_onco290':                       CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  adenocarcinoma mucinoso  8480/3  cc_onco290   218.0     195.0\n",
       " T2                  cT4N2M0  8000/6  cc_onco290   240.0     233.0\n",
       " T3                       Ca  8000/3  cc_onco290   309.0     307.0\n",
       " T4          lóbulo hepático  8000/6  cc_onco290  1610.0    1595.0\n",
       " T5              metastásica  8000/6  cc_onco290  1793.0    1782.0\n",
       " T6       lesiones hepáticas  8000/6  cc_onco290  1846.0    1828.0\n",
       " T7               metástasis  8000/6  cc_onco290  2079.0    2069.0\n",
       " T8               neoplásico  8000/1  cc_onco290  2351.0    2341.0\n",
       " T9          enfermedad ósea  8000/6  cc_onco290  3223.0    3208.0,\n",
       " 'cc_onco292':                     CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1             metástasis  8000/6  cc_onco292    81.0      71.0\n",
       " T2              Carcinoma  8010/3  cc_onco292   117.0     108.0\n",
       " T3                 cáncer  8000/3  cc_onco292   256.0     250.0\n",
       " T4                tumores  8000/1  cc_onco292   920.0     913.0\n",
       " T5             malignidad  8000/3  cc_onco292  1149.0    1139.0\n",
       " T6             tumoración  8000/1  cc_onco292  1876.0    1866.0\n",
       " T7  carcinoma metastásico  8010/6  cc_onco292  2081.0    2060.0\n",
       " T8              tumorales  8000/1  cc_onco292  4014.0    4005.0\n",
       " T9                     HE  9133/1  cc_onco292  4648.0    4646.0,\n",
       " 'cc_onco294':                                          CLAVE ICD-O-3   documento  endpos  \\\n",
       " T1                                     tumoral  8000/1  cc_onco294  1160.0   \n",
       " T2                                  metástasis  8000/6  cc_onco294  1578.0   \n",
       " T3                                  malignidad  8000/3  cc_onco294  1662.0   \n",
       " T4  Carcinoma neuroendocrino de célula pequeña  8041/3  cc_onco294  2091.0   \n",
       " T5                              neuroendocrino  8240/3  cc_onco294  2073.0   \n",
       " \n",
       "     startpos  \n",
       " T1    1153.0  \n",
       " T2    1568.0  \n",
       " T3    1652.0  \n",
       " T4    2049.0  \n",
       " T5    2059.0  ,\n",
       " 'cc_onco304':                         CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  linfoma folicular grado 1  9695/3  cc_onco304   514.0     489.0\n",
       " T2                      tumor  8000/1  cc_onco304  2949.0    2944.0\n",
       " T3                  neoplasia  8000/1  cc_onco304  3092.0    3083.0\n",
       " T4   síndrome mielodisplásico  9989/3  cc_onco304  3990.0    3966.0,\n",
       " 'cc_onco305':                    CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1               sarcoma    8800/3  cc_onco305   601.0     594.0\n",
       " T2          LOE hepática    8000/6  cc_onco305  1034.0    1022.0\n",
       " T3                 tumor    8000/1  cc_onco305  1159.0    1154.0\n",
       " T4        LOEs hepáticas    8000/6  cc_onco305  1190.0    1176.0\n",
       " T5       nódulo hepático    8000/6  cc_onco305  1414.0    1399.0\n",
       " T6        Leiomiosarcoma    8890/3  cc_onco305  1465.0    1451.0\n",
       " T7   sarcoma pleomórfico    8802/3  cc_onco305  1477.0    1458.0\n",
       " T8        angiomiolipoma    8860/0  cc_onco305  1714.0    1700.0\n",
       " T9               maligno    8000/3  cc_onco305  1722.0    1715.0\n",
       " T10                  AML    8860/0  cc_onco305  1727.0    1724.0\n",
       " T11           metástasis    8000/6  cc_onco305  1807.0    1797.0\n",
       " T12         metastásicas    8000/6  cc_onco305  2916.0    2904.0\n",
       " T13      lesión hepática    8000/6  cc_onco305  3039.0    3024.0\n",
       " T14              tumoral    8000/1  cc_onco305  3076.0    3069.0\n",
       " T15          metástasica    8000/6  cc_onco305  3290.0    3279.0\n",
       " T16              tumores    8000/1  cc_onco305  3351.0    3344.0\n",
       " T17             sarcomas    8800/3  cc_onco305  3363.0    3355.0\n",
       " T18               PEComa  8011/1/H  cc_onco305  3708.0    3702.0,\n",
       " 'cc_onco323':                                    CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                            tumoración  8000/1  cc_onco323   462.0     452.0\n",
       " T2                            neoplásico  8000/1  cc_onco323   748.0     738.0\n",
       " T3                              melanoma  8720/3  cc_onco323   854.0     846.0\n",
       " T4                               pT4N3M0  8000/6  cc_onco323   948.0     941.0\n",
       " T5                            metástasis  8000/6  cc_onco323  1188.0    1178.0\n",
       " T6                        LOEs hepáticas  8000/6  cc_onco323  1515.0    1501.0\n",
       " T7   progresión tumoral a nivel hepático  8000/6  cc_onco323  1736.0    1701.0\n",
       " T8                               tumoral  8000/1  cc_onco323  1719.0    1712.0\n",
       " T9           progresión a nivel hepático  8000/6  cc_onco323  2234.0    2207.0\n",
       " T10                   masa paravertebral  8000/6  cc_onco323  4327.0    4309.0\n",
       " T11                          metastásica  8000/6  cc_onco323  4772.0    4761.0,\n",
       " 'cc_onco329':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                     Carcinoma  8010/3  cc_onco329   553.0     544.0\n",
       " T2             carcinoma papilar  8260/3  cc_onco329   659.0     642.0\n",
       " T3   carcinoma de células claras  8310/3  cc_onco329   709.0     682.0\n",
       " T4                     neoplasia  8000/1  cc_onco329   748.0     739.0\n",
       " T5           carcinoma urotelial  8120/3  cc_onco329   811.0     792.0\n",
       " T6         enfermedad diseminada  8000/6  cc_onco329  1041.0    1020.0\n",
       " T7               nódulo pulmonar  8000/6  cc_onco329  1114.0    1099.0\n",
       " T8                 lesión lítica  8000/6  cc_onco329  1146.0    1133.0\n",
       " T9                lesiones óseas  8000/6  cc_onco329  3133.0    3119.0\n",
       " T10                   metástasis  8000/6  cc_onco329  3187.0    3177.0\n",
       " T11                      tumoral  8000/1  cc_onco329  3355.0    3348.0\n",
       " T12              lesión pulmonar  8000/6  cc_onco329  4025.0    4010.0\n",
       " T13                  lesión ósea  8000/6  cc_onco329  5377.0    5366.0,\n",
       " 'cc_onco33':                             CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1                          tumor  8000/1  cc_onco33  1348.0    1343.0\n",
       " T2                        tumoral  8000/1  cc_onco33  1529.0    1522.0\n",
       " T3   carcinoma ductal infiltrante  8500/3  cc_onco33  1665.0    1637.0\n",
       " T4                            CDI  8500/3  cc_onco33  1670.0    1667.0\n",
       " T5        metástasis de carcinoma  8010/6  cc_onco33  1862.0    1839.0\n",
       " T6         carcinoma inflamatorio  8530/3  cc_onco33  2199.0    2177.0\n",
       " T7                        cT4N1M0  8000/6  cc_onco33  2246.0    2239.0\n",
       " T8                        tumores  8000/1  cc_onco33  2423.0    2416.0\n",
       " T9                      neoplasia  8000/1  cc_onco33  2478.0    2469.0\n",
       " T10                     tumorales  8000/1  cc_onco33  3893.0    3884.0\n",
       " T11            lesiones hepáticas  8000/6  cc_onco33  4991.0    4973.0,\n",
       " 'cc_onco332':                                          CLAVE   ICD-O-3   documento  endpos  \\\n",
       " T1                             hepatocarcinoma    8170/3  cc_onco332   324.0   \n",
       " T2                              adenocarcinoma    8140/3  cc_onco332   688.0   \n",
       " T3                                  tumoración    8000/1  cc_onco332   779.0   \n",
       " T4   adenocarcinoma de colon bien diferenciado   8140/31  cc_onco332  1068.0   \n",
       " T5                      enfermedad a distancia    8000/6  cc_onco332  1339.0   \n",
       " T6                  adenocarcinoma infiltrante  8140/3/H  cc_onco332  2282.0   \n",
       " T7                                  metástasis    8000/6  cc_onco332  2369.0   \n",
       " T8   adenocarcinoma moderadamente diferenciado   8140/32  cc_onco332  2546.0   \n",
       " T9                                     tumoral    8000/1  cc_onco332  3130.0   \n",
       " T10                                metastásica    8000/6  cc_onco332  3167.0   \n",
       " T11                                 malignidad    8000/3  cc_onco332  3677.0   \n",
       " T12                            lesión hepática    8000/6  cc_onco332  4030.0   \n",
       " T13                  adenocarcinoma intestinal    8144/3  cc_onco332  4204.0   \n",
       " T14                                    tumores    8000/1  cc_onco332  5177.0   \n",
       " T15                                   implante    8000/6  cc_onco332  6258.0   \n",
       " \n",
       "      startpos  \n",
       " T1      309.0  \n",
       " T2      674.0  \n",
       " T3      769.0  \n",
       " T4     1027.0  \n",
       " T5     1317.0  \n",
       " T6     2256.0  \n",
       " T7     2359.0  \n",
       " T8     2505.0  \n",
       " T9     3123.0  \n",
       " T10    3156.0  \n",
       " T11    3667.0  \n",
       " T12    4015.0  \n",
       " T13    4179.0  \n",
       " T14    5170.0  \n",
       " T15    6250.0  ,\n",
       " 'cc_onco333':                                  CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1               carcinoma epidermoide   8070/3  cc_onco333   141.0     120.0\n",
       " T2        Carcinoma de células grandes   8012/3  cc_onco333   328.0     300.0\n",
       " T3                     LOES cerebrales   8000/6  cc_onco333   380.0     365.0\n",
       " T4  sarcoma pleomórfico indiferenciado  8802/34  cc_onco333  2528.0    2494.0\n",
       " T5                             tumores   8000/1  cc_onco333  3009.0    3002.0\n",
       " T6                             tumoral   8000/1  cc_onco333  3256.0    3249.0\n",
       " T7                            sarcomas   8800/3  cc_onco333  4972.0    4964.0,\n",
       " 'cc_onco339':                               CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                        neoplasia  8000/1  cc_onco339  1141.0    1132.0\n",
       " T2                          maligno  8000/3  cc_onco339  1160.0    1153.0\n",
       " T3   nódulos pulmonares bilaterales  8000/6  cc_onco339  1549.0    1519.0\n",
       " T4                       metástasis  8000/6  cc_onco339  1598.0    1588.0\n",
       " T5                     neoformación  8000/1  cc_onco339  2083.0    2071.0\n",
       " T6         Carcinoma indiferenciado  8020/3  cc_onco339  2619.0    2595.0\n",
       " T7                          sarcoma  8800/3  cc_onco339  2632.0    2625.0\n",
       " T8                         rabdoide  8963/3  cc_onco339  2651.0    2643.0\n",
       " T9             Carcinoma anaplásico  8021/3  cc_onco339  2840.0    2820.0\n",
       " T10                              M1  8000/6  cc_onco339  2995.0    2993.0\n",
       " T11                         tumores  8000/1  cc_onco339  3117.0    3110.0\n",
       " T12                      tumoración  8000/1  cc_onco339  4765.0    4755.0,\n",
       " 'cc_onco349':                CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  suelta de globos  8000/6  cc_onco349  2244.0    2228.0\n",
       " T2   lesión hepática  8000/6  cc_onco349  2585.0    2570.0\n",
       " T3   hepatocarcinoma  8170/3  cc_onco349  2647.0    2632.0\n",
       " T4      diseminación  8000/6  cc_onco349  2812.0    2800.0\n",
       " T5        neoplásica  8000/1  cc_onco349  3005.0    2995.0,\n",
       " 'cc_onco358':                          CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                   Carcinoma  8010/3  cc_onco358   209.0     200.0\n",
       " T2                neoformación  8000/1  cc_onco358   956.0     944.0\n",
       " T3     adenocarcinoma mucinoso  8480/3  cc_onco358  1212.0    1189.0\n",
       " T4                  tumoración  8000/1  cc_onco358  1572.0    1562.0\n",
       " T5                   tumorales  8000/1  cc_onco358  1816.0    1807.0\n",
       " T6                     pT3N0M0  8000/6  cc_onco358  2659.0    2652.0\n",
       " T7         recidiva peritoneal  8000/6  cc_onco358  3399.0    3380.0\n",
       " T8  enfermedad a nivel pleural  8000/6  cc_onco358  4462.0    4436.0,\n",
       " 'cc_onco359':                          CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1                     tumoral    8000/1  cc_onco359   961.0     954.0\n",
       " T2  Cáncer de mama metastásico    8000/6  cc_onco359  1006.0     980.0\n",
       " T3        infiltración medular    8000/6  cc_onco359  1096.0    1076.0\n",
       " T4       carcinoma infiltrante  8010/3/H  cc_onco359  1767.0    1746.0\n",
       " T5               carcinomatosa    8010/9  cc_onco359  2256.0    2243.0\n",
       " T6                  metástasis    8000/6  cc_onco359  2269.0    2259.0,\n",
       " 'cc_onco365':                CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1         tumorales  8000/1  cc_onco365   845.0     836.0\n",
       " T2  seminoma clásico  9061/3  cc_onco365  1011.0     995.0\n",
       " T3           pT1N0M0  8000/6  cc_onco365  1141.0    1134.0,\n",
       " 'cc_onco373':                           CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1               lesión cutánea  8000/6  cc_onco373   118.0     104.0\n",
       " T2             melanoma maligno  8720/3  cc_onco373   169.0     153.0\n",
       " T3   Melanoma lentiginoso acral  8744/3  cc_onco373   345.0     319.0\n",
       " T4                  peritumoral  8000/1  cc_onco373   481.0     470.0\n",
       " T5                     adenomas  8140/0  cc_onco373  1280.0    1272.0\n",
       " T6            lesiones cutáneas  8000/6  cc_onco373  1860.0    1843.0\n",
       " T7                   metástasis  8000/6  cc_onco373  1961.0    1951.0\n",
       " T8       enfermedad a distancia  8000/6  cc_onco373  2017.0    1995.0\n",
       " T9          enfermedad cerebral  8000/6  cc_onco373  2325.0    2306.0\n",
       " T10                 metastásica  8000/6  cc_onco373  2337.0    2326.0,\n",
       " 'cc_onco383':                              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                          cáncer  8000/3  cc_onco383   249.0     243.0\n",
       " T2                  lesión cutánea  8000/6  cc_onco383   353.0     339.0\n",
       " T3                  nevus de Spitz  8770/0  cc_onco383   477.0     463.0\n",
       " T4         bultoma supraclavicular  8000/6  cc_onco383  1017.0     994.0\n",
       " T5               lesiones cutáneas  8000/6  cc_onco383  1812.0    1795.0\n",
       " T6      adenopatía supraclavicular  8000/6  cc_onco383  2930.0    2904.0\n",
       " T7  metástasis de melanoma maligno  8720/6  cc_onco383  2972.0    2942.0\n",
       " T8            Melanoma metastásico  8720/6  cc_onco383  3069.0    3049.0,\n",
       " 'cc_onco386':                     CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1             tumoración  8000/1  cc_onco386   478.0     468.0\n",
       " T2             malignidad  8000/3  cc_onco386   588.0     578.0\n",
       " T3  carcinoma epidermoide  8070/3  cc_onco386   882.0     861.0\n",
       " T4                     Mx  8000/6  cc_onco386   921.0     919.0\n",
       " T5         adenocarcinoma  8140/3  cc_onco386  1569.0    1555.0\n",
       " T6       células malignas  8001/3  cc_onco386  1940.0    1924.0\n",
       " T7                tumoral  8000/1  cc_onco386  2260.0    2253.0,\n",
       " 'cc_onco389':                            CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1    adenopatía supraclavicular   8000/6  cc_onco389   365.0     339.0\n",
       " T2                       linfoma   9590/3  cc_onco389  1387.0    1380.0\n",
       " T3  tumoración de partes blandas   8800/1  cc_onco389  1597.0    1569.0\n",
       " T4                       tumoral   8000/1  cc_onco389  1779.0    1772.0\n",
       " T5        masa de partes blandas   8000/6  cc_onco389  1900.0    1878.0\n",
       " T6             infiltración ósea   8000/6  cc_onco389  2674.0    2657.0\n",
       " T7  leiomiosarcoma de alto grado  8890/34  cc_onco389  2775.0    2747.0\n",
       " T8                       maligna   8000/3  cc_onco389  3219.0    3212.0\n",
       " T9                    metástasis   8000/6  cc_onco389  4103.0    4093.0,\n",
       " 'cc_onco397':                   CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1         neoformación  8000/1  cc_onco397   408.0     396.0\n",
       " T2       adenocarcinoma  8140/3  cc_onco397   473.0     459.0\n",
       " T3           metástasis  8000/6  cc_onco397   597.0     587.0\n",
       " T4      lóbulo hepático  8000/6  cc_onco397  1017.0    1002.0\n",
       " T5  progresión hepática  8000/6  cc_onco397  1667.0    1648.0\n",
       " T6   lesiones hepáticas  8000/6  cc_onco397  1869.0    1851.0\n",
       " T7     células malignas  8001/3  cc_onco397  3151.0    3135.0\n",
       " T8              linfoma  9590/3  cc_onco397  3368.0    3361.0\n",
       " T9     recaída hepática  8000/6  cc_onco397  4493.0    4477.0,\n",
       " 'cc_onco398':                   CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1           metástasis  8000/6  cc_onco398   712.0     702.0\n",
       " T2       adenocarcinoma  8140/3  cc_onco398  1127.0    1113.0\n",
       " T3  implantes pleurales  8000/6  cc_onco398  4080.0    4061.0,\n",
       " 'cc_onco399':                               CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1                           cáncer    8000/3  cc_onco399   532.0     526.0\n",
       " T2                        neoplasia    8000/1  cc_onco399   709.0     700.0\n",
       " T3                               M1    8000/6  cc_onco399   764.0     762.0\n",
       " T4                       metástasis    8000/6  cc_onco399   777.0     767.0\n",
       " T5                   adenocarcinoma    8140/3  cc_onco399   847.0     833.0\n",
       " T6               linfoma anaplásico  9590/3/H  cc_onco399  1033.0    1015.0\n",
       " T7                          tumores    8000/1  cc_onco399  1131.0    1124.0\n",
       " T8                 oligometastásica    8000/6  cc_onco399  1407.0    1391.0\n",
       " T9                 masa suprarrenal    8000/6  cc_onco399  1772.0    1756.0\n",
       " T10  nódulos pulmonares bilaterales    8000/6  cc_onco399  2358.0    2328.0\n",
       " T11                     metastásico    8000/6  cc_onco399  2405.0    2394.0\n",
       " T12                    metastásicas    8000/6  cc_onco399  3519.0    3507.0\n",
       " T13                 nódulo pulmonar    8000/6  cc_onco399  3607.0    3592.0\n",
       " T14                    metastásicos    8000/6  cc_onco399  4653.0    4641.0\n",
       " T15                         tumoral    8000/1  cc_onco399  4814.0    4807.0,\n",
       " 'cc_onco410':                  CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1           neoplasia  8000/1  cc_onco410   256.0     247.0\n",
       " T2            melanoma  8720/3  cc_onco410   406.0     398.0\n",
       " T3      adenocarcinoma  8140/3  cc_onco410   562.0     548.0\n",
       " T4  lesiones hepáticas  8000/6  cc_onco410   966.0     948.0\n",
       " T5          metástasis  8000/6  cc_onco410  1021.0    1011.0\n",
       " T6             tumoral  8000/1  cc_onco410  2526.0    2519.0,\n",
       " 'cc_onco414':                     CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1       suelta de globos  8000/6  cc_onco414  1157.0    1141.0\n",
       " T2             metástasis  8000/6  cc_onco414  1571.0    1561.0\n",
       " T3     lesiones hepáticas  8000/6  cc_onco414  1711.0    1693.0\n",
       " T4            hemangiomas  9120/0  cc_onco414  1752.0    1741.0\n",
       " T5              formación  8000/1  cc_onco414  2084.0    2075.0\n",
       " T6              neoplasia  8000/1  cc_onco414  2383.0    2374.0\n",
       " T7    afectación pulmonar  8000/6  cc_onco414  2446.0    2427.0\n",
       " T8   múltiples pulmonares  8000/6  cc_onco414  2926.0    2906.0\n",
       " T9         coriocarcinoma  9100/3  cc_onco414  3409.0    3395.0\n",
       " T10   lesiones pulmonares  8000/6  cc_onco414  4496.0    4477.0,\n",
       " 'cc_onco418':                              CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1                           Mioma    8895/0  cc_onco418   325.0     320.0\n",
       " T2                 hepatocarcinoma    8170/3  cc_onco418   490.0     475.0\n",
       " T3                          cáncer    8000/3  cc_onco418   528.0     522.0\n",
       " T4                        leucemia    9800/3  cc_onco418   584.0     576.0\n",
       " T5                    diseminación    8000/6  cc_onco418  1437.0    1425.0\n",
       " T6                           tumor    8000/1  cc_onco418  1493.0    1488.0\n",
       " T7                  adenocarcinoma    8140/3  cc_onco418  1638.0    1624.0\n",
       " T8   progresión pulmonar bilateral    8000/6  cc_onco418  2450.0    2421.0\n",
       " T9                     tumor mixto  8000/1/H  cc_onco418  2817.0    2806.0\n",
       " T10       carcinoma neuroendocrino    8246/3  cc_onco418  2895.0    2871.0\n",
       " T11            progresión hepática    8000/6  cc_onco418  3909.0    3890.0\n",
       " T12                        tumoral    8000/1  cc_onco418  3987.0    3980.0\n",
       " T13                     neoplásico    8000/1  cc_onco418  4766.0    4756.0,\n",
       " 'cc_onco421':                              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                 hepatocarcinoma  8170/3  cc_onco421    89.0      74.0\n",
       " T2  carcinoma de células escamosas  8070/3  cc_onco421  1569.0    1539.0\n",
       " T3           carcinoma epidermoide  8070/3  cc_onco421  1696.0    1675.0\n",
       " T4                          T1N0M0  8000/6  cc_onco421  1726.0    1720.0,\n",
       " 'cc_onco422':              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  cc_onco422  2732.0    2718.0\n",
       " T2           tumor  8000/1  cc_onco422  3139.0    3134.0,\n",
       " 'cc_onco426':               CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1   adenocarcinoma  8140/3  cc_onco426   428.0     414.0\n",
       " T2       metástasis  8000/6  cc_onco426  1039.0    1029.0\n",
       " T3          tumoral  8000/1  cc_onco426  1657.0    1650.0\n",
       " T4       malignidad  8000/3  cc_onco426  1761.0    1751.0\n",
       " T5       tumoración  8000/1  cc_onco426  1805.0    1795.0\n",
       " T6  afectación ósea  8000/6  cc_onco426  2625.0    2610.0\n",
       " T7               HE  9133/1  cc_onco426  3408.0    3406.0,\n",
       " 'cc_onco429':                                  CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                      masa abdominal  8000/6  cc_onco429   340.0     326.0\n",
       " T2                        hipernefroma  8312/3  cc_onco429   403.0     391.0\n",
       " T3                     nódulo pulmonar  8000/6  cc_onco429   909.0     894.0\n",
       " T4                  nódulos pulmonares  8000/6  cc_onco429  1274.0    1256.0\n",
       " T5   carcinoma renal de células claras  8310/3  cc_onco429  1712.0    1679.0\n",
       " T6                         metastásica  8000/6  cc_onco429  1874.0    1863.0\n",
       " T7                  lesiones hepáticas  8000/6  cc_onco429  1916.0    1898.0\n",
       " T8                          metástasis  8000/6  cc_onco429  1941.0    1931.0\n",
       " T9                             tumoral  8000/1  cc_onco429  1968.0    1961.0\n",
       " T10                progresión pulmonar  8000/6  cc_onco429  2098.0    2079.0\n",
       " T11                progresión hepática  8000/6  cc_onco429  3580.0    3561.0\n",
       " T12         lesiones focales hepáticas  8000/6  cc_onco429  3859.0    3833.0,\n",
       " 'cc_onco431':                                CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                        neoplásica  8000/1  cc_onco431  1029.0    1019.0\n",
       " T2                         neoplasia  8000/1  cc_onco431  1093.0    1084.0\n",
       " T3                         Carcinoma  8010/3  cc_onco431  1570.0    1561.0\n",
       " T4                    adenocarcinoma  8140/3  cc_onco431  1965.0    1951.0\n",
       " T5                        metástasis  8000/6  cc_onco431  2561.0    2551.0\n",
       " T6                   progresión ósea  8000/6  cc_onco431  2896.0    2881.0\n",
       " T7         linfangitis carcinomatosa  8000/3  cc_onco431  4725.0    4700.0\n",
       " T8               lesiones esplénicas  8000/6  cc_onco431  4771.0    4752.0\n",
       " T9   enfermedad estable a nivel óseo  8000/6  cc_onco431  5354.0    5323.0\n",
       " T10                  enfermedad ósea  8000/6  cc_onco431  6854.0    6839.0\n",
       " T11                      metastásica  8000/6  cc_onco431  7804.0    7793.0\n",
       " T12                  afectación ósea  8000/6  cc_onco431  7935.0    7920.0\n",
       " T13                     diseminación  8000/6  cc_onco431  7963.0    7951.0,\n",
       " 'cc_onco434':                       CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  glioblastoma multiforme  9440/3  cc_onco434    88.0      65.0\n",
       " T2                 blastoma  8000/3  cc_onco434    77.0      69.0,\n",
       " 'cc_onco436':                                               CLAVE ICD-O-3   documento  \\\n",
       " T1                            Carcinoma microcítico  8041/3  cc_onco436   \n",
       " T2                             enfermedad extendida  8000/6  cc_onco436   \n",
       " T3                              afectación cerebral  8000/6  cc_onco436   \n",
       " T4                                       neoplásica  8000/1  cc_onco436   \n",
       " T5                                      metastásico  8000/6  cc_onco436   \n",
       " T6                                       neoplásico  8000/1  cc_onco436   \n",
       " T7  enfermedad a nivel del sistema nervioso central  8000/6  cc_onco436   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   280.0     259.0  \n",
       " T2   315.0     295.0  \n",
       " T3  1358.0    1339.0  \n",
       " T4  1633.0    1623.0  \n",
       " T5  1798.0    1787.0  \n",
       " T6  3018.0    3008.0  \n",
       " T7  3243.0    3196.0  ,\n",
       " 'cc_onco440':                        CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                    cáncer  8000/3  cc_onco440   225.0     219.0\n",
       " T2                  leucemia  9800/3  cc_onco440   318.0     310.0\n",
       " T3                   tumoral  8000/1  cc_onco440   673.0     666.0\n",
       " T4                metástasis  8000/6  cc_onco440  1235.0    1225.0\n",
       " T5                   tumores  8000/1  cc_onco440  1278.0    1271.0\n",
       " T6                        Mx  8000/6  cc_onco440  2166.0    2164.0\n",
       " T7        lesiones hepáticas  8000/6  cc_onco440  3426.0    3408.0\n",
       " T8   tumores neuroendocrinos  8240/3  cc_onco440  4331.0    4308.0\n",
       " T9            neuroendocrino  8240/3  cc_onco440  4330.0    4316.0\n",
       " T10          lesión hepática  8000/6  cc_onco440  4530.0    4515.0\n",
       " T11              metastásico  8000/6  cc_onco440  5647.0    5636.0,\n",
       " 'cc_onco441':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                        cáncer  8000/3  cc_onco441   131.0     125.0\n",
       " T2          masa retroperitoneal  8000/6  cc_onco441   599.0     579.0\n",
       " T3                 Paraganglioma  8680/1  cc_onco441   744.0     731.0\n",
       " T4                masa abdominal  8000/6  cc_onco441  1014.0    1000.0\n",
       " T5                    metástasis  8000/6  cc_onco441  1309.0    1299.0\n",
       " T6  enfermedad a nivel abdominal  8000/6  cc_onco441  1891.0    1863.0\n",
       " T7    paraganglioma extraadrenal  8693/1  cc_onco441  2703.0    2677.0,\n",
       " 'cc_onco445':              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  cc_onco445    86.0      72.0\n",
       " T2      metástasis  8000/6  cc_onco445  1880.0    1870.0,\n",
       " 'cc_onco447':                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1     adenocarcinoma  8140/3  cc_onco447   157.0     143.0\n",
       " T2               cM1c  8000/6  cc_onco447   196.0     192.0\n",
       " T3         metástasis  8000/6  cc_onco447   224.0     214.0\n",
       " T4         neoplásico  8000/1  cc_onco447  2486.0    2476.0\n",
       " T5  lesiones cutáneas  8000/6  cc_onco447  2950.0    2933.0,\n",
       " 'cc_onco448':                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1         meningioma  9530/0  cc_onco448   227.0     217.0\n",
       " T2            tumoral  8000/1  cc_onco448   344.0     337.0\n",
       " T3          Carcinoma  8010/3  cc_onco448  1508.0    1499.0\n",
       " T4    afectación ósea  8000/6  cc_onco448  2123.0    2108.0\n",
       " T5  infiltración ósea  8000/6  cc_onco448  2234.0    2217.0\n",
       " T6         tumoración  8000/1  cc_onco448  2249.0    2239.0\n",
       " T7         metástasis  8000/6  cc_onco448  2970.0    2960.0\n",
       " T8        metastásico  8000/6  cc_onco448  3059.0    3048.0\n",
       " T9     lesiones óseas  8000/6  cc_onco448  3697.0    3683.0,\n",
       " 'cc_onco451':                                   CLAVE   ICD-O-3   documento  endpos  \\\n",
       " T1                   nódulos pulmonares    8000/6  cc_onco451   883.0   \n",
       " T2                carcinoma infiltrante  8010/3/H  cc_onco451  1584.0   \n",
       " T3                    carcinoma in situ    8010/2  cc_onco451  1672.0   \n",
       " T4                    células tumorales    8001/1  cc_onco451  1878.0   \n",
       " T5        Adenopatías supraclaviculares    8000/6  cc_onco451  2141.0   \n",
       " T6                           malignidad    8000/3  cc_onco451  2231.0   \n",
       " T7                           metástasis    8000/6  cc_onco451  2404.0   \n",
       " T8  carcinoma compatible con metástasis    8010/6  cc_onco451  2543.0   \n",
       " \n",
       "     startpos  \n",
       " T1     865.0  \n",
       " T2    1563.0  \n",
       " T3    1655.0  \n",
       " T4    1861.0  \n",
       " T5    2112.0  \n",
       " T6    2221.0  \n",
       " T7    2394.0  \n",
       " T8    2508.0  ,\n",
       " 'cc_onco454':                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  lesiones cutáneas  8000/6  cc_onco454   416.0     399.0\n",
       " T2  sarcoma de Kaposi  9140/3  cc_onco454   450.0     433.0\n",
       " T3     lesión cutánea  8000/6  cc_onco454  1958.0    1944.0,\n",
       " 'cc_onco456':                                    CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1                                cáncer   8000/3  cc_onco456    82.0   \n",
       " T2                           metastásico   8000/6  cc_onco456   106.0   \n",
       " T3                                lipoma   8850/0  cc_onco456   390.0   \n",
       " T4                            metástasis   8000/6  cc_onco456  1003.0   \n",
       " T5  adenocarcinoma de próstata Gleason 8  8140/33  cc_onco456  1616.0   \n",
       " T6                             Carcinoma   8010/3  cc_onco456  1594.0   \n",
       " T7                        lesiones óseas   8000/6  cc_onco456  2289.0   \n",
       " T8                          metastásicas   8000/6  cc_onco456  2702.0   \n",
       " T9                     lesiones pélvicas   8000/6  cc_onco456  2890.0   \n",
       " \n",
       "     startpos  \n",
       " T1      76.0  \n",
       " T2      95.0  \n",
       " T3     384.0  \n",
       " T4     993.0  \n",
       " T5    1580.0  \n",
       " T6    1585.0  \n",
       " T7    2275.0  \n",
       " T8    2690.0  \n",
       " T9    2873.0  ,\n",
       " 'cc_onco461':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1   carcinoma ductal infiltrante  8500/3  cc_onco461   177.0     149.0\n",
       " T2                             M0  8000/6  cc_onco461   226.0     224.0\n",
       " T3                          tumor  8000/1  cc_onco461   701.0     696.0\n",
       " T4                      neoplasia  8000/1  cc_onco461  1846.0    1837.0\n",
       " T5      linfangitis carcinomatosa  8000/3  cc_onco461  2021.0    1996.0\n",
       " T6                     metástasis  8000/6  cc_onco461  2039.0    2029.0\n",
       " T7    carcinoma no célula pequeña  8046/3  cc_onco461  2362.0    2335.0\n",
       " T8                          NSCLC  8046/3  cc_onco461  2369.0    2364.0\n",
       " T9                         cancer  8000/3  cc_onco461  2421.0    2415.0\n",
       " T10                adenocarcinoma  8140/3  cc_onco461  2513.0    2499.0\n",
       " T11                           M1b  8000/6  cc_onco461  2790.0    2787.0\n",
       " T12                     tumorales  8000/1  cc_onco461  3211.0    3202.0\n",
       " T13                   metastásica  8000/6  cc_onco461  4238.0    4227.0\n",
       " T14           progresión pulmonar  8000/6  cc_onco461  5551.0    5532.0\n",
       " T15           progresión hepática  8000/6  cc_onco461  5786.0    5767.0\n",
       " T16               lesión hepática  8000/6  cc_onco461  5863.0    5848.0\n",
       " T17           lesiones cerebrales  8000/6  cc_onco461  6130.0    6111.0\n",
       " T18           afectación cerebral  8000/6  cc_onco461  6223.0    6204.0\n",
       " T19           enfermedad cerebral  8000/6  cc_onco461  6755.0    6736.0,\n",
       " 'cc_onco465':                                                  CLAVE  ICD-O-3   documento  \\\n",
       " T1                                        neoformación   8000/1  cc_onco465   \n",
       " T2                                           Carcinoma   8010/3  cc_onco465   \n",
       " T3                                           neoplasia   8000/1  cc_onco465   \n",
       " T4                                         metastásica   8000/6  cc_onco465   \n",
       " T5                                          metástasis   8000/6  cc_onco465   \n",
       " T6   adenocarcinoma colorrectal moderadamente difer...  8140/32  cc_onco465   \n",
       " T7                                 afectación hepática   8000/6  cc_onco465   \n",
       " T8                                   neoplasia maligna   8000/3  cc_onco465   \n",
       " T9                                          neoplásica   8000/1  cc_onco465   \n",
       " T10                                 lesiones hepáticas   8000/6  cc_onco465   \n",
       " T11                                progresión hepática   8000/6  cc_onco465   \n",
       " T12                                           implante   8000/6  cc_onco465   \n",
       " T13                                      LOE hepáticas   8000/6  cc_onco465   \n",
       " T14                                              tumor   8000/1  cc_onco465   \n",
       " T15                                               GIST   8936/3  cc_onco465   \n",
       " T16                                            tumores   8000/1  cc_onco465   \n",
       " T17                                   masa mesentérica   8000/6  cc_onco465   \n",
       " T18                 tumor del estroma gastrointestinal   8936/3  cc_onco465   \n",
       " T19                                        metastásico   8000/6  cc_onco465   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1   1108.0    1096.0  \n",
       " T2   1175.0    1166.0  \n",
       " T3   1315.0    1306.0  \n",
       " T4   1420.0    1409.0  \n",
       " T5   1520.0    1510.0  \n",
       " T6   1686.0    1633.0  \n",
       " T7   1746.0    1727.0  \n",
       " T8   1806.0    1789.0  \n",
       " T9   2310.0    2300.0  \n",
       " T10  2865.0    2847.0  \n",
       " T11  3425.0    3406.0  \n",
       " T12  3464.0    3456.0  \n",
       " T13  3826.0    3813.0  \n",
       " T14  4043.0    4038.0  \n",
       " T15  4069.0    4065.0  \n",
       " T16  4323.0    4316.0  \n",
       " T17  4657.0    4641.0  \n",
       " T18  4740.0    4706.0  \n",
       " T19  4824.0    4813.0  ,\n",
       " 'cc_onco466':                                 CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1                carcinoma urotelial   8120/3  cc_onco466   499.0     480.0\n",
       " T2  carcinoma urotelial de alto grado  8120/34  cc_onco466   808.0     775.0\n",
       " T3      Adenopatías supraclaviculares   8000/6  cc_onco466  1104.0    1075.0\n",
       " T4           metástasis por carcinoma   8010/6  cc_onco466  1346.0    1322.0\n",
       " T5                        metastásica   8000/6  cc_onco466  3192.0    3181.0\n",
       " T6                     lesiones óseas   8000/6  cc_onco466  3271.0    3257.0\n",
       " T7                            tumoral   8000/1  cc_onco466  3660.0    3653.0\n",
       " T8                        metastásico   8000/6  cc_onco466  3708.0    3697.0,\n",
       " 'cc_onco469':              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  cc_onco469   255.0     241.0\n",
       " T2          cancer  8000/3  cc_onco469   302.0     296.0,\n",
       " 'cc_onco47':                                        CLAVE  ICD-O-3  documento  endpos  \\\n",
       " T1                                metástasis   8000/6  cc_onco47  1513.0   \n",
       " T2                      masa retroperitoneal   8000/6  cc_onco47  1596.0   \n",
       " T3                             tumor maligno   8000/3  cc_onco47  1647.0   \n",
       " T4             diferenciación neuroendocrina   8574/3  cc_onco47  1732.0   \n",
       " T5          tumor neuroectodérmico primitivo   9473/3  cc_onco47  1814.0   \n",
       " T6                                      PNET   9364/3  cc_onco47  1820.0   \n",
       " T7   lesiones ocupantes de espacio hepáticas   8000/6  cc_onco47  2428.0   \n",
       " T8                           afectación ósea   8000/6  cc_onco47  2603.0   \n",
       " T9                        lesiones blásticas   8000/6  cc_onco47  2653.0   \n",
       " T10                     tumor indiferenciado  8000/34  cc_onco47  3612.0   \n",
       " T11              infiltración de médula ósea   8000/6  cc_onco47  3739.0   \n",
       " T12                              metastásica   8000/6  cc_onco47  4644.0   \n",
       " T13                               malignidad   8000/3  cc_onco47  5151.0   \n",
       " T14                         neoproliferativo   8000/1  cc_onco47  6507.0   \n",
       " T15                          teratoma maduro   9080/0  cc_onco47  7030.0   \n",
       " T16                           lesiones óseas   8000/6  cc_onco47  7430.0   \n",
       " \n",
       "      startpos  \n",
       " T1     1503.0  \n",
       " T2     1576.0  \n",
       " T3     1634.0  \n",
       " T4     1703.0  \n",
       " T5     1782.0  \n",
       " T6     1816.0  \n",
       " T7     2389.0  \n",
       " T8     2588.0  \n",
       " T9     2635.0  \n",
       " T10    3592.0  \n",
       " T11    3712.0  \n",
       " T12    4633.0  \n",
       " T13    5141.0  \n",
       " T14    6491.0  \n",
       " T15    7015.0  \n",
       " T16    7416.0  ,\n",
       " 'cc_onco470':                      CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1   carcinoma basocelular  8090/3  cc_onco470   269.0     248.0\n",
       " T2     enfermedad pulmonar  8000/6  cc_onco470   588.0     569.0\n",
       " T3                  cáncer  8000/3  cc_onco470   707.0     701.0\n",
       " T4           masa pulmonar  8000/6  cc_onco470  1469.0    1456.0\n",
       " T5               tumorales  8000/1  cc_onco470  1616.0    1607.0\n",
       " T6          Carcinomatosis  8010/9  cc_onco470  2308.0    2294.0\n",
       " T7        células malignas  8001/3  cc_onco470  2521.0    2505.0\n",
       " T8      lesiones pleurales  8000/6  cc_onco470  2616.0    2598.0\n",
       " T9             mesotelioma  9050/3  cc_onco470  2790.0    2779.0\n",
       " T10      nódulos pleurales  8000/6  cc_onco470  4135.0    4118.0\n",
       " T11     afectación pleural  8000/6  cc_onco470  4890.0    4872.0,\n",
       " 'cc_onco471':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                adenocarcinoma  8140/3  cc_onco471   431.0     417.0\n",
       " T2                           ADC  8140/3  cc_onco471   436.0     433.0\n",
       " T3                    metástasis  8000/6  cc_onco471   880.0     870.0\n",
       " T4       enfermedad a nivel óseo  8000/6  cc_onco471  1211.0    1188.0\n",
       " T5                lesiones óseas  8000/6  cc_onco471  1421.0    1407.0\n",
       " T6                    neoplásica  8000/1  cc_onco471  3068.0    3058.0\n",
       " T7                        cáncer  8000/3  cc_onco471  3088.0    3082.0\n",
       " T8                   metastásico  8000/6  cc_onco471  3112.0    3101.0\n",
       " T9   infiltración de médula ósea  8000/6  cc_onco471  3679.0    3652.0\n",
       " T10                   tumoración  8000/1  cc_onco471  3750.0    3740.0\n",
       " T11                   neoplásico  8000/1  cc_onco471  4133.0    4123.0,\n",
       " 'cc_onco473':                      CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                melanoma  8720/3  cc_onco473   256.0     248.0\n",
       " T2              malignidad  8000/3  cc_onco473   489.0     479.0\n",
       " T3              metástasis  8000/6  cc_onco473   539.0     529.0\n",
       " T4     progresión hepática  8000/6  cc_onco473   670.0     651.0\n",
       " T5         lesión hepática  8000/6  cc_onco473  1055.0    1040.0\n",
       " T6  metástasis de melanoma  8720/6  cc_onco473  3415.0    3393.0,\n",
       " 'cc_onco474':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1   carcinoma ductal infiltrante  8500/3  cc_onco474   147.0     119.0\n",
       " T2                   recaída ósea  8000/6  cc_onco474   640.0     628.0\n",
       " T3            enfermedad hepática  8000/6  cc_onco474   963.0     944.0\n",
       " T4                progresión ósea  8000/6  cc_onco474  1208.0    1193.0\n",
       " T5            progresión hepática  8000/6  cc_onco474  1526.0    1507.0\n",
       " T6                     neoplásica  8000/1  cc_onco474  2797.0    2787.0\n",
       " T7             lesiones hepáticas  8000/6  cc_onco474  2860.0    2842.0\n",
       " T8                   metastásicas  8000/6  cc_onco474  2891.0    2879.0\n",
       " T9                      neoplasia  8000/1  cc_onco474  2981.0    2972.0\n",
       " T10       metástasis de carcinoma  8010/6  cc_onco474  3645.0    3622.0,\n",
       " 'cc_onco476':                     CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1              Carcinoma  8010/3  cc_onco476  2020.0    2011.0\n",
       " T2               melanoma  8720/3  cc_onco476  2284.0    2276.0\n",
       " T3             malignidad  8000/3  cc_onco476  2559.0    2549.0\n",
       " T4       melanoma maligno  8720/3  cc_onco476  2643.0    2627.0\n",
       " T5  infiltración meníngea  8000/6  cc_onco476  3051.0    3030.0\n",
       " T6         Carcinomatosis  8010/9  cc_onco476  3420.0    3406.0\n",
       " T7   enfermedad sistémica  8000/6  cc_onco476  4367.0    4347.0\n",
       " T8       células malignas  8001/3  cc_onco476  4729.0    4713.0,\n",
       " 'cc_onco478':                                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                             miomas  8895/0  cc_onco478   104.0      98.0\n",
       " T2                              tumor  8000/1  cc_onco478   306.0     301.0\n",
       " T3   carcinoma lobulillar infiltrante  8520/3  cc_onco478   425.0     393.0\n",
       " T4       carcinoma lobulillar in situ  8520/2  cc_onco478   507.0     479.0\n",
       " T5                         malignidad  8000/3  cc_onco478  1593.0    1583.0\n",
       " T6                   células malignas  8001/3  cc_onco478  1759.0    1743.0\n",
       " T7             enfermedad a distancia  8000/6  cc_onco478  2050.0    2028.0\n",
       " T8                            tumores  8000/1  cc_onco478  2318.0    2311.0\n",
       " T9      enfermedad de Paget del pezón  8540/3  cc_onco478  2676.0    2647.0\n",
       " T10                                HE  9133/1  cc_onco478  2786.0    2784.0\n",
       " T11          metástasis del carcinoma  8010/6  cc_onco478  2888.0    2864.0\n",
       " T12                           tumoral  8000/1  cc_onco478  3035.0    3028.0\n",
       " T13                                M0  8000/6  cc_onco478  3056.0    3054.0\n",
       " T14              enfermedad sistémica  8000/6  cc_onco478  6030.0    6010.0\n",
       " T15                 lesión cerebelosa  8000/6  cc_onco478  6389.0    6372.0\n",
       " T16                      metastásicas  8000/6  cc_onco478  6992.0    6980.0\n",
       " T17                    Carcinomatosis  8010/9  cc_onco478  7834.0    7820.0,\n",
       " 'cc_onco484':                        CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1              neoformación   8000/1  cc_onco484   532.0     520.0\n",
       " T2   glioblastoma multiforme   9440/3  cc_onco484   575.0     552.0\n",
       " T3                  blastoma   8000/3  cc_onco484   564.0     556.0\n",
       " T4                 neoplasia   8000/1  cc_onco484  1634.0    1625.0\n",
       " T5               astrocitoma   9400/3  cc_onco484  1765.0    1754.0\n",
       " T6           lesión cerebral   8000/6  cc_onco484  2340.0    2325.0\n",
       " T7               metastásica   8000/6  cc_onco484  2352.0    2341.0\n",
       " T8      glioma de alto grado  9380/34  cc_onco484  2402.0    2382.0\n",
       " T9                   sarcoma   8800/3  cc_onco484  2429.0    2422.0\n",
       " T10                    tumor   8000/1  cc_onco484  2662.0    2657.0\n",
       " T11                  maligno   8000/3  cc_onco484  2676.0    2669.0\n",
       " T12               metástasis   8000/6  cc_onco484  2711.0    2701.0\n",
       " T13                  tumoral   8000/1  cc_onco484  3624.0    3617.0\n",
       " T14                tumorales   8000/1  cc_onco484  5956.0    5947.0\n",
       " T15             diseminación   8000/6  cc_onco484  6471.0    6459.0,\n",
       " 'cc_onco487':                      CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1     enfermedad pulmonar  8000/6  cc_onco487   209.0     190.0\n",
       " T2          adenocarcinoma  8140/3  cc_onco487   655.0     641.0\n",
       " T3                  T4N2M0  8000/6  cc_onco487   682.0     676.0\n",
       " T4     progresión pulmonar  8000/6  cc_onco487  1287.0    1268.0\n",
       " T5         nódulo pulmonar  8000/6  cc_onco487  1314.0    1299.0\n",
       " T6         lesión pulmonar  8000/6  cc_onco487  1571.0    1556.0\n",
       " T7  enfermedad a distancia  8000/6  cc_onco487  2749.0    2727.0,\n",
       " 'cc_onco489':                                      CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1       adenocarcinoma de tipo intestinal   8144/3  cc_onco489   587.0   \n",
       " T2                               Carcinoma   8010/3  cc_onco489   568.0   \n",
       " T3                                      HE   9133/1  cc_onco489   591.0   \n",
       " T4  adenocarcinoma pobremente diferenciado  8140/33  cc_onco489  1891.0   \n",
       " T5                              metástasis   8000/6  cc_onco489  2627.0   \n",
       " T6                            diseminación   8000/6  cc_onco489  2880.0   \n",
       " T7                             metastásica   8000/6  cc_onco489  2892.0   \n",
       " T8                    lesiones cerebelosas   8000/6  cc_onco489  2953.0   \n",
       " T9                              malignidad   8000/3  cc_onco489  3084.0   \n",
       " \n",
       "     startpos  \n",
       " T1     554.0  \n",
       " T2     559.0  \n",
       " T3     589.0  \n",
       " T4    1853.0  \n",
       " T5    2617.0  \n",
       " T6    2868.0  \n",
       " T7    2881.0  \n",
       " T8    2933.0  \n",
       " T9    3074.0  ,\n",
       " 'cc_onco494':                                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                          neoplasia  8000/1  cc_onco494   627.0     618.0\n",
       " T2  carcinoma renal de células claras  8310/3  cc_onco494   902.0     869.0\n",
       " T3                                cM0  8000/6  cc_onco494  1057.0    1054.0\n",
       " T4                 nódulos pulmonares  8000/6  cc_onco494  1300.0    1282.0\n",
       " T5                         metástasis  8000/6  cc_onco494  1371.0    1361.0\n",
       " T6                progresión pulmonar  8000/6  cc_onco494  1834.0    1815.0,\n",
       " 'cc_onco495':                                          CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1  carcinoma escamoso pobremente diferenciado  8070/33  cc_onco495  1071.0   \n",
       " T2                                 metastásica   8000/6  cc_onco495  1141.0   \n",
       " T3                                      T4N3M1   8000/6  cc_onco495  1224.0   \n",
       " T4                                     tumoral   8000/1  cc_onco495  1532.0   \n",
       " T5                 enfermedad a nivel pulmonar   8000/6  cc_onco495  2116.0   \n",
       " T6                                     tumores   8000/1  cc_onco495  2209.0   \n",
       " T7                    Carcinoma indiferenciado   8020/3  cc_onco495  2304.0   \n",
       " T8                                   tumorales   8000/1  cc_onco495  3299.0   \n",
       " \n",
       "     startpos  \n",
       " T1    1029.0  \n",
       " T2    1130.0  \n",
       " T3    1218.0  \n",
       " T4    1525.0  \n",
       " T5    2089.0  \n",
       " T6    2202.0  \n",
       " T7    2280.0  \n",
       " T8    3290.0  ,\n",
       " 'cc_onco497':                   CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1              tumoral  8000/1  cc_onco497  1500.0    1493.0\n",
       " T2              tumores  8000/1  cc_onco497  1938.0    1931.0\n",
       " T3  progresión pulmonar  8000/6  cc_onco497  2943.0    2924.0,\n",
       " 'cc_onco498':                         CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                         MO  8000/6  cc_onco498  1163.0    1161.0\n",
       " T2        lesiones cerebrales  8000/6  cc_onco498  2407.0    2388.0\n",
       " T3                 metástasis  8000/6  cc_onco498  2535.0    2525.0\n",
       " T4         nevus melanocítico  8720/0  cc_onco498  3430.0    3412.0\n",
       " T5        celularidad tumoral  8001/1  cc_onco498  4171.0    4152.0\n",
       " T6   metástasis por carcinoma  8010/6  cc_onco498  4694.0    4670.0\n",
       " T7             neuroendocrino  8240/3  cc_onco498  4720.0    4706.0\n",
       " T8                    tumores  8000/1  cc_onco498  4975.0    4968.0\n",
       " T9            tumoral maligna  8000/3  cc_onco498  5167.0    5152.0\n",
       " T10              LOE cerebral  8000/6  cc_onco498  5371.0    5359.0\n",
       " T11       lesiones pulmonares  8000/6  cc_onco498  5511.0    5492.0\n",
       " T12    enfermedad a distancia  8000/6  cc_onco498  7085.0    7063.0,\n",
       " 'cc_onco503':                           CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                       cáncer  8000/3  cc_onco503   275.0     269.0\n",
       " T2              hepatocarcinoma  8170/3  cc_onco503   435.0     420.0\n",
       " T3  Lesiones en lóbulo hepático  8000/6  cc_onco503   550.0     523.0\n",
       " T4                    tumorales  8000/1  cc_onco503  1828.0    1819.0,\n",
       " 'cc_onco505':                                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1       carcinoma de células renales  8312/3  cc_onco505    73.0      45.0\n",
       " T2                            tumores  8000/1  cc_onco505   158.0     151.0\n",
       " T3  carcinoma renal de células claras  8310/3  cc_onco505   404.0     371.0\n",
       " T4        progresión a nivel pulmonar  8000/6  cc_onco505   647.0     620.0\n",
       " T5     nódulos pulmonares bilaterales  8000/6  cc_onco505   692.0     662.0\n",
       " T6                    lesión pulmonar  8000/6  cc_onco505  1329.0    1314.0\n",
       " T7                lesiones pulmonares  8000/6  cc_onco505  1572.0    1553.0,\n",
       " 'cc_onco508':                    CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1            metástasis  8000/6  cc_onco508   884.0     874.0\n",
       " T2      oligometastásica  8000/6  cc_onco508  1366.0    1350.0\n",
       " T3        adenocarcinoma  8140/3  cc_onco508  1608.0    1594.0\n",
       " T4   lesiones cerebrales  8000/6  cc_onco508  2619.0    2600.0\n",
       " T5     progresión en SNC  8000/6  cc_onco508  2912.0    2895.0\n",
       " T6  enfermedad sistémica  8000/6  cc_onco508  3491.0    3471.0,\n",
       " 'cc_onco51':                                    CLAVE  ICD-O-3  documento  endpos  startpos\n",
       " T1                          plasmocitoma   9731/3  cc_onco51   771.0     759.0\n",
       " T2                               tumoral   8000/1  cc_onco51  1237.0    1230.0\n",
       " T3  adenocarcinoma de próstata Gleason 9  8140/33  cc_onco51  1975.0    1939.0\n",
       " T4                             Carcinoma   8010/3  cc_onco51  1953.0    1944.0\n",
       " T5                               pT2N0M0   8000/6  cc_onco51  1989.0    1982.0\n",
       " T6              melanoma maligno nodular   8721/3  cc_onco51  2220.0    2196.0\n",
       " T7                               maligno   8000/3  cc_onco51  2212.0    2205.0\n",
       " T8                            metástasis   8000/6  cc_onco51  2356.0    2346.0,\n",
       " 'cc_onco511':                 CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1          tumorales    8000/1  cc_onco511   530.0     521.0\n",
       " T2          neoplasia    8000/1  cc_onco511   636.0     627.0\n",
       " T3        tumor mixto  8000/1/H  cc_onco511   766.0     755.0\n",
       " T4    teratoma maduro    9080/0  cc_onco511   862.0     847.0\n",
       " T5        metastásica    8000/6  cc_onco511  1147.0    1136.0\n",
       " T6     masa abdominal    8000/6  cc_onco511  1776.0    1762.0\n",
       " T7         metástasis    8000/6  cc_onco511  4404.0    4394.0\n",
       " T8  Masa mediastínica    8000/6  cc_onco511  5283.0    5266.0,\n",
       " 'cc_onco512':                               CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                   adenocarcinoma  8140/3  cc_onco512   320.0     306.0\n",
       " T2                         melanoma  8720/3  cc_onco512   606.0     598.0\n",
       " T3                         pT2aN0M0  8000/6  cc_onco512   747.0     739.0\n",
       " T4                       tumoración  8000/1  cc_onco512   877.0     867.0\n",
       " T5             Melanoma metastásico  8720/6  cc_onco512   941.0     921.0\n",
       " T6           enfermedad a distancia  8000/6  cc_onco512   980.0     958.0\n",
       " T7                 melanoma maligno  8720/3  cc_onco512  1182.0    1166.0\n",
       " T8             implantes musculares  8000/6  cc_onco512  2968.0    2948.0\n",
       " T9   nódulos pulmonares bilaterales  8000/6  cc_onco512  3079.0    3049.0\n",
       " T10                      malignidad  8000/3  cc_onco512  3626.0    3616.0\n",
       " T11                      metástasis  8000/6  cc_onco512  3710.0    3700.0\n",
       " T12                         tumoral  8000/1  cc_onco512  6634.0    6627.0,\n",
       " 'cc_onco514':                           CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1              nódulo pulmonar  8000/6  cc_onco514   124.0     109.0\n",
       " T2        carcinoma epidermoide  8070/3  cc_onco514   293.0     272.0\n",
       " T3                    neoplasia  8000/1  cc_onco514   439.0     430.0\n",
       " T4        Carcinoma microcítico  8041/3  cc_onco514   735.0     714.0\n",
       " T5                   malignidad  8000/3  cc_onco514  1563.0    1553.0\n",
       " T6                   neoplásico  8000/1  cc_onco514  2087.0    2077.0\n",
       " T7  enfermedad a nivel pulmonar  8000/6  cc_onco514  3825.0    3798.0\n",
       " T8          enfermedad pulmonar  8000/6  cc_onco514  4123.0    4104.0\n",
       " T9                   neoplásica  8000/1  cc_onco514  4310.0    4300.0,\n",
       " 'cc_onco515':                                       CLAVE ICD-O-3   documento  endpos  \\\n",
       " T1                                neoplasia  8000/1  cc_onco515   937.0   \n",
       " T2                               metástasis  8000/6  cc_onco515  1164.0   \n",
       " T3                           adenocarcinoma  8140/3  cc_onco515  1323.0   \n",
       " T4                                 cT2cN1M0  8000/6  cc_onco515  1342.0   \n",
       " T5                         Recaída pulmonar  8000/6  cc_onco515  1692.0   \n",
       " T6                          lesión cerebral  8000/6  cc_onco515  2173.0   \n",
       " T7            lesión única a nivel cerebral  8000/6  cc_onco515  2231.0   \n",
       " T8                          lesión parietal  8000/6  cc_onco515  2488.0   \n",
       " T9               progresión a nivel pleural  8000/6  cc_onco515  2714.0   \n",
       " T10             enfermedad a nivel cerebral  8000/6  cc_onco515  2998.0   \n",
       " T11  lesiones milimétricas supratentoriales  8000/6  cc_onco515  3249.0   \n",
       " T12                     lesiones cerebrales  8000/6  cc_onco515  3583.0   \n",
       " \n",
       "      startpos  \n",
       " T1      928.0  \n",
       " T2     1154.0  \n",
       " T3     1309.0  \n",
       " T4     1334.0  \n",
       " T5     1676.0  \n",
       " T6     2158.0  \n",
       " T7     2202.0  \n",
       " T8     2473.0  \n",
       " T9     2688.0  \n",
       " T10    2971.0  \n",
       " T11    3211.0  \n",
       " T12    3564.0  ,\n",
       " 'cc_onco518':                                                CLAVE ICD-O-3   documento  \\\n",
       " T1                                         Carcinoma  8010/3  cc_onco518   \n",
       " T2                      carcinoma ductal infiltrante  8500/3  cc_onco518   \n",
       " T3                                               cM0  8000/6  cc_onco518   \n",
       " T4                  carcinoma lobulillar infiltrante  8520/3  cc_onco518   \n",
       " T5                                        malignidad  8000/3  cc_onco518   \n",
       " T6                                                HE  9133/1  cc_onco518   \n",
       " T7                                       metastásica  8000/6  cc_onco518   \n",
       " T8                                   enfermedad ósea  8000/6  cc_onco518   \n",
       " T9                                    lesiones óseas  8000/6  cc_onco518   \n",
       " T10                                       metástasis  8000/6  cc_onco518   \n",
       " T11                                  afectación ósea  8000/6  cc_onco518   \n",
       " T12                       Cáncer de mama metastásico  8000/6  cc_onco518   \n",
       " T13  enfermedad a nivel del sistema nervioso central  8000/6  cc_onco518   \n",
       " T14                                      neoplásicos  8000/1  cc_onco518   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    886.0     877.0  \n",
       " T2   1020.0     992.0  \n",
       " T3   1048.0    1045.0  \n",
       " T4   1120.0    1088.0  \n",
       " T5   1895.0    1885.0  \n",
       " T6   2020.0    2018.0  \n",
       " T7   2917.0    2906.0  \n",
       " T8   2964.0    2949.0  \n",
       " T9   4925.0    4911.0  \n",
       " T10  5065.0    5055.0  \n",
       " T11  6993.0    6978.0  \n",
       " T12  7671.0    7645.0  \n",
       " T13  7836.0    7789.0  \n",
       " T14  7995.0    7984.0  ,\n",
       " 'cc_onco52':                       CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1               tumoración  8000/1  cc_onco52   238.0     228.0\n",
       " T2         seminoma clásico  9061/3  cc_onco52   684.0     668.0\n",
       " T3  metástasis del seminoma  9061/6  cc_onco52  2836.0    2813.0\n",
       " T4    carcinoma epidermoide  8070/3  cc_onco52  2932.0    2911.0,\n",
       " 'cc_onco520':                     CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1    implantes pleurales  8000/6  cc_onco520   881.0     862.0\n",
       " T2             malignidad  8000/3  cc_onco520  1471.0    1461.0\n",
       " T3      neoplasia maligna  8000/3  cc_onco520  1533.0    1516.0\n",
       " T4  carcinoma metastásico  8010/6  cc_onco520  1569.0    1548.0\n",
       " T5         adenocarcinoma  8140/3  cc_onco520  1647.0    1633.0\n",
       " T6             neoplásica  8000/1  cc_onco520  1913.0    1903.0\n",
       " T7        tumoral maligna  8000/3  cc_onco520  2367.0    2352.0,\n",
       " 'cc_onco524':                          CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                   Carcinoma  8010/3  cc_onco524   123.0     114.0\n",
       " T2           carcinoma papilar  8260/3  cc_onco524   410.0     393.0\n",
       " T3  afectación retroperitoneal  8000/6  cc_onco524   503.0     477.0\n",
       " T4              Carcinomatosis  8010/9  cc_onco524   522.0     508.0\n",
       " T5        lesiones a distancia  8000/6  cc_onco524  1228.0    1208.0\n",
       " T6                  neoplásico  8000/1  cc_onco524  1376.0    1366.0\n",
       " T7                 metastásica  8000/6  cc_onco524  2265.0    2254.0\n",
       " T8                    implante  8000/6  cc_onco524  2382.0    2374.0\n",
       " T9      adenocarcinoma papilar  8260/3  cc_onco524  2438.0    2416.0,\n",
       " 'cc_onco526':                    CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  enfermedad sistémica  8000/6  cc_onco526  1197.0    1177.0\n",
       " T2     sarcoma de Kaposi  9140/3  cc_onco526  1322.0    1305.0\n",
       " T3     lesiones cutáneas  8000/6  cc_onco526  1628.0    1611.0,\n",
       " 'cc_onco527':                       CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                  tumores  8000/1  cc_onco527    90.0      83.0\n",
       " T2               tumoración  8000/1  cc_onco527   512.0     502.0\n",
       " T3               malignidad  8000/3  cc_onco527   761.0     751.0\n",
       " T4             osteosarcoma  9180/3  cc_onco527  1959.0    1947.0\n",
       " T5              metastásica  8000/6  cc_onco527  2230.0    2219.0\n",
       " T6               metástasis  8000/6  cc_onco527  2487.0    2477.0\n",
       " T7   masa de partes blandas  8000/6  cc_onco527  3187.0    3165.0\n",
       " T8              peritumoral  8000/1  cc_onco527  3914.0    3903.0\n",
       " T9       nódulos pulmonares  8000/6  cc_onco527  4702.0    4684.0\n",
       " T10     enfermedad pulmonar  8000/6  cc_onco527  5827.0    5808.0,\n",
       " 'cc_onco53':                                  CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1   melanoma de extensión superficial  8743/3  cc_onco53   321.0     288.0\n",
       " T2                          metástasis  8000/6  cc_onco53  2320.0    2310.0\n",
       " T3                        metastásicas  8000/6  cc_onco53  3007.0    2995.0\n",
       " T4                 Nódulos subcutáneos  8000/6  cc_onco53  3401.0    3382.0\n",
       " T5                         metastásico  8000/6  cc_onco53  4554.0    4543.0\n",
       " T6                           tumorales  8000/1  cc_onco53  4746.0    4737.0\n",
       " T7                 implantes pleurales  8000/6  cc_onco53  5301.0    5282.0\n",
       " T8        afectación de partes blandas  8000/6  cc_onco53  5683.0    5655.0\n",
       " T9                     lóbulo hepático  8000/6  cc_onco53  6317.0    6302.0\n",
       " T10                         neoplásica  8000/1  cc_onco53  6859.0    6849.0\n",
       " T11           implante retroperitoneal  8000/6  cc_onco53  6938.0    6914.0\n",
       " T12           lesión de partes blandas  8000/6  cc_onco53  7096.0    7072.0\n",
       " T13                         tumoración  8000/1  cc_onco53  7361.0    7351.0,\n",
       " 'cc_onco530':                           CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1   adenopatía supraclavicular  8000/6  cc_onco530   831.0     805.0\n",
       " T2                   tumoración  8000/1  cc_onco530  1747.0    1737.0\n",
       " T3                 neoformación  8000/1  cc_onco530  2292.0    2280.0\n",
       " T4                      maligna  8000/3  cc_onco530  2576.0    2569.0\n",
       " T5        tumor no seminomatoso  9065/3  cc_onco530  2842.0    2821.0\n",
       " T6                     seminoma  9061/3  cc_onco530  2838.0    2830.0\n",
       " T7        carcinoma embrionario  9070/3  cc_onco530  2893.0    2872.0\n",
       " T8                    neoplasia  8000/1  cc_onco530  2996.0    2987.0\n",
       " T9                      tumoral  8000/1  cc_onco530  3197.0    3190.0\n",
       " T10                          Mx  8000/6  cc_onco530  3252.0    3250.0\n",
       " T11                          M1  8000/6  cc_onco530  4688.0    4686.0\n",
       " T12             teratoma maduro  9080/0  cc_onco530  5529.0    5514.0,\n",
       " 'cc_onco532':                                    CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                masa de partes blandas  8000/6  cc_onco532  1400.0    1378.0\n",
       " T2                            malignidad  8000/3  cc_onco532  1772.0    1762.0\n",
       " T3                        lesiones óseas  8000/6  cc_onco532  1827.0    1813.0\n",
       " T4                         masa pulmonar  8000/6  cc_onco532  2008.0    1995.0\n",
       " T5              carcinoma no microcítico  8046/3  cc_onco532  2229.0    2205.0\n",
       " T6                        adenocarcinoma  8140/3  cc_onco532  2259.0    2245.0\n",
       " T7                           metastásica  8000/6  cc_onco532  2747.0    2736.0\n",
       " T8                                   cM1  8000/6  cc_onco532  2992.0    2989.0\n",
       " T9                            metástasis  8000/6  cc_onco532  3005.0    2995.0\n",
       " T10  micronódulos pulmonares bilaterales  8000/6  cc_onco532  4562.0    4527.0,\n",
       " 'cc_onco534':                                          CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1                              adenocarcinoma   8140/3  cc_onco534   646.0   \n",
       " T2                         afectación hepática   8000/6  cc_onco534   700.0   \n",
       " T3                                       tumor   8000/1  cc_onco534   759.0   \n",
       " T4   adenocarcinoma moderadamente diferenciado  8140/32  cc_onco534   974.0   \n",
       " T5                                  malignidad   8000/3  cc_onco534  1173.0   \n",
       " T6                                  metástasis   8000/6  cc_onco534  1347.0   \n",
       " T7                             lóbulo hepático   8000/6  cc_onco534  1379.0   \n",
       " T8                              Carcinomatosis   8010/9  cc_onco534  2418.0   \n",
       " T9                                   formación   8000/1  cc_onco534  2930.0   \n",
       " T10                      afectación peritoneal   8000/6  cc_onco534  6861.0   \n",
       " T11                              masa hepática   8000/6  cc_onco534  6969.0   \n",
       " T12                            hepatocarcinoma   8170/3  cc_onco534  7048.0   \n",
       " T13                                  tumorales   8000/1  cc_onco534  7130.0   \n",
       " T14                                     cáncer   8000/3  cc_onco534  7142.0   \n",
       " \n",
       "      startpos  \n",
       " T1      632.0  \n",
       " T2      681.0  \n",
       " T3      754.0  \n",
       " T4      933.0  \n",
       " T5     1163.0  \n",
       " T6     1337.0  \n",
       " T7     1364.0  \n",
       " T8     2404.0  \n",
       " T9     2921.0  \n",
       " T10    6840.0  \n",
       " T11    6956.0  \n",
       " T12    7033.0  \n",
       " T13    7121.0  \n",
       " T14    7136.0  ,\n",
       " 'cc_onco536':                     CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1           diseminación  8000/6  cc_onco536   647.0     635.0\n",
       " T2                  tumor  8000/1  cc_onco536   961.0     956.0\n",
       " T3                tumoral  8000/1  cc_onco536  2193.0    2186.0\n",
       " T4  diseminación meníngea  8000/6  cc_onco536  2533.0    2512.0\n",
       " T5   diseminación tumoral  8000/6  cc_onco536  3616.0    3596.0,\n",
       " 'cc_onco538':                                CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                        malignidad  8000/3  cc_onco538  2806.0    2796.0\n",
       " T2  carcinoma de células no pequeñas  8046/3  cc_onco538  3184.0    3152.0\n",
       " T3                    adenocarcinoma  8140/3  cc_onco538  3204.0    3190.0\n",
       " T4               células neoplásicas  8001/1  cc_onco538  3229.0    3210.0\n",
       " T5               afectación hepática  8000/6  cc_onco538  3503.0    3484.0\n",
       " T6                         tumorales  8000/1  cc_onco538  4144.0    4135.0\n",
       " T7               afectación pulmonar  8000/6  cc_onco538  4676.0    4657.0\n",
       " T8                       metastásica  8000/6  cc_onco538  4688.0    4677.0\n",
       " T9                lesiones hepáticas  8000/6  cc_onco538  4828.0    4810.0,\n",
       " 'cc_onco539':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                         cáncer  8000/3  cc_onco539   127.0     121.0\n",
       " T2                      neoplasia  8000/1  cc_onco539   147.0     138.0\n",
       " T3                    metastásica  8000/6  cc_onco539   159.0     148.0\n",
       " T4             cáncer metastásico  8000/6  cc_onco539   238.0     220.0\n",
       " T5                 adenocarcinoma  8140/3  cc_onco539   277.0     263.0\n",
       " T6                     malignidad  8000/3  cc_onco539  1032.0    1022.0\n",
       " T7   carcinoma ductal infiltrante  8500/3  cc_onco539  1149.0    1121.0\n",
       " T8            células neoplásicas  8001/1  cc_onco539  1350.0    1331.0\n",
       " T9                             HE  9133/1  cc_onco539  1380.0    1378.0\n",
       " T10                    Hemangioma  9120/0  cc_onco539  1923.0    1913.0\n",
       " T11                    metástasis  8000/6  cc_onco539  1957.0    1947.0\n",
       " T12                  metastásicas  8000/6  cc_onco539  2271.0    2259.0\n",
       " T13               Macrometástasis  8000/6  cc_onco539  2900.0    2885.0\n",
       " T14       enfermedad a nivel óseo  8000/6  cc_onco539  3266.0    3243.0\n",
       " T15     progresión a nivel de SNC  8000/6  cc_onco539  3822.0    3797.0,\n",
       " 'cc_onco540':                                                 CLAVE ICD-O-3   documento  \\\n",
       " T1                                     adenocarcinoma  8140/3  cc_onco540   \n",
       " T2                       carcinoma ductal infiltrante  8500/3  cc_onco540   \n",
       " T3                                                 HE  9133/1  cc_onco540   \n",
       " T4                                         metástasis  8000/6  cc_onco540   \n",
       " T5                                          tumorales  8000/1  cc_onco540   \n",
       " T6                                                 Ca  8000/3  cc_onco540   \n",
       " T7                           lesiones parenquimatosas  8000/6  cc_onco540   \n",
       " T8  adenocarcinoma de colon estadio IV por metástasis  8140/6  cc_onco540   \n",
       " T9                                        metastásica  8000/6  cc_onco540   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   222.0     208.0  \n",
       " T2   435.0     407.0  \n",
       " T3   590.0     588.0  \n",
       " T4   629.0     619.0  \n",
       " T5  1893.0    1884.0  \n",
       " T6  1907.0    1905.0  \n",
       " T7  3270.0    3246.0  \n",
       " T8  3609.0    3560.0  \n",
       " T9  3869.0    3858.0  ,\n",
       " 'cc_onco542':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                        linfoma  9590/3  cc_onco542   220.0     213.0\n",
       " T2    infiltración de médula ósea  8000/6  cc_onco542  1527.0    1500.0\n",
       " T3                Nódulo tiroideo  8000/6  cc_onco542  1598.0    1583.0\n",
       " T4  Adenopatías supraclaviculares  8000/6  cc_onco542  1857.0    1828.0\n",
       " T5     proceso linfoproliferativo  9970/1  cc_onco542  3154.0    3128.0\n",
       " T6              células tumorales  8001/1  cc_onco542  3663.0    3646.0,\n",
       " 'cc_onco543':                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1     adenocarcinoma  8140/3  cc_onco543   373.0     359.0\n",
       " T2                 M1  8000/6  cc_onco543   420.0     418.0\n",
       " T3         metástasis  8000/6  cc_onco543   433.0     423.0\n",
       " T4  células tumorales  8001/1  cc_onco543   592.0     575.0,\n",
       " 'cc_onco546':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                      neoplasia  8000/1  cc_onco546   403.0     394.0\n",
       " T2                    metastásica  8000/6  cc_onco546   423.0     412.0\n",
       " T3                     malignidad  8000/3  cc_onco546   996.0     986.0\n",
       " T4         enfermedad a distancia  8000/6  cc_onco546  1078.0    1056.0\n",
       " T5   carcinoma ductal infiltrante  8500/3  cc_onco546  1215.0    1187.0\n",
       " T6                            CDI  8500/3  cc_onco546  1220.0    1217.0\n",
       " T7                             HE  9133/1  cc_onco546  1327.0    1325.0\n",
       " T8                        cT1N0M0  8000/6  cc_onco546  1754.0    1747.0\n",
       " T9                         cáncer  8000/3  cc_onco546  2151.0    2145.0\n",
       " T10                Carcinomatosis  8010/9  cc_onco546  3091.0    3077.0\n",
       " T11                    neoplásica  8000/1  cc_onco546  3627.0    3617.0,\n",
       " 'cc_onco548':                          CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                   neoplasia  8000/1  cc_onco548   192.0     183.0\n",
       " T2              adenocarcinoma  8140/3  cc_onco548   359.0     345.0\n",
       " T3        enfermedad sistémica  8000/6  cc_onco548  2144.0    2124.0\n",
       " T4  adenopatía supraclavicular  8000/6  cc_onco548  2332.0    2306.0\n",
       " T5             lesión pulmonar  8000/6  cc_onco548  3106.0    3091.0\n",
       " T6                  metástasis  8000/6  cc_onco548  3932.0    3922.0\n",
       " T7                     tumoral  8000/1  cc_onco548  4353.0    4346.0\n",
       " T8          afectación del SNC  8000/6  cc_onco548  4824.0    4806.0,\n",
       " 'cc_onco549':                                                CLAVE ICD-O-3   documento  \\\n",
       " T1                                  hemangioblastoma  9161/1  cc_onco549   \n",
       " T2                                            cáncer  8000/3  cc_onco549   \n",
       " T3                                           tumoral  8000/1  cc_onco549   \n",
       " T4                                        Hemangioma  9120/0  cc_onco549   \n",
       " T5                           micronódulos pulmonares  8000/6  cc_onco549   \n",
       " T6                                        neoplásico  8000/1  cc_onco549   \n",
       " T7   metástasis de carcinoma renal de células claras  8310/6  cc_onco549   \n",
       " T8     carcinoma renal de células claras metastásico  8310/6  cc_onco549   \n",
       " T9                               lesiones pulmonares  8000/6  cc_onco549   \n",
       " T10                                     lesión renal  8000/6  cc_onco549   \n",
       " T11                                         rabdoide  8963/3  cc_onco549   \n",
       " T12                                     sarcomatoide  8033/3  cc_onco549   \n",
       " T13                           enfermedad a distancia  8000/6  cc_onco549   \n",
       " T14                                       tumoración  8000/1  cc_onco549   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    297.0     281.0  \n",
       " T2    512.0     506.0  \n",
       " T3   2295.0    2288.0  \n",
       " T4   2361.0    2351.0  \n",
       " T5   2568.0    2545.0  \n",
       " T6   2676.0    2666.0  \n",
       " T7   2865.0    2818.0  \n",
       " T8   2925.0    2880.0  \n",
       " T9   3004.0    2985.0  \n",
       " T10  3298.0    3286.0  \n",
       " T11  3418.0    3410.0  \n",
       " T12  3433.0    3421.0  \n",
       " T13  3478.0    3456.0  \n",
       " T14  3829.0    3819.0  ,\n",
       " 'cc_onco554':                           CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1             nódulos cutáneos   8000/6  cc_onco554   137.0     121.0\n",
       " T2  carcinoma poco diferenciado  8010/33  cc_onco554   493.0     466.0\n",
       " T3               lesiones óseas   8000/6  cc_onco554  1610.0    1596.0\n",
       " T4                 metastásicas   8000/6  cc_onco554  1623.0    1611.0,\n",
       " 'cc_onco561':                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  lesiones cutáneas  8000/6  cc_onco561   551.0     534.0\n",
       " T2     lesiones óseas  8000/6  cc_onco561  1292.0    1278.0\n",
       " T3         neoplásica  8000/1  cc_onco561  1504.0    1494.0\n",
       " T4           malignas  8000/3  cc_onco561  1858.0    1850.0\n",
       " T5         neoplásico  8000/1  cc_onco561  2365.0    2355.0,\n",
       " 'cc_onco564':                                      CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1                              tumoración   8000/1  cc_onco564   208.0   \n",
       " T2                               tumorales   8000/1  cc_onco564   971.0   \n",
       " T3  adenocarcinoma pobremente diferenciado  8140/33  cc_onco564  1106.0   \n",
       " T4                                papiloma   8050/0  cc_onco564  1148.0   \n",
       " T5                              metástasis   8000/6  cc_onco564  1499.0   \n",
       " T6                                 tumores   8000/1  cc_onco564  1926.0   \n",
       " T7                             metastásica   8000/6  cc_onco564  2747.0   \n",
       " T8                     enfermedad hepática   8000/6  cc_onco564  5634.0   \n",
       " T9                      lesiones hepáticas   8000/6  cc_onco564  5958.0   \n",
       " \n",
       "     startpos  \n",
       " T1     198.0  \n",
       " T2     962.0  \n",
       " T3    1068.0  \n",
       " T4    1140.0  \n",
       " T5    1489.0  \n",
       " T6    1919.0  \n",
       " T7    2736.0  \n",
       " T8    5615.0  \n",
       " T9    5940.0  ,\n",
       " 'cc_onco568':                          CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1           lesiones cutáneas  8000/6  cc_onco568   660.0     643.0\n",
       " T2  células tumorales malignas  8001/3  cc_onco568  2248.0    2222.0\n",
       " T3                   tumorales  8000/1  cc_onco568  2239.0    2230.0\n",
       " T4                     linfoma  9590/3  cc_onco568  2323.0    2316.0\n",
       " T5           sarcoma de Kaposi  9140/3  cc_onco568  2540.0    2523.0,\n",
       " 'cc_onco569':                                                  CLAVE ICD-O-3   documento  \\\n",
       " T1                                         metastásica  8000/6  cc_onco569   \n",
       " T2                                           neoplasia  8000/1  cc_onco569   \n",
       " T3                                  masas peritoneales  8000/6  cc_onco569   \n",
       " T4                                          metástasis  8000/6  cc_onco569   \n",
       " T5   tumor desmoplásico de células pequeñas y redondas  8806/3  cc_onco569   \n",
       " T6                                          neoplásica  8000/1  cc_onco569   \n",
       " T7                                     afectación ósea  8000/6  cc_onco569   \n",
       " T8                                            sarcomas  8800/3  cc_onco569   \n",
       " T9                                             tumores  8000/1  cc_onco569   \n",
       " T10                                enfermedad hepática  8000/6  cc_onco569   \n",
       " T11                                            tumoral  8000/1  cc_onco569   \n",
       " T12                                       diseminación  8000/6  cc_onco569   \n",
       " T13                             implantes peritoneales  8000/6  cc_onco569   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1   1319.0    1308.0  \n",
       " T2   1406.0    1397.0  \n",
       " T3   1498.0    1480.0  \n",
       " T4   1586.0    1576.0  \n",
       " T5   1745.0    1696.0  \n",
       " T6   1815.0    1805.0  \n",
       " T7   2790.0    2775.0  \n",
       " T8   4091.0    4083.0  \n",
       " T9   4460.0    4453.0  \n",
       " T10  4541.0    4522.0  \n",
       " T11  4583.0    4576.0  \n",
       " T12  4803.0    4791.0  \n",
       " T13  5054.0    5032.0  ,\n",
       " 'cc_onco574':                                            CLAVE ICD-O-3   documento  endpos  \\\n",
       " T1                                     neoplasia  8000/1  cc_onco574    74.0   \n",
       " T2  neoplasia intratubular de células germinales  9064/2  cc_onco574   192.0   \n",
       " T3                              suelta de globos  8000/6  cc_onco574   299.0   \n",
       " T4                                     tumorales  8000/1  cc_onco574   382.0   \n",
       " T5                                      seminoma  9061/3  cc_onco574   509.0   \n",
       " T6                                    metástasis  8000/6  cc_onco574  1352.0   \n",
       " T7                            nódulos pulmonares  8000/6  cc_onco574  3675.0   \n",
       " T8                          masa retroperitoneal  8000/6  cc_onco574  3698.0   \n",
       " T9                 masa residual retroperitoneal  8000/6  cc_onco574  3796.0   \n",
       " \n",
       "     startpos  \n",
       " T1      65.0  \n",
       " T2     148.0  \n",
       " T3     283.0  \n",
       " T4     373.0  \n",
       " T5     501.0  \n",
       " T6    1342.0  \n",
       " T7    3657.0  \n",
       " T8    3678.0  \n",
       " T9    3767.0  ,\n",
       " 'cc_onco575':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                       malignas  8000/3  cc_onco575   776.0     768.0\n",
       " T2                     malignidad  8000/3  cc_onco575   843.0     833.0\n",
       " T3                    metastásico  8000/6  cc_onco575   902.0     891.0\n",
       " T4                 nódulo mamario  8000/6  cc_onco575  1009.0     995.0\n",
       " T5   carcinoma ductal infiltrante  8500/3  cc_onco575  1039.0    1011.0\n",
       " T6                            CDI  8500/3  cc_onco575  1044.0    1041.0\n",
       " T7            enfermedad de Paget  9184/3  cc_onco575  1223.0    1204.0\n",
       " T8              citología maligna  8001/3  cc_onco575  1257.0    1240.0\n",
       " T9                     metástasis  8000/6  cc_onco575  1411.0    1401.0\n",
       " T10                        T2N2M0  8000/6  cc_onco575  1535.0    1529.0\n",
       " T11                  diseminación  8000/6  cc_onco575  2059.0    2047.0\n",
       " T12                     neoplasia  8000/1  cc_onco575  2182.0    2173.0\n",
       " T13                            CM  8000/3  cc_onco575  2378.0    2376.0\n",
       " T14                lesiones óseas  8000/6  cc_onco575  3112.0    3098.0\n",
       " T15                  metastásicas  8000/6  cc_onco575  3125.0    3113.0\n",
       " T16                 carcinomatosa  8010/9  cc_onco575  3456.0    3443.0\n",
       " T17                            HE  9133/1  cc_onco575  3630.0    3628.0\n",
       " T18            lesión osteolítica  8000/6  cc_onco575  4325.0    4307.0\n",
       " T19                 lesión lítica  8000/6  cc_onco575  4584.0    4571.0\n",
       " T20           afectación hepática  8000/6  cc_onco575  5294.0    5275.0,\n",
       " 'cc_onco576':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                adenocarcinoma  8140/3  cc_onco576   288.0     274.0\n",
       " T2                    metástasis  8000/6  cc_onco576  2408.0    2398.0\n",
       " T3                       maligna  8000/3  cc_onco576  2519.0    2512.0\n",
       " T4  metástasis de adenocarcinoma  8140/6  cc_onco576  2998.0    2970.0,\n",
       " 'cc_onco579':                              CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1                      tumoración    8000/1  cc_onco579   881.0     871.0\n",
       " T2  carcinoma escamoso infiltrante  8070/3/H  cc_onco579  1044.0    1014.0\n",
       " T3                         T2bN1M0    8000/6  cc_onco579  1574.0    1567.0\n",
       " T4                      metástasis    8000/6  cc_onco579  3455.0    3445.0\n",
       " T5                     metastásica    8000/6  cc_onco579  3622.0    3611.0\n",
       " T6                          cáncer    8000/3  cc_onco579  3635.0    3629.0,\n",
       " 'cc_onco581':              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  cc_onco581   235.0     221.0,\n",
       " 'cc_onco584':                               CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                            nevus  8720/0  cc_onco584   336.0     331.0\n",
       " T2                         Fibromas  8810/0  cc_onco584   605.0     597.0\n",
       " T3                           cáncer  8000/3  cc_onco584   770.0     764.0\n",
       " T4                         papiloma  8050/0  cc_onco584  1164.0    1156.0\n",
       " T5   enfermedad de Lhermitte-Duclos  9493/0  cc_onco584  1765.0    1735.0\n",
       " T6                 cáncer folicular  8330/3  cc_onco584  2049.0    2033.0\n",
       " T7                    fibroadenomas  9010/0  cc_onco584  2236.0    2223.0\n",
       " T8                          lipomas  8850/0  cc_onco584  2281.0    2274.0\n",
       " T9                        poliposis  8210/0  cc_onco584  3637.0    3628.0\n",
       " T10              síndrome de Gorlin  8090/3  cc_onco584  3872.0    3854.0\n",
       " T11        carcinomas basocelulares  8090/3  cc_onco584  3942.0    3918.0\n",
       " T12                         tumores  8000/1  cc_onco584  4809.0    4802.0\n",
       " T13                        malignos  8000/3  cc_onco584  4818.0    4810.0,\n",
       " 'cc_onco586':                               CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                         blastoma  8000/3  cc_onco586   421.0     413.0\n",
       " T2                           cáncer  8000/3  cc_onco586   496.0     490.0\n",
       " T3           adenocarcinoma papilar  8260/3  cc_onco586  1854.0    1832.0\n",
       " T4      enfermedad a nivel cerebral  8000/6  cc_onco586  2448.0    2421.0\n",
       " T5                   lesión frontal  8000/6  cc_onco586  3076.0    3062.0\n",
       " T6                        formación  8000/1  cc_onco586  3824.0    3815.0\n",
       " T7            Carcinoma microcítico  8041/3  cc_onco586  3860.0    3839.0\n",
       " T8  enfermedad a nivel mediastínico  8000/6  cc_onco586  4266.0    4235.0,\n",
       " 'cc_onco589':                              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1           gammapatía monoclonal  9765/1  cc_onco589   342.0     321.0\n",
       " T2  Carcinoma de células de Merkel  8247/3  cc_onco589  1062.0    1032.0\n",
       " T3                         pT2N0M0  8000/6  cc_onco589  1083.0    1076.0\n",
       " T4                         tumores  8000/1  cc_onco589  1213.0    1206.0\n",
       " T5                      malignidad  8000/3  cc_onco589  1494.0    1484.0\n",
       " T6               lesiones cutáneas  8000/6  cc_onco589  2206.0    2189.0\n",
       " T7                      metástasis  8000/6  cc_onco589  2948.0    2938.0,\n",
       " 'cc_onco594':                                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                        metastásico  8000/6  cc_onco594   795.0     784.0\n",
       " T2                             cancer  8000/3  cc_onco594   896.0     890.0\n",
       " T3                          Carcinoma  8010/3  cc_onco594   962.0     953.0\n",
       " T4  carcinoma renal de células claras  8310/3  cc_onco594  1180.0    1147.0\n",
       " T5                lesiones pulmonares  8000/6  cc_onco594  1888.0    1869.0\n",
       " T6                 lesiones hepáticas  8000/6  cc_onco594  2220.0    2202.0,\n",
       " 'cc_onco595':                                CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  carcinoma lobulillar infiltrante  8520/3  cc_onco595   584.0     552.0\n",
       " T2                            T3N1M0  8000/6  cc_onco595   624.0     618.0\n",
       " T3                                HE  9133/1  cc_onco595   720.0     718.0\n",
       " T4                         tumorales  8000/1  cc_onco595  1220.0    1211.0\n",
       " T5                        neoplásica  8000/1  cc_onco595  1390.0    1380.0\n",
       " T6                        metástasis  8000/6  cc_onco595  1459.0    1449.0\n",
       " T7                                CM  8000/3  cc_onco595  4740.0    4738.0,\n",
       " 'cc_onco599':                     CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1         adenocarcinoma  8140/3  cc_onco599   147.0     133.0\n",
       " T2                     M1  8000/6  cc_onco599   180.0     178.0\n",
       " T3          lesión costal  8000/6  cc_onco599   547.0     534.0\n",
       " T4  afectación secundaria  8000/6  cc_onco599  4151.0    4130.0,\n",
       " 'cc_onco60':                                  CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1   melanoma de extensión superficial  8743/3  cc_onco60   268.0     235.0\n",
       " T2                             pT2N0M0  8000/6  cc_onco60   291.0     284.0\n",
       " T3                 Nódulos subcutáneos  8000/6  cc_onco60   836.0     817.0\n",
       " T4                         metastásico  8000/6  cc_onco60  1059.0    1048.0\n",
       " T5      nódulos pulmonares bilaterales  8000/6  cc_onco60  1319.0    1289.0\n",
       " T6                          metástasis  8000/6  cc_onco60  1524.0    1514.0\n",
       " T7             metástasis por melanoma  8720/6  cc_onco60  1575.0    1552.0\n",
       " T8                   recaída sistémica  8000/6  cc_onco60  1763.0    1746.0\n",
       " T9                 afectación pulmonar  8000/6  cc_onco60  1787.0    1768.0\n",
       " T10                        metastásica  8000/6  cc_onco60  3684.0    3673.0\n",
       " T11                            tumoral  8000/1  cc_onco60  3741.0    3734.0,\n",
       " 'cc_onco600':                                      CLAVE   ICD-O-3   documento  endpos  \\\n",
       " T1                         afectación ósea    8000/6  cc_onco600  1548.0   \n",
       " T2                         lesión gástrica    8000/6  cc_onco600  1682.0   \n",
       " T3         neoplásica de estirpe epitelial  8000/1/H  cc_onco600  1844.0   \n",
       " T4                           patrón difuso    8145/3  cc_onco600  1934.0   \n",
       " T5                     células neoplásicas    8001/1  cc_onco600  1971.0   \n",
       " T6                         anillo de sello    8490/3  cc_onco600  2094.0   \n",
       " T7  adenocarcinoma gástrico de tipo difuso    8145/3  cc_onco600  2168.0   \n",
       " T8                               Carcinoma    8010/3  cc_onco600  2144.0   \n",
       " T9                              neoplásico    8000/1  cc_onco600  2387.0   \n",
       " \n",
       "     startpos  \n",
       " T1    1533.0  \n",
       " T2    1667.0  \n",
       " T3    1813.0  \n",
       " T4    1921.0  \n",
       " T5    1952.0  \n",
       " T6    2079.0  \n",
       " T7    2130.0  \n",
       " T8    2135.0  \n",
       " T9    2377.0  ,\n",
       " 'cc_onco601':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                        cáncer  8000/3  cc_onco601   277.0     271.0\n",
       " T2                    neoplásica  8000/1  cc_onco601   958.0     948.0\n",
       " T3                    metástasis  8000/6  cc_onco601  1103.0    1093.0\n",
       " T4                nódulo mamario  8000/6  cc_onco601  1178.0    1164.0\n",
       " T5  carcinoma ductal infiltrante  8500/3  cc_onco601  1304.0    1276.0\n",
       " T6                            HE  9133/1  cc_onco601  1422.0    1420.0\n",
       " T7                         tumor  8000/1  cc_onco601  1947.0    1942.0\n",
       " T8                       tumores  8000/1  cc_onco601  3053.0    3046.0,\n",
       " 'cc_onco604':                          CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1               masa pulmonar  8000/6  cc_onco604  1121.0    1108.0\n",
       " T2          nódulos pulmonares  8000/6  cc_onco604  1623.0    1605.0\n",
       " T3  lesiones focales hepáticas  8000/6  cc_onco604  1986.0    1960.0\n",
       " T4         enfermedad pulmonar  8000/6  cc_onco604  2555.0    2536.0\n",
       " T5                      cáncer  8000/3  cc_onco604  2845.0    2839.0,\n",
       " 'cc_onco606':                                        CLAVE ICD-O-3   documento  endpos  \\\n",
       " T1                                    cáncer  8000/3  cc_onco606    53.0   \n",
       " T2                 adenocarcinoma intestinal  8144/3  cc_onco606   896.0   \n",
       " T3                                 Carcinoma  8010/3  cc_onco606   885.0   \n",
       " T4                        lesiones hepáticas  8000/6  cc_onco606   982.0   \n",
       " T5                                metástasis  8000/6  cc_onco606  1057.0   \n",
       " T6                                   tumores  8000/1  cc_onco606  1128.0   \n",
       " T7                                   tumoral  8000/1  cc_onco606  2547.0   \n",
       " T8                                 neoplasia  8000/1  cc_onco606  3170.0   \n",
       " T9                                malignidad  8000/3  cc_onco606  4613.0   \n",
       " T10  metástasis de adenocarcinoma intestinal  8144/6  cc_onco606  4949.0   \n",
       " T11                              metastásico  8000/6  cc_onco606  5413.0   \n",
       " T12                              metastásica  8000/6  cc_onco606  6313.0   \n",
       " T13                                tumorales  8000/1  cc_onco606  6356.0   \n",
       " T14              progresión a nivel hepático  8000/6  cc_onco606  6948.0   \n",
       " T15              enfermedad a nivel hepático  8000/6  cc_onco606  7738.0   \n",
       " \n",
       "      startpos  \n",
       " T1       47.0  \n",
       " T2      871.0  \n",
       " T3      876.0  \n",
       " T4      964.0  \n",
       " T5     1047.0  \n",
       " T6     1121.0  \n",
       " T7     2540.0  \n",
       " T8     3161.0  \n",
       " T9     4603.0  \n",
       " T10    4910.0  \n",
       " T11    5402.0  \n",
       " T12    6302.0  \n",
       " T13    6347.0  \n",
       " T14    6921.0  \n",
       " T15    7711.0  ,\n",
       " 'cc_onco607':                              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                          cáncer  8000/3  cc_onco607    51.0      45.0\n",
       " T2                   lesión dorsal  8000/6  cc_onco607   619.0     606.0\n",
       " T3                          lipoma  8850/0  cc_onco607   662.0     656.0\n",
       " T4                    fibrosarcoma  8810/3  cc_onco607   963.0     951.0\n",
       " T5               células tumorales  8001/1  cc_onco607  1891.0    1874.0\n",
       " T6                     metastásico  8000/6  cc_onco607  4042.0    4031.0\n",
       " T7     progresión a nivel pulmonar  8000/6  cc_onco607  4480.0    4453.0\n",
       " T8   lesiones nodulares pulmonares  8000/6  cc_onco607  5027.0    4998.0\n",
       " T9                      malignidad  8000/3  cc_onco607  5321.0    5311.0\n",
       " T10                        tumores  8000/1  cc_onco607  5369.0    5362.0\n",
       " T11            lesiones pulmonares  8000/6  cc_onco607  5430.0    5411.0\n",
       " T12                     metástasis  8000/6  cc_onco607  5467.0    5457.0,\n",
       " 'cc_onco61':              CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  cc_onco61   317.0     303.0\n",
       " T2      metástasis  8000/6  cc_onco61   365.0     355.0\n",
       " T3       neoplasia  8000/1  cc_onco61  1448.0    1439.0,\n",
       " 'cc_onco611':                             CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1                 adenocarcinoma    8140/3  cc_onco611   321.0     307.0\n",
       " T2                     tumoración    8000/1  cc_onco611   446.0     436.0\n",
       " T3                     malignidad    8000/3  cc_onco611   839.0     829.0\n",
       " T4                      neoplasia    8000/1  cc_onco611  1197.0    1188.0\n",
       " T5                        tumoral    8000/1  cc_onco611  1634.0    1627.0\n",
       " T6                     neoplásico    8000/1  cc_onco611  2210.0    2200.0\n",
       " T7            enfermedad de Paget    9184/3  cc_onco611  2341.0    2322.0\n",
       " T8                      tumorales    8000/1  cc_onco611  2812.0    2803.0\n",
       " T9          carcinoma infiltrante  8010/3/H  cc_onco611  3396.0    3375.0\n",
       " T10  carcinoma ductal infiltrante    8500/3  cc_onco611  3810.0    3782.0,\n",
       " 'cc_onco612':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1               nódulo pulmonar  8000/6  cc_onco612   348.0     333.0\n",
       " T2                       tumores  8000/1  cc_onco612   804.0     797.0\n",
       " T3                 masa pulmonar  8000/6  cc_onco612  1213.0    1200.0\n",
       " T4                     neoplasia  8000/1  cc_onco612  1695.0    1686.0\n",
       " T5                            Mx  8000/6  cc_onco612  1724.0    1722.0\n",
       " T6          lesiones a distancia  8000/6  cc_onco612  2088.0    2068.0\n",
       " T7                            M0  8000/6  cc_onco612  2091.0    2089.0\n",
       " T8                     tumorales  8000/1  cc_onco612  2129.0    2120.0\n",
       " T9    adenopatía supraclavicular  8000/6  cc_onco612  2275.0    2249.0\n",
       " T10               adenocarcinoma  8140/3  cc_onco612  2313.0    2299.0\n",
       " T11  adenopático supraclavicular  8000/6  cc_onco612  2770.0    2743.0\n",
       " T12          progresión pulmonar  8000/6  cc_onco612  3097.0    3078.0,\n",
       " 'cc_onco615':                       CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1             masa adrenal  8000/6  cc_onco615  1223.0    1211.0\n",
       " T2            masa pulmonar  8000/6  cc_onco615  1534.0    1521.0\n",
       " T3       nódulos pulmonares  8000/6  cc_onco615  1740.0    1722.0\n",
       " T4             metastásicos  8000/6  cc_onco615  1753.0    1741.0\n",
       " T5          lóbulo hepático  8000/6  cc_onco615  2135.0    2120.0\n",
       " T6              metastásica  8000/6  cc_onco615  2322.0    2311.0\n",
       " T7              lesión ósea  8000/6  cc_onco615  2373.0    2362.0\n",
       " T8               metástasis  8000/6  cc_onco615  2483.0    2473.0\n",
       " T9         masa suprarrenal  8000/6  cc_onco615  2579.0    2563.0\n",
       " T10      nódulo suprarrenal  8000/6  cc_onco615  2654.0    2636.0\n",
       " T11  masa de partes blandas  8000/6  cc_onco615  2760.0    2738.0\n",
       " T12     células neoplásicas  8001/1  cc_onco615  2975.0    2956.0\n",
       " T13      lesión suprarrenal  8000/6  cc_onco615  3336.0    3318.0\n",
       " T14               Carcinoma  8010/3  cc_onco615  3667.0    3658.0\n",
       " T15               neoplasia  8000/1  cc_onco615  3716.0    3707.0\n",
       " T16                  T4N0M1  8000/6  cc_onco615  4071.0    4065.0\n",
       " T17                 tumores  8000/1  cc_onco615  4788.0    4781.0\n",
       " T18     progresión pulmonar  8000/6  cc_onco615  5750.0    5731.0\n",
       " T19              neoplásico  8000/1  cc_onco615  5964.0    5954.0,\n",
       " 'cc_onco621':                            CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1                       tumoral   8000/1  cc_onco621  3066.0    3059.0\n",
       " T2                   metastásica   8000/6  cc_onco621  3079.0    3068.0\n",
       " T3                       linfoma   9590/3  cc_onco621  3094.0    3087.0\n",
       " T4           lesiones cerebrales   8000/6  cc_onco621  3299.0    3280.0\n",
       " T5                     tumorales   8000/1  cc_onco621  4523.0    4514.0\n",
       " T6                  diseminación   8000/6  cc_onco621  5331.0    5319.0\n",
       " T7             masa paratraqueal   8000/6  cc_onco621  5593.0    5576.0\n",
       " T8         nódulos suprarrenales   8000/6  cc_onco621  5848.0    5827.0\n",
       " T9                    metástasis   8000/6  cc_onco621  5887.0    5877.0\n",
       " T10                      maligno   8000/3  cc_onco621  6229.0    6222.0\n",
       " T11  carcinoma poco diferenciado  8010/33  cc_onco621  6368.0    6341.0\n",
       " T12                  metastásico   8000/6  cc_onco621  6583.0    6572.0\n",
       " T13                masa pulmonar   8000/6  cc_onco621  7198.0    7185.0\n",
       " T14           cáncer microcítico   8041/3  cc_onco621  7441.0    7423.0\n",
       " T15         metástasis de cáncer   8000/6  cc_onco621  7578.0    7558.0\n",
       " T16                   neoplásico   8000/1  cc_onco621  8054.0    8044.0\n",
       " T17                      tumores   8000/1  cc_onco621  8209.0    8202.0\n",
       " T18                   neoplásica   8000/1  cc_onco621  8638.0    8628.0\n",
       " T19          afectación cerebral   8000/6  cc_onco621  9091.0    9072.0,\n",
       " 'cc_onco623':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                         miomas  8895/0  cc_onco623   263.0     257.0\n",
       " T2      Tumor de células gigantes  8003/3  cc_onco623   318.0     293.0\n",
       " T3                         cáncer  8000/3  cc_onco623   676.0     670.0\n",
       " T4                 nódulo mamario  8000/6  cc_onco623   715.0     701.0\n",
       " T5   carcinoma ductal infiltrante  8500/3  cc_onco623   858.0     830.0\n",
       " T6                            CDI  8500/3  cc_onco623   863.0     860.0\n",
       " T7                             HE  9133/1  cc_onco623  1001.0     999.0\n",
       " T8     adenopatía supraclavicular  8000/6  cc_onco623  2040.0    2014.0\n",
       " T9        metástasis de carcinoma  8010/6  cc_onco623  2080.0    2057.0\n",
       " T10           progresión hepática  8000/6  cc_onco623  3410.0    3391.0\n",
       " T11            lesiones hepáticas  8000/6  cc_onco623  5350.0    5332.0\n",
       " T12                  metastásicas  8000/6  cc_onco623  5363.0    5351.0\n",
       " T13               lóbulo hepático  8000/6  cc_onco623  5507.0    5492.0\n",
       " T14                lesiones óseas  8000/6  cc_onco623  5741.0    5727.0\n",
       " T15        masa de partes blandas  8000/6  cc_onco623  5798.0    5776.0,\n",
       " 'cc_onco624':              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  cc_onco624  1438.0    1424.0\n",
       " T2             ADC  8140/3  cc_onco624  1443.0    1440.0\n",
       " T3      neoplásica  8000/1  cc_onco624  2162.0    2152.0\n",
       " T4      malignidad  8000/3  cc_onco624  2304.0    2294.0\n",
       " T5              M0  8000/6  cc_onco624  2490.0    2488.0\n",
       " T6             CCR  8312/3  cc_onco624  2553.0    2550.0\n",
       " T7       neoplasia  8000/1  cc_onco624  3507.0    3498.0\n",
       " T8         tumores  8000/1  cc_onco624  4516.0    4509.0,\n",
       " 'cc_onco627':                      CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1              tumoración  8000/1  cc_onco627   602.0     592.0\n",
       " T2      carcinoma escamoso  8070/3  cc_onco627  2123.0    2105.0\n",
       " T3     implantes tumorales  8000/6  cc_onco627  2361.0    2342.0\n",
       " T4              metástasis  8000/6  cc_onco627  2618.0    2608.0\n",
       " T5  implantes peritoneales  8000/6  cc_onco627  3014.0    2992.0\n",
       " T6                 tumores  8000/1  cc_onco627  3093.0    3086.0,\n",
       " 'cc_onco629':                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1          neoplasia  8000/1  cc_onco629   194.0     185.0\n",
       " T2   neoproliferativo  8000/1  cc_onco629   526.0     510.0\n",
       " T3   masa pancreática  8000/6  cc_onco629  2218.0    2202.0\n",
       " T4   células malignas  8001/3  cc_onco629  2325.0    2309.0\n",
       " T5     adenocarcinoma  8140/3  cc_onco629  2356.0    2342.0\n",
       " T6              tumor  8000/1  cc_onco629  2458.0    2453.0\n",
       " T7         metástasis  8000/6  cc_onco629  2575.0    2565.0\n",
       " T8     neuroendocrina  8574/3  cc_onco629  2657.0    2643.0\n",
       " T9          tumorales  8000/1  cc_onco629  2683.0    2674.0\n",
       " T10           tumores  8000/1  cc_onco629  3046.0    3039.0\n",
       " T11    neuroendocrino  8240/3  cc_onco629  3217.0    3203.0,\n",
       " 'cc_onco63':                                 CLAVE  ICD-O-3  documento  endpos  startpos\n",
       " T1                            CIN III   8077/2  cc_onco63   235.0     228.0\n",
       " T2                     adenocarcinoma   8140/3  cc_onco63  1085.0    1071.0\n",
       " T3                           blastoma   8000/3  cc_onco63  1166.0    1158.0\n",
       " T4                         metástasis   8000/6  cc_onco63  2527.0    2517.0\n",
       " T5                       neoformación   8000/1  cc_onco63  4003.0    3991.0\n",
       " T6   adenocarcinoma bien diferenciado  8140/31  cc_onco63  4569.0    4537.0\n",
       " T7                        metastatiza   8000/6  cc_onco63  4653.0    4642.0\n",
       " T8                    lóbulo hepático   8000/6  cc_onco63  5720.0    5705.0\n",
       " T9                   recaída cerebral   8000/6  cc_onco63  6412.0    6396.0\n",
       " T10                 recaída sistémica   8000/6  cc_onco63  6556.0    6539.0\n",
       " T11                afectación pleural   8000/6  cc_onco63  7124.0    7106.0,\n",
       " 'cc_onco632':                                   CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                       masa abdominal  8000/6  cc_onco632   226.0     212.0\n",
       " T2                    tumor fusocelular  8032/1  cc_onco632   495.0     478.0\n",
       " T3   tumor del estroma gastrointestinal  8936/3  cc_onco632   593.0     559.0\n",
       " T4                                 GIST  8936/3  cc_onco632   599.0     595.0\n",
       " T5                             sarcomas  8800/3  cc_onco632  1129.0    1121.0\n",
       " T6                           tumoración  8000/1  cc_onco632  1486.0    1476.0\n",
       " T7              tumor fibroso solitario  8815/0  cc_onco632  2127.0    2104.0\n",
       " T8                   enfermedad pélvica  8000/6  cc_onco632  2309.0    2291.0\n",
       " T9                              tumores  8000/1  cc_onco632  2389.0    2382.0\n",
       " T10                        masa pélvica  8000/6  cc_onco632  3320.0    3308.0,\n",
       " 'cc_onco637':                                                CLAVE  ICD-O-3   documento  \\\n",
       " T1  carcinoma epidermoide moderadamente diferenciado  8070/32  cc_onco637   \n",
       " T2                                             tumor   8000/1  cc_onco637   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1  1108.0    1060.0  \n",
       " T2  2417.0    2412.0  ,\n",
       " 'cc_onco641':                                 CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1                             cáncer   8000/3  cc_onco641   327.0     321.0\n",
       " T2                          tumorales   8000/1  cc_onco641   854.0     845.0\n",
       " T3                         metástasis   8000/6  cc_onco641  1009.0     999.0\n",
       " T4                         tumoración   8000/1  cc_onco641  1125.0    1115.0\n",
       " T5   adenocarcinoma bien diferenciado  8140/31  cc_onco641  1317.0    1285.0\n",
       " T6                          Carcinoma   8010/3  cc_onco641  1299.0    1290.0\n",
       " T7       metástasis de adenocarcinoma   8140/6  cc_onco641  2042.0    2014.0\n",
       " T8        enfermedad a nivel hepático   8000/6  cc_onco641  2330.0    2303.0\n",
       " T9                progresión hepática   8000/6  cc_onco641  2768.0    2749.0\n",
       " T10       progresión a nivel pulmonar   8000/6  cc_onco641  3411.0    3384.0\n",
       " T11                       RC hepática   8000/6  cc_onco641  3627.0    3616.0\n",
       " T12     metástasis por adenocarcinoma   8140/6  cc_onco641  3891.0    3862.0\n",
       " T13         adenocarcinoma intestinal   8144/3  cc_onco641  3902.0    3877.0\n",
       " T14                 recidiva pulmonar   8000/6  cc_onco641  4085.0    4068.0\n",
       " T15                       RC pulmonar   8000/6  cc_onco641  4263.0    4252.0\n",
       " T16                lesiones hepáticas   8000/6  cc_onco641  4317.0    4299.0\n",
       " T17                nódulos pulmonares   8000/6  cc_onco641  4498.0    4480.0,\n",
       " 'cc_onco651':                                  CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                           Carcinoma  8010/3  cc_onco651   873.0     864.0\n",
       " T2                   células tumorales  8001/1  cc_onco651  1229.0    1212.0\n",
       " T3                             tumores  8000/1  cc_onco651  1272.0    1265.0\n",
       " T4   metástasis de carcinoma de Merkel  8247/6  cc_onco651  1954.0    1921.0\n",
       " T5      Carcinoma de células de Merkel  8247/3  cc_onco651  2439.0    2409.0\n",
       " T6                    masa pancreática  8000/6  cc_onco651  2881.0    2865.0\n",
       " T7                  nódulo suprarrenal  8000/6  cc_onco651  3049.0    3031.0\n",
       " T8                           formación  8000/1  cc_onco651  3570.0    3561.0\n",
       " T9                masa retroperitoneal  8000/6  cc_onco651  3961.0    3941.0\n",
       " T10                            maligna  8000/3  cc_onco651  4451.0    4444.0,\n",
       " 'cc_onco652':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                      Carcinoma  8010/3  cc_onco652   456.0     447.0\n",
       " T2                  masa pulmonar  8000/6  cc_onco652   949.0     936.0\n",
       " T3  Carcinoma de células pequeñas  8041/3  cc_onco652  1301.0    1272.0\n",
       " T4        metástasis de carcinoma  8010/6  cc_onco652  1377.0    1354.0\n",
       " T5                lesión pulmonar  8000/6  cc_onco652  1443.0    1428.0\n",
       " T6                   diseminación  8000/6  cc_onco652  5299.0    5287.0\n",
       " T7                    metastásica  8000/6  cc_onco652  5311.0    5300.0\n",
       " T8                        tumoral  8000/1  cc_onco652  5615.0    5608.0,\n",
       " 'cc_onco655':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                 nódulo mamario  8000/6  cc_onco655   269.0     255.0\n",
       " T2                     tumoración  8000/1  cc_onco655   486.0     476.0\n",
       " T3              lesiones cutáneas  8000/6  cc_onco655   674.0     657.0\n",
       " T4                        maligna  8000/3  cc_onco655   869.0     862.0\n",
       " T5   carcinoma ductal infiltrante  8500/3  cc_onco655   972.0     944.0\n",
       " T6                             HE  9133/1  cc_onco655  1021.0    1019.0\n",
       " T7          enfermedad diseminada  8000/6  cc_onco655  1173.0    1152.0\n",
       " T8                    metastásico  8000/6  cc_onco655  1293.0    1282.0\n",
       " T9                        tumores  8000/1  cc_onco655  1372.0    1365.0\n",
       " T10           Nódulos subcutáneos  8000/6  cc_onco655  2522.0    2503.0\n",
       " T11   progresión tumoral pulmonar  8000/6  cc_onco655  2725.0    2698.0\n",
       " T12                       tumoral  8000/1  cc_onco655  2716.0    2709.0\n",
       " T13    progresión pulmonar y ósea  8000/6  cc_onco655  2846.0    2820.0,\n",
       " 'cc_onco656':                                  CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1                   síndrome de Lynch    8000/3  cc_onco656    90.0      73.0\n",
       " T2                           neoplasia    8000/1  cc_onco656   193.0     184.0\n",
       " T3                      adenocarcinoma    8140/3  cc_onco656   306.0     292.0\n",
       " T4                          neoplásica    8000/1  cc_onco656   573.0     563.0\n",
       " T5                        tumoraciones    8000/1  cc_onco656   912.0     900.0\n",
       " T6                          malignidad    8000/3  cc_onco656  1321.0    1311.0\n",
       " T7          proceso linfoproliferativo    9970/1  cc_onco656  1777.0    1751.0\n",
       " T8   Linfoma Difuso de Célula Grande B    9680/3  cc_onco656  1842.0    1809.0\n",
       " T9                               LDCGB    9680/3  cc_onco656  1901.0    1896.0\n",
       " T10              carcinoma infiltrante  8010/3/H  cc_onco656  3529.0    3508.0\n",
       " T11                                 HE    9133/1  cc_onco656  3624.0    3622.0\n",
       " T12                 Linfoma no Hodgkin    9591/3  cc_onco656  4807.0    4789.0,\n",
       " 'cc_onco658':                       CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                   cáncer  8000/3  cc_onco658   652.0     646.0\n",
       " T2          hepatocarcinoma  8170/3  cc_onco658   697.0     682.0\n",
       " T3                neoplasia  8000/1  cc_onco658   962.0     953.0\n",
       " T4    carcinoma epidermoide  8070/3  cc_onco658  1042.0    1021.0\n",
       " T5                   cancer  8000/3  cc_onco658  1200.0    1194.0\n",
       " T6                    tumor  8000/1  cc_onco658  1284.0    1279.0\n",
       " T7   enfermedad a distancia  8000/6  cc_onco658  1688.0    1666.0\n",
       " T8               neoplásica  8000/1  cc_onco658  2492.0    2482.0\n",
       " T9                  tumoral  8000/1  cc_onco658  2526.0    2519.0\n",
       " T10                      M1  8000/6  cc_onco658  3572.0    3570.0\n",
       " T11             metastásica  8000/6  cc_onco658  4000.0    3989.0\n",
       " T12                implante  8000/6  cc_onco658  6924.0    6916.0,\n",
       " 'cc_onco659':                                                 CLAVE ICD-O-3   documento  \\\n",
       " T1                                             cáncer  8000/3  cc_onco659   \n",
       " T2                                 lesiones hepáticas  8000/6  cc_onco659   \n",
       " T3                                         metástasis  8000/6  cc_onco659   \n",
       " T4                                          neoplasia  8000/1  cc_onco659   \n",
       " T5  metástasis de tumor neuroendocrino bien difere...  8240/6  cc_onco659   \n",
       " T6                                     neuroendocrino  8240/3  cc_onco659   \n",
       " T7                                         carcinoide  8240/3  cc_onco659   \n",
       " T8                                afectación hepática  8000/6  cc_onco659   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   290.0     284.0  \n",
       " T2   656.0     638.0  \n",
       " T3   682.0     672.0  \n",
       " T4  1150.0    1141.0  \n",
       " T5  2290.0    2238.0  \n",
       " T6  2272.0    2258.0  \n",
       " T7  3281.0    3271.0  \n",
       " T8  5342.0    5323.0  ,\n",
       " 'cc_onco660':                    CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  tumor neuroendocrino  8240/3  cc_onco660   228.0     208.0\n",
       " T2            metástasis  8000/6  cc_onco660   328.0     318.0\n",
       " T3   progresión pulmonar  8000/6  cc_onco660   708.0     689.0\n",
       " T4            carcinoide  8240/3  cc_onco660   981.0     971.0\n",
       " T5               tumoral  8000/1  cc_onco660  1119.0    1112.0,\n",
       " 'cc_onco661':                                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                         tumoración  8000/1  cc_onco661  1354.0    1344.0\n",
       " T2  Linfoma Difuso de Célula Grande B  9680/3  cc_onco661  1801.0    1768.0\n",
       " T3  linfoma B difuso de célula grande  9680/3  cc_onco661  2242.0    2209.0,\n",
       " 'cc_onco664':                                   CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                           malignidad  8000/3  cc_onco664  1037.0    1027.0\n",
       " T2     carcinoma de células no pequeñas  8046/3  cc_onco664  1289.0    1257.0\n",
       " T3                               T4N0M0  8000/6  cc_onco664  1503.0    1497.0\n",
       " T4  metástasis de carcinoma epidermoide  8070/6  cc_onco664  2501.0    2466.0,\n",
       " 'cc_onco665':                               CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                        tumorales  8000/1  cc_onco665  3548.0    3539.0\n",
       " T2                               CM  8000/3  cc_onco665  3715.0    3713.0\n",
       " T3                       malignidad  8000/3  cc_onco665  4590.0    4580.0\n",
       " T4   nódulos pulmonares bilaterales  8000/6  cc_onco665  5104.0    5074.0\n",
       " T5               lesiones hepáticas  8000/6  cc_onco665  5181.0    5163.0\n",
       " T6                  hepatocarcinoma  8170/3  cc_onco665  5342.0    5327.0\n",
       " T7                       metástasis  8000/6  cc_onco665  5751.0    5741.0\n",
       " T8      adenopático supraclavicular  8000/6  cc_onco665  5960.0    5933.0\n",
       " T9                     diseminación  8000/6  cc_onco665  6369.0    6357.0\n",
       " T10                          cancer  8000/3  cc_onco665  6533.0    6527.0\n",
       " T11        afectación extrahepática  8000/6  cc_onco665  6597.0    6573.0,\n",
       " 'cc_onco668':                      CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1           masa pulmonar  8000/6  cc_onco668   752.0     739.0\n",
       " T2   invasión mediastínica  8000/6  cc_onco668   944.0     923.0\n",
       " T3             metastásica  8000/6  cc_onco668  1232.0    1221.0\n",
       " T4     células neoplásicas  8001/1  cc_onco668  1773.0    1754.0\n",
       " T5        células malignas  8001/3  cc_onco668  2205.0    2189.0\n",
       " T6                   tumor  8000/1  cc_onco668  2307.0    2302.0\n",
       " T7              malignidad  8000/3  cc_onco668  2444.0    2434.0\n",
       " T8        sarcoma sinovial  9040/3  cc_onco668  2507.0    2491.0\n",
       " T9                 tumoral  8000/1  cc_onco668  2632.0    2625.0\n",
       " T10        nódulo pulmonar  8000/6  cc_onco668  3840.0    3825.0,\n",
       " 'cc_onco680':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                            CM  8000/3  cc_onco680  1247.0    1245.0\n",
       " T2  carcinoma ductal infiltrante  8500/3  cc_onco680  1657.0    1629.0\n",
       " T3           afectación hepática  8000/6  cc_onco680  1731.0    1712.0\n",
       " T4                       tumoral  8000/1  cc_onco680  1853.0    1846.0,\n",
       " 'cc_onco683':                       CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                    nevus  8720/0  cc_onco683   104.0      99.0\n",
       " T2                 melanoma  8720/3  cc_onco683   295.0     287.0\n",
       " T3               neoplásica  8000/1  cc_onco683   662.0     652.0\n",
       " T4               neoplásico  8000/1  cc_onco683  3925.0    3915.0\n",
       " T5                 teratoma  9080/1  cc_onco683  4071.0    4063.0\n",
       " T6           Carcinomatosis  8010/9  cc_onco683  4120.0    4106.0\n",
       " T7              metastásico  8000/6  cc_onco683  4623.0    4612.0\n",
       " T8       lesión suprarrenal  8000/6  cc_onco683  4648.0    4630.0\n",
       " T9   metástasis de melanoma  8720/6  cc_onco683  4874.0    4852.0\n",
       " T10              malignidad  8000/3  cc_onco683  5248.0    5238.0\n",
       " T11       teratoma quístico  9080/0  cc_onco683  5307.0    5290.0\n",
       " T12                   tumor  8000/1  cc_onco683  6392.0    6387.0\n",
       " T13         lesión pulmonar  8000/6  cc_onco683  6422.0    6407.0\n",
       " T14           masa pulmonar  8000/6  cc_onco683  7003.0    6990.0,\n",
       " 'cc_onco69':                                   CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1                              tumoral  8000/1  cc_onco69  1668.0    1661.0\n",
       " T2                    Masa mediastínica  8000/6  cc_onco69  1760.0    1743.0\n",
       " T3                  implantes pleurales  8000/6  cc_onco69  1832.0    1813.0\n",
       " T4  linfoma B difuso de células grandes  9680/3  cc_onco69  2023.0    1988.0\n",
       " T5                                LBDCG  9680/3  cc_onco69  2044.0    2039.0\n",
       " T6                   Linfoma no Hodgkin  9591/3  cc_onco69  2270.0    2252.0\n",
       " T7                                  LNH  9591/3  cc_onco69  2275.0    2272.0\n",
       " T8                  afectación pulmonar  8000/6  cc_onco69  4275.0    4256.0,\n",
       " 'cc_onco693':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                    tumoración  8000/1  cc_onco693   513.0     503.0\n",
       " T2                       maligno  8000/3  cc_onco693   942.0     935.0\n",
       " T3               lesión hepática  8000/6  cc_onco693  1288.0    1273.0\n",
       " T4                    metástasis  8000/6  cc_onco693  1335.0    1325.0\n",
       " T5                     neoplasia  8000/1  cc_onco693  2184.0    2175.0\n",
       " T6   adenocarcinoma mucosecretor  8481/3  cc_onco693  2346.0    2319.0\n",
       " T7                     Carcinoma  8010/3  cc_onco693  2333.0    2324.0\n",
       " T8                     tumorales  8000/1  cc_onco693  2431.0    2422.0\n",
       " T9                            HE  9133/1  cc_onco693  2758.0    2756.0\n",
       " T10             micrometastásica  8000/6  cc_onco693  4868.0    4852.0\n",
       " T11                   neoplásica  8000/1  cc_onco693  5490.0    5480.0\n",
       " T12                      tumores  8000/1  cc_onco693  6361.0    6354.0,\n",
       " 'cc_onco70':                            CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1  carcinoma ductal infiltrante  8500/3  cc_onco70   199.0     171.0\n",
       " T2             carcinoma in situ  8010/2  cc_onco70   628.0     611.0\n",
       " T3                    metástasis  8000/6  cc_onco70   676.0     666.0\n",
       " T4       metástasis de carcinoma  8010/6  cc_onco70  2239.0    2216.0\n",
       " T5              células malignas  8001/3  cc_onco70  2872.0    2856.0,\n",
       " 'cc_onco701':              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1       neoplasia  8000/1  cc_onco701   300.0     291.0\n",
       " T2  adenocarcinoma  8140/3  cc_onco701   875.0     861.0\n",
       " T3      metástasis  8000/6  cc_onco701  1884.0    1874.0,\n",
       " 'cc_onco703':                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1          neoplasia  8000/1  cc_onco703  1092.0    1083.0\n",
       " T2              tumor  8000/1  cc_onco703  1213.0    1208.0\n",
       " T3         metástasis  8000/6  cc_onco703  1391.0    1381.0\n",
       " T4   carcinoma sólido  8230/3  cc_onco703  1476.0    1460.0\n",
       " T5            pT2N0M0  8000/6  cc_onco703  1518.0    1511.0\n",
       " T6  recidiva hepática  8000/6  cc_onco703  2638.0    2621.0\n",
       " T7         malignidad  8000/3  cc_onco703  2871.0    2861.0\n",
       " T8         neoplásico  8000/1  cc_onco703  3737.0    3727.0,\n",
       " 'cc_onco712':                                        CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1   carcinoma epidermoide bien diferenciado  8070/31  cc_onco712   184.0   \n",
       " T2                  tumor carcinoide atípico   8249/3  cc_onco712   233.0   \n",
       " T3                       enfermedad pulmonar   8000/6  cc_onco712   497.0   \n",
       " T4                                metástasis   8000/6  cc_onco712  1021.0   \n",
       " T5                       lesiones pulmonares   8000/6  cc_onco712  1874.0   \n",
       " T6                     infiltración hepática   8000/6  cc_onco712  1977.0   \n",
       " T7                           lóbulo hepático   8000/6  cc_onco712  2010.0   \n",
       " T8                               metastásico   8000/6  cc_onco712  2051.0   \n",
       " T9                            neuroendocrina   8574/3  cc_onco712  2275.0   \n",
       " T10                           neuroendocrino   8240/3  cc_onco712  2393.0   \n",
       " T11                     tumor neuroendocrino   8240/3  cc_onco712  3265.0   \n",
       " \n",
       "      startpos  \n",
       " T1      145.0  \n",
       " T2      209.0  \n",
       " T3      478.0  \n",
       " T4     1011.0  \n",
       " T5     1855.0  \n",
       " T6     1956.0  \n",
       " T7     1995.0  \n",
       " T8     2040.0  \n",
       " T9     2261.0  \n",
       " T10    2379.0  \n",
       " T11    3245.0  ,\n",
       " 'cc_onco713':                     CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1     nódulo suprarrenal  8000/6  cc_onco713   435.0     417.0\n",
       " T2              neoplasia  8000/1  cc_onco713  1112.0    1103.0\n",
       " T3             metástasis  8000/6  cc_onco713  1206.0    1196.0\n",
       " T4    lesiones pulmonares  8000/6  cc_onco713  1470.0    1451.0\n",
       " T5           metastásicas  8000/6  cc_onco713  1483.0    1471.0\n",
       " T6         feocromocitoma  8700/3  cc_onco713  1527.0    1513.0\n",
       " T7              Carcinoma  8010/3  cc_onco713  1644.0    1635.0\n",
       " T8    afectación pulmonar  8000/6  cc_onco713  1771.0    1752.0\n",
       " T9                  tumor  8000/1  cc_onco713  1848.0    1843.0\n",
       " T10  masa retroperitoneal  8000/6  cc_onco713  2254.0    2234.0\n",
       " T11            neoplásica  8000/1  cc_onco713  3958.0    3948.0\n",
       " T12    nódulos pulmonares  8000/6  cc_onco713  5275.0    5257.0\n",
       " T13   enfermedad pulmonar  8000/6  cc_onco713  5814.0    5795.0\n",
       " T14  enfermedad abdominal  8000/6  cc_onco713  5858.0    5838.0,\n",
       " 'cc_onco715':              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  feocromocitoma  8700/3  cc_onco715   337.0     323.0\n",
       " T2        malignos  8000/3  cc_onco715   427.0     419.0\n",
       " T3      Hemangioma  9120/0  cc_onco715   928.0     918.0\n",
       " T4      metástasis  8000/6  cc_onco715  1740.0    1730.0\n",
       " T5          cancer  8000/3  cc_onco715  2630.0    2624.0,\n",
       " 'cc_onco716':                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1           melanoma  8720/3  cc_onco716   304.0     296.0\n",
       " T2  células tumorales  8001/1  cc_onco716  1488.0    1471.0\n",
       " T3            tumores  8000/1  cc_onco716  1614.0    1607.0,\n",
       " 'cc_onco719':                            CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1                     Carcinoma    8010/3  cc_onco719    67.0      58.0\n",
       " T2                            Ca    8000/3  cc_onco719    71.0      69.0\n",
       " T3  carcinoma ductal infiltrante    8500/3  cc_onco719  1135.0    1107.0\n",
       " T4                            HE    9133/1  cc_onco719  1328.0    1326.0\n",
       " T5                       tumoral    8000/1  cc_onco719  1973.0    1966.0\n",
       " T6         carcinoma infiltrante  8010/3/H  cc_onco719  2214.0    2193.0\n",
       " T7             Masa mediastínica    8000/6  cc_onco719  2864.0    2847.0\n",
       " T8                            CM    8000/3  cc_onco719  6347.0    6345.0,\n",
       " 'cc_onco72':                                   CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1                           tumoración  8000/1  cc_onco72   282.0     272.0\n",
       " T2       nódulos pulmonares bilaterales  8000/6  cc_onco72  1295.0    1265.0\n",
       " T3                           metástasis  8000/6  cc_onco72  1401.0    1391.0\n",
       " T4                        LOE hepáticas  8000/6  cc_onco72  1490.0    1477.0\n",
       " T5                           malignidad  8000/3  cc_onco72  1611.0    1601.0\n",
       " T6   neoplasia del estroma fibromixoide  8811/0  cc_onco72  1926.0    1892.0\n",
       " T7                  hemangioendotelioma  9130/1  cc_onco72  2196.0    2177.0\n",
       " T8                              maligno  8000/3  cc_onco72  2214.0    2207.0\n",
       " T9                                   HE  9133/1  cc_onco72  2226.0    2224.0\n",
       " T10                             tumores  8000/1  cc_onco72  2298.0    2291.0\n",
       " T11                            malignos  8000/3  cc_onco72  2325.0    2317.0\n",
       " T12                         metastásico  8000/6  cc_onco72  2527.0    2516.0\n",
       " T13                            sarcomas  8800/3  cc_onco72  2572.0    2564.0\n",
       " T14              masa de partes blandas  8000/6  cc_onco72  3499.0    3477.0\n",
       " T15                  lesiones hepáticas  8000/6  cc_onco72  6181.0    6163.0,\n",
       " 'cc_onco722':                           CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                   tumoración  8000/1  cc_onco722   129.0     119.0\n",
       " T2       Sarcoma indiferenciado  8805/3  cc_onco722   203.0     181.0\n",
       " T3                       cáncer  8000/3  cc_onco722  1229.0    1223.0\n",
       " T4                      tumoral  8000/1  cc_onco722  2120.0    2113.0\n",
       " T5                           MO  8000/6  cc_onco722  2364.0    2362.0\n",
       " T6   adenopatía supraclavicular  8000/6  cc_onco722  2402.0    2376.0\n",
       " T7                    miomatoso  8895/0  cc_onco722  2943.0    2934.0\n",
       " T8                   malignidad  8000/3  cc_onco722  3309.0    3299.0\n",
       " T9                 diseminación  8000/6  cc_onco722  3434.0    3422.0\n",
       " T10                 metastásica  8000/6  cc_onco722  3446.0    3435.0\n",
       " T11                metastásicas  8000/6  cc_onco722  3873.0    3861.0\n",
       " T12              lesiones óseas  8000/6  cc_onco722  3932.0    3918.0\n",
       " T13                  metástasis  8000/6  cc_onco722  3959.0    3949.0\n",
       " T14    carcinoma neuroendocrino  8246/3  cc_onco722  4100.0    4076.0,\n",
       " 'cc_onco729':              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1          cáncer  8000/3  cc_onco729   956.0     950.0\n",
       " T2  adenocarcinoma  8140/3  cc_onco729  1050.0    1036.0\n",
       " T3         cT3N0M1  8000/6  cc_onco729  1080.0    1073.0\n",
       " T4      metástasis  8000/6  cc_onco729  1093.0    1083.0\n",
       " T5  Carcinomatosis  8010/9  cc_onco729  1698.0    1684.0\n",
       " T6     metastásica  8000/6  cc_onco729  1785.0    1774.0\n",
       " T7   masa pulmonar  8000/6  cc_onco729  2220.0    2207.0,\n",
       " 'cc_onco737':                                      CLAVE ICD-O-3   documento  endpos  \\\n",
       " T1  adenocarcinoma gástrico de tipo difuso  8145/3  cc_onco737   649.0   \n",
       " T2                               Carcinoma  8010/3  cc_onco737   625.0   \n",
       " T3              células en anillo de sello  8490/3  cc_onco737   680.0   \n",
       " T4                                      HE  9133/1  cc_onco737   740.0   \n",
       " T5                      lesiones hepáticas  8000/6  cc_onco737   811.0   \n",
       " T6                              metástasis  8000/6  cc_onco737   866.0   \n",
       " T7                          Carcinomatosis  8010/9  cc_onco737   901.0   \n",
       " T8                                 tumoral  8000/1  cc_onco737  1347.0   \n",
       " \n",
       "     startpos  \n",
       " T1     611.0  \n",
       " T2     616.0  \n",
       " T3     654.0  \n",
       " T4     738.0  \n",
       " T5     793.0  \n",
       " T6     856.0  \n",
       " T7     887.0  \n",
       " T8    1340.0  ,\n",
       " 'cc_onco742':                               CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1                           cáncer    8000/3  cc_onco742   105.0      99.0\n",
       " T2            carcinoma infiltrante  8010/3/H  cc_onco742   244.0     223.0\n",
       " T3                  enfermedad ósea    8000/6  cc_onco742   890.0     875.0\n",
       " T4                      metastásica    8000/6  cc_onco742   902.0     891.0\n",
       " T5      infiltración de médula ósea    8000/6  cc_onco742  1300.0    1273.0\n",
       " T6                  afectación ósea    8000/6  cc_onco742  2513.0    2498.0\n",
       " T7                        tumorales    8000/1  cc_onco742  3753.0    3744.0\n",
       " T8                       metástasis    8000/6  cc_onco742  3913.0    3903.0\n",
       " T9            infiltración hepática    8000/6  cc_onco742  4201.0    4180.0\n",
       " T10  infiltración de la médula ósea    8000/6  cc_onco742  4306.0    4276.0,\n",
       " 'cc_onco748':          CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1      cáncer  8000/3  cc_onco748   103.0      97.0\n",
       " T2  tumoración  8000/1  cc_onco748   495.0     485.0\n",
       " T3     tumoral  8000/1  cc_onco748  1332.0    1325.0\n",
       " T4   formación  8000/1  cc_onco748  1508.0    1499.0\n",
       " T5     tumores  8000/1  cc_onco748  2378.0    2371.0,\n",
       " 'cc_onco749':                                   CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                            Carcinoma  8010/3  cc_onco749   537.0     528.0\n",
       " T2               implantes peritoneales  8000/6  cc_onco749   877.0     855.0\n",
       " T3                              tumoral  8000/1  cc_onco749   905.0     898.0\n",
       " T4                     carcinoma seroso  8441/3  cc_onco749  1604.0    1588.0\n",
       " T5  progresión tumoral a nivel hepático  8000/6  cc_onco749  2186.0    2151.0,\n",
       " 'cc_onco75':                                                  CLAVE   ICD-O-3  documento  \\\n",
       " T1                                              miomas    8895/0  cc_onco75   \n",
       " T2                           lesiones supratentoriales    8000/6  cc_onco75   \n",
       " T3                                         metastásico    8000/6  cc_onco75   \n",
       " T4                              afectación a distancia    8000/6  cc_onco75   \n",
       " T5                               carcinoma infiltrante  8010/3/H  cc_onco75   \n",
       " T6                                           tumorales    8000/1  cc_onco75   \n",
       " T7                                           neoplasia    8000/1  cc_onco75   \n",
       " T8                                          metástasis    8000/6  cc_onco75   \n",
       " T9   Carcinoma ductal infiltrante pobremente difere...   8500/33  cc_onco75   \n",
       " T10                          linfangitis carcinomatosa    8000/3  cc_onco75   \n",
       " T11                                  células tumorales    8001/1  cc_onco75   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    324.0     318.0  \n",
       " T2   1097.0    1072.0  \n",
       " T3   1631.0    1620.0  \n",
       " T4   1674.0    1652.0  \n",
       " T5   2231.0    2210.0  \n",
       " T6   2543.0    2534.0  \n",
       " T7   5840.0    5831.0  \n",
       " T8   5871.0    5861.0  \n",
       " T9   7427.0    7375.0  \n",
       " T10  7510.0    7485.0  \n",
       " T11  7620.0    7603.0  ,\n",
       " 'cc_onco750':                                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  melanoma de extensión superficial  8743/3  cc_onco750   178.0     145.0\n",
       " T2                             T1N0M0  8000/6  cc_onco750   227.0     221.0\n",
       " T3             metástasis de melanoma  8720/6  cc_onco750   879.0     857.0\n",
       " T4                        metastásica  8000/6  cc_onco750  1156.0    1145.0\n",
       " T5                        metastásico  8000/6  cc_onco750  1464.0    1453.0\n",
       " T6                            tumoral  8000/1  cc_onco750  3039.0    3032.0,\n",
       " 'cc_onco756':                           CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1       enfermedad a distancia  8000/6  cc_onco756   573.0     551.0\n",
       " T2                        tumor  8000/1  cc_onco756   593.0     588.0\n",
       " T3  carcinoma de células claras  8310/3  cc_onco756   812.0     785.0\n",
       " T4                    neoplasia  8000/1  cc_onco756   867.0     858.0\n",
       " T5                      tumoral  8000/1  cc_onco756  1268.0    1261.0\n",
       " T6                   metástasis  8000/6  cc_onco756  2487.0    2477.0,\n",
       " 'cc_onco770':                                                CLAVE ICD-O-3   documento  \\\n",
       " T1                                         neoplasia  8000/1  cc_onco770   \n",
       " T2                                            cáncer  8000/3  cc_onco770   \n",
       " T3   adenopatías laterocervicales, supraclaviculares  8000/6  cc_onco770   \n",
       " T4                                             Mioma  8895/0  cc_onco770   \n",
       " T5                                      LOE hepática  8000/6  cc_onco770   \n",
       " T6                                      metastásicas  8000/6  cc_onco770   \n",
       " T7                                         tumorales  8000/1  cc_onco770   \n",
       " T8                                         Carcinoma  8010/3  cc_onco770   \n",
       " T9                                    Carcinomatosis  8010/9  cc_onco770   \n",
       " T10                                       tumoración  8000/1  cc_onco770   \n",
       " T11                                     masa anexial  8000/6  cc_onco770   \n",
       " T12                         Carcinoma indiferenciado  8020/3  cc_onco770   \n",
       " T13                               lesiones hepáticas  8000/6  cc_onco770   \n",
       " T14                                       neoplásico  8000/1  cc_onco770   \n",
       " T15                                    LOE hepáticas  8000/6  cc_onco770   \n",
       " T16                                   adenocarcinoma  8140/3  cc_onco770   \n",
       " T17                                          tumores  8000/1  cc_onco770   \n",
       " T18                                células tumorales  8001/1  cc_onco770   \n",
       " T19                              enfermedad hepática  8000/6  cc_onco770   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    399.0     390.0  \n",
       " T2    435.0     429.0  \n",
       " T3    856.0     809.0  \n",
       " T4   1279.0    1274.0  \n",
       " T5   1861.0    1849.0  \n",
       " T6   1988.0    1976.0  \n",
       " T7   2355.0    2346.0  \n",
       " T8   2457.0    2448.0  \n",
       " T9   2531.0    2517.0  \n",
       " T10  2559.0    2549.0  \n",
       " T11  2837.0    2825.0  \n",
       " T12  2888.0    2864.0  \n",
       " T13  3402.0    3384.0  \n",
       " T14  3767.0    3757.0  \n",
       " T15  3922.0    3909.0  \n",
       " T16  4262.0    4248.0  \n",
       " T17  4384.0    4377.0  \n",
       " T18  4695.0    4678.0  \n",
       " T19  6002.0    5983.0  ,\n",
       " 'cc_onco772':                              CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1                       tumorales    8000/1  cc_onco772  2509.0    2500.0\n",
       " T2      diseminación leptomeníngea    8000/6  cc_onco772  2650.0    2624.0\n",
       " T3                    neoformativo    8000/1  cc_onco772  2842.0    2830.0\n",
       " T4                  lesión medular    8000/6  cc_onco772  3459.0    3445.0\n",
       " T5        Neoplasia indiferenciada   8000/14  cc_onco772  3892.0    3868.0\n",
       " T6                       Carcinoma    8010/3  cc_onco772  4143.0    4134.0\n",
       " T7                         linfoma    9590/3  cc_onco772  4228.0    4221.0\n",
       " T8                        melanoma    8720/3  cc_onco772  4254.0    4246.0\n",
       " T9                 rabdomiosarcoma    8900/3  cc_onco772  4289.0    4274.0\n",
       " T10                 neuroendocrino    8240/3  cc_onco772  4366.0    4352.0\n",
       " T11                       sarcomas    8800/3  cc_onco772  4760.0    4752.0\n",
       " T12     infiltración leptomeníngea    8000/6  cc_onco772  4801.0    4775.0\n",
       " T13               sarcoma de Ewing    9260/3  cc_onco772  5038.0    5022.0\n",
       " T14                     Ewing-like  8800/3/H  cc_onco772  5051.0    5041.0\n",
       " T15        metástasis de carcinoma    8010/6  cc_onco772  5084.0    5061.0\n",
       " T16  diferenciación neuroendocrina    8574/3  cc_onco772  5130.0    5101.0\n",
       " T17                             LB    9687/3  cc_onco772  7533.0    7531.0\n",
       " T18            implante peritoneal    8000/6  cc_onco772  9236.0    9217.0,\n",
       " 'cc_onco775':                                                CLAVE ICD-O-3   documento  \\\n",
       " T1   Adenocarcinoma de endometrio tipo endometrioide  8380/3  cc_onco775   \n",
       " T2                                         Carcinoma  8010/3  cc_onco775   \n",
       " T3                           tumor fibroso solitario  8815/0  cc_onco775   \n",
       " T4                                        neoplasias  8000/1  cc_onco775   \n",
       " T5                                        leiomiomas  8890/0  cc_onco775   \n",
       " T6                                    tumor desmoide  8821/1  cc_onco775   \n",
       " T7                                           tumores  8000/1  cc_onco775   \n",
       " T8                                   lóbulo hepático  8000/6  cc_onco775   \n",
       " T9                                 células tumorales  8001/1  cc_onco775   \n",
       " T10                                         implante  8000/6  cc_onco775   \n",
       " T11                                       metástasis  8000/6  cc_onco775   \n",
       " \n",
       "      endpos  startpos  \n",
       " T1    211.0     164.0  \n",
       " T2    178.0     169.0  \n",
       " T3    603.0     580.0  \n",
       " T4   2528.0    2518.0  \n",
       " T5   2597.0    2587.0  \n",
       " T6   2613.0    2599.0  \n",
       " T7   2820.0    2813.0  \n",
       " T8   3120.0    3105.0  \n",
       " T9   3563.0    3546.0  \n",
       " T10  4690.0    4682.0  \n",
       " T11  4701.0    4691.0  ,\n",
       " 'cc_onco781':                                    CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                         masa pulmonar  8000/6  cc_onco781  1424.0    1411.0\n",
       " T2                          metastásicos  8000/6  cc_onco781  1554.0    1542.0\n",
       " T3                          diseminación  8000/6  cc_onco781  1646.0    1634.0\n",
       " T4                        adenocarcinoma  8140/3  cc_onco781  1738.0    1724.0\n",
       " T5                            metástasis  8000/6  cc_onco781  3948.0    3938.0\n",
       " T6             linfangitis carcinomatosa  8000/3  cc_onco781  4054.0    4029.0\n",
       " T7              diseminación a distancia  8000/6  cc_onco781  4242.0    4218.0\n",
       " T8           progresión tumoral pulmonar  8000/6  cc_onco781  4517.0    4490.0\n",
       " T9                               tumoral  8000/1  cc_onco781  4508.0    4501.0\n",
       " T10  progresión tumoral a nivel pulmonar  8000/6  cc_onco781  5080.0    5045.0\n",
       " T11                   lesiones pleurales  8000/6  cc_onco781  5642.0    5624.0,\n",
       " 'cc_onco782':                                    CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                             neoplasia  8000/1  cc_onco782  1483.0    1474.0\n",
       " T2                nodulares subpleurales  8000/6  cc_onco782  2469.0    2447.0\n",
       " T3   metástasis de carcinoma epidermoide  8070/6  cc_onco782  2647.0    2612.0\n",
       " T4                                    M0  8000/6  cc_onco782  2721.0    2719.0\n",
       " T5                           metastásica  8000/6  cc_onco782  4243.0    4232.0\n",
       " T6                                 tumor  8000/1  cc_onco782  4432.0    4427.0\n",
       " T7                           metastásico  8000/6  cc_onco782  4465.0    4454.0\n",
       " T8                        adenocarcinoma  8140/3  cc_onco782  4588.0    4574.0\n",
       " T9                               maligna  8000/3  cc_onco782  6847.0    6840.0\n",
       " T10                             cT1bN0M0  8000/6  cc_onco782  7196.0    7188.0\n",
       " T11                   carcinoma escamoso  8070/3  cc_onco782  7274.0    7256.0\n",
       " T12    carcinoma de próstata metastásico  8010/6  cc_onco782  7345.0    7312.0\n",
       " T13                      lesión pulmonar  8000/6  cc_onco782  7491.0    7476.0,\n",
       " 'cc_onco785':                                CLAVE   ICD-O-3   documento  endpos  startpos\n",
       " T1              diseminación tumoral    8000/6  cc_onco785   852.0     832.0\n",
       " T2      adenocarcinoma endometrioide    8380/3  cc_onco785   893.0     865.0\n",
       " T3                         Carcinoma    8010/3  cc_onco785   879.0     870.0\n",
       " T4   endometrioide bien diferenciado   8380/31  cc_onco785   911.0     880.0\n",
       " T5        adenocarcinoma infiltrante  8140/3/H  cc_onco785  1119.0    1093.0\n",
       " T6                        malignidad    8000/3  cc_onco785  1382.0    1372.0\n",
       " T7                               cM0    8000/6  cc_onco785  1528.0    1525.0\n",
       " T8               implantes tumorales    8000/6  cc_onco785  2014.0    1995.0\n",
       " T9                   lesión pulmonar    8000/6  cc_onco785  2279.0    2264.0\n",
       " T10                       metástasis    8000/6  cc_onco785  2325.0    2315.0\n",
       " T11                  nódulo pulmonar    8000/6  cc_onco785  2855.0    2840.0\n",
       " T12     metástasis de adenocarcinoma    8140/6  cc_onco785  3077.0    3049.0,\n",
       " 'cc_onco792':                                      CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1  carcinoma neuroendocrino de alto grado  8246/34  cc_onco792   148.0   \n",
       " T2                          neuroendocrino   8240/3  cc_onco792   134.0   \n",
       " T3                                 tumores   8000/1  cc_onco792   335.0   \n",
       " T4                                 tumoral   8000/1  cc_onco792  2040.0   \n",
       " \n",
       "     startpos  \n",
       " T1     110.0  \n",
       " T2     120.0  \n",
       " T3     328.0  \n",
       " T4    2033.0  ,\n",
       " 'cc_onco793':                      CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1               neoplasia  8000/1  cc_onco793   953.0     944.0\n",
       " T2            omental cake  8000/6  cc_onco793  1143.0    1131.0\n",
       " T3     implante peritoneal  8000/6  cc_onco793  1166.0    1147.0\n",
       " T4                 tumoral  8000/1  cc_onco793  1659.0    1652.0\n",
       " T5         lóbulo hepático  8000/6  cc_onco793  1708.0    1693.0\n",
       " T6     mesotelioma maligno  9050/3  cc_onco793  1740.0    1721.0\n",
       " T7   afectación peritoneal  8000/6  cc_onco793  3275.0    3254.0\n",
       " T8  implantes peritoneales  8000/6  cc_onco793  3585.0    3563.0,\n",
       " 'cc_onco801':                                      CLAVE ICD-O-3   documento  endpos  \\\n",
       " T1   cáncer de mama lobulillar infiltrante  8520/3  cc_onco801   267.0   \n",
       " T2                              malignidad  8000/3  cc_onco801   729.0   \n",
       " T3        carcinoma lobulillar infiltrante  8520/3  cc_onco801   929.0   \n",
       " T4                                     pM0  8000/6  cc_onco801   965.0   \n",
       " T5                                      HE  9133/1  cc_onco801  1003.0   \n",
       " T6                                   tumor  8000/1  cc_onco801  1978.0   \n",
       " T7                                 tumoral  8000/1  cc_onco801  2403.0   \n",
       " T8                                      Ca  8000/3  cc_onco801  2434.0   \n",
       " T9                         afectación ósea  8000/6  cc_onco801  2681.0   \n",
       " T10                            metastásica  8000/6  cc_onco801  2788.0   \n",
       " T11                    afectación visceral  8000/6  cc_onco801  2812.0   \n",
       " T12                           metastásicas  8000/6  cc_onco801  3685.0   \n",
       " T13                            metastásico  8000/6  cc_onco801  5344.0   \n",
       " T14                         lesiones óseas  8000/6  cc_onco801  5366.0   \n",
       " T15               lesiones blásticas óseas  8000/6  cc_onco801  5564.0   \n",
       " T16                        enfermedad ósea  8000/6  cc_onco801  6077.0   \n",
       " \n",
       "      startpos  \n",
       " T1      230.0  \n",
       " T2      719.0  \n",
       " T3      897.0  \n",
       " T4      962.0  \n",
       " T5     1001.0  \n",
       " T6     1973.0  \n",
       " T7     2396.0  \n",
       " T8     2432.0  \n",
       " T9     2666.0  \n",
       " T10    2777.0  \n",
       " T11    2793.0  \n",
       " T12    3673.0  \n",
       " T13    5333.0  \n",
       " T14    5352.0  \n",
       " T15    5540.0  \n",
       " T16    6062.0  ,\n",
       " 'cc_onco805':                    CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1             neoplasia  8000/1  cc_onco805   353.0     344.0\n",
       " T2             tumorales  8000/1  cc_onco805   401.0     392.0\n",
       " T3              seminoma  9061/3  cc_onco805   633.0     625.0\n",
       " T4            neoplásica  8000/1  cc_onco805  3033.0    3023.0\n",
       " T5            malignidad  8000/3  cc_onco805  3165.0    3155.0\n",
       " T6  masa retroperitoneal  8000/6  cc_onco805  6308.0    6288.0\n",
       " T7    nódulos pulmonares  8000/6  cc_onco805  7233.0    7215.0\n",
       " T8            metástasis  8000/6  cc_onco805  7258.0    7248.0\n",
       " T9                cancer  8000/3  cc_onco805  9999.0    9993.0,\n",
       " 'cc_onco809':                        CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  carcinoma no microcítico  8046/3  cc_onco809  1262.0    1238.0\n",
       " T2            adenocarcinoma  8140/3  cc_onco809  1292.0    1278.0\n",
       " T3             masa pulmonar  8000/6  cc_onco809  2119.0    2106.0\n",
       " T4                 neoplasia  8000/1  cc_onco809  2410.0    2401.0\n",
       " T5                  T2bN2M1b  8000/6  cc_onco809  2637.0    2629.0\n",
       " T6              LOE cerebral  8000/6  cc_onco809  2651.0    2639.0\n",
       " T7       lesiones pulmonares  8000/6  cc_onco809  5079.0    5060.0\n",
       " T8                neoplásico  8000/1  cc_onco809  5129.0    5119.0,\n",
       " 'cc_onco810':                                      CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1                                  cáncer   8000/3  cc_onco810   104.0   \n",
       " T2                                   tumor   8000/1  cc_onco810   461.0   \n",
       " T3                          masa abdominal   8000/6  cc_onco810   620.0   \n",
       " T4                               tumorales   8000/1  cc_onco810  1344.0   \n",
       " T5                            masa pélvica   8000/6  cc_onco810  1457.0   \n",
       " T6                              malignidad   8000/3  cc_onco810  1826.0   \n",
       " T7  adenocarcinoma pobremente diferenciado  8140/33  cc_onco810  2129.0   \n",
       " T8           Carcinoma de células pequeñas   8041/3  cc_onco810  2636.0   \n",
       " \n",
       "     startpos  \n",
       " T1      98.0  \n",
       " T2     456.0  \n",
       " T3     606.0  \n",
       " T4    1335.0  \n",
       " T5    1445.0  \n",
       " T6    1816.0  \n",
       " T7    2091.0  \n",
       " T8    2607.0  ,\n",
       " 'cc_onco811':                         CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1  Astrocitoma de alto grado  9400/34  cc_onco811   794.0     769.0\n",
       " T2                 malignidad   8000/3  cc_onco811   808.0     798.0\n",
       " T3            lesión cerebral   8000/6  cc_onco811   838.0     823.0\n",
       " T4                 tumoración   8000/1  cc_onco811  1183.0    1173.0\n",
       " T5    glioblastoma multiforme   9440/3  cc_onco811  1679.0    1656.0\n",
       " T6                   blastoma   8000/3  cc_onco811  1668.0    1660.0\n",
       " T7                    tumoral   8000/1  cc_onco811  2090.0    2083.0\n",
       " T8                    tumores   8000/1  cc_onco811  2894.0    2887.0,\n",
       " 'cc_onco812':                      CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1   adenocarcinoma ductal  8500/3  cc_onco812   152.0     131.0\n",
       " T2                     cM0  8000/6  cc_onco812   265.0     262.0\n",
       " T3               tumorales  8000/1  cc_onco812   479.0     470.0\n",
       " T4                 tumores  8000/1  cc_onco812   671.0     664.0\n",
       " T5  enfermedad a distancia  8000/6  cc_onco812   773.0     751.0\n",
       " T6                 maligna  8000/3  cc_onco812  4189.0    4182.0\n",
       " T7              malignidad  8000/3  cc_onco812  4281.0    4271.0\n",
       " T8               neoplasia  8000/1  cc_onco812  4672.0    4663.0,\n",
       " 'cc_onco822':                               CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                           cáncer  8000/3  cc_onco822   343.0     337.0\n",
       " T2                       tumoración  8000/1  cc_onco822  1333.0    1323.0\n",
       " T3                          T2aN0M0  8000/6  cc_onco822  1411.0    1404.0\n",
       " T4      carcinoma de células claras  8310/3  cc_onco822  1556.0    1529.0\n",
       " T5               lesiones en pulmón  8000/6  cc_onco822  1873.0    1855.0\n",
       " T6                       metástasis  8000/6  cc_onco822  1910.0    1900.0\n",
       " T7                      metastásico  8000/6  cc_onco822  2183.0    2172.0\n",
       " T8                          tumoral  8000/1  cc_onco822  2567.0    2560.0\n",
       " T9   nódulos pulmonares bilaterales  8000/6  cc_onco822  3160.0    3130.0\n",
       " T10             lesiones pulmonares  8000/6  cc_onco822  3674.0    3655.0,\n",
       " 'cc_onco827':                        CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1        síndrome de Gorlin  8090/3  cc_onco827   109.0      91.0\n",
       " T2  carcinomas basocelulares  8090/3  cc_onco827   181.0     157.0\n",
       " T3       afectación muscular  8000/6  cc_onco827  3669.0    3650.0,\n",
       " 'cc_onco831':                          CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1            células malignas  8001/3  cc_onco831   708.0     692.0\n",
       " T2                  malignidad  8000/3  cc_onco831   847.0     837.0\n",
       " T3                  metástasis  8000/6  cc_onco831  1156.0    1146.0\n",
       " T4              adenocarcinoma  8140/3  cc_onco831  1276.0    1262.0\n",
       " T5                         M1a  8000/6  cc_onco831  1351.0    1348.0\n",
       " T6          nódulos pulmonares  8000/6  cc_onco831  2032.0    2014.0\n",
       " T7           lesiones cutáneas  8000/6  cc_onco831  2466.0    2449.0\n",
       " T8                     tumoral  8000/1  cc_onco831  5126.0    5119.0\n",
       " T9         progresión pulmonar  8000/6  cc_onco831  5249.0    5230.0\n",
       " T10  linfangitis carcinomatosa  8000/3  cc_onco831  5279.0    5254.0\n",
       " T11        progresión cerebral  8000/6  cc_onco831  5500.0    5481.0,\n",
       " 'cc_onco834':                               CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1              cistoadenocarcinoma  8440/3  cc_onco834  1399.0    1380.0\n",
       " T2          adenocarcinoma mucinoso  8480/3  cc_onco834  1408.0    1385.0\n",
       " T3          pseudomixoma peritoneal  8480/6  cc_onco834  1684.0    1661.0\n",
       " T4                           mixoma  8840/0  cc_onco834  1673.0    1667.0\n",
       " T5   neoplasia mucinosa apendicular  8480/1  cc_onco834  1728.0    1698.0\n",
       " T6                       metástasis  8000/6  cc_onco834  1743.0    1733.0\n",
       " T7                           cancer  8000/3  cc_onco834  1913.0    1907.0\n",
       " T8            afectación peritoneal  8000/6  cc_onco834  2005.0    1984.0\n",
       " T9                            tumor  8000/1  cc_onco834  2018.0    2013.0\n",
       " T10          implantes peritoneales  8000/6  cc_onco834  2180.0    2158.0\n",
       " T11                              M1  8000/6  cc_onco834  3029.0    3027.0,\n",
       " 'cc_onco838':                                         CLAVE ICD-O-3   documento  endpos  \\\n",
       " T1   adenopatías axilares o supraclaviculares  8000/6  cc_onco838  1551.0   \n",
       " T2                                 metástasis  8000/6  cc_onco838  1990.0   \n",
       " T3                             lesiones óseas  8000/6  cc_onco838  2083.0   \n",
       " T4                                  tumorales  8000/1  cc_onco838  2328.0   \n",
       " T5                                  formación  8000/1  cc_onco838  2440.0   \n",
       " T6                               cistoadenoma  8440/0  cc_onco838  2521.0   \n",
       " T7               carcinoma ductal infiltrante  8500/3  cc_onco838  3369.0   \n",
       " T8                                metastásica  8000/6  cc_onco838  3782.0   \n",
       " T9                    enfermedad a nivel óseo  8000/6  cc_onco838  4111.0   \n",
       " T10                                 neoplasia  8000/1  cc_onco838  4530.0   \n",
       " T11                               neoplásicas  8000/1  cc_onco838  5005.0   \n",
       " T12                                malignidad  8000/3  cc_onco838  5271.0   \n",
       " T13                       células neoplásicas  8001/1  cc_onco838  5529.0   \n",
       " T14                                 cutánides  8000/6  cc_onco838  5703.0   \n",
       " T15                           recaída cutánea  8000/6  cc_onco838  5992.0   \n",
       " \n",
       "      startpos  \n",
       " T1     1511.0  \n",
       " T2     1980.0  \n",
       " T3     2069.0  \n",
       " T4     2319.0  \n",
       " T5     2431.0  \n",
       " T6     2509.0  \n",
       " T7     3341.0  \n",
       " T8     3771.0  \n",
       " T9     4088.0  \n",
       " T10    4521.0  \n",
       " T11    4994.0  \n",
       " T12    5261.0  \n",
       " T13    5510.0  \n",
       " T14    5694.0  \n",
       " T15    5977.0  ,\n",
       " 'cc_onco842':                                 CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1                         malignidad   8000/3  cc_onco842   779.0     769.0\n",
       " T2                          tumorales   8000/1  cc_onco842  1316.0    1307.0\n",
       " T3                         metástasis   8000/6  cc_onco842  2059.0    2049.0\n",
       " T4  carcinoma pobremente diferenciado  8010/33  cc_onco842  2107.0    2074.0\n",
       " T5                  células tumorales   8001/1  cc_onco842  2182.0    2165.0\n",
       " T6      Adenopatías supraclaviculares   8000/6  cc_onco842  2682.0    2653.0\n",
       " T7      tumores de origen desconocido   8000/9  cc_onco842  4177.0    4148.0,\n",
       " 'cc_onco843':                        CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1          melanoma maligno  8720/3  cc_onco843   608.0     592.0\n",
       " T2                metástasis  8000/6  cc_onco843   843.0     833.0\n",
       " T3    metástasis de melanoma  8720/6  cc_onco843  1818.0    1796.0\n",
       " T4                 letálides  8000/6  cc_onco843  2039.0    2030.0\n",
       " T5   micronódulos pulmonares  8000/6  cc_onco843  2903.0    2880.0\n",
       " T6            lesión frontal  8000/6  cc_onco843  4053.0    4039.0\n",
       " T7                   tumoral  8000/1  cc_onco843  4600.0    4593.0\n",
       " T8           lesión temporal  8000/6  cc_onco843  5201.0    5186.0\n",
       " T9              metastásicas  8000/6  cc_onco843  6197.0    6185.0\n",
       " T10      progresión cerebral  8000/6  cc_onco843  6541.0    6522.0\n",
       " T11    lesión frontoparietal  8000/6  cc_onco843  6694.0    6673.0,\n",
       " 'cc_onco855':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                masa abdominal  8000/6  cc_onco855   597.0     583.0\n",
       " T2                         tumor  8000/1  cc_onco855   896.0     891.0\n",
       " T3          nódulos peritoneales  8000/6  cc_onco855  1469.0    1449.0\n",
       " T4                    metástasis  8000/6  cc_onco855  1505.0    1495.0\n",
       " T5                    tumoración  8000/1  cc_onco855  1999.0    1989.0\n",
       " T6                Timoma tipo B2  8584/1  cc_onco855  2092.0    2078.0\n",
       " T7                      implante  8000/6  cc_onco855  2652.0    2644.0\n",
       " T8           progresión hepática  8000/6  cc_onco855  2951.0    2932.0\n",
       " T9   progresión a nivel hepático  8000/6  cc_onco855  3657.0    3630.0\n",
       " T10                      maligna  8000/3  cc_onco855  4088.0    4081.0,\n",
       " 'cc_onco867':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                       papiloma  8050/0  cc_onco867    74.0      66.0\n",
       " T2                        maligno  8000/3  cc_onco867   569.0     562.0\n",
       " T3             carcinoma escamoso  8070/3  cc_onco867   714.0     696.0\n",
       " T4               células malignas  8001/3  cc_onco867  1409.0    1393.0\n",
       " T5                        tumoral  8000/1  cc_onco867  1497.0    1490.0\n",
       " T6                     metástasis  8000/6  cc_onco867  2679.0    2669.0\n",
       " T7             nódulos pulmonares  8000/6  cc_onco867  3114.0    3096.0\n",
       " T8  progresión pulmonar bilateral  8000/6  cc_onco867  3780.0    3751.0,\n",
       " 'cc_onco877':                                          CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1                                   Carcinoma   8010/3  cc_onco877   155.0   \n",
       " T2                                      cáncer   8000/3  cc_onco877   422.0   \n",
       " T3                                   poliposis   8210/0  cc_onco877   486.0   \n",
       " T4                carcinoma ductal infiltrante   8500/3  cc_onco877   525.0   \n",
       " T5                                    pT2pN0M0   8000/6  cc_onco877   547.0   \n",
       " T6                                     tumoral   8000/1  cc_onco877   566.0   \n",
       " T7                                          HE   9133/1  cc_onco877   587.0   \n",
       " T8                          nódulos pulmonares   8000/6  cc_onco877  1537.0   \n",
       " T9                       enfermedad secundaria   8000/6  cc_onco877  1715.0   \n",
       " T10                                  tumorales   8000/1  cc_onco877  1880.0   \n",
       " T11                                    tumores   8000/1  cc_onco877  2522.0   \n",
       " T12                             adenocarcinoma   8140/3  cc_onco877  2713.0   \n",
       " T13                                 malignidad   8000/3  cc_onco877  3253.0   \n",
       " T14                            nódulo pulmonar   8000/6  cc_onco877  3364.0   \n",
       " T15  adenocarcinoma moderadamente diferenciado  8140/32  cc_onco877  3970.0   \n",
       " T16                                   pT1aN0M0   8000/6  cc_onco877  3998.0   \n",
       " T17                              masa pulmonar   8000/6  cc_onco877  4361.0   \n",
       " T18                               metastásicos   8000/6  cc_onco877  4404.0   \n",
       " T19                                metastásica   8000/6  cc_onco877  4440.0   \n",
       " T20                          diseminación ósea   8000/6  cc_onco877  4505.0   \n",
       " T21                                 metástasis   8000/6  cc_onco877  5329.0   \n",
       " T22                             lesiones óseas   8000/6  cc_onco877  5837.0   \n",
       " \n",
       "      startpos  \n",
       " T1      146.0  \n",
       " T2      416.0  \n",
       " T3      477.0  \n",
       " T4      497.0  \n",
       " T5      539.0  \n",
       " T6      559.0  \n",
       " T7      585.0  \n",
       " T8     1519.0  \n",
       " T9     1694.0  \n",
       " T10    1871.0  \n",
       " T11    2515.0  \n",
       " T12    2699.0  \n",
       " T13    3243.0  \n",
       " T14    3349.0  \n",
       " T15    3929.0  \n",
       " T16    3990.0  \n",
       " T17    4348.0  \n",
       " T18    4392.0  \n",
       " T19    4429.0  \n",
       " T20    4488.0  \n",
       " T21    5319.0  \n",
       " T22    5823.0  ,\n",
       " 'cc_onco880':              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1          cáncer  8000/3  cc_onco880   425.0     419.0\n",
       " T2      tumoración  8000/1  cc_onco880  1118.0    1108.0\n",
       " T3         tumoral  8000/1  cc_onco880  1569.0    1562.0\n",
       " T4      metástasis  8000/6  cc_onco880  1810.0    1800.0\n",
       " T5              HE  9133/1  cc_onco880  1932.0    1930.0\n",
       " T6  adenocarcinoma  8140/3  cc_onco880  1986.0    1972.0,\n",
       " 'cc_onco881':                              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1     carcinoma ducal infiltrante  8500/3  cc_onco881   268.0     241.0\n",
       " T2                         tumoral  8000/1  cc_onco881   502.0     495.0\n",
       " T3  nódulos pulmonares bilaterales  8000/6  cc_onco881  1586.0    1556.0\n",
       " T4                     metastásica  8000/6  cc_onco881  1898.0    1887.0\n",
       " T5                       neoplasia  8000/1  cc_onco881  2072.0    2063.0\n",
       " T6             lesiones pulmonares  8000/6  cc_onco881  2608.0    2589.0\n",
       " T7                    metastásicas  8000/6  cc_onco881  2694.0    2682.0\n",
       " T8                    lesión renal  8000/6  cc_onco881  2721.0    2709.0,\n",
       " 'cc_onco887':              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1      malignidad  8000/3  cc_onco887   553.0     543.0\n",
       " T2  adenocarcinoma  8140/3  cc_onco887   612.0     598.0\n",
       " T3     metastásica  8000/6  cc_onco887   687.0     676.0\n",
       " T4             M1a  8000/6  cc_onco887   772.0     769.0\n",
       " T5         tumoral  8000/1  cc_onco887   820.0     813.0,\n",
       " 'cc_onco89':                CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1  Masa medistínica  8000/6  cc_onco89   724.0     708.0\n",
       " T2        malignidad  8000/3  cc_onco89   890.0     880.0\n",
       " T3            Timoma  8580/1  cc_onco89  1032.0    1026.0\n",
       " T4  carcinoma tímico  8586/3  cc_onco89  1063.0    1047.0\n",
       " T5      sarcomatoide  8033/3  cc_onco89  1084.0    1072.0\n",
       " T6        tumoración  8000/1  cc_onco89  1208.0    1198.0\n",
       " T7          implante  8000/6  cc_onco89  2857.0    2849.0,\n",
       " 'cc_onco899':                           CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1  carcinoma adenoide quístico  8200/3  cc_onco899   285.0     258.0\n",
       " T2      metástasis de carcinoma  8010/6  cc_onco899   497.0     474.0\n",
       " T3           lesiones hepáticas  8000/6  cc_onco899   743.0     725.0\n",
       " T4                  metastásico  8000/6  cc_onco899  1368.0    1357.0\n",
       " T5                        tumor  8000/1  cc_onco899  1522.0    1517.0\n",
       " T6          progresión hepática  8000/6  cc_onco899  1743.0    1724.0,\n",
       " 'cc_onco9':                              CLAVE   ICD-O-3 documento  endpos  startpos\n",
       " T1               lesiones cutáneas    8000/6  cc_onco9  1055.0    1038.0\n",
       " T2                   masa pulmonar    8000/6  cc_onco9  1211.0    1198.0\n",
       " T3   nódulo pulmonar contralateral    8000/6  cc_onco9  1797.0    1768.0\n",
       " T4                    metastásicas    8000/6  cc_onco9  1907.0    1895.0\n",
       " T5                      neoplásica    8000/1  cc_onco9  2410.0    2400.0\n",
       " T6      adenocarcinoma infiltrante  8140/3/H  cc_onco9  2742.0    2716.0\n",
       " T7               células tumorales    8001/1  cc_onco9  2801.0    2784.0\n",
       " T8                             cM1    8000/6  cc_onco9  2976.0    2973.0\n",
       " T9                 lesión pulmonar    8000/6  cc_onco9  3019.0    3004.0\n",
       " T10                     carcinomas    8010/3  cc_onco9  3183.0    3173.0,\n",
       " 'cc_onco901':                                                 CLAVE ICD-O-3   documento  \\\n",
       " T1                        síndrome linfoproliferativo  9970/1  cc_onco901   \n",
       " T2                             implantes peritoneales  8000/6  cc_onco901   \n",
       " T3  tumor desmoplásico de células pequeñas y redondas  8806/3  cc_onco901   \n",
       " T4                                         tumoración  8000/1  cc_onco901   \n",
       " T5                               nódulos peritoneales  8000/6  cc_onco901   \n",
       " T6                                            tumores  8000/1  cc_onco901   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1  1952.0    1925.0  \n",
       " T2  2208.0    2186.0  \n",
       " T3  2344.0    2295.0  \n",
       " T4  2359.0    2349.0  \n",
       " T5  4643.0    4623.0  \n",
       " T6  4881.0    4874.0  ,\n",
       " 'cc_onco902':                               CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1     carcinoma ductal infiltrante  8500/3  cc_onco902   266.0     238.0\n",
       " T2                              CDI  8500/3  cc_onco902   279.0     276.0\n",
       " T3                carcinoma in situ  8010/2  cc_onco902   347.0     330.0\n",
       " T4                       metástasis  8000/6  cc_onco902   484.0     474.0\n",
       " T5                               M0  8000/6  cc_onco902   648.0     646.0\n",
       " T6                          tumores  8000/1  cc_onco902   682.0     675.0\n",
       " T7   nódulos pulmonares bilaterales  8000/6  cc_onco902  2666.0    2636.0\n",
       " T8                      metastásica  8000/6  cc_onco902  2784.0    2773.0\n",
       " T9                   lesiones óseas  8000/6  cc_onco902  2815.0    2801.0\n",
       " T10                      malignidad  8000/3  cc_onco902  2840.0    2830.0\n",
       " T11                   lesión lítica  8000/6  cc_onco902  2872.0    2859.0\n",
       " T12          masa de partes blandas  8000/6  cc_onco902  2899.0    2877.0\n",
       " T13                 lesión pulmonar  8000/6  cc_onco902  3422.0    3407.0\n",
       " T14                mieloma múltiple  9732/3  cc_onco902  4694.0    4678.0\n",
       " T15                    plasmocitoma  9731/3  cc_onco902  4726.0    4714.0,\n",
       " 'cc_onco926':                            CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1                    tumoración   8000/1  cc_onco926   979.0     969.0\n",
       " T2                       lipomas   8850/0  cc_onco926  1137.0    1130.0\n",
       " T3                    neoplásico   8000/1  cc_onco926  2856.0    2846.0\n",
       " T4      carcinoma no microcítico   8046/3  cc_onco926  3352.0    3328.0\n",
       " T5  tumoración de partes blandas   8800/1  cc_onco926  3479.0    3451.0\n",
       " T6       metástasis de carcinoma   8010/6  cc_onco926  3533.0    3510.0\n",
       " T7   carcinoma poco diferenciado  8010/33  cc_onco926  3551.0    3524.0,\n",
       " 'cc_onco928':                            CLAVE  ICD-O-3   documento  endpos  startpos\n",
       " T1           implante peritoneal   8000/6  cc_onco928  1326.0    1307.0\n",
       " T2                adenocarcinoma   8140/3  cc_onco928  1418.0    1404.0\n",
       " T3                     neoplasia   8000/1  cc_onco928  1796.0    1787.0\n",
       " T4                    metástasis   8000/6  cc_onco928  1831.0    1821.0\n",
       " T5            lesiones hepáticas   8000/6  cc_onco928  2871.0    2853.0\n",
       " T6                       tumoral   8000/1  cc_onco928  3357.0    3350.0\n",
       " T7               lesión hepática   8000/6  cc_onco928  3388.0    3373.0\n",
       " T8  adenocarcinoma de bajo grado  8140/31  cc_onco928  3779.0    3751.0,\n",
       " 'cc_onco938':                                       CLAVE  ICD-O-3   documento  endpos  \\\n",
       " T1                                    tumor   8000/1  cc_onco938   790.0   \n",
       " T2                               malignidad   8000/3  cc_onco938  1027.0   \n",
       " T3   adenocarcinoma pobremente diferenciado  8140/33  cc_onco938  1201.0   \n",
       " T4                           Carcinomatosis   8010/9  cc_onco938  1333.0   \n",
       " T5                                   cáncer   8000/3  cc_onco938  1909.0   \n",
       " T6                          progresión ósea   8000/6  cc_onco938  2309.0   \n",
       " T7                               metástasis   8000/6  cc_onco938  2502.0   \n",
       " T8                           lesiones óseas   8000/6  cc_onco938  2811.0   \n",
       " T9                                 adenomas   8140/0  cc_onco938  2915.0   \n",
       " T10                               formación   8000/1  cc_onco938  2955.0   \n",
       " T11                                 maligna   8000/3  cc_onco938  2963.0   \n",
       " T12                                 tumores   8000/1  cc_onco938  3031.0   \n",
       " T13                 metástasis de carcinoma   8010/6  cc_onco938  3115.0   \n",
       " T14                             metastático   8000/6  cc_onco938  3255.0   \n",
       " \n",
       "      startpos  \n",
       " T1      785.0  \n",
       " T2     1017.0  \n",
       " T3     1163.0  \n",
       " T4     1319.0  \n",
       " T5     1903.0  \n",
       " T6     2294.0  \n",
       " T7     2492.0  \n",
       " T8     2797.0  \n",
       " T9     2907.0  \n",
       " T10    2946.0  \n",
       " T11    2956.0  \n",
       " T12    3024.0  \n",
       " T13    3092.0  \n",
       " T14    3244.0  ,\n",
       " 'cc_onco94':                              CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1  nódulos pulmonares bilaterales  8000/6  cc_onco94  1338.0    1308.0\n",
       " T2                         linfoma  9590/3  cc_onco94  1697.0    1690.0\n",
       " T3                      malignidad  8000/3  cc_onco94  1867.0    1857.0\n",
       " T4      proceso linfoproliferativo  9970/1  cc_onco94  2041.0    2015.0\n",
       " T5                       Carcinoma  8010/3  cc_onco94  2053.0    2044.0\n",
       " T6               sarcoma de Kaposi  9140/3  cc_onco94  2370.0    2353.0,\n",
       " 'cc_onco941':                               CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                  masa parahiliar  8000/6  cc_onco941   394.0     379.0\n",
       " T2                    masa pulmonar  8000/6  cc_onco941   447.0     434.0\n",
       " T3   nódulos pulmonares bilaterales  8000/6  cc_onco941   581.0     551.0\n",
       " T4        linfangitis carcinomatosa  8000/3  cc_onco941   611.0     586.0\n",
       " T5    lesiones blásticas en columna  8000/6  cc_onco941   662.0     633.0\n",
       " T6                   adenocarcinoma  8140/3  cc_onco941  1061.0    1047.0\n",
       " T7                  anillo de sello  8490/3  cc_onco941  1080.0    1065.0\n",
       " T8                         T2bN2M1b  8000/6  cc_onco941  1549.0    1541.0\n",
       " T9                            CPCNP  8046/3  cc_onco941  2451.0    2446.0\n",
       " T10                     metastásica  8000/6  cc_onco941  2949.0    2938.0\n",
       " T11             lesiones pulmonares  8000/6  cc_onco941  3004.0    2985.0\n",
       " T12                       tumorales  8000/1  cc_onco941  3207.0    3198.0\n",
       " T13                lesiones renales  8000/6  cc_onco941  3590.0    3574.0,\n",
       " 'cc_onco943':                                 CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1            glioblastoma multiforme  9440/3  cc_onco943  1202.0    1179.0\n",
       " T2                           blastoma  8000/3  cc_onco943  1191.0    1183.0\n",
       " T3                 lesión osteolítica  8000/6  cc_onco943  2337.0    2319.0\n",
       " T4                   Lesiones líticas  8000/6  cc_onco943  2605.0    2589.0\n",
       " T5             masa de partes blandas  8000/6  cc_onco943  2810.0    2788.0\n",
       " T6                          tumorales  8000/1  cc_onco943  2856.0    2847.0\n",
       " T7                            tumores  8000/1  cc_onco943  3035.0    3028.0\n",
       " T8   neoplasia de células plasmáticas  9731/3  cc_onco943  3217.0    3185.0\n",
       " T9                       plasmocitoma  9731/3  cc_onco943  3231.0    3219.0\n",
       " T10                 infiltración ósea  8000/6  cc_onco943  3292.0    3275.0\n",
       " T11                   lesión cerebral  8000/6  cc_onco943  3799.0    3784.0,\n",
       " 'cc_onco95':                                 CLAVE ICD-O-3  documento  endpos  startpos\n",
       " T1  carcinoma renal de células claras  8310/3  cc_onco95   107.0      74.0\n",
       " T2                            pT3N0M0  8000/6  cc_onco95   115.0     108.0\n",
       " T3                         metástasis  8000/6  cc_onco95   209.0     199.0\n",
       " T4                 nódulos pulmonares  8000/6  cc_onco95  2393.0    2375.0,\n",
       " 'cc_onco950':                          CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1        lesiones a distancia  8000/6  cc_onco950  1240.0    1220.0\n",
       " T2   tumor de células pequeñas  8002/1  cc_onco950  1315.0    1290.0\n",
       " T3                     maligno  8000/3  cc_onco950  1560.0    1553.0\n",
       " T4                      cáncer  8000/3  cc_onco950  1683.0    1677.0\n",
       " T5                       Ewing  9260/3  cc_onco950  1798.0    1793.0\n",
       " T6           células tumorales  8001/1  cc_onco950  1861.0    1844.0\n",
       " T7            sarcoma de Ewing  9260/3  cc_onco950  1965.0    1949.0\n",
       " T8                     tumores  8000/1  cc_onco950  2150.0    2143.0\n",
       " T9                  tumoración  8000/1  cc_onco950  2542.0    2532.0\n",
       " T10     masa de partes blandas  8000/6  cc_onco950  2792.0    2770.0\n",
       " T11  tumor de células redondas  8041/1  cc_onco950  4351.0    4326.0\n",
       " T12         lesiones hepáticas  8000/6  cc_onco950  5305.0    5287.0,\n",
       " 'cc_onco953':                              CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                       tumorales  8000/1  cc_onco953   769.0     760.0\n",
       " T2               Masa mediastínica  8000/6  cc_onco953   828.0     811.0\n",
       " T3               células tumorales  8001/1  cc_onco953  1578.0    1561.0\n",
       " T4       tumor de seno endodérmico  9071/3  cc_onco953  1649.0    1624.0\n",
       " T5                  yolk sac tumor  9071/3  cc_onco953  1665.0    1651.0\n",
       " T6  tumor germinal no seminomatoso  9065/3  cc_onco953  1713.0    1683.0\n",
       " T7                        seminoma  9061/3  cc_onco953  1709.0    1701.0\n",
       " T8                         tumores  8000/1  cc_onco953  2003.0    1996.0\n",
       " T9                      tumoración  8000/1  cc_onco953  3115.0    3105.0,\n",
       " 'cc_onco956':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                    malignidad  8000/3  cc_onco956  1761.0    1751.0\n",
       " T2                    metástasis  8000/6  cc_onco956  1906.0    1896.0\n",
       " T3  enfermedad a nivel sistémico  8000/6  cc_onco956  2046.0    2018.0,\n",
       " 'cc_onco958':                            CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                        cáncer  8000/3  cc_onco958   122.0     116.0\n",
       " T2                            CM  8000/3  cc_onco958   253.0     251.0\n",
       " T3                    tumoración  8000/1  cc_onco958   619.0     609.0\n",
       " T4  metástasis de adenocarcinoma  8140/6  cc_onco958  2031.0    2003.0\n",
       " T5           células neoplásicas  8001/1  cc_onco958  2443.0    2424.0\n",
       " T6            carcinoma secretor  8502/3  cc_onco958  3207.0    3189.0\n",
       " T7                            HE  9133/1  cc_onco958  3237.0    3235.0\n",
       " T8                       tumores  8000/1  cc_onco958  3411.0    3404.0\n",
       " T9                   lesión ósea  8000/6  cc_onco958  3611.0    3600.0,\n",
       " 'cc_onco960':                               CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                colangiocarcinoma  8160/3  cc_onco960  1432.0    1415.0\n",
       " T2               lesiones hepáticas  8000/6  cc_onco960  1471.0    1453.0\n",
       " T3                      hemangiomas  9120/0  cc_onco960  1593.0    1582.0\n",
       " T4              células neoplásicas  8001/1  cc_onco960  2202.0    2183.0\n",
       " T5  metástasis de colangiocarcinoma  8160/6  cc_onco960  2287.0    2256.0\n",
       " T6                  hepatocarcinoma  8170/3  cc_onco960  2650.0    2635.0\n",
       " T7                            tumor  8000/1  cc_onco960  2708.0    2703.0\n",
       " T8                  nódulo hepático  8000/6  cc_onco960  3782.0    3767.0\n",
       " T9              progresión hepática  8000/6  cc_onco960  4138.0    4119.0,\n",
       " 'cc_onco964':                   CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1       adenocarcinoma  8140/3  cc_onco964   108.0      94.0\n",
       " T2       Carcinomatosis  8010/9  cc_onco964   234.0     220.0\n",
       " T3                   HE  9133/1  cc_onco964   249.0     247.0\n",
       " T4            neoplasia  8000/1  cc_onco964  1354.0    1345.0\n",
       " T5              tumoral  8000/1  cc_onco964  1752.0    1745.0\n",
       " T6  progresión hepática  8000/6  cc_onco964  2761.0    2742.0,\n",
       " 'cc_onco975':                                  CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                              cáncer  8000/3  cc_onco975   241.0     235.0\n",
       " T2                        hipernefroma  8312/3  cc_onco975   924.0     912.0\n",
       " T3                           Carcinoma  8010/3  cc_onco975  1329.0    1320.0\n",
       " T4                          metástasis  8000/6  cc_onco975  1369.0    1359.0\n",
       " T5                             tumoral  8000/1  cc_onco975  2620.0    2613.0\n",
       " T6          adenopatía supraclavicular  8000/6  cc_onco975  2968.0    2942.0\n",
       " T7                             maligna  8000/3  cc_onco975  2987.0    2980.0\n",
       " T8            metástasis por carcinoma  8010/6  cc_onco975  3028.0    3004.0\n",
       " T9   carcinoma renal de células claras  8310/3  cc_onco975  3353.0    3320.0\n",
       " T10        carcinoma de células claras  8310/3  cc_onco975  3498.0    3471.0,\n",
       " 'cc_onco977':                             CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1                     neoplásico  8000/1  cc_onco977   789.0     779.0\n",
       " T2   carcinoma ductal infiltrante  8500/3  cc_onco977  1113.0    1085.0\n",
       " T3                             HE  9133/1  cc_onco977  1143.0    1141.0\n",
       " T4                     malignidad  8000/3  cc_onco977  1404.0    1394.0\n",
       " T5          extensión a distancia  8000/6  cc_onco977  1658.0    1637.0\n",
       " T6         malignidad a distancia  8000/6  cc_onco977  1793.0    1771.0\n",
       " T7                         T2N2M0  8000/6  cc_onco977  1908.0    1902.0\n",
       " T8                        tumores  8000/1  cc_onco977  1977.0    1970.0\n",
       " T9                      tumorales  8000/1  cc_onco977  5196.0    5187.0\n",
       " T10                    neoplásica  8000/1  cc_onco977  5258.0    5248.0,\n",
       " 'cc_onco978':                                    CLAVE ICD-O-3   documento  endpos  startpos\n",
       " T1          carcinoma ductal infiltrante  8500/3  cc_onco978   421.0     393.0\n",
       " T2                                T2N0M0  8000/6  cc_onco978   446.0     440.0\n",
       " T3                               tumoral  8000/1  cc_onco978   684.0     677.0\n",
       " T4                          metastásicas  8000/6  cc_onco978   726.0     714.0\n",
       " T5                             tumorales  8000/1  cc_onco978  1422.0    1413.0\n",
       " T6                            metástasis  8000/6  cc_onco978  1474.0    1464.0\n",
       " T7            Cáncer de mama metastásico  8000/6  cc_onco978  1910.0    1884.0\n",
       " T8                                    CM  8000/3  cc_onco978  1914.0    1912.0\n",
       " T9  Carcinoma de mama ductal infiltrante  8500/3  cc_onco978  3386.0    3350.0,\n",
       " 'S0004-06142005000100009-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  hipernefroma  8312/3  S0004-06142005000100009-1   779.0     767.0\n",
       " T2    tumoración  8000/1  S0004-06142005000100009-1  1670.0    1660.0\n",
       " T3       tumoral  8000/1  S0004-06142005000100009-1  1790.0    1783.0,\n",
       " 'S0004-06142005000200004-1':                       CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                Carcinoma  8010/3  S0004-06142005000200004-1    94.0   \n",
       " T2         masa suprarrenal  8000/6  S0004-06142005000200004-1   365.0   \n",
       " T3               tumoración  8000/1  S0004-06142005000200004-1   736.0   \n",
       " T4        nódulos hepáticos  8000/6  S0004-06142005000200004-1  1750.0   \n",
       " T5               metástasis  8000/6  S0004-06142005000200004-1  1775.0   \n",
       " T6  metástasis de carcinoma  8010/6  S0004-06142005000200004-1  2114.0   \n",
       " T7                  tumoral  8000/1  S0004-06142005000200004-1  2185.0   \n",
       " T8                tumorales  8000/1  S0004-06142005000200004-1  2672.0   \n",
       " \n",
       "     startpos  \n",
       " T1      85.0  \n",
       " T2     349.0  \n",
       " T3     726.0  \n",
       " T4    1733.0  \n",
       " T5    1765.0  \n",
       " T6    2091.0  \n",
       " T7    2178.0  \n",
       " T8    2663.0  ,\n",
       " 'S0004-06142005000200009-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoplásica  8000/1  S0004-06142005000200009-1   669.0     659.0,\n",
       " 'S0004-06142005000200009-2':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  S0004-06142005000200009-2   394.0     385.0,\n",
       " 'S0004-06142005000200009-3':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  S0004-06142005000200009-3   475.0     466.0,\n",
       " 'S0004-06142005000200009-4':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  S0004-06142005000200009-4   487.0     478.0,\n",
       " 'S0004-06142005000200009-5':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  S0004-06142005000200009-5   115.0     106.0,\n",
       " 'S0004-06142005000300011-1':                            CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1  carcinoma de células renales  8312/3  S0004-06142005000300011-1   560.0   \n",
       " T2                  neoformación  8000/1  S0004-06142005000300011-1   947.0   \n",
       " T3                    tumoración  8000/1  S0004-06142005000300011-1  1147.0   \n",
       " T4                   metastático  8000/6  S0004-06142005000300011-1  1482.0   \n",
       " T5                  sarcomatoide  8033/3  S0004-06142005000300011-1  1504.0   \n",
       " \n",
       "     startpos  \n",
       " T1     532.0  \n",
       " T2     935.0  \n",
       " T3    1137.0  \n",
       " T4    1471.0  \n",
       " T5    1492.0  ,\n",
       " 'S0004-06142005000300012-1':                           CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                 hipernefroma  8312/3  S0004-06142005000300012-1   282.0   \n",
       " T2                    formación  8000/1  S0004-06142005000300012-1   459.0   \n",
       " T3                   neoplásica  8000/1  S0004-06142005000300012-1   492.0   \n",
       " T4                   tumoración  8000/1  S0004-06142005000300012-1   568.0   \n",
       " T5  carcinoma de células claras  8310/3  S0004-06142005000300012-1  1725.0   \n",
       " \n",
       "     startpos  \n",
       " T1     270.0  \n",
       " T2     450.0  \n",
       " T3     482.0  \n",
       " T4     558.0  \n",
       " T5    1698.0  ,\n",
       " 'S0004-06142005000400011-1':                                   CLAVE ICD-O-3                  documento  \\\n",
       " T1  carcinoma de células transicionales  8120/3  S0004-06142005000400011-1   \n",
       " T2                                tumor  8000/1  S0004-06142005000400011-1   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1  1133.0    1098.0  \n",
       " T2  1655.0    1650.0  ,\n",
       " 'S0004-06142005000500011-1':                   CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1              adenoma  8140/0  S0004-06142005000500011-1   692.0     685.0\n",
       " T2           malignidad  8000/3  S0004-06142005000500011-1  1054.0    1044.0\n",
       " T3         tumoraciones  8000/1  S0004-06142005000500011-1  1822.0    1810.0\n",
       " T4  carcinoma urotelial  8120/3  S0004-06142005000500011-1  1927.0    1908.0,\n",
       " 'S0004-06142005000500014-1':                     CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  carcinoma epidermoide  8070/3  S0004-06142005000500014-1    98.0      77.0\n",
       " T2              neoplasia  8000/1  S0004-06142005000500014-1  1397.0    1388.0\n",
       " T3    carcinoma urotelial  8120/3  S0004-06142005000500014-1  1584.0    1565.0\n",
       " T4           hipernefroma  8312/3  S0004-06142005000500014-1  1623.0    1611.0\n",
       " T5             metástasis  8000/6  S0004-06142005000500014-1  2050.0    2040.0,\n",
       " 'S0004-06142005000900012-1':               CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  rabdomiosarcoma  8900/3  S0004-06142005000900012-1    58.0      43.0\n",
       " T2       neoplásica  8000/1  S0004-06142005000900012-1   221.0     211.0\n",
       " T3       metástasis  8000/6  S0004-06142005000900012-1  1171.0    1161.0\n",
       " T4       tumoración  8000/1  S0004-06142005000900012-1  1286.0    1276.0\n",
       " T5      neoplásicas  8000/1  S0004-06142005000900012-1  1767.0    1756.0,\n",
       " 'S0004-06142005000900013-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  S0004-06142005000900013-1   179.0     169.0\n",
       " T2       Mioma  8895/0  S0004-06142005000900013-1   998.0     993.0\n",
       " T3     adenoma  8140/0  S0004-06142005000900013-1  1164.0    1157.0\n",
       " T4   miomatoso  8895/0  S0004-06142005000900013-1  1829.0    1820.0,\n",
       " 'S0004-06142005000900014-1':     CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  Mioma  8895/0  S0004-06142005000900014-1   799.0     794.0,\n",
       " 'S0004-06142005000900015-1':                           CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1   afectación retroperitoneal  8000/6  S0004-06142005000900015-1   564.0   \n",
       " T2                        tumor  8000/1  S0004-06142005000900015-1   593.0   \n",
       " T3                   neoplásica  8000/1  S0004-06142005000900015-1   759.0   \n",
       " T4                      linfoma  9590/3  S0004-06142005000900015-1   798.0   \n",
       " T5  Rabdomiosarcoma pleomórfico  8901/3  S0004-06142005000900015-1   923.0   \n",
       " T6                    tumorales  8000/1  S0004-06142005000900015-1  1233.0   \n",
       " \n",
       "     startpos  \n",
       " T1     538.0  \n",
       " T2     588.0  \n",
       " T3     749.0  \n",
       " T4     791.0  \n",
       " T5     896.0  \n",
       " T6    1224.0  ,\n",
       " 'S0004-06142005000900016-1':                    CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  hemangioma cavernoso  9121/0  S0004-06142005000900016-1  1016.0     996.0\n",
       " T2               Angioma  9120/0  S0004-06142005000900016-1  1006.0     999.0,\n",
       " 'S0004-06142005001000010-1':           CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  adenomatosa  8140/0  S0004-06142005001000010-1   208.0     197.0,\n",
       " 'S0004-06142005001000011-1':                         CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1  lesiones a nivel cerebral  8000/6  S0004-06142005001000011-1  1755.0   \n",
       " \n",
       "     startpos  \n",
       " T1    1730.0  ,\n",
       " 'S0004-06142005001000011-2':        CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  implante  8000/6  S0004-06142005001000011-2   643.0     635.0,\n",
       " 'S0004-06142005001000011-3':               CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  hepatocarcinoma  8170/3  S0004-06142005001000011-3   381.0     366.0,\n",
       " 'S0004-06142005001000014-1':                CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  células malignas  8001/3  S0004-06142005001000014-1   720.0     704.0\n",
       " T2        tumoración  8000/1  S0004-06142005001000014-1   781.0     771.0\n",
       " T3         neoplasia  8000/1  S0004-06142005001000014-1   913.0     904.0\n",
       " T4         Carcinoma  8010/3  S0004-06142005001000014-1  1011.0    1002.0\n",
       " T5             Mioma  8895/0  S0004-06142005001000014-1  1834.0    1829.0,\n",
       " 'S0004-06142005001000016-1':                 CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración blanda  8800/1  S0004-06142005001000016-1   104.0      87.0\n",
       " T2        adenomatosa  8140/0  S0004-06142005001000016-1   409.0     398.0,\n",
       " 'S0004-06142006000100010-1':                CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  masa suprarrenal  8000/6  S0004-06142006000100010-1   267.0     251.0\n",
       " T2           tumoral  8000/1  S0004-06142006000100010-1   507.0     500.0\n",
       " T3            lipoma  8850/0  S0004-06142006000100010-1  1333.0    1327.0,\n",
       " 'S0004-06142006000100011-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  S0004-06142006000100011-1   237.0     227.0,\n",
       " 'S0004-06142006000100012-1':                                            CLAVE ICD-O-3  \\\n",
       " T1  neoplasia intratubular de células germinales  9064/2   \n",
       " T2                                         tumor  8000/1   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142006000100012-1   453.0     409.0  \n",
       " T2  S0004-06142006000100012-1   480.0     475.0  ,\n",
       " 'S0004-06142006000100013-1':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  S0004-06142006000100013-1   555.0     541.0\n",
       " T2      tumoración  8000/1  S0004-06142006000100013-1   733.0     723.0,\n",
       " 'S0004-06142006000100014-1':                            CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                adenocarcinoma  8140/3  S0004-06142006000100014-1   111.0   \n",
       " T2                    tumoración  8000/1  S0004-06142006000100014-1   469.0   \n",
       " T3                Carcinomatosis  8010/9  S0004-06142006000100014-1   750.0   \n",
       " T4                       tumoral  8000/1  S0004-06142006000100014-1   782.0   \n",
       " T5                     tumorales  8000/1  S0004-06142006000100014-1  1019.0   \n",
       " T6  carcinoma de células renales  8312/3  S0004-06142006000100014-1  3302.0   \n",
       " T7                    metástasis  8000/6  S0004-06142006000100014-1  3391.0   \n",
       " \n",
       "     startpos  \n",
       " T1      97.0  \n",
       " T2     459.0  \n",
       " T3     736.0  \n",
       " T4     775.0  \n",
       " T5    1010.0  \n",
       " T6    3274.0  \n",
       " T7    3381.0  ,\n",
       " 'S0004-06142006000100015-1':                    CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  masa retroperitoneal  8000/6  S0004-06142006000100015-1   133.0     113.0\n",
       " T2     tumor mesenquimal  8800/1  S0004-06142006000100015-1   200.0     183.0\n",
       " T3            tumoración  8000/1  S0004-06142006000100015-1   267.0     257.0,\n",
       " 'S0004-06142006000100015-2':                 CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumor mesenquimal  8800/1  S0004-06142006000100015-2   162.0     145.0,\n",
       " 'S0004-06142006000100016-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  lesión renal  8000/6  S0004-06142006000100016-1   157.0     145.0\n",
       " T2     Carcinoma  8010/3  S0004-06142006000100016-1   283.0     274.0\n",
       " T3     formación  8000/1  S0004-06142006000100016-1   428.0     419.0,\n",
       " 'S0004-06142006000200001-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1   formación  8000/1  S0004-06142006000200001-1  1400.0    1391.0\n",
       " T2  malignidad  8000/3  S0004-06142006000200001-1  2303.0    2293.0,\n",
       " 'S0004-06142006000200001-2':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1         tumor  8000/1  S0004-06142006000200001-2   444.0     439.0\n",
       " T2  neoformación  8000/1  S0004-06142006000200001-2   489.0     477.0,\n",
       " 'S0004-06142006000200010-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  S0004-06142006000200010-1   769.0     759.0\n",
       " T2    papiloma  8050/0  S0004-06142006000200010-1   941.0     933.0,\n",
       " 'S0004-06142006000200011-1':                       CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1               tumoración  8000/1  S0004-06142006000200011-1   742.0   \n",
       " T2                tumorales  8000/1  S0004-06142006000200011-1  1358.0   \n",
       " T3      celularidad maligna  8001/3  S0004-06142006000200011-1  1941.0   \n",
       " T4  tumor fibroso solitario  8815/0  S0004-06142006000200011-1  2236.0   \n",
       " \n",
       "     startpos  \n",
       " T1     732.0  \n",
       " T2    1349.0  \n",
       " T3    1922.0  \n",
       " T4    2213.0  ,\n",
       " 'S0004-06142006000200013-1':                   CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1           leiomiomas  8890/0  S0004-06142006000200013-1    51.0      41.0\n",
       " T2  células neoplásicas  8001/1  S0004-06142006000200013-1   248.0     229.0\n",
       " T3              tumoral  8000/1  S0004-06142006000200013-1   396.0     389.0\n",
       " T4            Carcinoma  8010/3  S0004-06142006000200013-1   723.0     714.0,\n",
       " 'S0004-06142006000200014-1':                       CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                  tumoral  8000/1  S0004-06142006000200014-1   517.0   \n",
       " T2             hipernefroma  8312/3  S0004-06142006000200014-1   569.0   \n",
       " T3  tumor fibroso solitario  8815/0  S0004-06142006000200014-1   995.0   \n",
       " \n",
       "     startpos  \n",
       " T1     510.0  \n",
       " T2     557.0  \n",
       " T3     972.0  ,\n",
       " 'S0004-06142006000200015-1':                   CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1         neoformación  8000/1  S0004-06142006000200015-1   272.0     260.0\n",
       " T2       Leiomiosarcoma  8890/3  S0004-06142006000200015-1  1185.0    1171.0\n",
       " T3  células neoplásicas  8001/1  S0004-06142006000200015-1  1644.0    1625.0,\n",
       " 'S0004-06142006000300009-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  fibroadenoma  9010/0  S0004-06142006000300009-1   742.0     730.0\n",
       " T2   adenomatosa  8140/0  S0004-06142006000300009-1   746.0     735.0\n",
       " T3    tumoración  8000/1  S0004-06142006000300009-1  1040.0    1030.0,\n",
       " 'S0004-06142006000300011-1':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoplasia  8000/1  S0004-06142006000300011-1    58.0      49.0,\n",
       " 'S0004-06142006000300012-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoformación  8000/1  S0004-06142006000300012-1   710.0     698.0,\n",
       " 'S0004-06142006000300013-1':      CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1   tumor  8000/1  S0004-06142006000300013-1   683.0     678.0\n",
       " T2  T1N0M0  8000/6  S0004-06142006000300013-1   733.0     727.0,\n",
       " 'S0004-06142006000300015-1':                                   CLAVE ICD-O-3                  documento  \\\n",
       " T1                           malignidad  8000/3  S0004-06142006000300015-1   \n",
       " T2                            tumorales  8000/1  S0004-06142006000300015-1   \n",
       " T3                  células neoplásicas  8001/1  S0004-06142006000300015-1   \n",
       " T4                    células tumorales  8001/1  S0004-06142006000300015-1   \n",
       " T5                            neoplasia  8000/1  S0004-06142006000300015-1   \n",
       " T6  carcinoma de células transicionales  8120/3  S0004-06142006000300015-1   \n",
       " T7                    Carcinoma coloide  8480/3  S0004-06142006000300015-1   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   239.0     229.0  \n",
       " T2  1007.0     998.0  \n",
       " T3  1234.0    1215.0  \n",
       " T4  1325.0    1308.0  \n",
       " T5  1815.0    1806.0  \n",
       " T6  1911.0    1876.0  \n",
       " T7  1998.0    1981.0  ,\n",
       " 'S0004-06142006000500002-1':                  CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1               tumor  8000/1  S0004-06142006000500002-1   452.0     447.0\n",
       " T2           tumorales  8000/1  S0004-06142006000500002-1   650.0     641.0\n",
       " T3          metástasis  8000/6  S0004-06142006000500002-1  1867.0    1857.0\n",
       " T4  lesiones hepáticas  8000/6  S0004-06142006000500002-1  2119.0    2101.0,\n",
       " 'S0004-06142006000500002-2':           CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1   metástasis  8000/6  S0004-06142006000500002-2   890.0     880.0\n",
       " T2  hemangiomas  9120/0  S0004-06142006000500002-2   904.0     893.0\n",
       " T3    tumorales  8000/1  S0004-06142006000500002-2  1048.0    1039.0\n",
       " T4    formación  8000/1  S0004-06142006000500002-2  1323.0    1314.0,\n",
       " 'S0004-06142006000500002-3':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1   neoplasia  8000/1  S0004-06142006000500002-3   155.0     146.0\n",
       " T2       tumor  8000/1  S0004-06142006000500002-3   936.0     931.0\n",
       " T3  metástasis  8000/6  S0004-06142006000500002-3  1303.0    1293.0\n",
       " T4   tumorales  8000/1  S0004-06142006000500002-3  1418.0    1409.0,\n",
       " 'S0004-06142006000500002-4':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  S0004-06142006000500002-4  1182.0    1172.0\n",
       " T2  malignidad  8000/3  S0004-06142006000500002-4  1513.0    1503.0\n",
       " T3   tumorales  8000/1  S0004-06142006000500002-4  1966.0    1957.0\n",
       " T4  metástasis  8000/6  S0004-06142006000500002-4  2155.0    2145.0,\n",
       " 'S0004-06142006000500010-1':               CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1            tumor  8000/1  S0004-06142006000500010-1   383.0     378.0\n",
       " T2        tumorales  8000/1  S0004-06142006000500010-1   736.0     727.0\n",
       " T3       tumoración  8000/1  S0004-06142006000500010-1   890.0     880.0\n",
       " T4  teratoma maduro  9080/0  S0004-06142006000500010-1  1107.0    1092.0\n",
       " T5         seminoma  9061/3  S0004-06142006000500010-1  1416.0    1408.0,\n",
       " 'S0004-06142006000500011-1':                              CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1             enfermedad pulmonar  8000/6  S0004-06142006000500011-1    64.0   \n",
       " T2           carcinoma epidermoide  8070/3  S0004-06142006000500011-1   156.0   \n",
       " T3                          T2N0M0  8000/6  S0004-06142006000500011-1   174.0   \n",
       " T4      tumoración sólido-quística  8452/1  S0004-06142006000500011-1  1076.0   \n",
       " T5                      metástasis  8000/6  S0004-06142006000500011-1  1622.0   \n",
       " T6                    lesión renal  8000/6  S0004-06142006000500011-1  2573.0   \n",
       " T7  neoplasia pulmonar metastásica  8000/6  S0004-06142006000500011-1  2715.0   \n",
       " \n",
       "     startpos  \n",
       " T1      45.0  \n",
       " T2     135.0  \n",
       " T3     168.0  \n",
       " T4    1050.0  \n",
       " T5    1612.0  \n",
       " T6    2561.0  \n",
       " T7    2685.0  ,\n",
       " 'S0004-06142006000500012-1':                                          CLAVE ICD-O-3  \\\n",
       " T1                                   neoplasia  8000/1   \n",
       " T2                                  tumoración  8000/1   \n",
       " T3                                     tumoral  8000/1   \n",
       " T4                                  metástasis  8000/6   \n",
       " T5                carcinoma de células renales  8312/3   \n",
       " T6                                 metastásica  8000/6   \n",
       " T7                                      T3N0M0  8000/6   \n",
       " T8                     metástasis de carcinoma  8010/6   \n",
       " T9                           células tumorales  8001/1   \n",
       " T10  metástasis de carcinoma de células claras  8310/6   \n",
       " T11                         nódulos pulmonares  8000/6   \n",
       " \n",
       "                      documento  endpos  startpos  \n",
       " T1   S0004-06142006000500012-1   168.0     159.0  \n",
       " T2   S0004-06142006000500012-1   420.0     410.0  \n",
       " T3   S0004-06142006000500012-1   598.0     591.0  \n",
       " T4   S0004-06142006000500012-1   690.0     680.0  \n",
       " T5   S0004-06142006000500012-1   939.0     911.0  \n",
       " T6   S0004-06142006000500012-1  1062.0    1051.0  \n",
       " T7   S0004-06142006000500012-1  1165.0    1159.0  \n",
       " T8   S0004-06142006000500012-1  1542.0    1519.0  \n",
       " T9   S0004-06142006000500012-1  1709.0    1692.0  \n",
       " T10  S0004-06142006000500012-1  1767.0    1726.0  \n",
       " T11  S0004-06142006000500012-1  2412.0    2394.0  ,\n",
       " 'S0004-06142006000500015-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  fibroadenoma  9010/0  S0004-06142006000500015-1   962.0     950.0\n",
       " T2   adenomatosa  8140/0  S0004-06142006000500015-1   966.0     955.0\n",
       " T3       linfoma  9590/3  S0004-06142006000500015-1  1578.0    1571.0,\n",
       " 'S0004-06142006000500016-1':                 CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoplasia maligna  8000/3  S0004-06142006000500016-1   909.0     892.0\n",
       " T2         tumoración  8000/1  S0004-06142006000500016-1   983.0     973.0\n",
       " T3          formación  8000/1  S0004-06142006000500016-1  1235.0    1226.0,\n",
       " 'S0004-06142006000600009-1':                           CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                    neoplasia  8000/1  S0004-06142006000600009-1   958.0   \n",
       " T2                Condrosarcoma  9220/3  S0004-06142006000600009-1  1189.0   \n",
       " T3      diferenciación escamosa  8070/3  S0004-06142006000600009-1  1247.0   \n",
       " T4                 osteosarcoma  9180/3  S0004-06142006000600009-1  1574.0   \n",
       " T5                  sarcomatosa  8800/9  S0004-06142006000600009-1  1578.0   \n",
       " T6                        tumor  8000/1  S0004-06142006000600009-1  1660.0   \n",
       " T7  carcinoma de células claras  8310/3  S0004-06142006000600009-1  1927.0   \n",
       " T8       carcinoma sarcomatoide  8033/3  S0004-06142006000600009-1  2213.0   \n",
       " T9                      maligna  8000/3  S0004-06142006000600009-1  2281.0   \n",
       " \n",
       "     startpos  \n",
       " T1     949.0  \n",
       " T2    1176.0  \n",
       " T3    1224.0  \n",
       " T4    1562.0  \n",
       " T5    1567.0  \n",
       " T6    1655.0  \n",
       " T7    1900.0  \n",
       " T8    2191.0  \n",
       " T9    2274.0  ,\n",
       " 'S0004-06142006000600010-1':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  formación  8000/1  S0004-06142006000600010-1  1356.0    1347.0,\n",
       " 'S0004-06142006000600012-1':                            CLAVE  ICD-O-3                  documento  endpos  \\\n",
       " T1                     formación   8000/1  S0004-06142006000600012-1   502.0   \n",
       " T2  tumor maligno indiferenciado  8000/34  S0004-06142006000600012-1  1005.0   \n",
       " T3                       maligno   8000/3  S0004-06142006000600012-1   990.0   \n",
       " T4                       tumoral   8000/1  S0004-06142006000600012-1  1076.0   \n",
       " T5                    neoplásico   8000/1  S0004-06142006000600012-1  1335.0   \n",
       " T6                 nefroblastoma   8960/3  S0004-06142006000600012-1  1549.0   \n",
       " \n",
       "     startpos  \n",
       " T1     493.0  \n",
       " T2     977.0  \n",
       " T3     983.0  \n",
       " T4    1069.0  \n",
       " T5    1325.0  \n",
       " T6    1536.0  ,\n",
       " 'S0004-06142006000600014-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  S0004-06142006000600014-1   770.0     760.0\n",
       " T2    papiloma  8050/0  S0004-06142006000600014-1   941.0     933.0,\n",
       " 'S0004-06142006000600015-1':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  formación  8000/1  S0004-06142006000600015-1   730.0     721.0,\n",
       " 'S0004-06142006000700008-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1   adenomatosa  8140/0  S0004-06142006000700008-1   298.0     287.0\n",
       " T2  neoformación  8000/1  S0004-06142006000700008-1   961.0     949.0\n",
       " T3     neoplasia  8000/1  S0004-06142006000700008-1  1600.0    1591.0\n",
       " T4    neoplásica  8000/1  S0004-06142006000700008-1  2110.0    2100.0,\n",
       " 'S0004-06142006000700009-1':                                       CLAVE  ICD-O-3  \\\n",
       " T1                                formación   8000/1   \n",
       " T2                        tumor fusocelular   8032/1   \n",
       " T3                tumor fusocelular maligno   8004/3   \n",
       " T4                                  tumoral   8000/1   \n",
       " T5             leiomiosarcoma de alto grado  8890/34   \n",
       " T6  tumor fusocelular maligno de alto grado  8004/34   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142006000700009-1   438.0     429.0  \n",
       " T2  S0004-06142006000700009-1   489.0     472.0  \n",
       " T3  S0004-06142006000700009-1   766.0     741.0  \n",
       " T4  S0004-06142006000700009-1   933.0     926.0  \n",
       " T5  S0004-06142006000700009-1  1016.0     988.0  \n",
       " T6  S0004-06142006000700009-1  1507.0    1468.0  ,\n",
       " 'S0004-06142006000700011-1':                                         CLAVE  ICD-O-3  \\\n",
       " T1                             adenocarcinoma   8140/3   \n",
       " T2                                 metástasis   8000/6   \n",
       " T3                  adenocarcinoma intestinal   8144/3   \n",
       " T4                                    tumoral   8000/1   \n",
       " T5                              carcinomatosa   8010/9   \n",
       " T6  adenocarcinoma moderadamente diferenciado  8140/32   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142006000700011-1   101.0      87.0  \n",
       " T2  S0004-06142006000700011-1   493.0     483.0  \n",
       " T3  S0004-06142006000700011-1   557.0     532.0  \n",
       " T4  S0004-06142006000700011-1   623.0     616.0  \n",
       " T5  S0004-06142006000700011-1   712.0     699.0  \n",
       " T6  S0004-06142006000700011-1   857.0     816.0  ,\n",
       " 'S0004-06142006000700013-1':                                         CLAVE  ICD-O-3  \\\n",
       " T1  adenocarcinoma moderadamente diferenciado  8140/32   \n",
       " T2                                  Carcinoma   8010/3   \n",
       " T3                                      tumor   8000/1   \n",
       " T4                                  tumorales   8000/1   \n",
       " T5                                 metástasis   8000/6   \n",
       " T6                                    tumores   8000/1   \n",
       " T7                                     cáncer   8000/3   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142006000700013-1   664.0     623.0  \n",
       " T2  S0004-06142006000700013-1   637.0     628.0  \n",
       " T3  S0004-06142006000700013-1   713.0     708.0  \n",
       " T4  S0004-06142006000700013-1  1199.0    1190.0  \n",
       " T5  S0004-06142006000700013-1  1297.0    1287.0  \n",
       " T6  S0004-06142006000700013-1  1345.0    1338.0  \n",
       " T7  S0004-06142006000700013-1  1967.0    1961.0  ,\n",
       " 'S0004-06142006000700014-1':                                                 CLAVE  ICD-O-3  \\\n",
       " T1                                          Carcinoma   8010/3   \n",
       " T2                                         tumoración   8000/1   \n",
       " T3  adenocarcinoma de colon moderadamente diferenc...  8140/32   \n",
       " T4                                           malignas   8000/3   \n",
       " T5                                         metástasis   8000/6   \n",
       " T6                                 nódulos pulmonares   8000/6   \n",
       " T7                             implantes mesentéricos   8000/6   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142006000700014-1   152.0     143.0  \n",
       " T2  S0004-06142006000700014-1   374.0     364.0  \n",
       " T3  S0004-06142006000700014-1   462.0     412.0  \n",
       " T4  S0004-06142006000700014-1  3003.0    2995.0  \n",
       " T5  S0004-06142006000700014-1  3058.0    3048.0  \n",
       " T6  S0004-06142006000700014-1  3724.0    3706.0  \n",
       " T7  S0004-06142006000700014-1  4020.0    3998.0  ,\n",
       " 'S0004-06142006000900004-1':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  S0004-06142006000900004-1    61.0      47.0,\n",
       " 'S0004-06142006000900004-3':                           CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                   tumoración  8000/1  S0004-06142006000900004-3    34.0   \n",
       " T2                      tumores  8000/1  S0004-06142006000900004-3  1110.0   \n",
       " T3                   neoplasias  8000/1  S0004-06142006000900004-3  1328.0   \n",
       " T4                       lipoma  8850/0  S0004-06142006000900004-3  1506.0   \n",
       " T5                      sarcoma  8800/3  S0004-06142006000900004-3  2182.0   \n",
       " T6                      maligno  8000/3  S0004-06142006000900004-3  2492.0   \n",
       " T7  liposarcoma desdiferenciado  8858/3  S0004-06142006000900004-3  2737.0   \n",
       " \n",
       "     startpos  \n",
       " T1      24.0  \n",
       " T2    1103.0  \n",
       " T3    1318.0  \n",
       " T4    1500.0  \n",
       " T5    2175.0  \n",
       " T6    2485.0  \n",
       " T7    2710.0  ,\n",
       " 'S0004-06142006000900008-1':                 CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1       neoformación  8000/1  S0004-06142006000900008-1   590.0     578.0\n",
       " T2  células tumorales  8001/1  S0004-06142006000900008-1  1162.0    1145.0\n",
       " T3  neurofibromatosis  9540/1  S0004-06142006000900008-1  1976.0    1959.0,\n",
       " 'S0004-06142006000900009-1':           CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  metastásica  8000/6  S0004-06142006000900009-1  1703.0    1692.0,\n",
       " 'S0004-06142006000900010-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1    tumoración  8000/1  S0004-06142006000900010-1   105.0      95.0\n",
       " T2        lipoma  8850/0  S0004-06142006000900010-1   496.0     490.0\n",
       " T3  neoformación  8000/1  S0004-06142006000900010-1  1039.0    1027.0\n",
       " T4  neurofibroma  9540/0  S0004-06142006000900010-1  2524.0    2512.0,\n",
       " 'S0004-06142006000900011-1':                      CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1            neoformación  8000/1  S0004-06142006000900011-1   427.0   \n",
       " T2           tumor maligno  8000/3  S0004-06142006000900011-1   784.0   \n",
       " T3  enfermedad a distancia  8000/6  S0004-06142006000900011-1   996.0   \n",
       " T4          Leiomiosarcoma  8890/3  S0004-06142006000900011-1  1391.0   \n",
       " \n",
       "     startpos  \n",
       " T1     415.0  \n",
       " T2     771.0  \n",
       " T3     974.0  \n",
       " T4    1377.0  ,\n",
       " 'S0004-06142006000900013-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1    leiomiomas  8890/0  S0004-06142006000900013-1   294.0     284.0\n",
       " T2     neoplasia  8000/1  S0004-06142006000900013-1   742.0     733.0\n",
       " T3    tumoración  8000/1  S0004-06142006000900013-1   950.0     940.0\n",
       " T4  neoformativo  8000/1  S0004-06142006000900013-1  1629.0    1617.0\n",
       " T5     formación  8000/1  S0004-06142006000900013-1  1737.0    1728.0,\n",
       " 'S0004-06142006000900014-1':                                 CLAVE ICD-O-3                  documento  \\\n",
       " T1                     adenocarcinoma  8140/3  S0004-06142006000900014-1   \n",
       " T2                          neoplasia  8000/1  S0004-06142006000900014-1   \n",
       " T3  adenocarcinoma de tipo intestinal  8144/3  S0004-06142006000900014-1   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1  2256.0    2242.0  \n",
       " T2  2354.0    2345.0  \n",
       " T3  2416.0    2383.0  ,\n",
       " 'S0004-06142006000900015-1':                                         CLAVE  ICD-O-3  \\\n",
       " T1          carcinoma renal de células claras   8310/3   \n",
       " T2                                  neoplasia   8000/1   \n",
       " T3                                    tumoral   8000/1   \n",
       " T4                     implantes peritoneales   8000/6   \n",
       " T5                                  tumorales   8000/1   \n",
       " T6  carcinoma de células claras de alto grado  8310/34   \n",
       " T7                       masa retroperitoneal   8000/6   \n",
       " T8                         lesiones hepáticas   8000/6   \n",
       " T9                                 metástasis   8000/6   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142006000900015-1   521.0     488.0  \n",
       " T2  S0004-06142006000900015-1   766.0     757.0  \n",
       " T3  S0004-06142006000900015-1   999.0     992.0  \n",
       " T4  S0004-06142006000900015-1  1135.0    1113.0  \n",
       " T5  S0004-06142006000900015-1  1256.0    1247.0  \n",
       " T6  S0004-06142006000900015-1  1463.0    1422.0  \n",
       " T7  S0004-06142006000900015-1  1488.0    1468.0  \n",
       " T8  S0004-06142006000900015-1  2006.0    1988.0  \n",
       " T9  S0004-06142006000900015-1  2031.0    2021.0  ,\n",
       " 'S0004-06142007000100011-1':       CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoral  8000/1  S0004-06142007000100011-1   677.0     670.0,\n",
       " 'S0004-06142007000100013-1':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1          miomas  8895/0  S0004-06142007000100013-1    52.0      46.0\n",
       " T2      tumoración  8000/1  S0004-06142007000100013-1   313.0     303.0\n",
       " T3       neoplasia  8000/1  S0004-06142007000100013-1  2049.0    2040.0\n",
       " T4      metástasis  8000/6  S0004-06142007000100013-1  2277.0    2267.0\n",
       " T5  Carcinomatosis  8010/9  S0004-06142007000100013-1  2304.0    2290.0,\n",
       " 'S0004-06142007000100015-1':     CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumor  8000/1  S0004-06142007000100015-1  1318.0    1313.0,\n",
       " 'S0004-06142007000200011-1':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1          lipoma  8850/0  S0004-06142007000200011-1    55.0      49.0\n",
       " T2  feocromocitoma  8700/3  S0004-06142007000200011-1   546.0     532.0\n",
       " T3         adenoma  8140/0  S0004-06142007000200011-1   561.0     554.0\n",
       " T4       formación  8000/1  S0004-06142007000200011-1   746.0     737.0\n",
       " T5         Angioma  9120/0  S0004-06142007000200011-1  1422.0    1415.0,\n",
       " 'S0004-06142007000200014-1':                     CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1                maligna  8000/3  S0004-06142007000200014-1   245.0     238.0\n",
       " T2  carcinoma epidermoide  8070/3  S0004-06142007000200014-1   276.0     255.0\n",
       " T3             tumoración  8000/1  S0004-06142007000200014-1   917.0     907.0\n",
       " T4                tumoral  8000/1  S0004-06142007000200014-1  1789.0    1782.0\n",
       " T5           neoformación  8000/1  S0004-06142007000200014-1  2164.0    2152.0,\n",
       " 'S0004-06142007000200015-1':                                         CLAVE  ICD-O-3  \\\n",
       " T1  adenocarcinoma moderadamente diferenciado  8140/32   \n",
       " T2                                  Carcinoma   8010/3   \n",
       " T3                                neoplásicas   8000/1   \n",
       " T4                                 metástasis   8000/6   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142007000200015-1  1160.0    1119.0  \n",
       " T2  S0004-06142007000200015-1  1133.0    1124.0  \n",
       " T3  S0004-06142007000200015-1  1745.0    1734.0  \n",
       " T4  S0004-06142007000200015-1  2262.0    2252.0  ,\n",
       " 'S0004-06142007000200016-1':                CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1            miomas  8895/0  S0004-06142007000200016-1   223.0     217.0\n",
       " T2  mieloma múltiple  9732/3  S0004-06142007000200016-1   327.0     311.0\n",
       " T3  células malignas  8001/3  S0004-06142007000200016-1  1044.0    1028.0\n",
       " T4        malignidad  8000/3  S0004-06142007000200016-1  1787.0    1777.0,\n",
       " 'S0004-06142007000200017-1':                                            CLAVE ICD-O-3  \\\n",
       " T1                                    tumoración  8000/1   \n",
       " T2                                     neoplasia  8000/1   \n",
       " T3                                    metástasis  8000/6   \n",
       " T4                              seminoma clásico  9061/3   \n",
       " T5  neoplasia intratubular de células germinales  9064/2   \n",
       " T6                                       tumoral  8000/1   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142007000200017-1   127.0     117.0  \n",
       " T2  S0004-06142007000200017-1   348.0     339.0  \n",
       " T3  S0004-06142007000200017-1  1563.0    1553.0  \n",
       " T4  S0004-06142007000200017-1  1881.0    1865.0  \n",
       " T5  S0004-06142007000200017-1  1954.0    1910.0  \n",
       " T6  S0004-06142007000200017-1  1998.0    1991.0  ,\n",
       " 'S0004-06142007000300010-1':                             CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                      neoplasia  8000/1  S0004-06142007000300010-1   761.0   \n",
       " T2                     metástasis  8000/6  S0004-06142007000300010-1  1133.0   \n",
       " T3  Adenopatías supraclaviculares  8000/6  S0004-06142007000300010-1  1579.0   \n",
       " T4                        tumoral  8000/1  S0004-06142007000300010-1  1847.0   \n",
       " T5                    metástasico  8000/6  S0004-06142007000300010-1  2022.0   \n",
       " T6                     neoplásico  8000/1  S0004-06142007000300010-1  3098.0   \n",
       " T7                     tumoración  8000/1  S0004-06142007000300010-1  3303.0   \n",
       " T8              células tumorales  8001/1  S0004-06142007000300010-1  3862.0   \n",
       " T9            células neoplásicas  8001/1  S0004-06142007000300010-1  4515.0   \n",
       " \n",
       "     startpos  \n",
       " T1     752.0  \n",
       " T2    1123.0  \n",
       " T3    1550.0  \n",
       " T4    1840.0  \n",
       " T5    2011.0  \n",
       " T6    3088.0  \n",
       " T7    3293.0  \n",
       " T8    3845.0  \n",
       " T9    4496.0  ,\n",
       " 'S0004-06142007000300011-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1         tumor  8000/1  S0004-06142007000300011-1   892.0     887.0\n",
       " T2       tumoral  8000/1  S0004-06142007000300011-1  1151.0    1144.0\n",
       " T3     tumorales  8000/1  S0004-06142007000300011-1  2728.0    2719.0\n",
       " T4    tumoración  8000/1  S0004-06142007000300011-1  2826.0    2816.0\n",
       " T5    neoplásica  8000/1  S0004-06142007000300011-1  3134.0    3124.0\n",
       " T6  fibrosarcoma  8810/3  S0004-06142007000300011-1  3470.0    3458.0\n",
       " T7       maligno  8000/3  S0004-06142007000300011-1  3500.0    3493.0,\n",
       " 'S0004-06142007000300012-1':                 CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1                CCR  8312/3  S0004-06142007000300012-1   937.0     934.0\n",
       " T2         tumoración  8000/1  S0004-06142007000300012-1  1117.0    1107.0\n",
       " T3            tumoral  8000/1  S0004-06142007000300012-1  1389.0    1382.0\n",
       " T4  carcinoma papilar  8260/3  S0004-06142007000300012-1  1621.0    1604.0\n",
       " T5                 Mx  8000/6  S0004-06142007000300012-1  1690.0    1688.0\n",
       " T6        peritumoral  8000/1  S0004-06142007000300012-1  1737.0    1726.0,\n",
       " 'S0004-06142007000500006-1':             CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  nefroblastoma  8960/3  S0004-06142007000500006-1   357.0     344.0\n",
       " T2     metástasis  8000/6  S0004-06142007000500006-1   528.0     518.0,\n",
       " 'S0004-06142007000500006-2':                              CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                 nódulo hepático  8000/6  S0004-06142007000500006-2   215.0   \n",
       " T2                      metástasis  8000/6  S0004-06142007000500006-2   240.0   \n",
       " T3  nódulos pulmonares bilaterales  8000/6  S0004-06142007000500006-2   288.0   \n",
       " T4                   nefroblastoma  8960/3  S0004-06142007000500006-2   417.0   \n",
       " T5                 nódulo pulmonar  8000/6  S0004-06142007000500006-2  1185.0   \n",
       " \n",
       "     startpos  \n",
       " T1     200.0  \n",
       " T2     230.0  \n",
       " T3     258.0  \n",
       " T4     404.0  \n",
       " T5    1170.0  ,\n",
       " 'S0004-06142007000500011-1':             CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1     tumoración  8000/1  S0004-06142007000500011-1   316.0     306.0\n",
       " T2  neuroblastoma  9500/3  S0004-06142007000500011-1  1135.0    1122.0\n",
       " T3   tumoraciones  8000/1  S0004-06142007000500011-1  1234.0    1222.0\n",
       " T4   fibromatosis  8000/0  S0004-06142007000500011-1  1882.0    1870.0,\n",
       " 'S0004-06142007000500014-1':                     CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1             tumoración  8000/1  S0004-06142007000500014-1    85.0      75.0\n",
       " T2              tumorales  8000/1  S0004-06142007000500014-1   388.0     379.0\n",
       " T3             carcinomas  8010/3  S0004-06142007000500014-1   843.0     833.0\n",
       " T4        teratoma maduro  9080/0  S0004-06142007000500014-1   860.0     845.0\n",
       " T5  carcinoma embrionario  9070/3  S0004-06142007000500014-1   884.0     863.0\n",
       " T6       seminoma clásico  9061/3  S0004-06142007000500014-1  1085.0    1069.0,\n",
       " 'S0004-06142007000500016-1':                        CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1  lesiones parenquimatosas  8000/6  S0004-06142007000500016-1  1687.0   \n",
       " T2                 formación  8000/1  S0004-06142007000500016-1  3374.0   \n",
       " \n",
       "     startpos  \n",
       " T1    1663.0  \n",
       " T2    3365.0  ,\n",
       " 'S0004-06142007000500017-1':           CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  adenomatosa  8140/0  S0004-06142007000500017-1   253.0     242.0\n",
       " T2   nevus azul  8780/0  S0004-06142007000500017-1   654.0     644.0\n",
       " T3   malignidad  8000/3  S0004-06142007000500017-1   891.0     881.0,\n",
       " 'S0004-06142007000600010-1':                  CLAVE   ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración papilar  8000/1/H  S0004-06142007000600010-1   533.0     515.0\n",
       " T2             adenoma    8140/0  S0004-06142007000600010-1   716.0     709.0\n",
       " T3            papiloma    8050/0  S0004-06142007000600010-1   737.0     729.0,\n",
       " 'S0004-06142007000600010-2':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  S0004-06142007000600010-2   138.0     124.0\n",
       " T2        papiloma  8050/0  S0004-06142007000600010-2   732.0     724.0,\n",
       " 'S0004-06142007000600011-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoformativa  8000/1  S0004-06142007000600011-1   173.0     161.0\n",
       " T2         Mioma  8895/0  S0004-06142007000600011-1   590.0     585.0,\n",
       " 'S0004-06142007000600011-2':     CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  Mioma  8895/0  S0004-06142007000600011-2   414.0     409.0,\n",
       " 'S0004-06142007000600012-1':           CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1           HE  9133/1  S0004-06142007000600012-1    99.0      97.0\n",
       " T2  lesión ósea  8000/6  S0004-06142007000600012-1   687.0     676.0,\n",
       " 'S0004-06142007000600014-1':                   CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1            tumorales  8000/1  S0004-06142007000600014-1   362.0     353.0\n",
       " T2           tumoración  8000/1  S0004-06142007000600014-1   895.0     885.0\n",
       " T3            formación  8000/1  S0004-06142007000600014-1  1164.0    1155.0\n",
       " T4  células neoplásicas  8001/1  S0004-06142007000600014-1  1754.0    1735.0,\n",
       " 'S0004-06142007000600015-1':                                      CLAVE   ICD-O-3  \\\n",
       " T1                                  miomas    8895/0   \n",
       " T2                         Nódulo tiroideo    8000/6   \n",
       " T3                       tumor heterogéneo  8000/1/H   \n",
       " T4                          adenocarcinoma    8140/3   \n",
       " T5                                 tumoral    8000/1   \n",
       " T6                              tumoración    8000/1   \n",
       " T7                       células tumorales    8001/1   \n",
       " T8            metástasis de adenocarcinoma    8140/6   \n",
       " T9  adenocarcinoma renal de células claras    8310/3   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142007000600015-1    92.0      86.0  \n",
       " T2  S0004-06142007000600015-1   213.0     198.0  \n",
       " T3  S0004-06142007000600015-1   384.0     367.0  \n",
       " T4  S0004-06142007000600015-1   531.0     517.0  \n",
       " T5  S0004-06142007000600015-1   783.0     776.0  \n",
       " T6  S0004-06142007000600015-1   961.0     951.0  \n",
       " T7  S0004-06142007000600015-1  2086.0    2069.0  \n",
       " T8  S0004-06142007000600015-1  2798.0    2770.0  \n",
       " T9  S0004-06142007000600015-1  2822.0    2784.0  ,\n",
       " 'S0004-06142007000600016-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  S0004-06142007000600016-1    50.0      40.0,\n",
       " 'S0004-06142007000600016-2':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  S0004-06142007000600016-2    40.0      30.0\n",
       " T2     adenoma  8140/0  S0004-06142007000600016-2   449.0     442.0\n",
       " T3   formación  8000/1  S0004-06142007000600016-2   769.0     760.0\n",
       " T4     tumoral  8000/1  S0004-06142007000600016-2   931.0     924.0,\n",
       " 'S0004-06142007000600017-1':                                  CLAVE ICD-O-3                  documento  \\\n",
       " T1                masa retroperitoneal  8000/6  S0004-06142007000600017-1   \n",
       " T2                            seminoma  9061/3  S0004-06142007000600017-1   \n",
       " T3                           tumorales  8000/1  S0004-06142007000600017-1   \n",
       " T4                           formación  8000/1  S0004-06142007000600017-1   \n",
       " T5                    masa mesentérica  8000/6  S0004-06142007000600017-1   \n",
       " T6                            implante  8000/6  S0004-06142007000600017-1   \n",
       " T7                          tumoración  8000/1  S0004-06142007000600017-1   \n",
       " T8                      tumor desmoide  8821/1  S0004-06142007000600017-1   \n",
       " T9  tumor del estroma gastrointestinal  8936/3  S0004-06142007000600017-1   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   275.0     255.0  \n",
       " T2   322.0     314.0  \n",
       " T3   628.0     619.0  \n",
       " T4   817.0     808.0  \n",
       " T5  1121.0    1105.0  \n",
       " T6  1261.0    1253.0  \n",
       " T7  1361.0    1351.0  \n",
       " T8  1759.0    1745.0  \n",
       " T9  1799.0    1765.0  ,\n",
       " 'S0004-06142007000700009-1':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  formación  8000/1  S0004-06142007000700009-1  1255.0    1246.0,\n",
       " 'S0004-06142007000700012-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoplasias  8000/1  S0004-06142007000700012-1  2511.0    2501.0\n",
       " T2  tumoración  8000/1  S0004-06142007000700012-1  2863.0    2853.0,\n",
       " 'S0004-06142007000700014-1':                   CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1            formación  8000/1  S0004-06142007000700014-1   232.0     223.0\n",
       " T2            neoplasia  8000/1  S0004-06142007000700014-1   560.0     551.0\n",
       " T3  sarcoma pleomórfico  8802/3  S0004-06142007000700014-1   698.0     679.0\n",
       " T4         osteosarcoma  9180/3  S0004-06142007000700014-1   738.0     726.0\n",
       " T5          sarcomatosa  8800/9  S0004-06142007000700014-1   742.0     731.0,\n",
       " 'S0004-06142007000700015-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1       Angioma  9120/0  S0004-06142007000700015-1  1008.0    1001.0\n",
       " T2  lesión renal  8000/6  S0004-06142007000700015-1  1186.0    1174.0,\n",
       " 'S0004-06142007000900011-1':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  feocromocitoma  8700/3  S0004-06142007000900011-1  1608.0    1594.0,\n",
       " 'S0004-06142007000900012-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoformación  8000/1  S0004-06142007000900012-1   261.0     249.0\n",
       " T2  hipernefroma  8312/3  S0004-06142007000900012-1   587.0     575.0,\n",
       " 'S0004-06142007000900014-1':                CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1        tumoración  8000/1  S0004-06142007000900014-1   923.0     913.0\n",
       " T2        metástasis  8000/6  S0004-06142007000900014-1  1007.0     997.0\n",
       " T3           tumoral  8000/1  S0004-06142007000900014-1  1332.0    1325.0\n",
       " T4  masa suprarrenal  8000/6  S0004-06142007000900014-1  1594.0    1578.0\n",
       " T5      intratumoral  8000/1  S0004-06142007000900014-1  2767.0    2755.0\n",
       " T6    Leiomiosarcoma  8890/3  S0004-06142007000900014-1  2876.0    2862.0,\n",
       " 'S0004-06142007000900015-1':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  feocromocitoma  8700/3  S0004-06142007000900015-1  1018.0    1004.0\n",
       " T2  masa abdominal  8000/6  S0004-06142007000900015-1  1403.0    1389.0,\n",
       " 'S0004-06142007000900017-1':                            CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                     poliposis  8210/0  S0004-06142007000900017-1   273.0   \n",
       " T2                adenocarcinoma  8140/3  S0004-06142007000900017-1   347.0   \n",
       " T3                    metástasis  8000/6  S0004-06142007000900017-1   509.0   \n",
       " T4  metástasis de adenocarcinoma  8140/6  S0004-06142007000900017-1  2518.0   \n",
       " T5          afectación orbitaria  8000/6  S0004-06142007000900017-1  2604.0   \n",
       " \n",
       "     startpos  \n",
       " T1     264.0  \n",
       " T2     333.0  \n",
       " T3     499.0  \n",
       " T4    2490.0  \n",
       " T5    2584.0  ,\n",
       " 'S0004-06142008000100001-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  S0004-06142008000100001-1   318.0     308.0,\n",
       " 'S0004-06142008000100001-6':                 CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1             cancer  8000/3  S0004-06142008000100001-6    64.0      58.0\n",
       " T2  tumoración blanda  8800/1  S0004-06142008000100001-6   444.0     427.0,\n",
       " 'S0004-06142008000100001-7':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  S0004-06142008000100001-7   160.0     150.0,\n",
       " 'S0004-06142008000100004-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1   tumorales  8000/1  S0004-06142008000100004-1   574.0     565.0\n",
       " T2  tumoración  8000/1  S0004-06142008000100004-1  1947.0    1937.0\n",
       " T3   neoplasia  8000/1  S0004-06142008000100004-1  2310.0    2301.0,\n",
       " 'S0004-06142008000100004-2':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1       tumor  8000/1  S0004-06142008000100004-2   799.0     794.0\n",
       " T2  tumoración  8000/1  S0004-06142008000100004-2  1089.0    1079.0\n",
       " T3     tumoral  8000/1  S0004-06142008000100004-2  1691.0    1684.0,\n",
       " 'S0004-06142008000100008-1':                                   CLAVE ICD-O-3                  documento  \\\n",
       " T1                           tumoración  8000/1  S0004-06142008000100008-1   \n",
       " T2                  celularidad tumoral  8001/1  S0004-06142008000100008-1   \n",
       " T3  tumor miofibroblástico inflamatorio  8825/1  S0004-06142008000100008-1   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   358.0     348.0  \n",
       " T2  1387.0    1368.0  \n",
       " T3  2088.0    2053.0  ,\n",
       " 'S0004-06142008000100010-1':                   CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  enfermedad pulmonar  8000/6  S0004-06142008000100010-1   251.0     232.0\n",
       " T2                tumor  8000/1  S0004-06142008000100010-1   764.0     759.0,\n",
       " 'S0004-06142008000100011-1':           CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  adenomatosa  8140/0  S0004-06142008000100011-1   301.0     290.0,\n",
       " 'S0004-06142008000200032-1':        CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  implante  8000/6  S0004-06142008000200032-1   182.0     174.0,\n",
       " 'S0004-06142008000200037-1':           CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  neoplásicos  8000/1  S0004-06142008000200037-1   680.0     669.0\n",
       " T2    tumorales  8000/1  S0004-06142008000200037-1  5243.0    5234.0,\n",
       " 'S0004-06142008000300009-1':                 CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1         tumoración  8000/1  S0004-06142008000300009-1   793.0     783.0\n",
       " T2         metástasis  8000/6  S0004-06142008000300009-1   877.0     867.0\n",
       " T3          Carcinoma  8010/3  S0004-06142008000300009-1  1057.0    1048.0\n",
       " T4  neoplasia maligna  8000/3  S0004-06142008000300009-1  1575.0    1558.0\n",
       " T5            tumoral  8000/1  S0004-06142008000300009-1  2383.0    2376.0\n",
       " T6    lesión hepática  8000/6  S0004-06142008000300009-1  2542.0    2527.0,\n",
       " 'S0004-06142008000300009-2':                 CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1       lesión renal  8000/6  S0004-06142008000300009-2   364.0     352.0\n",
       " T2         tumoración  8000/1  S0004-06142008000300009-2   861.0     851.0\n",
       " T3          Carcinoma  8010/3  S0004-06142008000300009-2  1084.0    1075.0\n",
       " T4  neoplasia maligna  8000/3  S0004-06142008000300009-2  1856.0    1839.0\n",
       " T5         metástasis  8000/6  S0004-06142008000300009-2  2061.0    2051.0\n",
       " T6       diseminación  8000/6  S0004-06142008000300009-2  2248.0    2236.0,\n",
       " 'S0004-06142008000300011-1':                               CLAVE ICD-O-3                  documento  \\\n",
       " T1                        neoplasia  8000/1  S0004-06142008000300011-1   \n",
       " T2                            tumor  8000/1  S0004-06142008000300011-1   \n",
       " T3                         seminoma  9061/3  S0004-06142008000300011-1   \n",
       " T4                        tumorales  8000/1  S0004-06142008000300011-1   \n",
       " T5                 seminoma clásico  9061/3  S0004-06142008000300011-1   \n",
       " T6  neoplasia germinal intratubular  9064/2  S0004-06142008000300011-1   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   426.0     417.0  \n",
       " T2   511.0     506.0  \n",
       " T3   536.0     528.0  \n",
       " T4   889.0     880.0  \n",
       " T5  1126.0    1110.0  \n",
       " T6  1349.0    1318.0  ,\n",
       " 'S0004-06142008000300012-1':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1          lipoma  8850/0  S0004-06142008000300012-1  1545.0    1539.0\n",
       " T2  angiomiolipoma  8860/0  S0004-06142008000300012-1  2027.0    2013.0\n",
       " T3             AML  8860/0  S0004-06142008000300012-1  2032.0    2029.0\n",
       " T4         tumoral  8000/1  S0004-06142008000300012-1  2677.0    2670.0,\n",
       " 'S0004-06142008000300015-1':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumorales  8000/1  S0004-06142008000300015-1   432.0     423.0,\n",
       " 'S0004-06142008000400004-1':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1    tumoración  8000/1  S0004-06142008000400004-1   145.0     135.0\n",
       " T2  tumoraciones  8000/1  S0004-06142008000400004-1  1194.0    1182.0\n",
       " T3  neoformación  8000/1  S0004-06142008000400004-1  1826.0    1814.0\n",
       " T4       maligna  8000/3  S0004-06142008000400004-1  2044.0    2037.0\n",
       " T5       tumoral  8000/1  S0004-06142008000400004-1  2220.0    2213.0\n",
       " T6     neoplasia  8000/1  S0004-06142008000400004-1  3265.0    3256.0\n",
       " T7       maligno  8000/3  S0004-06142008000400004-1  3437.0    3430.0\n",
       " T8         Mioma  8895/0  S0004-06142008000400004-1  3695.0    3690.0,\n",
       " 'S0004-06142008000400010-1':                            CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1        masa de partes blandas  8000/6  S0004-06142008000400010-1   902.0   \n",
       " T2                    meningioma  9530/0  S0004-06142008000400010-1  1121.0   \n",
       " T3  metástasis de adenocarcinoma  8140/6  S0004-06142008000400010-1  1603.0   \n",
       " T4                        cáncer  8000/3  S0004-06142008000400010-1  2009.0   \n",
       " T5                  neoformativo  8000/1  S0004-06142008000400010-1  3188.0   \n",
       " T6                lesiones óseas  8000/6  S0004-06142008000400010-1  3835.0   \n",
       " T7                  metastásicas  8000/6  S0004-06142008000400010-1  3848.0   \n",
       " T8    células tumorales malignas  8001/3  S0004-06142008000400010-1  3979.0   \n",
       " T9                     tumorales  8000/1  S0004-06142008000400010-1  3970.0   \n",
       " \n",
       "     startpos  \n",
       " T1     880.0  \n",
       " T2    1111.0  \n",
       " T3    1575.0  \n",
       " T4    2003.0  \n",
       " T5    3176.0  \n",
       " T6    3821.0  \n",
       " T7    3836.0  \n",
       " T8    3953.0  \n",
       " T9    3961.0  ,\n",
       " 'S0004-06142008000400011-1':                   CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1              tumores  8000/1  S0004-06142008000400011-1   294.0     287.0\n",
       " T2  afectación visceral  8000/6  S0004-06142008000400011-1   448.0     429.0\n",
       " T3              linfoma  9590/3  S0004-06142008000400011-1   562.0     555.0,\n",
       " 'S0004-06142008000400011-2':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  S0004-06142008000400011-2   121.0     112.0\n",
       " T2      tumor  8000/1  S0004-06142008000400011-2   365.0     360.0\n",
       " T3    linfoma  9590/3  S0004-06142008000400011-2   739.0     732.0,\n",
       " 'S0004-06142008000400013-1':                                          CLAVE ICD-O-3  \\\n",
       " T1                                masa anexial  8000/6   \n",
       " T2                                   Carcinoma  8010/3   \n",
       " T3                                    implante  8000/6   \n",
       " T4                                metastásicos  8000/6   \n",
       " T5                                  metástasis  8000/6   \n",
       " T6  metástasis de carcinoma de células renales  8312/6   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142008000400013-1   274.0     262.0  \n",
       " T2  S0004-06142008000400013-1   423.0     414.0  \n",
       " T3  S0004-06142008000400013-1  1017.0    1009.0  \n",
       " T4  S0004-06142008000400013-1  1031.0    1019.0  \n",
       " T5  S0004-06142008000400013-1  1117.0    1107.0  \n",
       " T6  S0004-06142008000400013-1  1381.0    1339.0  ,\n",
       " 'S0004-06142008000400014-1':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  formación  8000/1  S0004-06142008000400014-1   765.0     756.0\n",
       " T2  tumorales  8000/1  S0004-06142008000400014-1  1535.0    1526.0,\n",
       " 'S0004-06142008000400015-1':               CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  angiomiolipomas  8860/0  S0004-06142008000400015-1   186.0     171.0\n",
       " T2     hipernefroma  8312/3  S0004-06142008000400015-1   511.0     499.0\n",
       " T3          tumores  8000/1  S0004-06142008000400015-1   609.0     602.0,\n",
       " 'S0004-06142008000400016-1':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  adenocarcinoma  8140/3  S0004-06142008000400016-1    94.0      80.0\n",
       " T2           tumor  8000/1  S0004-06142008000400016-1   194.0     189.0\n",
       " T3      tumoración  8000/1  S0004-06142008000400016-1  1139.0    1129.0\n",
       " T4        melanoma  8720/3  S0004-06142008000400016-1  1520.0    1512.0\n",
       " T5     metastásica  8000/6  S0004-06142008000400016-1  1818.0    1807.0,\n",
       " 'S0004-06142008000500009-1':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  formación  8000/1  S0004-06142008000500009-1  1002.0     993.0,\n",
       " 'S0004-06142008000500011-1':                   CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1            neoplasia  8000/1  S0004-06142008000500011-1   418.0     409.0\n",
       " T2  células neoplásicas  8001/1  S0004-06142008000500011-1   930.0     911.0,\n",
       " 'S0004-06142008000500012-1':                              CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                      tumoración  8000/1  S0004-06142008000500012-1  2851.0   \n",
       " T2                       formación  8000/1  S0004-06142008000500012-1  3149.0   \n",
       " T3                       Carcinoma  8010/3  S0004-06142008000500012-1  3658.0   \n",
       " T4         diferenciación escamosa  8070/3  S0004-06142008000500012-1  3703.0   \n",
       " T5  carcinoma de células escamosas  8070/3  S0004-06142008000500012-1  4097.0   \n",
       " T6                      metástasis  8000/6  S0004-06142008000500012-1  4181.0   \n",
       " \n",
       "     startpos  \n",
       " T1    2841.0  \n",
       " T2    3140.0  \n",
       " T3    3649.0  \n",
       " T4    3680.0  \n",
       " T5    4067.0  \n",
       " T6    4171.0  ,\n",
       " 'S0004-06142008000500013-1':                CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1      neoformativo  8000/1  S0004-06142008000500013-1   562.0     550.0\n",
       " T2             tumor  8000/1  S0004-06142008000500013-1   633.0     628.0\n",
       " T3  carcinoma ductal  8500/3  S0004-06142008000500013-1   724.0     708.0\n",
       " T4        metástasis  8000/6  S0004-06142008000500013-1  1000.0     990.0,\n",
       " 'S0004-06142008000500015-1':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1      tumor  8000/1  S0004-06142008000500015-1   281.0     276.0\n",
       " T2  formación  8000/1  S0004-06142008000500015-1   914.0     905.0,\n",
       " 'S0004-06142008000600011-1':              CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1         tumoral  8000/1  S0004-06142008000600011-1   522.0     515.0\n",
       " T2    neoformación  8000/1  S0004-06142008000600011-1  1473.0    1461.0\n",
       " T3         T3bN0M0  8000/6  S0004-06142008000600011-1  1495.0    1488.0\n",
       " T4    diseminación  8000/6  S0004-06142008000600011-1  2197.0    2185.0\n",
       " T5  adenocarcinoma  8140/3  S0004-06142008000600011-1  2665.0    2651.0\n",
       " T6   lesión lítica  8000/6  S0004-06142008000600011-1  2988.0    2975.0,\n",
       " 'S0004-06142008000600012-1':    CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1   LMA  9861/3  S0004-06142008000600012-1   473.0     470.0,\n",
       " 'S0004-06142008000600013-1':               CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  Nódulo tiroideo  8000/6  S0004-06142008000600013-1    88.0      73.0\n",
       " T2        Carcinoma  8010/3  S0004-06142008000600013-1   847.0     838.0,\n",
       " 'S0004-06142008000600013-2':                                               CLAVE ICD-O-3  \\\n",
       " T1                                        tumorales  8000/1   \n",
       " T2                                        neoplasia  8000/1   \n",
       " T3                                       metástasis  8000/6   \n",
       " T4                                     tumoraciones  8000/1   \n",
       " T5  metástasis de carcinoma renal de células claras  8310/6   \n",
       " T6                                     hipernefroma  8312/3   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142008000600013-2   255.0     246.0  \n",
       " T2  S0004-06142008000600013-2   379.0     370.0  \n",
       " T3  S0004-06142008000600013-2   917.0     907.0  \n",
       " T4  S0004-06142008000600013-2  1506.0    1494.0  \n",
       " T5  S0004-06142008000600013-2  1854.0    1807.0  \n",
       " T6  S0004-06142008000600013-2  2019.0    2007.0  ,\n",
       " 'S0004-06142008000600014-1':                     CLAVE   ICD-O-3                  documento  endpos  \\\n",
       " T1              neoplasia    8000/1  S0004-06142008000600014-1   827.0   \n",
       " T2              tumorales    8000/1  S0004-06142008000600014-1   875.0   \n",
       " T3       células malignas    8001/3  S0004-06142008000600014-1  1394.0   \n",
       " T4             tumoración    8000/1  S0004-06142008000600014-1  1573.0   \n",
       " T5   tumor germinal mixto  9064/3/H  S0004-06142008000600014-1  1656.0   \n",
       " T6  carcinoma embrionario    9070/3  S0004-06142008000600014-1  1716.0   \n",
       " T7               teratoma    9080/1  S0004-06142008000600014-1  1734.0   \n",
       " T8               seminoma    9061/3  S0004-06142008000600014-1  1896.0   \n",
       " \n",
       "     startpos  \n",
       " T1     818.0  \n",
       " T2     866.0  \n",
       " T3    1378.0  \n",
       " T4    1563.0  \n",
       " T5    1636.0  \n",
       " T6    1695.0  \n",
       " T7    1726.0  \n",
       " T8    1888.0  ,\n",
       " 'S0004-06142008000700009-1':                        CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                     tumor  8000/1  S0004-06142008000700009-1   257.0   \n",
       " T2                metástasis  8000/6  S0004-06142008000700009-1   323.0   \n",
       " T3      lesiones a distancia  8000/6  S0004-06142008000700009-1   362.0   \n",
       " T4                 Carcinoma  8010/3  S0004-06142008000700009-1   751.0   \n",
       " T5              lesión renal  8000/6  S0004-06142008000700009-1  1007.0   \n",
       " T6  carcinoma neuroendocrino  8246/3  S0004-06142008000700009-1  1148.0   \n",
       " \n",
       "     startpos  \n",
       " T1     252.0  \n",
       " T2     313.0  \n",
       " T3     342.0  \n",
       " T4     742.0  \n",
       " T5     995.0  \n",
       " T6    1124.0  ,\n",
       " 'S0004-06142008000700011-1':               CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1        tumorales  8000/1  S0004-06142008000700011-1   413.0     404.0\n",
       " T2  Tumor fusiforme  8004/3  S0004-06142008000700011-1   724.0     709.0\n",
       " T3       malignidad  8000/3  S0004-06142008000700011-1   769.0     759.0,\n",
       " 'S0004-06142008000700012-1':                  CLAVE   ICD-O-3                  documento  endpos  startpos\n",
       " T1               tumor    8000/1  S0004-06142008000700012-1   467.0     462.0\n",
       " T2      adenocarcinoma    8140/3  S0004-06142008000700012-1   609.0     595.0\n",
       " T3  carcinoma invasivo  8010/3/H  S0004-06142008000700012-1   618.0     600.0\n",
       " T4          metástasis    8000/6  S0004-06142008000700012-1   775.0     765.0\n",
       " T5           neoplasia    8000/1  S0004-06142008000700012-1  1195.0    1186.0,\n",
       " 'S0004-06142008000700014-1':                 CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1            maligno  8000/3  S0004-06142008000700014-1   836.0     829.0\n",
       " T2          tumorales  8000/1  S0004-06142008000700014-1  1131.0    1122.0\n",
       " T3       sarcomatoide  8033/3  S0004-06142008000700014-1  1547.0    1535.0\n",
       " T4         tumoración  8000/1  S0004-06142008000700014-1  1982.0    1972.0\n",
       " T5  células tumorales  8001/1  S0004-06142008000700014-1  2496.0    2479.0,\n",
       " 'S0004-06142009000100008-1':                       CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                    tumor  8000/1  S0004-06142009000100008-1    82.0   \n",
       " T2  adenocarcinoma mucinoso  8480/3  S0004-06142009000100008-1   481.0   \n",
       " T3                  pT2N0M0  8000/6  S0004-06142009000100008-1   528.0   \n",
       " \n",
       "     startpos  \n",
       " T1      77.0  \n",
       " T2     458.0  \n",
       " T3     521.0  ,\n",
       " 'S0004-06142009000100009-1':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumorales  8000/1  S0004-06142009000100009-1   697.0     688.0,\n",
       " 'S0004-06142009000100010-1':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1      tumor  8000/1  S0004-06142009000100010-1  1308.0    1303.0\n",
       " T2  Carcinoma  8010/3  S0004-06142009000100010-1  1335.0    1326.0,\n",
       " 'S0004-06142009000100010-2':                            CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1  carcinoma de células renales  8312/3  S0004-06142009000100010-2  1479.0   \n",
       " T2                    tumoración  8000/1  S0004-06142009000100010-2  1641.0   \n",
       " \n",
       "     startpos  \n",
       " T1    1451.0  \n",
       " T2    1631.0  ,\n",
       " 'S0004-06142009000100010-3':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  S0004-06142009000100010-3   623.0     613.0\n",
       " T2  malignidad  8000/3  S0004-06142009000100010-3   946.0     936.0\n",
       " T3   formación  8000/1  S0004-06142009000100010-3  1056.0    1047.0,\n",
       " 'S0004-06142009000100011-1':                     CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1                 lipoma  8850/0  S0004-06142009000100011-1   244.0     238.0\n",
       " T2         adenocarcinoma  8140/3  S0004-06142009000100011-1   603.0     589.0\n",
       " T3             tumoración  8000/1  S0004-06142009000100011-1   930.0     920.0\n",
       " T4       células malignas  8001/3  S0004-06142009000100011-1  1206.0    1190.0\n",
       " T5             neoplásica  8000/1  S0004-06142009000100011-1  1340.0    1330.0\n",
       " T6             metástasis  8000/6  S0004-06142009000100011-1  1564.0    1554.0\n",
       " T7  enfermedad diseminada  8000/6  S0004-06142009000100011-1  1831.0    1810.0,\n",
       " 'S0004-06142009000100012-1':                            CLAVE  ICD-O-3                  documento  endpos  \\\n",
       " T1                adenocarcinoma   8140/3  S0004-06142009000100012-1   192.0   \n",
       " T2                    tumoración   8000/1  S0004-06142009000100012-1   719.0   \n",
       " T3                Leiomiosarcoma   8890/3  S0004-06142009000100012-1  1027.0   \n",
       " T4  leiomiosarcoma de alto grado  8890/34  S0004-06142009000100012-1  2153.0   \n",
       " T5                    metástasis   8000/6  S0004-06142009000100012-1  2559.0   \n",
       " \n",
       "     startpos  \n",
       " T1     178.0  \n",
       " T2     709.0  \n",
       " T3    1013.0  \n",
       " T4    2125.0  \n",
       " T5    2549.0  ,\n",
       " 'S0004-06142009000100014-1':               CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1   adenocarcinoma  8140/3  S0004-06142009000100014-1   170.0     156.0\n",
       " T2  afectación ósea  8000/6  S0004-06142009000100014-1   216.0     201.0\n",
       " T3      metastásica  8000/6  S0004-06142009000100014-1   228.0     217.0\n",
       " T4       metástasis  8000/6  S0004-06142009000100014-1   746.0     736.0,\n",
       " 'S0004-06142009000200008-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  S0004-06142009000200008-1   319.0     309.0\n",
       " T2  metástasis  8000/6  S0004-06142009000200008-1   609.0     599.0\n",
       " T3   Carcinoma  8010/3  S0004-06142009000200008-1  1608.0    1599.0,\n",
       " 'S0004-06142009000200012-1':                CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1        metástasis  8000/6  S0004-06142009000200012-1  1025.0    1015.0\n",
       " T2             tumor  8000/1  S0004-06142009000200012-1  1272.0    1267.0\n",
       " T3  tumor carcinoide  8240/3  S0004-06142009000200012-1  1604.0    1588.0,\n",
       " 'S0004-06142009000300006-1':                            CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1         carcinoma epidermoide  8070/3  S0004-06142009000300006-1   570.0   \n",
       " T2  carcinoma de células renales  8312/3  S0004-06142009000300006-1  1111.0   \n",
       " T3                       tumoral  8000/1  S0004-06142009000300006-1  1402.0   \n",
       " T4                    metástasis  8000/6  S0004-06142009000300006-1  1951.0   \n",
       " \n",
       "     startpos  \n",
       " T1     549.0  \n",
       " T2    1083.0  \n",
       " T3    1395.0  \n",
       " T4    1941.0  ,\n",
       " 'S0004-06142009000300006-3':            CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  metastásicas  8000/6  S0004-06142009000300006-3   528.0     516.0\n",
       " T2      implante  8000/6  S0004-06142009000300006-3   548.0     540.0,\n",
       " 'S0004-06142009000300008-1':               CLAVE   ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumor primitivo  8000/1/H  S0004-06142009000300008-1   833.0     818.0\n",
       " T2       tumoración    8000/1  S0004-06142009000300008-1  1066.0    1056.0\n",
       " T3         melanoma    8720/3  S0004-06142009000300008-1  1469.0    1461.0,\n",
       " 'S0004-06142009000300010-1':                                              CLAVE ICD-O-3  \\\n",
       " T1  linfoma no Hodgkin B difuso de células grandes  9680/3   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142009000300010-1  1133.0    1087.0  ,\n",
       " 'S0004-06142009000300012-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1   tumorales  8000/1  S0004-06142009000300012-1   313.0     304.0\n",
       " T2  tumoración  8000/1  S0004-06142009000300012-1   604.0     594.0\n",
       " T3  malignidad  8000/3  S0004-06142009000300012-1  1143.0    1133.0,\n",
       " 'S0004-06142009000300013-1':                       CLAVE ICD-O-3                  documento  endpos  \\\n",
       " T1                neoplasia  8000/1  S0004-06142009000300013-1   107.0   \n",
       " T2               metástasis  8000/6  S0004-06142009000300013-1   256.0   \n",
       " T3                  tumoral  8000/1  S0004-06142009000300013-1   860.0   \n",
       " T4               malignidad  8000/3  S0004-06142009000300013-1  1293.0   \n",
       " T5  metástasis de carcinoma  8010/6  S0004-06142009000300013-1  1597.0   \n",
       " \n",
       "     startpos  \n",
       " T1      98.0  \n",
       " T2     246.0  \n",
       " T3     853.0  \n",
       " T4    1283.0  \n",
       " T5    1574.0  ,\n",
       " 'S0004-06142009000300014-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  tumoración  8000/1  S0004-06142009000300014-1   107.0      97.0\n",
       " T2      lipoma  8850/0  S0004-06142009000300014-1   558.0     552.0\n",
       " T3     tumoral  8000/1  S0004-06142009000300014-1  1298.0    1291.0,\n",
       " 'S0004-06142009000300014-2':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1      lipoma  8850/0  S0004-06142009000300014-2   138.0     132.0\n",
       " T2  tumoración  8000/1  S0004-06142009000300014-2   220.0     210.0\n",
       " T3     tumoral  8000/1  S0004-06142009000300014-2  1085.0    1078.0,\n",
       " 'S0004-06142009000300014-3':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1      lipoma  8850/0  S0004-06142009000300014-3   661.0     655.0\n",
       " T2  metástasis  8000/6  S0004-06142009000300014-3   828.0     818.0\n",
       " T3       tumor  8000/1  S0004-06142009000300014-3  1462.0    1457.0\n",
       " T4     tumoral  8000/1  S0004-06142009000300014-3  1608.0    1601.0,\n",
       " 'S0004-06142009000300014-4':                     CLAVE  ICD-O-3                  documento  endpos  \\\n",
       " T1             tumoración   8000/1  S0004-06142009000300014-4   107.0   \n",
       " T2  Sarcoma de alto grado  8800/34  S0004-06142009000300014-4   361.0   \n",
       " T3                maligno   8000/3  S0004-06142009000300014-4   392.0   \n",
       " T4                tumoral   8000/1  S0004-06142009000300014-4   948.0   \n",
       " \n",
       "     startpos  \n",
       " T1      97.0  \n",
       " T2     340.0  \n",
       " T3     385.0  \n",
       " T4     941.0  ,\n",
       " 'S0004-06142009000400006-1':                                      CLAVE ICD-O-3                  documento  \\\n",
       " T1             carcinoma de células claras  8310/3  S0004-06142009000400006-1   \n",
       " T2                                 tumoral  8000/1  S0004-06142009000400006-1   \n",
       " T3  adenocarcinoma renal de células claras  8310/3  S0004-06142009000400006-1   \n",
       " T4                    masa retroperitoneal  8000/6  S0004-06142009000400006-1   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   768.0     741.0  \n",
       " T2  1028.0    1021.0  \n",
       " T3  1699.0    1661.0  \n",
       " T4  2109.0    2089.0  ,\n",
       " 'S0004-06142009000400007-1':          CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  miomatosis  8895/0  S0004-06142009000400007-1    87.0      77.0\n",
       " T2     tumoral  8000/1  S0004-06142009000400007-1   412.0     405.0\n",
       " T3   Carcinoma  8010/3  S0004-06142009000400007-1   515.0     506.0,\n",
       " 'S0004-06142009000400008-1':         CLAVE ICD-O-3                  documento  endpos  startpos\n",
       " T1  Carcinoma  8010/3  S0004-06142009000400008-1   233.0     224.0,\n",
       " 'S0004-06142009000400009-1':                                          CLAVE ICD-O-3  \\\n",
       " T1  afectación intersticial pulmonar bilateral  8000/6   \n",
       " T2                          masa paravertebral  8000/6   \n",
       " T3                              adenocarcinoma  8140/3   \n",
       " \n",
       "                     documento  endpos  startpos  \n",
       " T1  S0004-06142009000400009-1  2289.0    2247.0  \n",
       " T2  S0004-06142009000400009-1  2610.0    2592.0  \n",
       " T3  S0004-06142009000400009-1  2986.0    2972.0  ,\n",
       " 'S0004-06142009000400011-1':                       CLAVE  ICD-O-3                  documento  endpos  \\\n",
       " T1                neoplasia   8000/1  S0004-06142009000400011-1   777.0   \n",
       " T2                    tumor   8000/1  S0004-06142009000400011-1   917.0   \n",
       " T3  tumor fibroso solitario   8815/0  S0004-06142009000400011-1  1406.0   \n",
       " T4           Leiomiosarcoma   8890/3  S0004-06142009000400011-1  1608.0   \n",
       " T5    Sarcoma de bajo grado  8800/31  S0004-06142009000400011-1  1622.0   \n",
       " T6             intratumoral   8000/1  S0004-06142009000400011-1  1724.0   \n",
       " T7              peritumoral   8000/1  S0004-06142009000400011-1  1848.0   \n",
       " T8        células tumorales   8001/1  S0004-06142009000400011-1  2067.0   \n",
       " T9   enfermedad a distancia   8000/6  S0004-06142009000400011-1  2664.0   \n",
       " \n",
       "     startpos  \n",
       " T1     768.0  \n",
       " T2     912.0  \n",
       " T3    1383.0  \n",
       " T4    1594.0  \n",
       " T5    1601.0  \n",
       " T6    1712.0  \n",
       " T7    1837.0  \n",
       " T8    2050.0  \n",
       " T9    2642.0  ,\n",
       " 'S0004-06142009000400012-1':                                      CLAVE ICD-O-3                  documento  \\\n",
       " T1                             adenomatosa  8140/0  S0004-06142009000400012-1   \n",
       " T2                              tumoración  8000/1  S0004-06142009000400012-1   \n",
       " T3                                 tumoral  8000/1  S0004-06142009000400012-1   \n",
       " T4  adenocarcinoma renal de células claras  8310/3  S0004-06142009000400012-1   \n",
       " T5                              metástasis  8000/6  S0004-06142009000400012-1   \n",
       " \n",
       "     endpos  startpos  \n",
       " T1   434.0     423.0  \n",
       " T2   569.0     559.0  \n",
       " T3   751.0     744.0  \n",
       " T4  1310.0    1272.0  \n",
       " T5  1439.0    1429.0  ,\n",
       " ...}"
      ]
     },
     "execution_count": 159,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "d2[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
